0000746210-18-000026.txt : 20180509 0000746210-18-000026.hdr.sgml : 20180509 20180509080201 ACCESSION NUMBER: 0000746210-18-000026 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 71 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180509 DATE AS OF CHANGE: 20180509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLOWPOINT, INC. CENTRAL INDEX KEY: 0000746210 STANDARD INDUSTRIAL CLASSIFICATION: TELEPHONE COMMUNICATIONS (NO RADIO TELEPHONE) [4813] IRS NUMBER: 770312442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35376 FILM NUMBER: 18816720 BUSINESS ADDRESS: STREET 1: 1776 LINCOLN STREET STREET 2: SUITE 1300 CITY: DENVER STATE: CO ZIP: 80203 BUSINESS PHONE: 303-640-3838 MAIL ADDRESS: STREET 1: 1776 LINCOLN STREET STREET 2: SUITE 1300 CITY: DENVER STATE: CO ZIP: 80203 FORMER COMPANY: FORMER CONFORMED NAME: GLOWPOINT INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: WIRE ONE TECHNOLOGIES INC DATE OF NAME CHANGE: 20000606 FORMER COMPANY: FORMER CONFORMED NAME: VIEW TECH INC DATE OF NAME CHANGE: 19950418 10-Q 1 glow-20180331x10q.htm 10-Q Document
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
x
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2018.
or
¨
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission file number: 001-35376
GLOWPOINT, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
77-0312442
(I.R.S. Employer Identification No.)

1776 Lincoln Street, Suite 1300, Denver, CO, 80203
(Address of Principal Executive Offices, including Zip Code)

(303) 640-3838
(Registrant’s Telephone Number, including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x  No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o
Accelerated filer o
Non-accelerated filer o
Smaller reporting company x
 
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)
Yes o No x

The number of shares outstanding of the registrant’s common stock as of May 7, 2018 was 46,484,975.



GLOWPOINT, INC.
Index
PART I - FINANCIAL INFORMATION
 
Item 1. Financial Statements
 
Condensed Consolidated Balance Sheets at March 31, 2018 (unaudited) and December 31, 2017
 
Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2018 and 2017
 
Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the three months ended March 31, 2018
 
Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2018 and 2017
 
Notes to unaudited Condensed Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
 
 
 
PART II - OTHER INFORMATION
 
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
Signatures



CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q (this “Report”) contains statements that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and its rules and regulations (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, and its rules and regulations (the “Exchange Act”). These forward-looking statements include, but are not limited to, statements about the plans, objectives, expectations, and intentions of Glowpoint, Inc. (“Glowpoint” or “we” or “us” or the “Company”). All statements other than statements of current or historical fact contained in this Report, including statements regarding Glowpoint’s future financial position, business strategy, budgets, projected costs, and plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” and similar expressions, as they relate to Glowpoint, are intended to identify forward-looking statements. These statements are based on Glowpoint’s current plans, and Glowpoint’s actual future activities and results of operations may be materially different from those set forth in the forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. Any or all of the forward-looking statements in this Report may turn out to be inaccurate. Glowpoint has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy, and financial needs. The forward-looking statements can be affected by inaccurate assumptions or by known or unknown risks, uncertainties, and assumptions. There are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including our plans, objectives, expectations and intentions and other factors that are discussed under the section entitled “Part I. Item 1A. Risk Factors” and in our consolidated financial statements and the footnotes thereto for the fiscal year ended December 31, 2017, each included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 filed with the Securities and Exchange Commission on March 7, 2018. Glowpoint undertakes no obligation to publicly revise these forward-looking statements to reflect events occurring after the date hereof. All subsequent written and oral forward-looking statements attributable to Glowpoint or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements contained in this Report. Forward-looking statements in this Report include, among other things: our expectations and estimates relating to customer attrition, sales cycles, future revenues, expenses and cash flows; evolution of our customer solutions and our service platforms; our anticipated capital expenditures; our ability to fund operations; expectations regarding adjustments to our cost of revenue and other operating expenses; our ability to raise capital through sales of additional equity securities; our ability to continue as a going concern; and adequacy of our internal controls. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, those summarized below:

customer acceptance and demand for our video collaboration services and network applications;
the quality and reliability of our services;
the prices for our services;
customer renewal rates;
risks related to the concentration of our customers and the degree to which our sales, now or in the future, depend on certain large client relationships;
customer acquisition costs;
our ability to compete effectively in the video collaboration services and network services businesses;
actions by our competitors, including price reductions for their competitive services,
potential federal and state regulatory actions;
our need for and the availability of adequate working capital;
our ability to innovate technologically;
our ability to satisfy the standards for continued listing on the NYSE American;
changes in our capital structure and/or stockholder mix;
the costs, disruption, and diversion of management’s attention associated with campaigns commenced by activist investors; and
our management’s ability to execute its plans, strategies and objectives for future operations, including but not limited to transforming our product line to more automated / software-based solutions in order for us to service the rapidly evolving video communications market.







GLOWPOINT, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except par value, stated value, and shares)
 
March 31, 2018
 
December 31, 2017
 
(Unaudited)
 
 
ASSETS
 
 
 
Current assets:
 
 
 
Cash
$
3,068

 
$
3,946

Accounts receivable, net
1,295

 
1,220

Prepaid expenses and other current assets
696

 
715

Total current assets
5,059

 
5,881

Property and equipment, net
1,007

 
1,159

Goodwill
7,100

 
7,750

Intangibles, net
594

 
626

Other assets
8

 
8

Total assets
$
13,768

 
$
15,424

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Current portion of long-term debt
$

 
$
1,194

Accounts payable
309

 
337

Accrued expenses and other liabilities
714

 
1,003

Accrued sales taxes and regulatory fees
247

 
259

Total current liabilities
1,270

 
2,793

Long term liabilities:
 
 
 
Long term debt, net of current portion

 
369

Total long term liabilities

 
369

Total liabilities
1,270

 
3,162

Commitments and contingencies (see Note 10)


 


Stockholders’ equity:
 
 
 
Preferred stock Series A-2, convertible; $.0001 par value; $7,500 stated value; 7,500 shares authorized, 32 shares issued and outstanding and liquidation preference of $237 at March 31, 2018 and December 31, 2017

 

Preferred stock Series B, convertible; $.0001 par value; $1,000 stated value; 2,800 shares authorized, 375 shares issued and outstanding and liquidation preference of $375 at March 31, 2018 and 450 shares issued and outstanding and liquidation preference of $450 at December 31, 2017

 

Preferred stock Series C, convertible; $.0001 par value; $1,000 stated value; 1,750 shares authorized, 1,275 shares issued and outstanding and liquidation preference of $1,275 at March 31, 2018 and none at December 31, 2017

 

Common stock, $.0001 par value; 150,000,000 shares authorized; 47,318,000 issued and 46,485,000 outstanding at March 31, 2018 and 45,161,000 issued and 44,510,000 outstanding at December 31, 2017
5

 
5

Treasury stock, 833,000 and 651,000 shares at March 31, 2018 and December 31, 2017, respectively
(405
)
 
(352
)
Additional paid-in capital
184,688

 
183,114

Accumulated deficit
(171,790
)
 
(170,505
)
Total stockholders’ equity
12,498

 
12,262

Total liabilities and stockholders’ equity
$
13,768

 
$
15,424


See accompanying notes to condensed consolidated financial statements.
- 1-



GLOWPOINT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
 
Three Months Ended
 
March 31,
 
2018
 
2017
Revenue
$
3,474

 
$
4,080

Operating expenses:
 
 
 
Cost of revenue (exclusive of depreciation and amortization)
2,147

 
2,448

Research and development
250

 
287

Sales and marketing
177

 
140

General and administrative
898

 
1,016

Impairment charges
650

 

Depreciation and amortization
232

 
459

Total operating expenses
4,354

 
4,350

Loss from operations
(880
)
 
(270
)
Interest and other expense, net
(405
)
 
(371
)
Loss before income taxes
(1,285
)
 
(641
)
Income tax expense

 
(27
)
Net loss
(1,285
)
 
(668
)
Preferred stock dividends
3

 
3

Net loss attributable to common stockholders
$
(1,288
)
 
$
(671
)
 
 
 
 
Net loss attributable to common stockholders per share:
 
 
 
Basic and diluted net loss per share
$
(0.03
)
 
$
(0.02
)
 
 
 
 
Weighted-average number of shares of common stock:
 
 
 
Basic and diluted
46,232

 
36,181



See accompanying notes to condensed consolidated financial statements.
- 2-



GLOWPOINT, INC.
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
Three Months Ended March 31, 2018
(In thousands, except shares of Series A-2, Series B and Series C Preferred Stock)
(Unaudited)
 
Series A-2 Preferred Stock
 
Series B Preferred Stock
 
Series C Preferred Stock
 
Common Stock
 
Treasury Stock
 
Additional Paid-In Capital
 
Accumulated Deficit
 
 
 
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
 
 
 
Total
Balance at December 31, 2017
32

 
$

 
450

 
$

 

 

 
45,161

 
$
5

 
651

 
$
(352
)
 
$
183,114

 
$
(170,505
)
 
$
12,262

Net loss

 

 

 

 

 

 

 

 

 

 

 
(1,285
)
 
(1,285
)
Stock-based compensation

 

 

 

 

 

 

 

 

 

 
50

 

 
50

Issuance of preferred stock, net of expenses

 

 

 

 
1,750

 

 

 

 

 

 
1,527

 

 
1,527

Preferred stock conversion

 

 
(75
)
 

 
(475
)
 

 
1,851

 

 

 

 

 

 

Issuance of stock on vested restricted stock units

 

 

 

 

 

 
306

 

 

 

 

 

 

Preferred stock dividends

 

 

 

 

 

 

 

 

 

 
(3
)
 

 
(3
)
Purchase of treasury stock

 

 

 

 

 

 

 

 
182

 
(53
)
 

 

 
(53
)
Balance at March 31, 2018
32

 
$

 
375

 
$

 
1.275

 
$

 
47,318

 
$
5

 
833

 
$
(405
)
 
$
184,688

 
$
(171,790
)
 
$
12,498



See accompanying notes to condensed consolidated financial statements.
- 3-



GLOWPOINT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)


Three Months Ended March 31,
 
2018
 
2017
Cash flows from operating activities:
 
 
 
Net loss
$
(1,285
)
 
$
(668
)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
 
 
 
Depreciation and amortization
232

 
459

Bad debt expense (recovery)
5

 
(4
)
Amortization of debt discount, net of gain on extinguishment
104

 
18

Stock-based compensation
50

 
164

Impairment charges
650

 

Deferred tax provision

 
27

Changes in assets and liabilities:
 
 
 
Accounts receivable
(80
)
 
(2
)
Prepaid expenses and other current assets
19

 
(60
)
Accounts payable
(28
)
 
83

Accrued expenses and other liabilities
(127
)
 
56

Accrued sales taxes and regulatory fees
(12
)
 
(55
)
Net cash provided by (used in) operating activities
(472
)
 
18

Cash flows from investing activities:
 
 
 
Purchases of property and equipment
(48
)
 
(36
)
Net cash used in investing activities
(48
)
 
(36
)
Cash flows from financing activities:
 
 
 
Principal payments under borrowing arrangements
(1,832
)
 

Proceeds from Series C Preferred Stock issuance, net of expenses of $223
1,527

 

Purchase of treasury stock
(53
)
 
(12
)
Net cash used in financing activities
(358
)
 
(12
)
Decrease in cash and cash equivalents
(878
)
 
(30
)
Cash at beginning of period
3,946

 
1,140

Cash at end of period
$
3,068

 
$
1,110

 
 
 
 
Supplemental disclosures of cash flow information:
 
 
 
Cash paid during the period for interest
$
316

 
$
266

 
 
 
 
Non-cash investing and financing activities:
 
 
 
Accrued preferred stock dividends
$
3

 
$
3


See accompanying notes to condensed consolidated financial statements.
- 4-





GLOWPOINT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018
(Unaudited)

Note 1 - Business Description and Significant Accounting Policies

Business Description

Glowpoint, Inc. (“Glowpoint,” “we,” “us,” or the “Company”) is a managed service provider of video collaboration and network applications. Our services are designed to provide a comprehensive suite of automated and concierge applications to simplify the user experience and expedite the adoption of video as the primary means of collaboration. Our customers include Fortune 1000 companies, along with small and medium sized enterprises in a variety of industries. We market our services globally through a multi-channel sales approach that includes direct sales and channel partners. The Company was formed as a Delaware corporation in May 2000. The Company operates in one segment and therefore segment information is not presented.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Glowpoint and our 100%-owned subsidiary, GP Communications, LLC, whose business function is to provide interstate telecommunications services for regulatory purposes. All material inter-company balances and transactions have been eliminated in consolidation.

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2017. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2017 year-end condensed consolidated balance sheet data in this document were derived from audited consolidated financial statements and does not include all of the disclosures required by U.S. generally accepted accounting principles. These condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements as of and for the fiscal year ended December 31, 2017 and notes thereto included in the Company's fiscal 2017 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 7, 2018 (the “2017 10-K”).

The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

Significant Accounting Policies

The significant accounting policies used in preparation of these condensed consolidated financial statements are disclosed in our 2017 10-K.

Adopted Accounting Standards

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (ASU) 2014-09 (Topic 606) "Revenue from Contracts with Customers." Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605 “Revenue Recognition” (Topic 605), and requires entities to recognize revenue when control of promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. On January 1, 2018, we adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning


- 5-



after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Accounting Standards Codification Topic 605. We did not record an adjustment to opening accumulated deficit as of January 1, 2018 as the cumulative impact of adopting Topic 606 was not material. The costs associated with obtaining a customer contract were previously expensed in the period they were incurred. Under Topic 606, these payments are deferred on our consolidated balance sheet and amortized over the expected life of the customer contract. The impact to sales and marketing expense for the three months ended March 31, 2018 was not material as a result of applying Topic 606.

In August 2016, the FASB issued ASU No. 2016-15, which amends ASC 230, to clarify guidance on the classification of certain cash receipts and payments in the statement of cash flows. The FASB issued ASU 2016-15 with the intent of reducing diversity in practice with respect to eight types of cash flows. This guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.

In May 2017, the FASB issued ASU 2017-09, which clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as modifications. ASU 2017-09 will reduce diversity in practice and result in fewer changes to the terms of an award being accounted for as modifications. Under ASU 2017-09, an entity will not apply modification accounting to a share-based payment award if the award's fair value, vesting conditions and classification as an equity or liability instrument are the same immediately before and after the change. ASU 2017-09 will be applied prospectively to awards modified on or after the adoption date. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.

Recently Issued Accounting Pronouncements             

In February 2016 the FASB issued ASU 2016-02, “Leases”. The ASU introduces a lessee model that results in most leases impacting the balance sheet. The ASU addresses other concerns related to the current leases model.  Under ASU 2016-02, lessees will be required to recognize for all leases with terms longer than 12 months, at the commencement date of the lease, a lease liability, which is a lessee’s obligation to make lease payments arising from a lease measured on a discounted basis, and a right-to-use asset, which is an asset that represents the lessee’s right to use or control the use of a specified asset for the lease term.  Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition.  The update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. While we continue to evaluate the effect of adopting this guidance on our consolidated financial statements and related disclosures, we expect our operating leases, as disclosed in Note 10, will be subject to the new standard. We will recognize right-of-use assets and operating lease liabilities on our balance sheet upon adoption, which will increase our total assets and liabilities.

Note 2 - Liquidity and Going Concern

As of March 31, 2018, we had $3,068,000 of cash, working capital of $3,789,000 and no debt. For the three months ended March 31, 2018, we incurred a net loss of $1,285,000 and used $472,000 of net cash in operating activities. During the three months ended March 31, 2018 and the year ended December 31, 2017, a substantial portion of our cash flow from operations has been dedicated to the payment of interest on our then-existing indebtedness, thereby reducing our ability to use our cash flow to fund our operations, capital expenditures and investments in sales and marketing. For the three months ended March 31, 2018 and 2017, our cash flow from operations was reduced by $316,000 and $266,000, respectively, for interest payments on our then-existing indebtedness.

During the three months ended March 31, 2018, the Company completed a series of transactions (each of which is described further in Notes 6 and 7 below, as applicable) that improved our financial position and reduced the outstanding principal on our debt obligations from $1.8 million as of December 31, 2017 to $0 as of March 31, 2018. The following is a summary of these transactions:

On January 25, 2018, the Company closed a registered direct offering of 1,750 shares of our 0% Series C Convertible Preferred Stock (the “Series C Preferred Stock”) for net proceeds of $1,527,000 (the “Series C Offering”).
On January 26, 2018, the Company terminated the Business Loan and Security Agreement, dated July 31, 2017, by and between the Company and Super G Capital LLC (“Super G”), along with the accompanying Warrant to Purchase Shares of Common Stock, dated July 31, 2017, and paid off all remaining debt obligations with Super G (“the Super G Payoff”).
During the three months ended March 31, 2018, the Company made total principal payments of $800,000 on the Western Alliance Bank Loan Agreement, resulting in no outstanding debt as of March 31, 2018.



- 6-



Our capital requirements continue to depend on numerous factors, including the timing and amount of revenue, the expense to deliver our services, expense for sales and marketing, expense for research and development, capital improvements, and the cost involved in protecting our intellectual property rights. The Company believes that, based on our current projection of revenue, expenses, capital expenditures and cash flows, it has sufficient resources to fund its operations for at least the next twelve months following the filing of this Report. However, there is no assurance the Company will be able to accomplish this during this period or in the future following such period. The Company anticipates reduced cash flow from operations and increased levels of capital expenditures in 2018 as compared to 2017, and we believe additional capital may be required to fund investments in product development and sales and marketing as a means to reverse our revenue trends. While we expect to continue to adjust our cost of revenue and other operating expenses to partially offset the impact of revenue declines associated with our legacy services, we believe additional capital may be necessary to fund our obligations. In the event we need access to capital to fund operations or provide growth capital, we would likely need to raise capital in one or more equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The respective lead investors of the 0% Series B Convertible Preferred Stock (the “Series B Preferred Stock”) and the Series C Preferred Stock have certain rights to approve future financings. There can be no assurance that the lead investors will provide the required approvals, which may affect our ability to raise capital, refinance indebtedness or borrow additional funds on terms we deem advisable, or at all. Failure to obtain financing, or obtaining financing on unfavorable terms, could result in a decrease in our stock price, would have a material adverse effect on future operating prospects, and could require us to significantly reduce operations.

Note 3 - Capitalized Software Costs

The Company capitalizes certain costs incurred in connection with developing or obtaining internal-use software. All software development costs have been appropriately accounted for as required by ASC Topic 350-40 “Intangible – Goodwill and Other – Internal-Use Software”. Capitalized software costs are included in “Property and equipment, net” on our condensed consolidated balance sheets and are amortized over three to four years. Software costs that do not meet capitalization criteria are expensed as incurred. For the three months ended March 31, 2018, we capitalized $48,000 of internal-use software costs. For the three months ended March 31, 2018 and 2017, we amortized $131,000 and $157,000, respectively, of these costs. During the three months ended March 31, 2018 and 2017, we recorded no impairment losses related to capitalized software.

Note 4 - Goodwill & Intangibles

Goodwill is not amortized but is subject to periodic testing for impairment in accordance with ASC Topic 350 “Intangibles - Goodwill and Other - Testing Indefinite-Lived Intangible Assets for Impairment”. We test goodwill for impairment on an annual basis on September 30 of each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. As of March 31, 2018, the Company considered the declines in our revenue and stock price to be a triggering event for an interim goodwill impairment test. The Company operates as a single reporting unit and used market-based approaches to determine the fair value of the reporting unit. These approaches used quoted market prices in active markets and revenue multiples for comparable companies. As of March 31, 2018, the carrying amount of our reporting unit exceeded its fair value; therefore, the Company recorded a goodwill impairment charge of $650,000 in the three months ended March 31, 2018. This charge is recognized as “Impairment charges” on our Condensed Consolidated Statements of Operations. The remaining goodwill balance as of March 31, 2018 was $7,100,000. The continued future decline of our revenue, cash flows and/or stock price may give rise to a triggering event that may require the Company to record additional impairment charges on goodwill in the future.

The Company assesses the impairment of purchased intangible assets subject to amortization when events and circumstances indicate that the carrying value of the assets might not be recoverable.  Fair value of our intangible assets is determined using the relief from royalty methodology. This approach involves two steps: (a) estimating reasonable royalty rates for each intangible asset and (b) applying these royalty rates to a net revenue stream and discounting the resulting cash flows to determine fair value. This fair value is then compared with the carrying value of each intangible asset. If the carrying value of the intangible asset is greater than its implied fair value, an impairment in the amount of the excess is recognized and charged to operations. The determination of related estimated useful lives and whether or not these assets are impaired involves significant judgments, related primarily to the future profitability and/or future value of the assets. Changes in the Company’s strategic plan and/or other-than-temporary changes in market conditions could significantly impact these judgments and could require adjustments to recorded asset balances. Long-lived assets are evaluated for impairment at least annually, as well as whenever an event or change in circumstances has occurred that could have a significant adverse effect on the fair value of long-lived assets.  The Company performed an evaluation of intangible assets as of March 31, 2018 and determined that the fair value of the long-lived assets exceeded the carrying value, therefore no impairment charges were required for the three months ended March 31, 2018.



- 7-



Note 5 - Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following (in thousands):
 
March 31, 2018
 
December 31, 2017
Other accrued expenses
$
264

 
$
316

Accrued compensation costs
227

 
129

Accrued marketing expense
136

 

Deferred revenue
87

 
393

Super G Warrant liability

 
165

Accrued expenses and other liabilities
$
714

 
$
1,003


Note 6 - Debt

Debt consisted of the following (in thousands):
 
March 31, 2018
 
December 31, 2017
Western Alliance Bank A/R Revolver
$

 
$
800

Super G Loan

 
1,032

Unamortized debt discounts

 
(269
)
Net carrying value


1,563

Less: current maturities, net of debt discount

 
(1,194
)
Long-term obligations, net of debt discount
$

 
$
369


Western Alliance Bank Business Financing Agreement

On July 31, 2017, the Company and its subsidiary entered into a Business Financing Agreement with Western Alliance Bank, as lender (the “Western Alliance Bank Loan Agreement”). The Western Alliance Bank Loan Agreement provided the Company with up to a total of $1,500,000 of revolving loans (the “A/R Revolver”). The maximum amount available under the A/R Revolver was limited to the lesser of (x) $1,500,000 and (y) an amount equal to the borrowing base. The borrowing base included 85% of the Company’s eligible accounts receivable plus a non-formula amount (which was $400,000 at December 31, 2017, and which stepped down to $200,000 on January 1, 2018, and to $0 on April 1, 2018) (“the Non-Formula Amount”). The Western Alliance Bank Loan Agreement provided that all borrowings would bear interest at the prime rate (4.75% as of March 31, 2018) plus 2.25% (or a total of 7.00% as of March 31, 2018) per year. The prime rate was subject to a floor of 4.00%. Interest payments on the outstanding borrowings were due monthly. On July 31, 2017, the Company received a loan in an amount equal to $1,100,000 under the Western Alliance Bank Loan Agreement, consisting of $500,000 based on 85% of eligible accounts receivable and $600,000 of Non-Formula Amount. During the three months ended March 31, 2018, the Company made total principal payments of $800,000 on the A/R Revolver (including $400,000 on the Non-Formula Amount). As of March 31, 2018, there were no outstanding borrowings on the A/R Revolver and we had availability of $764,000. All loans under the A/R Revolver were to mature on July 31, 2019 (unless such loans are not supported by the borrowing base, in which case any loans exceeding the borrowing base must be immediately repaid). As of March 31, 2018, the Company was in compliance with all required covenants under the Western Alliance Bank Loan Agreement. On May 8, 2018, the Company terminated the Western Alliance Bank Loan Agreement.

Super G Loan Agreement and Warrant

On July 31, 2017, the Company and its subsidiary entered into a Business Loan and Security Agreement with Super G Capital, LLC (“Super G”), as lender (the “Super G Loan Agreement”) and received a term loan from Super G in an amount equal to $1,100,000 (the “Super G Loan”). Borrowings under the Super G Loan Agreement were to be repaid in installments (including interest) of $33,000 per month in the first 3 months following closing and approximately $68,600 per month in months four through twenty-four following closing, for total payments of $1,540,000. The effective interest rate of the Super G Loan was approximately 33%.

On July 31, 2017, the Company also issued a warrant that entitled Super G to purchase 550,000 shares of the Company’s common stock at an exercise price of $0.30 per share (the “Super G Warrant”). The Super G Warrant had a three year term and if the profit on such warrants was not equal to at least $165,000 over the term of the warrants, at the end of the three year term, the Company was required to pay an exit fee equal to the difference between $165,000 and the amount of profit recognized. During the three


- 8-



months ended March 31, 2018, no warrants were exercised. The $165,000 fair value of this warrant was recorded as a derivative liability and as a discount to the carrying amount of the debt as of December 31, 2017.

On January 26, 2018, the Company and Super G entered into a payoff letter that terminated the Super G Loan Agreement and the Super G Warrant in exchange for total cash payments from the Company of $1,269,000 (the “Super G Payoff”). The total obligations to Super G at the time of the Super G Payoff was $1,434,000, including principal, accrued and remaining interest due over the term of the Super G Loan, and the Super G Warrant Liability. Therefore, the Company recorded a gain on extinguishment of the debt of $165,000, which is recorded in “Interest and Other Expense, Net” on our Condensed Consolidated Statements of Operations. In connection with the Super G Payoff, the related warrant liability and corresponding debt discount were eliminated during the three months ended March 31, 2018. As of March 31, 2018, there are no outstanding obligations related to the Super G Loan.

The total debt discount on the Western Alliance Bank A/R Revolver and Super G Loan was $339,000, comprised of $174,000 of debt issuance costs and $165,000 related to the Super G Warrant. This debt discount was being amortized to interest expense using the effective interest method over the term of the debt. During the three months ended March 31, 2018, the Company amortized $269,000 of the debt discount, which is recorded in “Interest and Other Expense, Net” on our Condensed Consolidated Statements of Operations. As of March 31, 2018, there is no remaining unamortized debt discount.

Note 7 - Preferred Stock

Our Certificate of Incorporation authorizes us to issue up to 5,000,000 shares of preferred stock. As of March 31, 2018, there were: (i) 100 shares of Perpetual Series B-1 Preferred Stock authorized and no shares issued or outstanding; (ii) 7,500 shares of Series A-2 Convertible Preferred Stock authorized and 32 shares issued and outstanding (the “Series A-2 Preferred Stock”); (iii) 2,800 shares of Series B Preferred Stock authorized and 375 shares issued and outstanding; (iv) 1,750 shares of Series C Preferred Stock authorized and 1,275 shares issued and outstanding; (v) 4,000 shares of Series D Convertible Preferred Stock authorized and no shares issued or outstanding; and (vi) 100 shares of Perpetual Series B Preferred Stock authorized and no shares issued or outstanding.

Series A-2 Preferred Stock

Each share of Series A-2 Preferred Stock has a stated value of $7,500 per share (the “A-2 Stated Value”), a liquidation preference equal to the A-2 Stated Value, and is convertible at the holder’s election into common stock at a conversion price per share of $2.16 as of March 31, 2018. Therefore, each share of Series A-2 Preferred Stock is convertible into 3,472 shares of common stock as of March 31, 2018. The conversion price is subject to adjustment upon the occurrence of certain events set forth in our Certificate of Incorporation. During the three months ended March 31, 2018, the Series C Offering resulted in an adjustment to the Series A-2 Preferred Stock conversion price from $2.40 to $2.16 per share.

The Series A-2 Preferred Stock is subordinate to the Series B-1 Preferred Stock but senior to all other classes of equity, has weighted average anti-dilution protection and, since January 1, 2013, has been entitled to cumulative dividends at a rate of 5% per annum, payable quarterly, based on the A-2 Stated Value and payable at the option of the holder in cash or through the issuance of a number of additional shares of Series A-2 Preferred Stock with an aggregate liquidation preference equal to the dividend amount payable on the applicable dividend payment date. As of March 31, 2018, the Company has recorded $62,000 in accrued dividends in “Accrued expenses and other liabilities” on the accompanying Condensed Consolidated Balance Sheet related to the remaining Series A-2 Preferred Stock outstanding. The Company, at our option, may redeem all or a portion of the Series A-2 Preferred Stock in cash at a price per share of $8,250 per share (equal to $7,500 per share multiplied by 110%) plus all accrued and unpaid dividends.

Series B Preferred Stock

In October 2017, the Company closed a registered direct offering of 2,800 shares of its Series B Preferred Stock for total gross proceeds to the Company of $2,800,000. The shares of Series B Preferred Stock were sold at a price equal to their stated value of $1,000 per share and are convertible into shares of the Company’s common stock at a conversion price of $0.28 per share. During the three months ended March 31, 2018, 75 shares of Series B Preferred Stock were converted to 268,000 shares of the Company’s common stock. As of March 31, 2018, 375 shares of Series B Preferred Stock remain issued and outstanding. The Series B Preferred Stock is pari passu with the Company’s issued and outstanding shares of Series C Preferred Stock.

Subject to certain exceptions, the Company has agreed to provide the holders of Series B Preferred Stock a right of participation for up to 100% of any future offering of its common stock or other securities or equity linked debt obligations until October 2019. In addition, the Company agreed to expand the size of the Company’s board of directors to six members and to appoint a new


- 9-



independent director agreeable to the lead investor in the offering (the “Lead Investor”). Subject to limited exceptions, for as long as at least 333 shares of Series B Preferred Stock remain outstanding and unconverted (subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations and subdivisions or similar events occurring after the date of the Purchase Agreement with respect to the Series B Preferred Stock), the Company may not issue any common stock or convertible securities (or modify any of the foregoing that may be outstanding) to any person, or incur any debt, without the express written consent of the Lead Investor.

In addition, the Company has agreed that it will not enter into certain “fundamental transactions,” including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company’s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series B Preferred Stock including the Lead Investor and on terms with respect to the Series B Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series B Preferred Stock.

Series C Offering

On January 25, 2018, the Company closed a registered direct offering of 1,750 shares of its Series C Preferred Stock for total gross proceeds to the Company of $1,750,000. The shares of Series C Preferred Stock were sold at a price equal to their stated value of $1,000 per share and are convertible into shares of the Company’s common stock at a conversion price of $0.30 per share. The net proceeds to us from the sale of our securities in this offering were $1,527,000 after deducting offering expenses paid by us. During the three months ended March 31, 2018, 475 shares of Series C Preferred Stock were converted to 1,583,000 shares of the Company’s common stock. As of March 31, 2018, 1,275 shares of Series C Preferred Stock remain issued and outstanding. The Series C Preferred Stock is pari passu with the Company’s issued and outstanding shares of Series B Preferred Stock.

Subject to certain exceptions, the Company has agreed to provide the purchasers, during the period that the purchasers continue to hold Series C Preferred Stock, a right of participation for up to 100% of any future offering of its common stock or other securities or equity linked debt obligations until January 2020. Subject to limited exceptions, for as long as at least $500,000 of stated value of Series C Preferred Stock remain outstanding and unconverted (subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations and subdivisions or similar events occurring after the date of the Purchase Agreement with respect to the Series C Preferred Stock), the Company shall not issue any common stock or convertible securities (or modify any of the foregoing that may be outstanding) to any person at a price per share less than $0.30, or incur any debt, without the express written consent of the Lead Investor.

In addition, the Company has agreed that it will not enter into certain “fundamental transactions,” including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company’s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series C Preferred Stock including the Lead Investor and on terms with respect to the Series C Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series C Preferred Stock.

In accordance with ASC Topic 815, we evaluated whether our convertible preferred stock contains provisions that protect holders from declines in our stock price or otherwise could result in modification of the exercise price and/or shares to be issued under the respective preferred stock agreements based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and require a derivative liability. The Company determined no derivative liability is required under ASC Topic 815 with respect to our convertible preferred stock. A contingent beneficial conversion amount is required to be calculated and recognized when and if the adjusted $2.16 conversion price of the Series A-2 Preferred Stock is adjusted to reflect a down round stock issuance that reduces the conversion price below the $1.16 fair value of the common stock on the issuance date of the Series A-2 Preferred Stock.

Note 8 - Stock Based Compensation

Glowpoint 2014 Equity Incentive Plan

On May 28, 2014, the Glowpoint, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) was approved by the Company’s stockholders at the Company’s 2014 Annual Meeting of Stockholders. The purpose of the 2014 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means to attract, motivate, retain, and reward selected employees and other eligible persons through the grant of equity awards. Awards may be granted under the 2014 Plan to officers, employees, directors and consultants of the Company or its subsidiary. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted shares, restricted stock units, cash awards and other awards, including stock bonuses, performance


- 10-



stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Company’s common stock, upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof, or any similar securities with a value derived from the value of or related to the Company’s common stock, or returns thereon. A total of 4,400,000 shares of the Company’s common stock were initially available for issuance under the 2014 Plan. As of March 31, 2018, 1,824,000 shares were available for issuance under the 2014 Plan. In April 2018, 1,310,000 restricted stock units were granted under the 2014 Plan, leaving 514,000 shares available for issuance under the 2014 Plan. On April 12, 2018, the Company's compensation committee recommended, and the Company's board of directors adopted, subject to stockholder approval, an amendment to the 2014 Plan to, among other things, increase the number of shares of common stock available for issuance under the 2014 Plan by 3,000,000 shares (the "Amendment"), enabling the continued use of the 2014 Plan for share-based awards. The Company is seeking stockholder approval of the Amendment in connection with its 2018 Annual Meeting of Stockholders to be held on May 31, 2018.

Glowpoint 2007 Stock Incentive Plan

In May 2014, the Board terminated the Glowpoint 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of March 31, 2018, options to purchase a total of 1,191,000 shares of common stock and 113,000 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan.

Glowpoint 2000 Stock Incentive Plan

In June 2010, the Board terminated the Glowpoint 2000 Stock Incentive Plan (as amended, the “2000 Plan”). Notwithstanding the termination of the 2000 Plan, outstanding awards under the 2000 Plan will remain in effect in accordance with their terms. As of March 31, 2018, options to purchase a total of 500 shares of common stock were outstanding under the 2000 Plan. No shares are available for issuance under the 2000 Plan.

Stock Options

For the three months ended March 31, 2018, no stock options were granted; therefore, no fair value assumptions are presented herein. A summary of stock options expired and forfeited under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
Outstanding
 
Exercisable
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
Options outstanding, December 31, 2017
1,202

 
$
1.99

 
1,202

 
$
1.99

Expired
(1
)
 
2.30

 
 
 
 
Forfeited
(9
)
 
1.61

 
 
 
 
Options outstanding, March 31, 2018
1,192

 
$
1.99

 
1,192

 
$
1.99


Stock-based compensation expense related to stock options was $0 and $18,000 for the three months ended March 31, 2018 and 2017, respectively, and was recorded to general and administrative expenses. There is no remaining unrecognized stock-based compensation expense for stock options as of March 31, 2018.

Restricted Stock Awards

A summary of unvested restricted stock awards outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
Restricted Shares
 
Weighted Average
Grant Price
Unvested restricted stock outstanding, December 31, 2017
341

 
$
1.06

Vested
(228
)
 
0.84

Unvested restricted stock outstanding, March 31, 2018
113

 
$
1.49




- 11-



The number of restricted stock awards vested during the three months ended March 31, 2018 includes 78,000 shares withheld and repurchased by the Company from employees to satisfy $20,000 of tax obligations relating to the vesting of such shares. Such shares are held in the Company’s treasury stock as of March 31, 2018.

Stock-based compensation expense related to restricted stock awards is allocated as follows (in thousands):
 
Three Months Ended
 
March 31,
 
2018
 
2017
Cost of revenue
$

 
$
2

Research and development

 
1

General and administrative
10

 
12

 
$
10

 
$
15


Certain restricted stock awards have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, compensation expense is recognized over the relevant performance period. For those awards not subject to performance criteria, the cost of the restricted stock awards is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period.

The remaining unrecognized stock-based compensation expense for restricted stock awards as of March 31, 2018 was $144,000. Of this amount, $7,000 relates to time-based awards with a remaining weighted average period of 1.23 years. The remaining $137,000 of unrecognized stock-based compensation expense relates to performance-based awards for which expense will be recognized upon it becoming probable that the Company will achieve defined financial targets.

Restricted Stock Units

A summary of unvested restricted stock units (“RSUs”) outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
RSUs
 
Weighted Average
Grant Price
Unvested restricted stock units outstanding, December 31, 2017
1,752

 
$
0.57

Vested
(306
)
 
0.51

Forfeited
(456
)
 
0.28

Unvested restricted stock units outstanding, March 31, 2018
990

 
$
0.72


As of March 31, 2018, 988,000 vested RSUs issued to non-employee directors remain outstanding as shares of common stock have not yet been delivered due to the deferred payment provisions set forth in these RSUs.

As of March 31, 2018, 546,000 unvested RSUs have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, stock-based compensation expense is recognized over the relevant performance period. As of March 31, 2018, 443,000 unvested RSUs have timed-based vesting provisions, and the cost of the RSUs is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period.

Stock-based compensation expense related to RSUs is allocated as follows (in thousands):


- 12-



 
Three Months Ended
 
March 31,
 
2018
 
2017
Cost of revenue
$
5

 
$
12

Research and development
10

 
14

Sales and marketing
2

 
4

General and administrative
23

 
100

 
$
40

 
$
130


The remaining unrecognized stock-based compensation expense for RSUs as of March 31, 2018 was $419,000. Of this amount $118,000 relates to time-based RSUs with a remaining weighted average period of 0.47 years. The remaining $301,000 of unrecognized stock-based compensation expense relates to performance-based RSUs for which expense will be recognized upon it becoming probable that the Company achieves defined financial targets for fiscal year 2018.

Note 9 - Net Loss Per Share

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at March 31, 2018 and 2017, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant.

Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three months ended March 31, 2018 and 2017, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (decrease our net loss per share).

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):
 
Three Months Ended March 31,
 
2018
 
2017
Numerator:
 
 
 
Net loss
$
(1,285
)
 
$
(668
)
Less: preferred stock dividends
3

 
3

Net loss attributable to common stockholders
$
(1,288
)
 
$
(671
)
Denominator:
 
 
 
Weighted-average number of shares of common stock for basic and diluted net loss per share
46,232

 
36,181

Basic and diluted net loss per share
$
(0.03
)
 
$
(0.02
)

The weighted-average number of shares for the three months ended March 31, 2018 and 2017 includes 988,000 and 517,000 shares of vested RSUs, respectively, as discussed in Note 8.

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (in thousands):


- 13-



 
Three Months Ended March 31,
 
2018
 
2017
Unvested restricted stock units
742

 
2,938

Unvested restricted stock awards
113

 
354

Outstanding stock options
1,192

 
1,222

Shares of common stock issuable upon conversion of Series A-2 Preferred
79

 
79

Shares of common stock issuable upon conversion of Series B Preferred
1,339

 

Shares of common stock issuable upon conversion of Series C Preferred
4,250

 


Note 10 - Commitments and Contingencies

Operating Leases

We lease two facilities in Denver, CO and Oxnard, CA that are under operating leases through December 2018 and March 2020, respectively. Both of these leases require us to pay increases in real estate taxes, operating costs and repairs over certain base year amounts. Rent expense for the three months ended March 31, 2018 and 2017 was $77,000 and $74,000, respectively.

Future minimum rental commitments under all non-cancelable operating leases as of March 31, 2018, are as follows (in thousands):
Year Ending December 31,
 
Remaining 2018
$
231

2019
88

2020
23

 
$
342


Note 11 – Major Customers

Major customers are defined as direct customers or channel partners that account for more than 10% of the Company’s revenue. For the three months ended March 31, 2018, two major customers represented 24% and 23%, respectively of our revenue and represented 13% and 59%, respectively, of our accounts receivable balance at March 31, 2018. For the three months ended March 31, 2017, the same two major customers represented 16% and 21%, respectively, of our revenue.

Note 12 - Geographical Data
For the three months ended March 31, 2018 and 2017, there was no material revenue attributable to any individual foreign country. Revenue by geographic area, based on customer location, is allocated as follows (in thousands):
 
Three Months Ended March 31,
 
2018
 
2017
Domestic
$
2,269

 
$
2,853

Foreign
1,205

 
1,227

Total Revenue
$
3,474

 
$
4,080

Long-lived assets were 100% located in domestic markets as of March 31, 2018 and December 31, 2017.
Note 13 - Subsequent Events

As of March 31, 2018, there were no outstanding borrowings under the Company’s A/R Revolver with Western Alliance Bank and we had availability of $764,000. On May 8, 2018, the Company entered into a payoff letter with Western Alliance Bank that terminated the Western Alliance Bank Loan Agreement. See “Part II. Item 5. Other Information” below for additional information regarding the termination of the Western Alliance Bank Loan Agreement.


- 14-




Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

Glowpoint, Inc. (“Glowpoint,” “we,” “us,” or the “Company”) is a managed service provider of video collaboration and network applications. Our services are designed to provide a comprehensive suite of automated and concierge applications to simplify the user experience and expedite the adoption of video as the primary means of collaboration. Our customers include Fortune 1000 companies, along with small and medium sized enterprises in a variety of industries. We market our services globally through a multi-channel sales approach that includes direct sales and channel partners. The Company was formed as a Delaware corporation in May 2000. The Company operates in one segment and therefore segment information is not presented.

We experienced significant declines in revenue during 2017, 2016 and 2015 that have continued into the three months ended March 31, 2018. These revenue declines are primarily due to net attrition of customers and lower demand for our services given the competitive environment and pressure on pricing that exists in our industry.

On January 25, 2018, the Company closed a registered direct offering of 1,750 shares of 0% Series C Convertible Preferred Stock (the “Series C Preferred Stock”) for net proceeds of $1,527,000 (the “Series C Offering”). On January 26, 2018, the Company terminated the Business Loan and Security Agreement, dated July 31, 2017, by and between the Company and Super G Capital LLC (“Super G”), along with the accompanying Warrant to Purchase Shares of Common Stock, dated July 31, 2017, and paid off all remaining debt obligations with Super G (“the Super G Payoff”). Also, during the three months ended March 31, 2018, the Company paid off all remaining debt with Western Alliance Bank.

As of March 31, 2018, the Company had $3,068,000 in cash and no debt. With a strengthened balance sheet, the Company currently expects to fund investments in product development, sales and marketing expenses and capital expenditures in order to develop new service offerings, with the goal of reversing the Company’s negative revenue trends. The Company intends to release new services in the summer of 2018 that leverage our core strengths in information technology (“IT”) service management and are focused on automation and microlearning (or short bursts of focused information necessary to help a learner achieve a specific actionable objective). However, there can be no assurance that the Company will be successful in generating significant revenue with these new services, and the Company may be unable to grow revenue and may continue to experience declines in revenue in the future. In addition, as the Company continues to transform into a service-led organization, revenue attributable to its core and legacy product lines and services has declined. The Company has worked to migrate customers from legacy products, such as managed videoconferencing and video meeting suites, to more automated/software-based solutions. As a result of a growing market trend around cloud consumption preferences, more customers are exploring cost-effective software-based services for procuring technology. As this trend continues, the Company has remained focused on generating positive cash flow from operations and investing in future results by implementing cost savings programs designed to streamline its operations and eliminate overlapping processes and expenses. If the Company fails in its effort to develop new service offerings that achieve broad market acceptance on a timely basis, it will not be able to compete effectively and will likely experience continued declines in revenue and lower gross margins.

See further discussion of the Company’s business, future plans and liquidity in “Results of Operations” and “Liquidity and Capital Resources” below.

Results of Operations

Three Months Ended March 31, 2018 (the 2018 Quarter”) compared to Three Months Ended March 31, 2017 (the “2017 Quarter”)

Revenue. Total revenue decreased $606,000 to $3,474,000 (or 15%) in the 2018 Quarter from $4,080,000 in the 2017 Quarter. This decrease is mainly attributable to: (i) a decrease of $506,000 in revenue from video collaboration services and (ii) a decrease of $338,000 in revenue from network services, partially offset by an increase of $238,000 in revenue from professional and other services. The following table summarizes the changes in components of our revenue and the significant changes in revenue are discussed in more detail below.


- 15-



 
Three Months Ended
 
March 31,
 
($ in thousands)
 
2018
 
2017
Revenue
 
 
 
Video collaboration services
$
1,944

 
$
2,450

Network services
1,185

 
1,523

Professional and other services
345

 
107

Total revenue
$
3,474

 
$
4,080


Revenue for video collaboration services decreased $506,000 (or 21%) to $1,944,000 in the 2018 Quarter from $2,450,000 in the 2017 Quarter. This decrease is mainly attributable to the following: (i) 48% of this decrease is due to lower revenue for existing customers (either from reductions in price or level of services); (ii) 37% of this decrease is due to lower demand for video meeting suites as a result of increased usage of desktop and mobile video products and technologies; and (iii) 15% of this decrease is due to loss of customers to competition between 2017 and 2018.

Revenue for network services decreased $338,000 (or 22%) to $1,185,000 in the 2018 Quarter from $1,523,000 in the 2017 Quarter. This decrease is mainly attributable to net attrition of customers and lower demand for our services given the competitive environment and pressure on pricing that exists in the network services business.

Revenue for professional and other services increased $238,000 (or 222%) to $345,000 in the 2018 Quarter from $107,000 in the 2017 Quarter. The increase is mainly attributable to resale of video equipment.

We expect that the year-over-year negative revenue trend for the 2017 Quarter to the 2018 Quarter for video collaboration services and network services will continue for the remainder of 2018 given the dynamic and competitive environment for our services, and due to expected limited adoption of our planned new services in 2018. We believe sales cycles associated with selling our services directly to enterprise IT organizations and through our channel partners typically range from six to eighteen months. These factors create uncertainty as to when, and if, we will be able to stabilize and ultimately grow our revenue (see “Part II. Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 filed with the Securities and Exchange Commission (the “SEC”) on March 7, 2018 (the “2017 10-K”) for further discussion).

Cost of Revenue (exclusive of depreciation and amortization). Cost of revenue, exclusive of depreciation and amortization, includes all internal and external costs related to the delivery of revenue. Cost of revenue also includes taxes which have been billed to customers.

Cost of revenue decreased to $2,147,000 in the 2018 Quarter from $2,448,000 in the 2017 Quarter. This $301,000 decrease in cost of revenue is mainly attributable to lower costs associated with the $606,000 decrease in revenue during the same period. We reduced costs related to revenue in these areas during the 2018 Quarter: personnel costs, network costs, taxes, and external costs associated with video meeting suites. Cost of revenue, as a percentage of total revenue, was 62% and 60% for the 2018 Quarter and 2017 Quarter, respectively. This increase in cost of revenue as a percentage of revenue is mainly attributable to an increase in revenue for resale of equipment (in professional and other services) at relatively lower gross margins than our core services.

Research and Development. Research and development expenses include internal and external costs related to developing new service offerings and features and enhancements to our existing services. Research and development expenses decreased to $250,000 in the 2018 Quarter from $287,000 in the 2017 Quarter. This decrease is mainly attributable to lower headcount and corresponding personnel costs.

Sales and Marketing Expenses. Sales and marketing expenses increased to $177,000 in the 2018 Quarter from $140,000 in the 2017 Quarter. This increase is primarily attributable to an increase in third party marketing costs of $56,000, partially offset by lower headcount and corresponding personnel costs of $18,000.

General and Administrative Expenses. General and administrative expenses include direct corporate expenses and costs of personnel in the various corporate support categories, including executive, finance and accounting, legal, human resources and information technology. General and administrative expenses decreased $118,000 to $898,000 in the 2018 Quarter from $1,016,000


- 16-



in the 2017 Quarter. This decrease is primarily attributable to lower stock-based compensation expense of $98,000, and a decrease in administrative and overhead costs of $38,000, partially offset by an increase in personnel costs of $16,000. Additionally, we incur significant audit, legal, insurance and other administrative costs as a publicly traded corporation. These costs are included in general and administrative expenses. As our revenue declines, our costs associated with being a publicly traded corporation increase as a percentage of revenue.

Impairment Charges. Impairment charges on goodwill in the 2018 Quarter were $650,000, as compared to none in the 2017 Quarter. The continued future decline of our revenue, cash flows and/or stock price may give rise to a triggering event that may require the Company to record impairment charges in the future related to our goodwill, intangible assets and other long-lived assets.

Depreciation and Amortization Expenses. Depreciation and amortization expenses decreased to $232,000 in the 2018 Quarter from $459,000 in the 2017 Quarter. This $227,000 decrease is mainly attributable to lower amortization expense of $185,000 as certain intangible assets became fully amortized in the third quarter of 2017.

Loss from Operations. The Company recorded a loss from operations of $880,000 in the 2018 Quarter as compared to a loss from operations of $270,000 in the 2017 Quarter. The $610,000 increase in our loss from operations from the 2017 Quarter to the 2018 Quarter is mainly attributable to a $606,000 decrease in revenue, a $650,000 increase in impairment charges on goodwill, partially offset by decreases in cost of revenue, general and administrative expenses and depreciation and amortization as discussed above.

Liquidity and Capital Resources

As of March 31, 2018, we had $3,068,000 of cash and working capital of $3,789,000. For the three months ended March 31, 2018, we incurred a net loss of $1,285,000 and used $472,000 of net cash in operating activities. During the three months ended March 31, 2018 and the year ended December 31, 2017 a substantial portion of our cash flow from operations has been dedicated to the payment of interest on our then-existing indebtedness, thereby reducing our ability to use our cash flow to fund our operations, capital expenditures and investments in sales and marketing. For the three months ended March 31, 2018 and 2017, our cash flow was reduced by $316,000 and $266,000, respectively, for interest payments on our then-existing indebtedness. During the three months ended March 31, 2018, the Company reduced the outstanding principal on our debt obligations from $1.8 million as of December 31, 2017 to $0 as of March 31, 2018.

Net cash used in investing activities for the three months ended March 31, 2018 was $48,000 and primarily represented capitalized internal-use software costs.

Net cash used in financing activities for the three months ended March 31, 2018 was $358,000, primarily attributable to (i) $1,032,000 of aggregate principal payments on the Super G Loan Agreement, (ii) $800,000 of aggregate principal payments on the Western Alliance Bank Loan Agreement, and (iii) $53,000 for repurchase of treasury stock from employees to satisfy minimum statutory tax withholding requirements, partially offset by $1,527,000 of net proceeds from the Series C Offering.

Our capital requirements continue to depend on numerous factors, including the timing and amount of revenue, the expense to deliver our services, expense for sales and marketing, expense for research and development, capital improvements, and the cost involved in protecting our intellectual property rights. The Company believes that, based on our current projection of revenue, expenses, capital expenditures and cash flows, it has sufficient resources to fund its operations for at least the next twelve months following the filing of this Report. However, there is no assurance the Company will be able to accomplish this during this period or in the future following such period. The Company anticipates reduced cash flow from operations and increased levels of capital expenditures in 2018 as compared to 2017, and we believe additional capital may be required to fund investments in product development and sales and marketing as a means to reverse our negative revenue trends. While we expect to continue to adjust our cost of revenue and other operating expenses to partially offset the impact of revenue declines associated with our legacy services, we believe additional capital may be necessary to fund our obligations. In the event we need access to capital to fund operations or provide growth capital, we would likely need to raise capital in one or more equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The respective lead investors of the 0% Series B Convertible Preferred Stock (the “Series B Preferred Stock”) and the Series C Preferred Stock have certain rights to approve future financings. There can be no assurance that the lead investors will provide the required approvals, which may affect our ability to raise capital, refinance indebtedness or borrow additional funds on terms we deem advisable, or at all. Failure to obtain financing, or obtaining financing on unfavorable terms, could result in a decrease in our stock price, would have a material adverse effect on future operating prospects, and could require us to significantly reduce operations.


- 17-




Off-Balance Sheet Arrangements

As of March 31, 2018, we had no off-balance sheet arrangements.

Inflation

Management does not believe inflation had a significant effect on the condensed consolidated financial statements for the periods presented.

Critical Accounting Policies

Other than the adoption of Topic 606, there have been no changes to our critical accounting policies during the three months ended March 31, 2018. Critical accounting policies and the significant estimates made in accordance with such policies are regularly discussed with our Audit Committee. Those policies are discussed under “Critical Accounting Policies” in “Part II. Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in our consolidated financial statements and the footnotes thereto, each included in our 2017 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a “smaller reporting company” as defined by the rules and regulations of the SEC, we are not required to provide this information.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2018. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2018, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms and are designed to ensure that information required to be disclosed by the Company in the reports we file or submit under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

No change in our internal control over financial reporting occurred during the fiscal quarter ended March 31, 2018 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations or liquidity.

Item 1A. Risk Factors

A description of the risks associated with our business, financial conditions and results of operations is set forth in “Part I. Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 and filed with the Securities and Exchange Commission on March 7, 2018. There have been no material changes to these risks during the three months ended March 31, 2018.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds



- 18-


There have been no unregistered sales of securities during the period covered by this Report that have not been previously reported in a Current Report on Form 8-K.

During the period covered by this Report, the Company repurchased 182,000 shares of the Company’s common stock (and recorded such shares in treasury stock) from employees to satisfy $53,000 of minimum statutory tax withholding requirements relating to the vesting of stock awards.


Issuer Purchases of Equity Securities
Period
 
Total Number of Shares Purchased (1)(2)
 
 
Average Price Paid Per Share
January 1  31, 2018
 
67,000

 
$
0.36

February 1  28, 2018
 

 
$

March 1  31, 2018
 
115,000

 
$
0.25

Total
 
182,000

 
$
0.29

____________________________________
(1) All shares purchased by the Company during the period covered by this report were purchased from employees to offset $53,000 of minimum statutory tax withholding requirements relating to the vesting of stock awards.
(2) As of March 31, 2018, the maximum number of shares that may yet be purchased by the Company would not exceed the employees’ portion of taxes withheld on the vesting of the following outstanding unvested equity awards: 113,000 shares of restricted stock, 1,192,000 stock options, 990,000 restricted stock units, plus 1,824,000 shares yet to be granted under the 2014 Equity Incentive Plan as of March 31, 2018. See Note 8 to the Company’s condensed consolidated financial statements included elsewhere herein for information regarding certain actions taken by the Company with respect to its 2014 Equity Incentive Plan subsequent to March 31, 2018.

Item 3. Defaults upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.


- 19-



Item 5. Other Information

Item 1.02. Termination of a Material Definitive Agreement

As of March 31, 2018 and May 8, 2018, the Company had no outstanding principal or accrued interest due under the Business Financing Agreement (as amended, the “Western Alliance Bank Loan Agreement”), dated July 31, 2017, by and among the Company and GP Communications, LLC, a Delaware limited liability company (the “Subsidiary”), as borrowers, and Western Alliance Bank, an Arizona corporation, as lender (the “Lender”).

On May 8, 2018, the Company, the Subsidiary and the Lender entered into a payoff letter that terminated the Western Alliance Bank Loan Agreement. The Company did not pay any premiums or penalties in connection with its voluntary prepayment and termination of the Western Alliance Bank Loan Agreement.



- 20-


Item 6. Exhibits

Exhibit
Number
 
Description
 
 
 
101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase
101.LAB
 
XBRL Taxonomy Extension Label Linkbase
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase

* Filed herewith.
** Furnished herewith.





- 21-



SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
GLOWPOINT, INC.
 
 
 
5/9/2018
By:
/s/ Peter Holst
 
 
Peter Holst
 
 
Chief Executive Officer
 
 
(Principal Executive Officer)

5/9/2018
By:
/s/ David Clark
 
 
David Clark
 
 
Chief Financial Officer
 
 
(Principal Financial and Accounting Officer)


- 22-
EX-31.1 2 glow-ex311_20180331xq1.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
I, Peter Holst, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Glowpoint, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;  and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: May 9, 2018
/s/ Peter Holst    
Peter Holst
Chief Executive Officer
(principal executive officer)



EX-31.2 3 glow-ex312_20180331xq1.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
I, David Clark, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Glowpoint, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;  and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: May 9, 2018
/s/ David Clark    
David Clark
Chief Financial Officer
(principal financial and accounting officer)




EX-32.1 4 glow-ex321_20180331xq1.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1
SECTION 906 CERTIFICATION
The undersigned officers of Glowpoint, Inc., a Delaware corporation (the "Company"), do hereby certify, in accordance with 18 U.S.C. Section 1350, as created pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2018 (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 9, 2018
/s/ Peter Holst    
Peter Holst
Chief Executive Officer

/s/ David Clark    
David Clark
Chief Financial Officer



EX-101.INS 5 glow-20180331.xml XBRL INSTANCE DOCUMENT 0000746210 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0000746210 2018-05-07 0000746210 2017-12-31 0000746210 2018-03-31 0000746210 us-gaap:SeriesCPreferredStockMember 2018-03-31 0000746210 us-gaap:SeriesBPreferredStockMember 2018-03-31 0000746210 us-gaap:SeriesBPreferredStockMember 2017-12-31 0000746210 us-gaap:SeriesAPreferredStockMember 2017-12-31 0000746210 us-gaap:SeriesCPreferredStockMember 2017-12-31 0000746210 us-gaap:SeriesAPreferredStockMember 2018-03-31 0000746210 2017-01-01 2017-03-31 0000746210 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000746210 us-gaap:RetainedEarningsMember 2018-03-31 0000746210 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2018-03-31 0000746210 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0000746210 us-gaap:TreasuryStockMember 2017-12-31 0000746210 us-gaap:CommonStockMember 2018-03-31 0000746210 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2018-03-31 0000746210 us-gaap:TreasuryStockMember 2018-03-31 0000746210 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2018-03-31 0000746210 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2017-12-31 0000746210 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:CommonStockMember 2017-12-31 0000746210 us-gaap:RetainedEarningsMember 2017-12-31 0000746210 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0000746210 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2017-12-31 0000746210 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000746210 2016-12-31 0000746210 2017-03-31 0000746210 us-gaap:SeriesCPreferredStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2018-01-25 2018-01-25 0000746210 glow:WesternAllianceBankLoanAgreementMember 2018-01-01 2018-03-31 0000746210 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember us-gaap:MaximumMember 2018-01-01 2018-03-31 0000746210 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2017-01-01 2017-03-31 0000746210 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember us-gaap:MinimumMember 2018-01-01 2018-03-31 0000746210 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-01-01 2018-03-31 0000746210 glow:BridgeBankLoanAgreementARRevolverMember 2017-12-31 0000746210 glow:SuperGCapitalMember 2018-03-31 0000746210 glow:BridgeBankLoanAgreementARRevolverMember 2018-03-31 0000746210 glow:SuperGCapitalMember 2017-12-31 0000746210 glow:WesternAllianceBankAndSuperGCapitalMember 2018-01-26 0000746210 glow:BridgeBankLoanAgreementNonFormulaBorrowingsMember 2018-03-31 0000746210 glow:WesternAllianceBankLoanAgreementMember 2017-07-31 2017-07-31 0000746210 glow:WesternAllianceBankAndSuperGCapitalMember 2018-01-01 2018-03-31 0000746210 glow:BridgeBankLoanAgreementNonFormulaBorrowingsMember 2017-07-31 2017-07-31 0000746210 glow:BridgeBankLoanAgreementARRevolverMember 2017-07-31 0000746210 glow:BridgeBankLoanAgreementNonFormulaBorrowingsMember 2017-12-31 0000746210 glow:SuperGCapitalMember 2017-07-31 2017-07-31 0000746210 glow:SuperGCapitalMember 2017-07-31 0000746210 glow:SuperGCapitalMember 2018-01-26 0000746210 glow:BridgeBankLoanAgreementARRevolverMember 2017-07-31 2017-07-31 0000746210 glow:WesternAllianceBankAndSuperGCapitalMember 2018-03-31 0000746210 glow:BridgeBankLoanAgreementNonFormulaBorrowingsMember us-gaap:PrimeRateMember 2017-07-31 2017-07-31 0000746210 glow:SuperGCapitalMember us-gaap:WarrantMember 2017-12-31 0000746210 glow:BridgeBankLoanAgreementARRevolverMember 2018-01-01 2018-03-31 0000746210 glow:BridgeBankLoanAgreementNonFormulaBorrowingsMember us-gaap:PrimeRateMember 2018-01-01 2018-03-31 0000746210 glow:SuperGCapitalMember 2018-01-26 2018-01-26 0000746210 glow:BridgeBankLoanAgreementNonFormulaBorrowingsMember 2018-01-01 2018-03-31 0000746210 us-gaap:WarrantMember 2018-01-01 2018-03-31 0000746210 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2017-10-01 2017-10-31 0000746210 us-gaap:SeriesDPreferredStockMember 2018-03-31 0000746210 us-gaap:SeriesAPreferredStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:SeriesCPreferredStockMember us-gaap:CommonStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:SeriesBPreferredStockMember us-gaap:CommonStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:SeriesBPreferredStockMember 2017-10-31 0000746210 glow:PerpetualSeriesB1PreferredStockMember 2018-03-31 0000746210 glow:PerpetualSeriesBPreferredStockMember 2018-03-31 0000746210 us-gaap:SeriesCPreferredStockMember 2018-01-25 2018-01-25 0000746210 us-gaap:SeriesBPreferredStockMember 2017-10-01 2017-10-31 0000746210 us-gaap:SeriesCPreferredStockMember 2018-01-25 0000746210 glow:AmendedEquityIncentivePlan2014Member us-gaap:SubsequentEventMember 2018-04-12 0000746210 us-gaap:EmployeeStockOptionMember glow:StockIncentivePlan2007Member 2018-03-31 0000746210 us-gaap:EmployeeStockOptionMember glow:StockIncentivePlan2000Member 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember glow:EquityIncentivePlan2014Member us-gaap:SubsequentEventMember 2018-04-30 0000746210 glow:EquityIncentivePlan2014Member 2014-05-28 0000746210 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-03-31 0000746210 glow:EquityIncentivePlan2014Member us-gaap:MinimumMember 2014-05-28 0000746210 glow:EquityIncentivePlan2014Member 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember glow:EquityIncentivePlan2014Member us-gaap:SubsequentEventMember 2018-04-01 2018-04-30 0000746210 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockMember glow:StockIncentivePlan2007Member 2018-03-31 0000746210 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockMember us-gaap:CostOfSalesMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockMember us-gaap:CostOfSalesMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockMember 2017-12-31 0000746210 us-gaap:RestrictedStockMember 2018-03-31 0000746210 glow:TimebasedRestrictedStockAwardsMember 2018-01-01 2018-03-31 0000746210 glow:SharesWithheldandRepurchasedMember us-gaap:RestrictedStockMember 2018-01-01 2018-03-31 0000746210 glow:PerformancebasedRestrictedStockAwardsMember 2018-03-31 0000746210 glow:TimebasedRestrictedStockAwardsMember 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingAndMarketingExpenseMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CostOfSalesMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CostOfSalesMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingAndMarketingExpenseMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember us-gaap:GeneralAndAdministrativeExpenseMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2017-12-31 0000746210 glow:TimebasedRestrictedStockUnitsMember 2018-03-31 0000746210 glow:PerformancebasedRestrictedStockUnitsMember 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember glow:NonEmployeeDirectorMember 2018-01-01 2018-03-31 0000746210 glow:TimebasedRestrictedStockUnitsMember 2018-01-01 2018-03-31 0000746210 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-03-31 0000746210 us-gaap:SeriesCPreferredStockMember 2017-01-01 2017-03-31 0000746210 us-gaap:SeriesAPreferredStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockMember 2017-01-01 2017-03-31 0000746210 us-gaap:SeriesBPreferredStockMember 2017-01-01 2017-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0000746210 us-gaap:SeriesCPreferredStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-03-31 0000746210 us-gaap:SeriesBPreferredStockMember 2018-01-01 2018-03-31 0000746210 us-gaap:SeriesAPreferredStockMember 2017-01-01 2017-03-31 0000746210 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:CustomerNumberOneMember 2018-01-01 2018-03-31 0000746210 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember glow:CustomerNumberOneMember 2018-01-01 2018-03-31 0000746210 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember glow:CustomerNumberTwoMember 2017-01-01 2017-03-31 0000746210 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-03-31 0000746210 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember glow:CustomerNumberTwoMember 2018-01-01 2018-03-31 0000746210 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:CustomerNumberTwoMember 2018-01-01 2018-03-31 0000746210 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-03-31 0000746210 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember glow:CustomerNumberOneMember 2017-01-01 2017-03-31 0000746210 us-gaap:GeographicDistributionDomesticMember 2018-01-01 2018-03-31 0000746210 us-gaap:GeographicDistributionForeignMember 2018-01-01 2018-03-31 0000746210 us-gaap:GeographicDistributionDomesticMember 2017-01-01 2017-03-31 0000746210 us-gaap:GeographicDistributionForeignMember 2017-01-01 2017-03-31 glow:event iso4217:USD xbrli:shares glow:member glow:segment glow:facility iso4217:USD xbrli:pure glow:customer xbrli:shares false --12-31 Q1 2018 2018-03-31 10-Q 0000746210 46484975 Smaller Reporting Company GLOWPOINT, INC. 259000 247000 165000 P3Y 2 2 1.16 0.04 0.85 400000 1500000 200000 0 68600 33000 0.0475 6 -55000 -12000 1 1 2448000 2147000 2 333 500000 1 1 1.1 7500 7500 1000 1000 7500 1000 1000 0 0 3000000 517000 988000 988000 1 2.40 2.16 0.28 0.30 1 3789000 337000 309000 1220000 1295000 1003000 714000 0 136000 183114000 184688000 157000 131000 50000 50000 15000 2000 12000 1000 130000 12000 100000 14000 4000 18000 0 10000 0 5000 23000 10000 2000 0 10000 40000 4000 18000 269000 104000 1222000 354000 2938000 79000 0 0 1192000 113000 742000 79000 1339000 4250000 0 0 650000 15424000 13768000 5881000 5059000 1140000 1110000 3946000 3068000 -30000 -878000 0.30 550000 0.0001 0.0001 150000000 150000000 45161000 47318000 44510000 46485000 5000 5000 0.16 0.21 0.13 0.59 0.24 0.23 3472 4350000 4354000 0.0225 1800000 800000 1032000 0 0 0 400000 0 0 1434000 0.07 0.33 1540000 269000 0 0 339000 764000 174000 393000 87000 459000 232000 459000 232000 165000 0 165000 0 62000 3000 3000 3000 3000 -0.02 -0.03 129000 227000 P14M24D P5M20D 137000 301000 7000 118000 144000 419000 0 165000 1016000 898000 7750000 7100000 650000 0 -641000 -1285000 27000 0 83000 -28000 2000 80000 56000 -127000 -27000 0 60000 -19000 626000 594000 266000 316000 3162000 1270000 15424000 13768000 2793000 1270000 369000 0 1563000 0 0 1194000 0 369000 0 -12000 -358000 -36000 -48000 18000 -472000 -668000 -1285000 -1285000 -671000 -1288000 -371000 -405000 1 -270000 -880000 342000 23000 88000 231000 74000 77000 316000 264000 0 0 0 650000 8000 8000 12000 53000 223000 20000 36000 48000 0 0.05 0 3000 3000 237000 375000 0 237000 375000 1275000 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 1000 1000 8250 7500 2800 1750 5000000 100 100 7500 2800 1750 4000 32 450 0 0 0 32 375 1275 0 32 450 0 0 32 375 1275 0 0 0 0 0 0 0 715000 696000 500000 600000 1100000 1100000 2800000 1750000 0 1527000 48000 1159000 1007000 P4Y P3Y 5000 1269000 0 800000 1832000 800000 287000 250000 -170505000 -171790000 4080000 2853000 1227000 2269000 1205000 3474000 140000 177000 164000 50000 456000 0.28 1310000 341000 1752000 546000 443000 113000 113000 990000 1.06 0.57 1.49 0.72 228000 306000 0.84 0.51 0 0 1824000 4400000 514000 1202000 1192000 1.99 1.99 1000 2.30 9000 0 1202000 1192000 500 1191000 1.99 1.99 1.61 32 450 45161000 651000 32 375 1275 47318000 833000 78000 0 268000 -75 1583000 -475 1851000 2800 1750 1750 306000 0 0 0 1527000 1527000 1527000 0 0 12262000 0 183114000 5000 -170505000 -352000 12498000 0 184688000 5000 -171790000 -405000 651000 833000 182000 352000 405000 53000 53000 165000 36181000 46232000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liquidity and Going Concern</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">$3,068,000</font><font style="font-family:inherit;font-size:10pt;"> of cash, working capital of </font><font style="font-family:inherit;font-size:10pt;">$3,789,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> debt. For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we incurred a net loss of </font><font style="font-family:inherit;font-size:10pt;">$1,285,000</font><font style="font-family:inherit;font-size:10pt;"> and used </font><font style="font-family:inherit;font-size:10pt;">$472,000</font><font style="font-family:inherit;font-size:10pt;"> of net cash in operating activities. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, a substantial portion of our cash flow from operations has been dedicated to the payment of interest on our then-existing indebtedness, thereby reducing our ability to use our cash flow to fund our operations, capital expenditures and investments in sales and marketing. For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, our cash flow from operations was reduced by </font><font style="font-family:inherit;font-size:10pt;">$316,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$266,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, for interest payments on our then-existing indebtedness.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company completed a series of transactions (each of which is described further in Notes 6 and 7 below, as applicable) that improved our financial position and reduced the outstanding principal on our debt obligations from </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. The following is a summary of these transactions:</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:24px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">On January 25, 2018, the Company closed a registered direct offering of </font><font style="font-family:inherit;font-size:10pt;">1,750</font><font style="font-family:inherit;font-size:10pt;"> shares of our </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;"> Series C Convertible Preferred Stock (the &#8220;Series C Preferred Stock&#8221;) for net proceeds of </font><font style="font-family:inherit;font-size:10pt;">$1,527,000</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;Series C Offering&#8221;).</font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:24px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">On January 26, 2018, the Company terminated the Business Loan and Security Agreement, dated July 31, 2017, by and between the Company and Super G Capital LLC (&#8220;Super G&#8221;), along with the accompanying Warrant to Purchase Shares of Common Stock, dated July 31, 2017, and paid off all remaining debt obligations with Super G (&#8220;the Super G Payoff&#8221;).</font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:24px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company made total principal payments of </font><font style="font-family:inherit;font-size:10pt;">$800,000</font><font style="font-family:inherit;font-size:10pt;"> on the Western Alliance Bank Loan Agreement, resulting in </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding debt as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our capital requirements continue to depend on numerous factors, including the timing and amount of revenue, the expense to deliver our services, expense for sales and marketing, expense for research and development, capital improvements, and the cost involved in protecting our intellectual property rights. The Company believes that, based on our current projection of revenue, expenses, capital expenditures and cash flows, it has sufficient resources to fund its operations for at least the next twelve months following the filing of this Report. However, there is no assurance the Company will be able to accomplish this during this period or in the future following such period. The Company anticipates reduced cash flow from operations and increased levels of capital expenditures in 2018 as compared to 2017, and we believe additional capital may be required to fund investments in product development and sales and marketing as a means to reverse our revenue trends. While we expect to continue to adjust our cost of revenue and other operating expenses to partially offset the impact of revenue declines associated with our legacy services, we believe additional capital may be necessary to fund our obligations. In the event we need access to capital to fund operations or provide growth capital, we would likely need to raise capital in one or more equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The respective lead investors of the </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;"> Series B Convertible Preferred Stock (the &#8220;Series B Preferred Stock&#8221;) and the Series C Preferred Stock have certain rights to approve future financings. There can be no assurance that the lead investors will provide the required approvals, which may affect our ability to raise capital, refinance indebtedness or borrow additional funds on terms we deem advisable, or at all. Failure to obtain financing, or obtaining financing on unfavorable terms, could result in a decrease in our stock price, would have a material adverse effect on future operating prospects, and could require us to significantly reduce operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accrued Expenses and Other Liabilities</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other liabilities consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90412272291466%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued compensation costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued marketing expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Super G Warrant liability</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">714</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,003</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating Leases</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We lease </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> facilities in Denver, CO and Oxnard, CA that are under operating leases through December 2018 and March 2020, respectively. Both of these leases require us to pay increases in real estate taxes, operating costs and repairs over certain base year amounts. Rent expense for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$77,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$74,000</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum rental commitments under all non-cancelable operating leases as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, are as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remaining 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Major Customers</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Major customers are defined as direct customers or channel partners that account for more than </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of the Company&#8217;s revenue. For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> major customers represented </font><font style="font-family:inherit;font-size:10pt;">24%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">23%</font><font style="font-family:inherit;font-size:10pt;">, respectively of our revenue and represented </font><font style="font-family:inherit;font-size:10pt;">13%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">59%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of our accounts receivable balance at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the same </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> major customers represented </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of our revenue.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements include the accounts of Glowpoint and our </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">-owned subsidiary, GP Communications, LLC, whose business function is to provide interstate telecommunications services for regulatory purposes. All material inter-company balances and transactions have been eliminated in consolidation. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt consisted of the following (in thousands): </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Western Alliance Bank A/R Revolver</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Super G Loan</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,032</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt discounts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net carrying value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,563</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: current maturities, net of debt discount</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,194</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term obligations, net of debt discount</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Western Alliance Bank Business Financing Agreement</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 31, 2017, the Company and its subsidiary entered into a Business Financing Agreement with Western Alliance Bank, as lender (the &#8220;Western Alliance Bank Loan Agreement&#8221;). The Western Alliance Bank Loan Agreement provided the Company with up to a total of </font><font style="font-family:inherit;font-size:10pt;">$1,500,000</font><font style="font-family:inherit;font-size:10pt;"> of revolving loans (the &#8220;A/R Revolver&#8221;). The maximum amount available under the A/R Revolver was limited to the lesser of (x) </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$1,500,000</font><font style="font-family:inherit;font-size:10pt;"> and (y) an amount equal to the borrowing base. The borrowing base included </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the Company&#8217;s eligible accounts receivable plus a non-formula amount (which was </font><font style="font-family:inherit;font-size:10pt;">$400,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, and which stepped down to </font><font style="font-family:inherit;font-size:10pt;">$200,000</font><font style="font-family:inherit;font-size:10pt;"> on January 1, 2018, and to </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;"> on April 1, 2018) (&#8220;the Non-Formula Amount&#8221;). The Western Alliance Bank Loan Agreement provided that all borrowings would bear interest at the prime rate (</font><font style="font-family:inherit;font-size:10pt;">4.75%</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">) plus </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> (or a total of </font><font style="font-family:inherit;font-size:10pt;">7.00%</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">) per year. The prime rate was subject to a floor of </font><font style="font-family:inherit;font-size:10pt;">4.00%</font><font style="font-family:inherit;font-size:10pt;">. Interest payments on the outstanding borrowings were due monthly. On July 31, 2017, the Company received a loan in an amount equal to </font><font style="font-family:inherit;font-size:10pt;">$1,100,000</font><font style="font-family:inherit;font-size:10pt;"> under the Western Alliance Bank Loan Agreement, consisting of </font><font style="font-family:inherit;font-size:10pt;">$500,000</font><font style="font-family:inherit;font-size:10pt;"> based on </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of eligible accounts receivable and </font><font style="font-family:inherit;font-size:10pt;">$600,000</font><font style="font-family:inherit;font-size:10pt;"> of Non-Formula Amount. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company made total principal payments of </font><font style="font-family:inherit;font-size:10pt;">$800,000</font><font style="font-family:inherit;font-size:10pt;"> on the A/R Revolver (including </font><font style="font-family:inherit;font-size:10pt;">$400,000</font><font style="font-family:inherit;font-size:10pt;"> on the Non-Formula Amount). As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding borrowings on the A/R Revolver and we had availability of </font><font style="font-family:inherit;font-size:10pt;">$764,000</font><font style="font-family:inherit;font-size:10pt;">. All loans under the A/R Revolver were to mature on July 31, 2019 (unless such loans are not supported by the borrowing base, in which case any loans exceeding the borrowing base must be immediately repaid). As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company was in compliance with all required covenants under the Western Alliance Bank Loan Agreement. On </font><font style="font-family:inherit;font-size:10pt;">May 8, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company terminated the Western Alliance Bank Loan Agreement.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Super G Loan Agreement and Warrant</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 31, 2017, the Company and its subsidiary entered into a Business Loan and Security Agreement with Super G Capital, LLC (&#8220;Super G&#8221;), as lender (the &#8220;Super G Loan Agreement&#8221;) and received a term loan from Super G in an amount equal to </font><font style="font-family:inherit;font-size:10pt;">$1,100,000</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;Super G Loan&#8221;). Borrowings under the Super G Loan Agreement were to be repaid in installments (including interest) of </font><font style="font-family:inherit;font-size:10pt;">$33,000</font><font style="font-family:inherit;font-size:10pt;"> per month in the first 3 months following closing and approximately </font><font style="font-family:inherit;font-size:10pt;">$68,600</font><font style="font-family:inherit;font-size:10pt;"> per month in months four through twenty-four following closing, for total payments of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$1,540,000</font><font style="font-family:inherit;font-size:10pt;">. The effective interest rate of the Super G Loan was approximately </font><font style="font-family:inherit;font-size:10pt;">33%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 31, 2017, the Company also issued a warrant that entitled Super G to purchase </font><font style="font-family:inherit;font-size:10pt;">550,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock at an exercise price of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$0.30</font><font style="font-family:inherit;font-size:10pt;"> per share (the &#8220;Super G Warrant&#8221;). The Super G Warrant had a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> year term and if the profit on such warrants was not equal to at least </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$165,000</font><font style="font-family:inherit;font-size:10pt;"> over the term of the warrants, at the end of the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> year term, the Company was required to pay an exit fee equal to the difference between </font><font style="font-family:inherit;font-size:10pt;">$165,000</font><font style="font-family:inherit;font-size:10pt;"> and the amount of profit recognized. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> warrants were exercised. The </font><font style="font-family:inherit;font-size:10pt;">$165,000</font><font style="font-family:inherit;font-size:10pt;"> fair value of this warrant was recorded as a derivative liability and as a discount to the carrying amount of the debt as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 26, 2018, the Company and Super G entered into a payoff letter that terminated the Super G Loan Agreement and the Super G Warrant in exchange for total cash payments from the Company of </font><font style="font-family:inherit;font-size:10pt;">$1,269,000</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;Super G Payoff&#8221;). The total obligations to Super G at the time of the Super G Payoff was </font><font style="font-family:inherit;font-size:10pt;">$1,434,000</font><font style="font-family:inherit;font-size:10pt;">, including principal, accrued and remaining interest due over the term of the Super G Loan, and the Super G Warrant Liability. Therefore, the Company recorded a gain on extinguishment of the debt of </font><font style="font-family:inherit;font-size:10pt;">$165,000</font><font style="font-family:inherit;font-size:10pt;">, which is recorded in &#8220;Interest and Other Expense, Net&#8221; on our Condensed Consolidated Statements of Operations. In connection with the Super G Payoff, the related warrant liability and corresponding debt discount were eliminated during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there are </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding obligations related to the Super G Loan.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total debt discount on the Western Alliance Bank A/R Revolver and Super G Loan was </font><font style="font-family:inherit;font-size:10pt;">$339,000</font><font style="font-family:inherit;font-size:10pt;">, comprised of </font><font style="font-family:inherit;font-size:10pt;">$174,000</font><font style="font-family:inherit;font-size:10pt;"> of debt issuance costs and </font><font style="font-family:inherit;font-size:10pt;">$165,000</font><font style="font-family:inherit;font-size:10pt;"> related to the Super G Warrant.&#160;This debt discount was being amortized to interest expense using the effective interest method over the term of the debt.&#160;During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company amortized </font><font style="font-family:inherit;font-size:10pt;">$269,000</font><font style="font-family:inherit;font-size:10pt;"> of the debt discount, which is recorded in &#8220;Interest and Other Expense, Net&#8221; on our Condensed Consolidated Statements of Operations. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there is </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> remaining unamortized debt discount.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Units</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of unvested restricted stock units (&#8220;RSUs&#8221;) outstanding as of, and changes made during, the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, is presented below (shares in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:5px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RSUs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;text-indent:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted Average <br clear="none"/>Grant Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock units outstanding, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,752</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(306</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(456</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock units outstanding, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">990</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.72</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">988,000</font><font style="font-family:inherit;font-size:10pt;"> vested RSUs issued to non-employee directors remain outstanding as shares of common stock have not yet been delivered due to the deferred payment provisions set forth in these RSUs. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">546,000</font><font style="font-family:inherit;font-size:10pt;"> unvested RSUs have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, stock-based compensation expense is recognized over the relevant performance period. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">443,000</font><font style="font-family:inherit;font-size:10pt;"> unvested RSUs have timed-based vesting provisions, and the cost of the RSUs is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense related to RSUs is allocated as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The remaining unrecognized stock-based compensation expense for RSUs as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$419,000</font><font style="font-family:inherit;font-size:10pt;">. Of this amount </font><font style="font-family:inherit;font-size:10pt;">$118,000</font><font style="font-family:inherit;font-size:10pt;"> relates to time-based RSUs with a remaining weighted average period of </font><font style="font-family:inherit;font-size:10pt;">0.47</font><font style="font-family:inherit;font-size:10pt;"> years. The remaining </font><font style="font-family:inherit;font-size:10pt;">$301,000</font><font style="font-family:inherit;font-size:10pt;"> of unrecognized stock-based compensation expense relates to performance-based RSUs for which expense will be recognized upon it becoming probable that the Company achieves defined financial targets for fiscal year 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Awards</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of unvested restricted stock awards outstanding as of, and changes made during, the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, is presented below (shares in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:5px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:10px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;text-indent:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted Average <br clear="none"/>Grant Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock outstanding, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock outstanding, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.49</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The number of restricted stock awards vested during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> includes </font><font style="font-family:inherit;font-size:10pt;">78,000</font><font style="font-family:inherit;font-size:10pt;"> shares withheld and repurchased by the Company from employees to satisfy </font><font style="font-family:inherit;font-size:10pt;">$20,000</font><font style="font-family:inherit;font-size:10pt;"> of tax obligations relating to the vesting of such shares. Such shares are held in the Company&#8217;s treasury stock as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense related to restricted stock awards is allocated as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain restricted stock awards have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, compensation expense is recognized over the relevant performance period. For those awards not subject to performance criteria, the cost of the restricted stock awards is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The remaining unrecognized stock-based compensation expense for restricted stock awards as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$144,000</font><font style="font-family:inherit;font-size:10pt;">. Of this amount, </font><font style="font-family:inherit;font-size:10pt;">$7,000</font><font style="font-family:inherit;font-size:10pt;"> relates to time-based awards with a remaining weighted average period of </font><font style="font-family:inherit;font-size:10pt;">1.23 years</font><font style="font-family:inherit;font-size:10pt;">. The remaining </font><font style="font-family:inherit;font-size:10pt;">$137,000</font><font style="font-family:inherit;font-size:10pt;"> of unrecognized stock-based compensation expense relates to performance-based awards for which expense will be recognized upon it becoming probable that the Company will achieve defined financial targets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Based Compensation</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Glowpoint 2014 Equity Incentive Plan</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 28, 2014, the Glowpoint, Inc. 2014 Equity Incentive Plan (the &#8220;2014 Plan&#8221;) was approved by the Company&#8217;s stockholders at the Company&#8217;s 2014 Annual Meeting of Stockholders. The purpose of the 2014 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means to attract, motivate, retain, and reward selected employees and other eligible persons through the grant of equity awards. Awards may be granted under the 2014 Plan to officers, employees, directors and consultants of the Company or its subsidiary. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted shares, restricted stock units, cash awards and other awards, including stock bonuses, performance stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Company&#8217;s common stock, upon the passage of time, the occurrence of </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof, or any similar securities with a value derived from the value of or related to the Company&#8217;s common stock, or returns thereon. A total of </font><font style="font-family:inherit;font-size:10pt;">4,400,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock were initially available for issuance under the 2014 Plan. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1,824,000</font><font style="font-family:inherit;font-size:10pt;"> shares were available for issuance under the 2014 Plan. In April 2018, </font><font style="font-family:inherit;font-size:10pt;">1,310,000</font><font style="font-family:inherit;font-size:10pt;"> restricted stock units were granted under the 2014 Plan, leaving </font><font style="font-family:inherit;font-size:10pt;">514,000</font><font style="font-family:inherit;font-size:10pt;"> shares available for issuance under the 2014 Plan. On April 12, 2018, the Company's compensation committee recommended, and the Company's board of directors adopted, subject to stockholder approval, an amendment to the 2014 Plan to, among other things, increase the number of shares of common stock available for issuance under the 2014 Plan by </font><font style="font-family:inherit;font-size:10pt;">3,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares (the "Amendment"), enabling the continued use of the 2014 Plan for share-based awards. The Company is seeking stockholder approval of the Amendment in connection with its 2018 Annual Meeting of Stockholders to be held on May 31, 2018.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Glowpoint 2007 Stock Incentive Plan </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Board terminated the Glowpoint 2007 Stock Incentive Plan (the &#8220;2007 Plan&#8221;). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, options to purchase a total of </font><font style="font-family:inherit;font-size:10pt;">1,191,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock and </font><font style="font-family:inherit;font-size:10pt;">113,000</font><font style="font-family:inherit;font-size:10pt;"> shares of restricted stock were outstanding under the 2007 Plan. </font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;"> shares are available for issuance under the 2007 Plan.</font></div><div style="line-height:120%;text-align:justify;text-indent:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Glowpoint 2000 Stock Incentive Plan</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2010, the Board terminated the Glowpoint 2000 Stock Incentive Plan (as amended, the &#8220;2000 Plan&#8221;). Notwithstanding the termination of the 2000 Plan, outstanding awards under the 2000 Plan will remain in effect in accordance with their terms. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, options to purchase a total of </font><font style="font-family:inherit;font-size:10pt;">500</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock were outstanding under the 2000 Plan. </font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;"> shares are available for issuance under the 2000 Plan.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Options</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> stock options were granted; therefore, no fair value assumptions are presented herein. A summary of stock options expired and forfeited under our stock incentive plans and stock options outstanding as of, and changes made during, the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, is presented below (shares in thousands):</font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Shares Underlying Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted<br clear="none"/>Average<br clear="none"/>Exercise<br clear="none"/>Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Shares Underlying Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted<br clear="none"/>Average<br clear="none"/>Exercise<br clear="none"/>Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Options outstanding, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:22px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:22px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options outstanding, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,192</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,192</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense related to stock options was </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$18,000</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, and was recorded to general and administrative expenses. There is </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> remaining unrecognized stock-based compensation expense for stock options as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Loss Per Share</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">t include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (decrease our net loss per share).</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share (in thousands, except per share data): </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,285</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(668</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: preferred stock dividends</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,288</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(671</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average number of shares of common stock for basic and diluted net loss per share</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,232</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.03</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.02</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average number of shares for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> includes </font><font style="font-family:inherit;font-size:10pt;">988,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">517,000</font><font style="font-family:inherit;font-size:10pt;"> shares of vested RSUs, respectively, as discussed in Note 8. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,938</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,192</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares of common stock issuable upon conversion of Series A-2 Preferred</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares of common stock issuable upon conversion of Series B Preferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares of common stock issuable upon conversion of Series C Preferred</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,250</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill &amp; Intangibles</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill is not amortized but is subject to periodic testing for impairment in accordance with ASC Topic 350 &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other - Testing Indefinite-Lived Intangible Assets for Impairment</font><font style="font-family:inherit;font-size:10pt;">&#8221;. We test goodwill for impairment on an annual basis on September 30 of each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company considered the declines in our revenue and stock price to be a triggering event for an interim goodwill impairment test. The Company operates as a single reporting unit and used market-based approaches to determine the fair value of the reporting unit. These approaches used quoted market prices in active markets and revenue multiples for comparable companies. As of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the carrying amount of our reporting unit exceeded its fair value; therefore, the Company recorded a goodwill impairment charge of </font><font style="font-family:inherit;font-size:10pt;">$650,000</font><font style="font-family:inherit;font-size:10pt;"> in the </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. This charge is recognized as &#8220;Impairment charges&#8221; on our Condensed Consolidated Statements of Operations. The remaining goodwill balance as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$7,100,000</font><font style="font-family:inherit;font-size:10pt;">. The continued future decline of our revenue, cash flows and/or stock price may give rise to a triggering event that may require the Company to record additional impairment charges on goodwill in the future.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assesses the impairment of purchased intangible assets subject to amortization when events and circumstances indicate that the carrying value of the assets might not be recoverable. &#160;Fair value of our intangible assets is determined using the relief from royalty methodology. This approach involves two steps: (a) estimating reasonable royalty rates for each intangible asset and (b) applying these royalty rates to a net revenue stream and discounting the resulting cash flows to determine fair value. This fair value is then compared with the carrying value of each intangible asset. If the carrying value of the intangible asset is greater than its implied fair value, an impairment in the amount of the excess is recognized and charged to operations. The determination of related estimated useful lives and whether or not these assets are impaired involves significant judgments, related primarily to the future profitability and/or future value of the assets. Changes in the Company&#8217;s strategic plan and/or other-than-temporary changes in market conditions could significantly impact these judgments and could require adjustments to recorded asset balances.&#160;Long-lived assets are evaluated for impairment at least annually, as well as whenever an event or change in circumstances has occurred that could have a significant adverse effect on the fair value of long-lived assets.&#160; The Company performed an evaluation of intangible assets as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and determined that the fair value of the long-lived assets exceeded the carrying value, therefore </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impairment charges were required for the </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill &amp; Intangibles</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill is not amortized but is subject to periodic testing for impairment in accordance with ASC Topic 350 &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other - Testing Indefinite-Lived Intangible Assets for Impairment</font><font style="font-family:inherit;font-size:10pt;">&#8221;. We test goodwill for impairment on an annual basis on September 30 of each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company considered the declines in our revenue and stock price to be a triggering event for an interim goodwill impairment test. The Company operates as a single reporting unit and used market-based approaches to determine the fair value of the reporting unit. These approaches used quoted market prices in active markets and revenue multiples for comparable companies. As of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the carrying amount of our reporting unit exceeded its fair value; therefore, the Company recorded a goodwill impairment charge of </font><font style="font-family:inherit;font-size:10pt;">$650,000</font><font style="font-family:inherit;font-size:10pt;"> in the </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. This charge is recognized as &#8220;Impairment charges&#8221; on our Condensed Consolidated Statements of Operations. The remaining goodwill balance as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$7,100,000</font><font style="font-family:inherit;font-size:10pt;">. The continued future decline of our revenue, cash flows and/or stock price may give rise to a triggering event that may require the Company to record additional impairment charges on goodwill in the future.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assesses the impairment of purchased intangible assets subject to amortization when events and circumstances indicate that the carrying value of the assets might not be recoverable. &#160;Fair value of our intangible assets is determined using the relief from royalty methodology. This approach involves two steps: (a) estimating reasonable royalty rates for each intangible asset and (b) applying these royalty rates to a net revenue stream and discounting the resulting cash flows to determine fair value. This fair value is then compared with the carrying value of each intangible asset. If the carrying value of the intangible asset is greater than its implied fair value, an impairment in the amount of the excess is recognized and charged to operations. The determination of related estimated useful lives and whether or not these assets are impaired involves significant judgments, related primarily to the future profitability and/or future value of the assets. Changes in the Company&#8217;s strategic plan and/or other-than-temporary changes in market conditions could significantly impact these judgments and could require adjustments to recorded asset balances.&#160;Long-lived assets are evaluated for impairment at least annually, as well as whenever an event or change in circumstances has occurred that could have a significant adverse effect on the fair value of long-lived assets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capitalized Software Costs</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company capitalizes certain costs incurred in connection with developing or obtaining internal-use software. All software development costs have been appropriately accounted for as required by ASC Topic 350-40 &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangible &#8211; Goodwill and Other &#8211; Internal-Use Software</font><font style="font-family:inherit;font-size:10pt;">&#8221;.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">Capitalized software costs are included in &#8220;Property and equipment, net&#8221; on our condensed consolidated balance sheets and are amortized over </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> years. Software costs that do not meet capitalization criteria are expensed as incurred.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Adopted Accounting Standards</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (ASU) 2014-09 (Topic 606) "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">." Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605 &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;">&#8221; (Topic 605), and requires entities to recognize revenue when control of promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. On&#160;January&#160;1, 2018, we adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of&#160;January&#160;1, 2018. Results for reporting periods beginning after&#160;January&#160;1, 2018&#160;are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Accounting Standards Codification Topic 605. We did not record an adjustment to opening accumulated deficit as of&#160;January&#160;1, 2018&#160;as the cumulative impact of adopting Topic 606 was not material. The costs associated with obtaining a customer contract were previously expensed in the period they were incurred. Under Topic 606, these payments are deferred on our consolidated balance sheet and amortized over the expected life of the customer contract. The impact to sales and marketing expense for the three months ended&#160;March 31, 2018 was not material&#160;as a result of applying Topic 606. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the&#160;FASB&#160;issued ASU No. 2016-15,&#160;which amends ASC 230, to clarify guidance&#160;on the classification of certain cash receipts and payments in the statement of cash flows. The FASB issued ASU 2016-15 with the intent of reducing diversity in practice with respect to eight types of cash flows. This guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB issued ASU 2017-09, which clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as modifications. ASU 2017-09 will reduce diversity in practice and result in fewer changes to the terms of an award being accounted for as modifications. Under ASU 2017-09, an entity will not apply modification accounting to a share-based payment award if the award's fair value, vesting conditions and classification as an equity or liability instrument are the same immediately before and after the change. ASU 2017-09 will be applied prospectively to awards modified on or after the adoption date. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:174%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Recently Issued Accounting Pronouncements</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:174%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016 the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8220;Leases&#8221;</font><font style="font-family:inherit;font-size:10pt;">. The ASU introduces a lessee model that results in most leases impacting the balance sheet. The ASU addresses other concerns related to the current leases model.&#160; Under ASU 2016-02, lessees will be required to recognize for all leases with terms longer than 12 months, at the commencement date of the lease, a lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease measured on a discounted basis, and a right-to-use asset, which is an asset that represents the lessee&#8217;s right to use or control the use of a specified asset for the lease term.&#160; Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition.&#160; The update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. While we continue to evaluate the effect of adopting this guidance on our consolidated financial statements and related disclosures, we expect our operating leases, as disclosed in Note 10, will be subject to the new standard. We will recognize right-of-use assets and operating lease liabilities on our balance sheet upon adoption, which will increase our total assets and liabilities.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Preferred Stock</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Certificate of Incorporation authorizes us to issue up to </font><font style="font-family:inherit;font-size:10pt;">5,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of preferred stock. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there were: (i) </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> shares of Perpetual Series B-1 Preferred Stock authorized and </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> shares issued or outstanding; (ii) </font><font style="font-family:inherit;font-size:10pt;">7,500</font><font style="font-family:inherit;font-size:10pt;"> shares of Series A-2 Convertible Preferred Stock authorized and </font><font style="font-family:inherit;font-size:10pt;">32</font><font style="font-family:inherit;font-size:10pt;"> shares issued and outstanding (the &#8220;Series A-2 Preferred Stock&#8221;); (iii) </font><font style="font-family:inherit;font-size:10pt;">2,800</font><font style="font-family:inherit;font-size:10pt;"> shares of Series B Preferred Stock authorized and </font><font style="font-family:inherit;font-size:10pt;">375</font><font style="font-family:inherit;font-size:10pt;"> shares issued and outstanding; (iv) </font><font style="font-family:inherit;font-size:10pt;">1,750</font><font style="font-family:inherit;font-size:10pt;"> shares of Series C Preferred Stock authorized and </font><font style="font-family:inherit;font-size:10pt;">1,275</font><font style="font-family:inherit;font-size:10pt;"> shares issued and outstanding; (v) </font><font style="font-family:inherit;font-size:10pt;">4,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Series D Convertible Preferred Stock authorized and </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> shares issued or outstanding; and (vi) </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> shares of Perpetual Series B Preferred Stock authorized and </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> shares issued or outstanding.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Series A-2 Preferred Stock</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each share of Series A-2 Preferred Stock has a stated value of </font><font style="font-family:inherit;font-size:10pt;">$7,500</font><font style="font-family:inherit;font-size:10pt;"> per share (the &#8220;A-2 Stated Value&#8221;), a liquidation preference equal to the A-2 Stated Value, and is convertible at the holder&#8217;s election into common stock at a conversion price per share of </font><font style="font-family:inherit;font-size:10pt;">$2.16</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. Therefore, each share of Series A-2 Preferred Stock is convertible into </font><font style="font-family:inherit;font-size:10pt;">3,472</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. The conversion price is subject to adjustment upon the occurrence of certain events set forth in our Certificate of Incorporation. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Series C Offering resulted in an adjustment to the Series A-2 Preferred Stock conversion price from </font><font style="font-family:inherit;font-size:10pt;">$2.40</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$2.16</font><font style="font-family:inherit;font-size:10pt;"> per share.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Series A-2 Preferred Stock is subordinate to the Series B-1 Preferred Stock but senior to all other classes of equity, has weighted average anti-dilution protection and, since January 1, 2013, has been entitled to cumulative dividends at a rate of </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;"> per annum, payable quarterly, based on the A-2 Stated Value and payable at the option of the holder in cash or through the issuance of a number of additional shares of Series A-2 Preferred Stock with an aggregate liquidation preference equal to the dividend amount payable on the applicable dividend payment date. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has recorded </font><font style="font-family:inherit;font-size:10pt;">$62,000</font><font style="font-family:inherit;font-size:10pt;"> in accrued dividends in &#8220;Accrued expenses and other liabilities&#8221; on the accompanying Condensed Consolidated Balance Sheet related to the remaining Series A-2 Preferred Stock outstanding. The Company, at our option, may redeem all or a portion of the Series A-2 Preferred Stock in cash at a price per share of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$8,250</font><font style="font-family:inherit;font-size:10pt;"> per share (equal to </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$7,500</font><font style="font-family:inherit;font-size:10pt;"> per share multiplied by </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">110%</font><font style="font-family:inherit;font-size:10pt;">) plus all accrued and unpaid dividends.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Series B Preferred Stock</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2017, the Company closed a registered direct offering of </font><font style="font-family:inherit;font-size:10pt;">2,800</font><font style="font-family:inherit;font-size:10pt;"> shares of its Series B Preferred Stock for total gross proceeds to the Company of </font><font style="font-family:inherit;font-size:10pt;">$2,800,000</font><font style="font-family:inherit;font-size:10pt;">. The shares of Series B Preferred Stock were sold at a price equal to their stated value of </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> per share and are convertible into shares of the Company&#8217;s common stock at a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$0.28</font><font style="font-family:inherit;font-size:10pt;"> per share. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">75</font><font style="font-family:inherit;font-size:10pt;"> shares of Series B Preferred Stock were converted to </font><font style="font-family:inherit;font-size:10pt;">268,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">375</font><font style="font-family:inherit;font-size:10pt;"> shares of Series B Preferred Stock remain issued and outstanding. The Series B Preferred Stock is </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">pari passu</font><font style="font-family:inherit;font-size:10pt;"> with the Company&#8217;s issued and outstanding shares of Series C Preferred Stock.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to certain exceptions, the Company has agreed to provide the holders of Series B Preferred Stock a right of participation for up to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of any future offering of its common stock or other securities or equity linked debt obligations until October 2019. In addition, the Company agreed to expand the size of the Company&#8217;s board of directors to </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> members and to appoint a new independent director agreeable to the lead investor in the offering (the &#8220;Lead Investor&#8221;). Subject to limited exceptions, for as long as at least </font><font style="font-family:inherit;font-size:10pt;">333</font><font style="font-family:inherit;font-size:10pt;"> shares of Series B Preferred Stock remain outstanding and unconverted (subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations and subdivisions or similar events occurring after the date of the Purchase Agreement with respect to the Series B Preferred Stock), the Company may not issue any common stock or convertible securities (or modify any of the foregoing that may be outstanding) to any person, or incur any debt, without the express written consent of the Lead Investor.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Company has agreed that it will not enter into certain &#8220;fundamental transactions,&#8221; including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company&#8217;s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series B Preferred Stock including the Lead Investor and on terms with respect to the Series B Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series B Preferred Stock.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Series C Offering</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 25, 2018, the Company closed a registered direct offering of </font><font style="font-family:inherit;font-size:10pt;">1,750</font><font style="font-family:inherit;font-size:10pt;"> shares of its Series C Preferred Stock for total gross proceeds to the Company of </font><font style="font-family:inherit;font-size:10pt;">$1,750,000</font><font style="font-family:inherit;font-size:10pt;">. The shares of Series C Preferred Stock were sold at a price equal to their stated value of </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> per share and are convertible into shares of the Company&#8217;s common stock at a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$0.30</font><font style="font-family:inherit;font-size:10pt;"> per share. The net proceeds to us from the sale of our securities in this offering were </font><font style="font-family:inherit;font-size:10pt;">$1,527,000</font><font style="font-family:inherit;font-size:10pt;"> after deducting offering expenses paid by us. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">475</font><font style="font-family:inherit;font-size:10pt;"> shares of Series C Preferred Stock were converted to </font><font style="font-family:inherit;font-size:10pt;">1,583,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1,275</font><font style="font-family:inherit;font-size:10pt;"> shares of Series C Preferred Stock remain issued and outstanding. The Series C Preferred Stock is </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">pari passu</font><font style="font-family:inherit;font-size:10pt;"> with the Company&#8217;s issued and outstanding shares of Series B Preferred Stock.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to certain exceptions, the Company has agreed to provide the purchasers, during the period that the purchasers continue to hold Series C Preferred Stock, a right of participation for up to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of any future offering of its common stock or other securities or equity linked debt obligations until January 2020. Subject to limited exceptions, for as long as at least </font><font style="font-family:inherit;font-size:10pt;">$500,000</font><font style="font-family:inherit;font-size:10pt;"> of stated value of Series C Preferred Stock remain outstanding and unconverted (subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations and subdivisions or similar events occurring after the date of the Purchase Agreement with respect to the Series C Preferred Stock), the Company shall not issue any common stock or convertible securities (or modify any of the foregoing that may be outstanding) to any person at a price per share less than </font><font style="font-family:inherit;font-size:10pt;">$0.30</font><font style="font-family:inherit;font-size:10pt;">, or incur any debt, without the express written consent of the Lead Investor.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Company has agreed that it will not enter into certain &#8220;fundamental transactions,&#8221; including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company&#8217;s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series C Preferred Stock including the Lead Investor and on terms with respect to the Series C Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series C Preferred Stock.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with ASC Topic 815, we evaluated whether our convertible preferred stock contains provisions that protect holders from declines in our stock price or otherwise could</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">result in modification of the exercise price and/or shares to be issued under the respective preferred stock agreements based on a variable that is not an input to the fair</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">value of a &#8220;fixed-for-fixed&#8221; option and require a derivative liability. The Company determined </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> derivative liability is required under ASC Topic 815 with respect to our convertible preferred stock. A contingent beneficial conversion amount is required to be calculated and recognized when and if the adjusted </font><font style="font-family:inherit;font-size:10pt;">$2.16</font><font style="font-family:inherit;font-size:10pt;"> conversion price of the Series A-2 Preferred Stock is adjusted to reflect a down round stock issuance that reduces the conversion price below the </font><font style="font-family:inherit;font-size:10pt;">$1.16</font><font style="font-family:inherit;font-size:10pt;"> fair value of the common stock on the issuance date of the Series A-2 Preferred Stock.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capitalized Software Costs</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company capitalizes certain costs incurred in connection with developing or obtaining internal-use software. All software development costs have been appropriately accounted for as required by ASC Topic 350-40 &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangible &#8211; Goodwill and Other &#8211; Internal-Use Software</font><font style="font-family:inherit;font-size:10pt;">&#8221;.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">Capitalized software costs are included in &#8220;Property and equipment, net&#8221; on our condensed consolidated balance sheets and are amortized over </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> years. Software costs that do not meet capitalization criteria are expensed as incurred. For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we capitalized </font><font style="font-family:inherit;font-size:10pt;">$48,000</font><font style="font-family:inherit;font-size:10pt;"> of internal-use software costs. For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, we amortized </font><font style="font-family:inherit;font-size:10pt;">$131,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$157,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, of these costs. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, we recorded </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impairment losses related to capitalized software.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other liabilities consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90412272291466%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued compensation costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued marketing expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Super G Warrant liability</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">714</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,003</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,938</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,192</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares of common stock issuable upon conversion of Series A-2 Preferred</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares of common stock issuable upon conversion of Series B Preferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares of common stock issuable upon conversion of Series C Preferred</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,250</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt consisted of the following (in thousands): </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Western Alliance Bank A/R Revolver</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Super G Loan</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,032</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt discounts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net carrying value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,563</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: current maturities, net of debt discount</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,194</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term obligations, net of debt discount</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share (in thousands, except per share data): </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,285</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(668</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: preferred stock dividends</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,288</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(671</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average number of shares of common stock for basic and diluted net loss per share</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,232</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.03</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.02</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense related to restricted stock awards is allocated as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense related to RSUs is allocated as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum rental commitments under all non-cancelable operating leases as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, are as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remaining 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of unvested restricted stock units (&#8220;RSUs&#8221;) outstanding as of, and changes made during, the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, is presented below (shares in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:5px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RSUs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;text-indent:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted Average <br clear="none"/>Grant Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock units outstanding, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,752</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(306</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(456</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock units outstanding, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">990</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.72</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of unvested restricted stock awards outstanding as of, and changes made during, the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, is presented below (shares in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:5px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:10px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;text-indent:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted Average <br clear="none"/>Grant Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock outstanding, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock outstanding, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.49</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue by geographic area, based on customer location, is allocated as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,205</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,227</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,474</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,080</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of stock options expired and forfeited under our stock incentive plans and stock options outstanding as of, and changes made during, the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, is presented below (shares in thousands):</font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Shares Underlying Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted<br clear="none"/>Average<br clear="none"/>Exercise<br clear="none"/>Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Shares Underlying Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted<br clear="none"/>Average<br clear="none"/>Exercise<br clear="none"/>Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Options outstanding, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:22px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:22px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options outstanding, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,192</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,192</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographical Data</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> material revenue attributable to any individual foreign country. Revenue by geographic area, based on customer location, is allocated as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,205</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,227</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,474</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,080</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-lived assets were </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> located in domestic markets as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and December 31, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Description and Significant Accounting Policies</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Description</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Glowpoint, Inc. (&#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Glowpoint,</font><font style="font-family:inherit;font-size:10pt;">&#8221; &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">we,</font><font style="font-family:inherit;font-size:10pt;">&#8221; &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">us,</font><font style="font-family:inherit;font-size:10pt;">&#8221; or the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Company</font><font style="font-family:inherit;font-size:10pt;">&#8221;) is a managed service provider of video collaboration and network applications. Our services are designed to provide a comprehensive suite of automated and concierge applications to simplify the user experience and expedite the adoption of video as the primary means of collaboration. Our customers include Fortune 1000 companies, along with small and medium sized enterprises in a variety of industries. We market our services globally through a multi-channel sales approach that includes direct sales and channel partners. The Company was formed as a Delaware corporation in May 2000. The Company operates in </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> segment and therefore segment information is not presented.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements include the accounts of Glowpoint and our </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">-owned subsidiary, GP Communications, LLC, whose business function is to provide interstate telecommunications services for regulatory purposes. All material inter-company balances and transactions have been eliminated in consolidation. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The December 31, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> year-end condensed consolidated balance sheet data in this document were derived from audited consolidated financial statements and does not include all of the disclosures required by U.S. generally accepted accounting principles. These condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements as of and for the fiscal year ended December 31, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and notes thereto included in the Company's fiscal </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Annual Report on Form 10-K, filed with the Securities and Exchange Commission on </font><font style="font-family:inherit;font-size:10pt;font-style:normal;">March&#160;7, 2018</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;</font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> 10-K&#8221;).</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant Accounting Policies</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The significant accounting policies used in preparation of these condensed consolidated financial statements are disclosed in our </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> 10-K. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Adopted Accounting Standards</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (ASU) 2014-09 (Topic 606) "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">." Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605 &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;">&#8221; (Topic 605), and requires entities to recognize revenue when control of promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. On&#160;January&#160;1, 2018, we adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of&#160;January&#160;1, 2018. Results for reporting periods beginning after&#160;January&#160;1, 2018&#160;are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Accounting Standards Codification Topic 605. We did not record an adjustment to opening accumulated deficit as of&#160;January&#160;1, 2018&#160;as the cumulative impact of adopting Topic 606 was not material. The costs associated with obtaining a customer contract were previously expensed in the period they were incurred. Under Topic 606, these payments are deferred on our consolidated balance sheet and amortized over the expected life of the customer contract. The impact to sales and marketing expense for the three months ended&#160;March 31, 2018 was not material&#160;as a result of applying Topic 606. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the&#160;FASB&#160;issued ASU No. 2016-15,&#160;which amends ASC 230, to clarify guidance&#160;on the classification of certain cash receipts and payments in the statement of cash flows. The FASB issued ASU 2016-15 with the intent of reducing diversity in practice with respect to eight types of cash flows. This guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB issued ASU 2017-09, which clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as modifications. ASU 2017-09 will reduce diversity in practice and result in fewer changes to the terms of an award being accounted for as modifications. Under ASU 2017-09, an entity will not apply modification accounting to a share-based payment award if the award's fair value, vesting conditions and classification as an equity or liability instrument are the same immediately before and after the change. ASU 2017-09 will be applied prospectively to awards modified on or after the adoption date. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:174%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Recently Issued Accounting Pronouncements</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:174%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016 the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8220;Leases&#8221;</font><font style="font-family:inherit;font-size:10pt;">. The ASU introduces a lessee model that results in most leases impacting the balance sheet. The ASU addresses other concerns related to the current leases model.&#160; Under ASU 2016-02, lessees will be required to recognize for all leases with terms longer than 12 months, at the commencement date of the lease, a lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease measured on a discounted basis, and a right-to-use asset, which is an asset that represents the lessee&#8217;s right to use or control the use of a specified asset for the lease term.&#160; Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition.&#160; The update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. While we continue to evaluate the effect of adopting this guidance on our consolidated financial statements and related disclosures, we expect our operating leases, as disclosed in Note 10, will be subject to the new standard. We will recognize right-of-use assets and operating lease liabilities on our balance sheet upon adoption, which will increase our total assets and liabilities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Subsequent Events</font></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of March&#160;31, 2018, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding borrowings under the Company&#8217;s A/R Revolver with Western Alliance Bank and we had availability of </font><font style="font-family:inherit;font-size:10pt;">$764,000</font><font style="font-family:inherit;font-size:10pt;">. On </font><font style="font-family:inherit;font-size:10pt;">May 8, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company entered into a payoff letter with Western Alliance Bank that terminated the Western Alliance Bank Loan Agreement. See &#8220;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Part II. Item 5. Other Information</font><font style="font-family:inherit;font-size:10pt;">&#8221; below for additional information regarding the termination of the Western Alliance Bank Loan Agreement.</font></div></div> EX-101.SCH 6 glow-20180331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2106100 - Disclosure - Accrued Expenses and Other Liabilities link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Accrued Expenses and Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Business Description and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Business Description and Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Business Description and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Capitalized Software Costs link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - Capitalized Software Costs - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2129100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2429403 - Disclosure - Commitments and Contingencies - Future Minimum Rental Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 2429402 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2329301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1004001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2131100 - Disclosure - Geographical Data link:presentationLink link:calculationLink link:definitionLink 2431402 - Disclosure - Geographical Data - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2431403 - Disclosure - Geographical Data - Revenue by Geographic Area (Details) link:presentationLink link:calculationLink link:definitionLink 2331301 - Disclosure - Geographical Data (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Goodwill & Intangibles link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - Goodwill & Intangibles - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Liquidity and Going Concern link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - Liquidity and Going Concern - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2130100 - Disclosure - Major Customers link:presentationLink link:calculationLink link:definitionLink 2430401 - Disclosure - Major Customers - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2128100 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 2428403 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2428404 - Disclosure - Net Loss Per Share - Effect of Antidilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2428402 - Disclosure - Net Loss Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2328301 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Preferred Stock link:presentationLink link:calculationLink link:definitionLink 2413401 - Disclosure - Preferred Stock - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2126100 - Disclosure - Restricted Stock Awards link:presentationLink link:calculationLink link:definitionLink 2426403 - Disclosure - Restricted Stock Awards - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2426402 - Disclosure - Restricted Stock Awards - Summary of Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2426404 - Disclosure - Restricted Stock Awards - Summary of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2326301 - Disclosure - Restricted Stock Awards (Tables) link:presentationLink link:calculationLink link:definitionLink 2127100 - Disclosure - Restricted Stock Units link:presentationLink link:calculationLink link:definitionLink 2427403 - Disclosure - Restricted Stock Units - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2427402 - Disclosure - Restricted Stock Units - Summary of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2427404 - Disclosure - Restricted Stock Units - Summary of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2327301 - Disclosure - Restricted Stock Units (Tables) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - Stock Based Compensation link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - Stock Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2425403 - Disclosure - Stock Based Compensation - Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2133100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2433401 - Disclosure - Subsequent Events - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 glow-20180331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 glow-20180331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 glow-20180331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Earnings Per Share [Abstract] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Line of Credit Facility [Table] Line of Credit Facility [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Preferred Stock Preferred Stock [Member] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Series C Preferred Stock Series C Preferred Stock [Member] Series B Preferred Stock Series B Preferred Stock [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Western Alliance Bank Western Alliance Bank Loan Agreement [Member] Western Alliance Bank Loan Agreement [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Cash Cash Working capital Working Capital Positive working capital means that the company is able to pay off its short-term liabilities. Negative working capital means that a company currently is unable to meet its short-term liabilities with its current assets (cash, accounts receivable and inventory). Debt Long-term Debt Net loss Net Income (Loss) Attributable to Parent Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash paid for interest payments on then-existing indebtedness Interest Paid Outstanding principal, debt obligations Long-term Debt, Gross Issuance of stock (in shares) Stock Issued During Period, Shares, New Issues Dividend rate, percentage Preferred Stock, Dividend Rate, Percentage Issuance of preferred stock, net of expenses Stock Issued During Period, Value, New Issues Principal payment made Repayments of Long-term Debt Accounting Policies [Abstract] Principles of Consolidation Consolidation, Policy [Policy Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Adopted Accounting Standards and Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Capitalized Software Costs Internal Use Software, Policy [Policy Text Block] Goodwill & Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Commitments and Contingencies Disclosure [Abstract] Number of leased facilities Operating Leases, Number of Facilities Operating Leases, Number of Facilities Rent expense Operating Leases, Rent Expense, Net Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Western Alliance Bank A/R Revolver Bridge Bank Loan Agreement A/R Revolver [Member] Bridge Bank Loan Agreement A/R Revolver [Member] Super G Loan Super G Capital [Member] Super G Capital [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Long-term debt Unamortized debt discounts Debt Instrument, Unamortized Discount Net carrying value Less: current maturities, net of debt discount Long-term Debt, Current Maturities Long-term obligations, net of debt discount Long-term Debt, Excluding Current Maturities Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Series A-2 Preferred Stock Series A Preferred Stock [Member] Statement [Line Items] Statement [Line Items] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Accounts receivable, net Accounts Receivable, Net, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Goodwill Goodwill Intangibles, net Intangible Assets, Net (Excluding Goodwill) Other assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Current portion of long-term debt Accounts payable Accounts Payable, Current Accrued expenses and other liabilities Accrued Liabilities, Current Accrued sales taxes and regulatory fees Accrued Sales Taxes and Regulatory Fees Accrued Sales Taxes and Regulatory Fees Total current liabilities Liabilities, Current Long term liabilities: Liabilities, Noncurrent [Abstract] Long term debt, net of current portion Total long term liabilities Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies (see Note 10) Commitments and Contingencies Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock Preferred Stock, Value, Issued Common stock, $.0001 par value; 150,000,000 shares authorized; 47,318,000 issued and 46,485,000 outstanding at March 31, 2018 and 45,161,000 issued and 44,510,000 outstanding at December 31, 2017 Common Stock, Value, Issued Treasury stock, 833,000 and 651,000 shares at March 31, 2018 and December 31, 2017, respectively Treasury Stock, Value Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated deficit Retained Earnings (Accumulated Deficit) Total stockholders’ equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders’ equity Liabilities and Equity Equity [Abstract] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Perpetual Series B-1 Preferred Stock Perpetual Series B-1 Preferred Stock [Member] Perpetual Series B-1 Preferred Stock [Member] Series D Preferred Stock Series D Preferred Stock [Member] Perpetual Series B Preferred Stock Perpetual Series B Preferred Stock [Member] Perpetual Series B Preferred Stock [Member] Common Stock Common Stock [Member] Class of Stock [Line Items] Class of Stock [Line Items] Preferred stock, convertible, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Preferred stock, stated value Preferred Stock, Stated Value Preferred Stock, Stated Value Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Stated value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Stock issued during period, conversion of convertible securities, price (in dollars per share) Stock Issued During Period, Conversion of Convertible Securities, Price Stock Issued During Period, Conversion of Convertible Securities, Price Convertible preferred stock, shares issued upon conversion (in shares) Convertible Preferred Stock, Shares Issued upon Conversion Preferred stock, cumulative dividend percentage rate, per annum Accrued dividends Dividends Payable, Current Redemption price per share (in dollars per share) Preferred Stock, Redemption Price Per Share Redemption price per share, multiplier (in dollars per share) Preferred Stock, Redemption Price Per Share, Value Applied to Multiplier Preferred Stock, Redemption Price Per Share, Value Applied to Multiplier Redemption price per share, multiplier, percentage Preferred Stock, Redemption Price, Multiplier, Percentage Preferred Stock, Redemption Price, Multiplier, Percentage Proceeds from issuance of preferred stock gross Proceeds from Issuance of Preferred Stock and Preference Stock Issuance of stock Stock issued for conversion of convertible preferred stock, shares (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Participation rights, future offerings, max percentage Preferred Stock, Participation Rights, Future Offerings, Maximum Percentage Preferred Stock, Participation Rights, Future Offerings, Maximum Percentage Expansion of board of director members Expansion Of Board Of Director Members, Number Of Members Expansion Of Board Of Director Members, Number Of Members Minimum number of shares outstanding and unconverted (in shares) Preferred Stock, Minimum Number Of Shares Outstanding And Unconverted, Terms Of Stock Or Convertible Securities Issuance, Approved Written Consent Required Preferred Stock, Minimum Number Of Shares Outstanding And Unconverted, Terms Of Stock Or Convertible Securities Issuance, Approved Written Consent Required Participation rights, future offerings, limitation on stated value outstanding Preferred Stock, Participation Rights, Future Offerings, Limitation On Stated Value Outstanding Preferred Stock, Participation Rights, Future Offerings, Limitation On Stated Value Outstanding Derivative liability Derivative Liability Conversion price below this fair value of the common stock (in dollars per share) Conversion Price Below this Fair Value of the Common Stock, Per Share Conversion Price Below this Fair Value of the Common Stock, Per Share Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Equity Incentive Plan, 2014 Equity Incentive Plan, 2014 [Member] Equity Incentive Plan, 2014 [Member] Amended Equity Incentive Plan, 2014 Amended Equity Incentive Plan, 2014 [Member] Amended Equity Incentive Plan, 2014 [Member] Stock Incentive Plan, 2007 Stock Incentive Plan, 2007 [Member] Stock Incentive Plan, 2007 [Member] Stock Incentive Plan, 2000 Stock Incentive Plan, 2000 [Member] Stock Incentive Plan, 2000 [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Stock Options Employee Stock Option [Member] Restricted stock Restricted Stock [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of events to occur to permit granting (or more) Share-based Compensation Arrangement by Share-based Payment Award, Number of Events to Occur to Permit Granting Share-based Compensation Arrangement by Share-based Payment Award, Number of Events to Occur to Permit Granting Shares available for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Shares granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Proposed shares available for issuance (in shares) Share-based Compensation Arrangement By Share-based Payment Award, Proposed Number Of Shares Available For Grant Share-based Compensation Arrangement By Share-based Payment Award, Proposed Number Of Shares Available For Grant Outstanding number of shares underlying options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Shares outstanding (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Stock-based compensation expense Allocated Share-based Compensation Expense Unrecognized stock-based compensation expense Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event [Line Items] Subsequent Event [Line Items] Available borrowing capacity Debt Instrument, Unused Borrowing Capacity, Amount Segment Reporting [Abstract] Schedule of Revenue by Geographical Area Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of Long-term Debt Schedule of Long-term Debt Instruments [Table Text Block] Statement of Stockholders' Equity [Abstract] Treasury Stock Treasury Stock [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Accumulated Deficit Retained Earnings [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning Balance (in shares) Shares, Outstanding Beginning Balance, value Net loss Stock-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Issuance of preferred stock, net of expenses (in shares) Preferred stock conversion (in shares) Preferred stock conversion Stock Issued During Period, Value, Conversion of Convertible Securities Issuance of stock on vested restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Issuance of stock on vested restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Preferred stock dividends Dividends, Preferred Stock Purchase of treasury stock (in shares) Treasury Stock, Shares, Acquired Purchase of treasury stock Treasury Stock, Value, Acquired, Cost Method Ending Balance (in shares) Ending Balance, value Business Description and Significant Accounting Policies Significant Accounting Policies [Text Block] Risks and Uncertainties [Abstract] Concentration Risk [Table] Concentration Risk [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Customer Concentration Risk Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Revenues Sales Revenue, Services, Net [Member] Accounts Receivable Accounts Receivable [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Customer No. 1 Customer Number One [Member] Customer Number One [Member] Customer No. 2 Customer Number Two [Member] Customer Number Two [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Number of customers Concentration Risk, Number of Customers Concentration Risk, Number of Customers Concentration risk percentage Concentration Risk, Percentage Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of revenue Cost of Sales [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Number of operating segments Number of Operating Segments Ownership percentage in subsidiary Subsidiary Investee, Ownership Percentage by Parent Subsidiary Investee, Ownership Percentage by Parent Antidilutive securities excluded from computation of earnings per share, amount (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Vested and remaining outstanding (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Remain Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Remain Outstanding Net Loss Per Share Earnings Per Share [Text Block] Major Customers Concentration Risk Disclosure [Text Block] Bridge Bank Loan Agreement Non-Formula Borrowings Bridge Bank Loan Agreement Non-Formula Borrowings [Member] Bridge Bank Loan Agreement Non-Formula Borrowings [Member] Western Alliance Bank And Super G Capital Western Alliance Bank And Super G Capital [Member] Western Alliance Bank And Super G Capital [Member] Super G Capital Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Prime Rate Prime Rate [Member] Warrant Warrant [Member] Total current borrowing capacity (up to) Debt Instrument, Current Borrowing Capacity Debt Instrument, Current Borrowing Capacity Borrowing base of eligible accounts receivable Debt Instrument, Borrowing Base of Eligible Accounts Receivable Debt Instrument, Borrowing Base of Eligible Accounts Receivable Installment payment due January 1, 2018 Debt Instrument, Periodic Payment One Debt Instrument, Periodic Payment One Installment payment due April 1, 2018 Debt Instrument, Periodic Payment Two Debt Instrument, Periodic Payment Two Variable rate Debt Instrument, Variable Rate Debt Instrument, Variable Rate Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Interest rate during the period Debt Instrument, Interest Rate During Period Prime rate, floor Debt Instrument, Basis Spread on Variable Rate, Floor Debt Instrument, Basis Spread on Variable Rate, Floor Proceeds from issuance of debt Proceeds from Issuance of Debt Total borrowings Additional availability Monthly installment payment for first three months following closing Debt Instrument, Periodic Payments One Through Three Debt Instrument, Periodic Payments One Through Three Monthly installment payment for months four through twenty-four Debt Instrument, Periodic Payments Four Through Twenty-Four Debt Instrument, Periodic Payments Four Through Twenty-Four Total payments Debt Instrument, Periodic Payment Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Warrants issued (in shares) Class of Warrant or Right, Outstanding Exercise price for outstanding warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants, term period Class of Warrant or Right, Term, Period Class of Warrant or Right, Term, Period Warrant, profit over the term, or cash exit fee implemented (at least) Class of Warrant or Right, Profit Over the Term, or Cash Exit Fee Implemented Class of Warrant or Right, Profit Over the Term, or Cash Exit Fee Implemented Warrants exercised (in shares) Stock Redeemed or Called During Period, Shares Fair value of warrant recorded as derivative liability Repayments of debt, total cash payments Repayments of Debt Long-term debt Gain on debt extinguishment Gain (Loss) on Extinguishment of Debt Unamortized debt discount Debt issuance costs Debt Issuance Costs, Gross Warrants issued Warrants and Rights Outstanding Amortization of debt discount Amortization of Debt Discount (Premium) Summary of Stock Option Activity Share-based Compensation, Stock Options, Activity [Table Text Block] Maximum Maximum [Member] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Software and Software Development Costs Software and Software Development Costs [Member] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Capitalized software costs, useful life Property, Plant and Equipment, Useful Life Capitalized software costs, additions Property, Plant and Equipment, Additions Amortization Amortization Impairment losses Other Asset Impairment Charges Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Cost of revenue Research and development Research and Development Expense [Member] Sales and marketing Selling and Marketing Expense [Member] General and administrative General and Administrative Expense [Member] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Research and development General and administrative Other Liabilities Disclosure [Abstract] Accrued Expenses, Current [Abstract] Accrued Liabilities, Current [Abstract] Other accrued expenses Other Accrued Liabilities, Current Accrued compensation costs Employee-related Liabilities, Current Accrued marketing expense Accrued Marketing Costs, Current Deferred revenue Deferred Revenue Super G Warrant liability Derivative Liability, Current Accrued expenses and other liabilities Stock Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Summary of Restricted Stock Activity Schedule of Nonvested Share Activity [Table Text Block] Summary of Compensation Expense Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Preferred stock, convertible, par value (in dollars per share) Preferred stock, convertible, stated value Preferred stock, convertible, shares issued (in shares) Preferred stock, convertible, shares outstanding (in shares) Preferred stock, convertible, liquidation value Preferred Stock, Liquidation Preference, Value Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Treasury stock, shares (in shares) Treasury Stock, Shares Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Unvested restricted stock units Unvested restricted stock awards Outstanding stock options Shares of common stock issuable upon conversion of Series A-2 Preferred Shares of common stock issuable upon conversion of Series B Preferred Shares of common stock issuable upon conversion of Series C Preferred Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill & Intangibles Goodwill and Intangible Assets Disclosure [Text Block] Restricted Stock Units, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Unvested restricted shares/units outstanding, beginning (in shares) Vested, restricted shares/units (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited, restricted shares/units (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Unvested restricted shares/units outstanding, ending (in shares) Restricted Stock Units, Weighted Average Grant Price [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Unvested restricted shares/units, weighted average grant price, beginning (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Vested, weighted average grant price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited, weighted average grant price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Unvested restricted shares/units, weighted average grant price, ending (in dollars per share) Equity Securities, Status [Axis] Equity Securities, Status [Axis] Equity Securities, Status [Axis] Equity Securities, Status [Domain] Equity Securities, Status [Domain] [Domain] for Equity Securities, Status [Axis] Shares Withheld and Repurchased Shares Withheld and Repurchased [Member] Shares Withheld and Repurchased [Member] Time-based Restricted Stock Awards Time-based Restricted Stock Awards [Member] Time-based Restricted Stock Awards [Member] Performance-based Restricted Stock Awards Performance-based Restricted Stock Awards [Member] Performance-based Restricted Stock Awards [Member] Shares withheld and repurchased to satisfy tax obligation (in shares) Shares Paid for Tax Withholding for Share Based Compensation Statutory tax withholding requirements Payments Related to Tax Withholding for Share-based Compensation Unrecognized stock-based compensation expense Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Weighted average period for amortization of unrecognized stock-based compensation Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Subsequent Events Subsequent Events [Text Block] Capitalized Software Costs Research, Development, and Computer Software Disclosure [Text Block] Material revenue attributable to individual foreign country Revenue Attributable to Individual Foreign Country Revenue Attributable to Individual Foreign Country Long lived assets located in domestic markets Long Lived Assets Located in Domestic Markets Long Lived Assets Located in Domestic Markets Schedule of Future Minimum Rental Payments for Operating Leases Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Accrued Expenses and Other Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Goodwill impairment charge Goodwill, Impairment Loss Impairment charges of intangible assets Impairment of Intangible Assets (Excluding Goodwill) Schedule of Accrued Expenses and Other Liabilities Schedule of Accrued Liabilities [Table Text Block] Preferred Stock Preferred Stock [Text Block] Restricted Stock, Number of Shares [Roll Forward] Restricted Stock, Weighted Average Grant Price [Roll Forward] Unvested restricted stock Restricted Stock Awards Summary of Restricted Stock Units Activity Summary of Compensation Expense Debt Debt Disclosure [Text Block] Liquidity and Going Concern Liquidity [Text Block] Liquidity [Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Domestic Geographic Distribution, Domestic [Member] Foreign Geographic Distribution, Foreign [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total Revenue Sales Revenue, Services, Net Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net loss Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Bad debt expense Provision for Doubtful Accounts Bad debt (recovery) Allowance for Doubtful Accounts Receivable, Recoveries Amortization of debt discount, net of gain on extinguishment Stock-based compensation Share-based Compensation Impairment charges Deferred tax provision Increase (Decrease) in Deferred Income Taxes Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable Increase (Decrease) in Accounts Payable Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued sales taxes and regulatory fees Increase (Decrease) In Accrued Expenses, Sales Taxes And Regulatory Fees Increase (Decrease) In Accrued Expenses, Sales Taxes And Regulatory Fees Net cash provided by (used in) operating activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Principal payments under borrowing arrangements Proceeds from Series C Preferred Stock issuance, net of expenses of $223 Purchase of treasury stock Payments for Repurchase of Common Stock Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Decrease in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash at beginning of period Cash at end of period Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Cash paid during the period for interest Non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Accrued preferred stock dividends Dividends Payable Vested deferred restricted stock units Performance-based Restricted Stock Units Performance-based Restricted Stock Units [Member] Performance-based Restricted Stock Units [Member] Time-based Restricted Stock Units Time-based Restricted Stock Units [Member] Time-based Restricted Stock Units [Member] Title of Individual [Axis] Title of Individual [Axis] Relationship to Entity [Domain] Relationship to Entity [Domain] Non-Employee Directors Non-Employee Director [Member] Non-Employee Director [Member] Unvested units outstanding (in shares) Document and Entity Information -- None. No documentation exists for this element. -- Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Stock issuance costs Payments of Stock Issuance Costs Geographical Data Segment Reporting Disclosure [Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Income Statement [Abstract] Revenue Operating expenses: Costs and Expenses [Abstract] Cost of revenue (exclusive of depreciation and amortization) Network and infrastructure Research and development Research and Development Expense Sales and marketing Selling and Marketing Expense General and administrative General and Administrative Expense Impairment charges Asset Impairment Charges Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Total operating expenses Costs and Expenses Loss from operations Operating Income (Loss) Interest and other expense, net Nonoperating Income (Expense) Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income tax expense Income Tax Expense (Benefit) Net loss Preferred stock dividends Preferred Stock Dividends, Income Statement Impact Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Net loss attributable to common stockholders per share: Basic and diluted net loss per share (in dollars per share) Earnings Per Share, Basic and Diluted Weighted-average number of shares of common stock: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic and diluted (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding Number of Shares Underlying Options, Beginning ( in shares) Outstanding Number of Shares Underlying Options, Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Outstanding Number of Shares Underlying Options, Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Outstanding Number of Shares Underlying Options, Ending (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Outstanding Weighted Average Exercise Price, Beginning (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding Weighted Average Exercise Price, Expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Outstanding Weighted Average Exercise Price, Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Outstanding Weighted Average Exercise Price, Ending (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] Exercisable Number of Shares Underlying Options, Beginning (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable Number of Shares Underlying Options, Ending (in shares) Exercisable Weighted Average Exercise Price, Beginning (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable Weighted Average Exercise Price, Ending (in dollars per share) Numerator: Numerator [Abstract] Numerator [Abstract] Net loss Less: preferred stock dividends Denominator: Denominator [Abstract] Denominator [Abstract] Weighted-average number of shares of common stock for basic and diluted net loss per share (in shares) Remaining 2018 Operating Leases, Future Minimum Payments, Remainder of Fiscal Year 2019 Operating Leases, Future Minimum Payments, Due in Two Years 2020 Operating Leases, Future Minimum Payments, Due in Three Years Total Operating Leases, Future Minimum Payments Due Restricted Stock Units EX-101.PRE 10 glow-20180331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2018
May 07, 2018
Document and Entity Information    
Entity Registrant Name GLOWPOINT, INC.  
Entity Central Index Key 0000746210  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Document Type 10-Q  
Document Period End Date Mar. 31, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Entity Common Stock, Shares Outstanding (in shares)   46,484,975
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash $ 3,068 $ 3,946
Accounts receivable, net 1,295 1,220
Prepaid expenses and other current assets 696 715
Total current assets 5,059 5,881
Property and equipment, net 1,007 1,159
Goodwill 7,100 7,750
Intangibles, net 594 626
Other assets 8 8
Total assets 13,768 15,424
Current liabilities:    
Current portion of long-term debt 0 1,194
Accounts payable 309 337
Accrued expenses and other liabilities 714 1,003
Accrued sales taxes and regulatory fees 247 259
Total current liabilities 1,270 2,793
Long term liabilities:    
Long term debt, net of current portion 0 369
Total long term liabilities 0 369
Total liabilities 1,270 3,162
Commitments and contingencies (see Note 10)
Stockholders’ equity:    
Common stock, $.0001 par value; 150,000,000 shares authorized; 47,318,000 issued and 46,485,000 outstanding at March 31, 2018 and 45,161,000 issued and 44,510,000 outstanding at December 31, 2017 5 5
Treasury stock, 833,000 and 651,000 shares at March 31, 2018 and December 31, 2017, respectively (405) (352)
Additional paid-in capital 184,688 183,114
Accumulated deficit (171,790) (170,505)
Total stockholders’ equity 12,498 12,262
Total liabilities and stockholders’ equity 13,768 15,424
Series A-2 Preferred Stock    
Stockholders’ equity:    
Preferred stock 0 0
Series B Preferred Stock    
Stockholders’ equity:    
Preferred stock 0 0
Series C Preferred Stock    
Stockholders’ equity:    
Preferred stock $ 0 $ 0
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Preferred stock, convertible, shares authorized (in shares) 5,000,000  
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 150,000,000 150,000,000
Common stock, shares issued (in shares) 47,318,000 45,161,000
Common stock, shares outstanding (in shares) 46,485,000 44,510,000
Treasury stock, shares (in shares) 833,000 651,000
Series A-2 Preferred Stock    
Preferred stock, convertible, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, convertible, stated value $ 7,500 $ 7,500
Preferred stock, convertible, shares authorized (in shares) 7,500 7,500
Preferred stock, convertible, shares issued (in shares) 32 32
Preferred stock, convertible, shares outstanding (in shares) 32 32
Preferred stock, convertible, liquidation value $ 237,000 $ 237,000
Series B Preferred Stock    
Preferred stock, convertible, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, convertible, stated value $ 1,000 $ 1,000
Preferred stock, convertible, shares authorized (in shares) 2,800 2,800
Preferred stock, convertible, shares issued (in shares) 375 450
Preferred stock, convertible, shares outstanding (in shares) 375 450
Preferred stock, convertible, liquidation value $ 375,000 $ 375,000
Series C Preferred Stock    
Preferred stock, convertible, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, convertible, stated value $ 1,000 $ 1,000
Preferred stock, convertible, shares authorized (in shares) 1,750 1,750
Preferred stock, convertible, shares issued (in shares) 1,275 0
Preferred stock, convertible, shares outstanding (in shares) 1,275 0
Preferred stock, convertible, liquidation value $ 1,275,000 $ 0
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Revenue $ 3,474 $ 4,080
Operating expenses:    
Cost of revenue (exclusive of depreciation and amortization) 2,147 2,448
Research and development 250 287
Sales and marketing 177 140
General and administrative 898 1,016
Impairment charges 650 0
Depreciation and amortization 232 459
Total operating expenses 4,354 4,350
Loss from operations (880) (270)
Interest and other expense, net (405) (371)
Loss before income taxes (1,285) (641)
Income tax expense 0 (27)
Net loss (1,285) (668)
Preferred stock dividends 3 3
Net loss attributable to common stockholders $ (1,288) $ (671)
Net loss attributable to common stockholders per share:    
Basic and diluted net loss per share (in dollars per share) $ (0.03) $ (0.02)
Weighted-average number of shares of common stock:    
Basic and diluted (in shares) 46,232 36,181
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - 3 months ended Mar. 31, 2018 - USD ($)
$ in Thousands
Total
Preferred Stock
Series A-2 Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Common Stock
Common Stock
Series B Preferred Stock
Common Stock
Series C Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2017   32 450   45,161,000     651,000    
Beginning Balance, value at Dec. 31, 2017 $ 12,262 $ 0     $ 5     $ (352) $ 183,114 $ (170,505)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net loss (1,285)                 (1,285)
Stock-based compensation 50               50  
Issuance of preferred stock, net of expenses (in shares)       1,750            
Issuance of preferred stock, net of expenses 1,527               1,527  
Preferred stock conversion (in shares)   0 (75) (475) 1,851,000 268,000 1,583,000      
Preferred stock conversion 0 $ 0             0  
Issuance of stock on vested restricted stock units (in shares)         306,000          
Issuance of stock on vested restricted stock units 0                  
Preferred stock dividends (3)               (3)  
Purchase of treasury stock (in shares)               182,000    
Purchase of treasury stock (53)             $ (53)    
Ending Balance (in shares) at Mar. 31, 2018   32 375 1,275 47,318,000     833,000    
Ending Balance, value at Mar. 31, 2018 $ 12,498 $ 0     $ 5     $ (405) $ 184,688 $ (171,790)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net loss $ (1,285) $ (668)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 232 459
Bad debt expense 5  
Bad debt (recovery)   (4)
Amortization of debt discount, net of gain on extinguishment 104 18
Stock-based compensation 50 164
Impairment charges 650 0
Deferred tax provision 0 27
Changes in assets and liabilities:    
Accounts receivable (80) (2)
Prepaid expenses and other current assets 19 (60)
Accounts payable (28) 83
Accrued expenses and other liabilities (127) 56
Accrued sales taxes and regulatory fees (12) (55)
Net cash provided by (used in) operating activities (472) 18
Cash flows from investing activities:    
Purchases of property and equipment (48) (36)
Net cash used in investing activities (48) (36)
Cash flows from financing activities:    
Principal payments under borrowing arrangements (1,832) 0
Proceeds from Series C Preferred Stock issuance, net of expenses of $223 1,527 0
Purchase of treasury stock (53) (12)
Net cash used in financing activities (358) (12)
Decrease in cash and cash equivalents (878) (30)
Cash at beginning of period 3,946 1,140
Cash at end of period 3,068 1,110
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 316 266
Non-cash investing and financing activities:    
Accrued preferred stock dividends $ 3 $ 3
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)
$ in Thousands
3 Months Ended
Mar. 31, 2018
USD ($)
Series C Preferred Stock  
Stock issuance costs $ 223
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Description and Significant Accounting Policies
3 Months Ended
Mar. 31, 2018
Accounting Policies [Abstract]  
Business Description and Significant Accounting Policies
Business Description and Significant Accounting Policies

Business Description

Glowpoint, Inc. (“Glowpoint,” “we,” “us,” or the “Company”) is a managed service provider of video collaboration and network applications. Our services are designed to provide a comprehensive suite of automated and concierge applications to simplify the user experience and expedite the adoption of video as the primary means of collaboration. Our customers include Fortune 1000 companies, along with small and medium sized enterprises in a variety of industries. We market our services globally through a multi-channel sales approach that includes direct sales and channel partners. The Company was formed as a Delaware corporation in May 2000. The Company operates in one segment and therefore segment information is not presented.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Glowpoint and our 100%-owned subsidiary, GP Communications, LLC, whose business function is to provide interstate telecommunications services for regulatory purposes. All material inter-company balances and transactions have been eliminated in consolidation.

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2017. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2017 year-end condensed consolidated balance sheet data in this document were derived from audited consolidated financial statements and does not include all of the disclosures required by U.S. generally accepted accounting principles. These condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements as of and for the fiscal year ended December 31, 2017 and notes thereto included in the Company's fiscal 2017 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 7, 2018 (the “2017 10-K”).

The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

Significant Accounting Policies

The significant accounting policies used in preparation of these condensed consolidated financial statements are disclosed in our 2017 10-K.

Adopted Accounting Standards

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (ASU) 2014-09 (Topic 606) "Revenue from Contracts with Customers." Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605 “Revenue Recognition” (Topic 605), and requires entities to recognize revenue when control of promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. On January 1, 2018, we adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Accounting Standards Codification Topic 605. We did not record an adjustment to opening accumulated deficit as of January 1, 2018 as the cumulative impact of adopting Topic 606 was not material. The costs associated with obtaining a customer contract were previously expensed in the period they were incurred. Under Topic 606, these payments are deferred on our consolidated balance sheet and amortized over the expected life of the customer contract. The impact to sales and marketing expense for the three months ended March 31, 2018 was not material as a result of applying Topic 606.

In August 2016, the FASB issued ASU No. 2016-15, which amends ASC 230, to clarify guidance on the classification of certain cash receipts and payments in the statement of cash flows. The FASB issued ASU 2016-15 with the intent of reducing diversity in practice with respect to eight types of cash flows. This guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.

In May 2017, the FASB issued ASU 2017-09, which clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as modifications. ASU 2017-09 will reduce diversity in practice and result in fewer changes to the terms of an award being accounted for as modifications. Under ASU 2017-09, an entity will not apply modification accounting to a share-based payment award if the award's fair value, vesting conditions and classification as an equity or liability instrument are the same immediately before and after the change. ASU 2017-09 will be applied prospectively to awards modified on or after the adoption date. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.

Recently Issued Accounting Pronouncements             

In February 2016 the FASB issued ASU 2016-02, “Leases”. The ASU introduces a lessee model that results in most leases impacting the balance sheet. The ASU addresses other concerns related to the current leases model.  Under ASU 2016-02, lessees will be required to recognize for all leases with terms longer than 12 months, at the commencement date of the lease, a lease liability, which is a lessee’s obligation to make lease payments arising from a lease measured on a discounted basis, and a right-to-use asset, which is an asset that represents the lessee’s right to use or control the use of a specified asset for the lease term.  Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition.  The update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. While we continue to evaluate the effect of adopting this guidance on our consolidated financial statements and related disclosures, we expect our operating leases, as disclosed in Note 10, will be subject to the new standard. We will recognize right-of-use assets and operating lease liabilities on our balance sheet upon adoption, which will increase our total assets and liabilities.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Liquidity and Going Concern
3 Months Ended
Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Liquidity and Going Concern
Liquidity and Going Concern

As of March 31, 2018, we had $3,068,000 of cash, working capital of $3,789,000 and no debt. For the three months ended March 31, 2018, we incurred a net loss of $1,285,000 and used $472,000 of net cash in operating activities. During the three months ended March 31, 2018 and the year ended December 31, 2017, a substantial portion of our cash flow from operations has been dedicated to the payment of interest on our then-existing indebtedness, thereby reducing our ability to use our cash flow to fund our operations, capital expenditures and investments in sales and marketing. For the three months ended March 31, 2018 and 2017, our cash flow from operations was reduced by $316,000 and $266,000, respectively, for interest payments on our then-existing indebtedness.

During the three months ended March 31, 2018, the Company completed a series of transactions (each of which is described further in Notes 6 and 7 below, as applicable) that improved our financial position and reduced the outstanding principal on our debt obligations from $1.8 million as of December 31, 2017 to $0 as of March 31, 2018. The following is a summary of these transactions:

On January 25, 2018, the Company closed a registered direct offering of 1,750 shares of our 0% Series C Convertible Preferred Stock (the “Series C Preferred Stock”) for net proceeds of $1,527,000 (the “Series C Offering”).
On January 26, 2018, the Company terminated the Business Loan and Security Agreement, dated July 31, 2017, by and between the Company and Super G Capital LLC (“Super G”), along with the accompanying Warrant to Purchase Shares of Common Stock, dated July 31, 2017, and paid off all remaining debt obligations with Super G (“the Super G Payoff”).
During the three months ended March 31, 2018, the Company made total principal payments of $800,000 on the Western Alliance Bank Loan Agreement, resulting in no outstanding debt as of March 31, 2018.

Our capital requirements continue to depend on numerous factors, including the timing and amount of revenue, the expense to deliver our services, expense for sales and marketing, expense for research and development, capital improvements, and the cost involved in protecting our intellectual property rights. The Company believes that, based on our current projection of revenue, expenses, capital expenditures and cash flows, it has sufficient resources to fund its operations for at least the next twelve months following the filing of this Report. However, there is no assurance the Company will be able to accomplish this during this period or in the future following such period. The Company anticipates reduced cash flow from operations and increased levels of capital expenditures in 2018 as compared to 2017, and we believe additional capital may be required to fund investments in product development and sales and marketing as a means to reverse our revenue trends. While we expect to continue to adjust our cost of revenue and other operating expenses to partially offset the impact of revenue declines associated with our legacy services, we believe additional capital may be necessary to fund our obligations. In the event we need access to capital to fund operations or provide growth capital, we would likely need to raise capital in one or more equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The respective lead investors of the 0% Series B Convertible Preferred Stock (the “Series B Preferred Stock”) and the Series C Preferred Stock have certain rights to approve future financings. There can be no assurance that the lead investors will provide the required approvals, which may affect our ability to raise capital, refinance indebtedness or borrow additional funds on terms we deem advisable, or at all. Failure to obtain financing, or obtaining financing on unfavorable terms, could result in a decrease in our stock price, would have a material adverse effect on future operating prospects, and could require us to significantly reduce operations.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Capitalized Software Costs
3 Months Ended
Mar. 31, 2018
Accounting Policies [Abstract]  
Capitalized Software Costs
Capitalized Software Costs

The Company capitalizes certain costs incurred in connection with developing or obtaining internal-use software. All software development costs have been appropriately accounted for as required by ASC Topic 350-40 “Intangible – Goodwill and Other – Internal-Use Software”. Capitalized software costs are included in “Property and equipment, net” on our condensed consolidated balance sheets and are amortized over three to four years. Software costs that do not meet capitalization criteria are expensed as incurred. For the three months ended March 31, 2018, we capitalized $48,000 of internal-use software costs. For the three months ended March 31, 2018 and 2017, we amortized $131,000 and $157,000, respectively, of these costs. During the three months ended March 31, 2018 and 2017, we recorded no impairment losses related to capitalized software.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill & Intangibles
3 Months Ended
Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill & Intangibles
Goodwill & Intangibles

Goodwill is not amortized but is subject to periodic testing for impairment in accordance with ASC Topic 350 “Intangibles - Goodwill and Other - Testing Indefinite-Lived Intangible Assets for Impairment”. We test goodwill for impairment on an annual basis on September 30 of each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. As of March 31, 2018, the Company considered the declines in our revenue and stock price to be a triggering event for an interim goodwill impairment test. The Company operates as a single reporting unit and used market-based approaches to determine the fair value of the reporting unit. These approaches used quoted market prices in active markets and revenue multiples for comparable companies. As of March 31, 2018, the carrying amount of our reporting unit exceeded its fair value; therefore, the Company recorded a goodwill impairment charge of $650,000 in the three months ended March 31, 2018. This charge is recognized as “Impairment charges” on our Condensed Consolidated Statements of Operations. The remaining goodwill balance as of March 31, 2018 was $7,100,000. The continued future decline of our revenue, cash flows and/or stock price may give rise to a triggering event that may require the Company to record additional impairment charges on goodwill in the future.

The Company assesses the impairment of purchased intangible assets subject to amortization when events and circumstances indicate that the carrying value of the assets might not be recoverable.  Fair value of our intangible assets is determined using the relief from royalty methodology. This approach involves two steps: (a) estimating reasonable royalty rates for each intangible asset and (b) applying these royalty rates to a net revenue stream and discounting the resulting cash flows to determine fair value. This fair value is then compared with the carrying value of each intangible asset. If the carrying value of the intangible asset is greater than its implied fair value, an impairment in the amount of the excess is recognized and charged to operations. The determination of related estimated useful lives and whether or not these assets are impaired involves significant judgments, related primarily to the future profitability and/or future value of the assets. Changes in the Company’s strategic plan and/or other-than-temporary changes in market conditions could significantly impact these judgments and could require adjustments to recorded asset balances. Long-lived assets are evaluated for impairment at least annually, as well as whenever an event or change in circumstances has occurred that could have a significant adverse effect on the fair value of long-lived assets.  The Company performed an evaluation of intangible assets as of March 31, 2018 and determined that the fair value of the long-lived assets exceeded the carrying value, therefore no impairment charges were required for the three months ended March 31, 2018.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Accrued Expenses and Other Liabilities
3 Months Ended
Mar. 31, 2018
Other Liabilities Disclosure [Abstract]  
Accrued Expenses and Other Liabilities
Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following (in thousands):
 
March 31, 2018
 
December 31, 2017
Other accrued expenses
$
264

 
$
316

Accrued compensation costs
227

 
129

Accrued marketing expense
136

 

Deferred revenue
87

 
393

Super G Warrant liability

 
165

Accrued expenses and other liabilities
$
714

 
$
1,003

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Debt
3 Months Ended
Mar. 31, 2018
Debt Disclosure [Abstract]  
Debt
Debt

Debt consisted of the following (in thousands):
 
March 31, 2018
 
December 31, 2017
Western Alliance Bank A/R Revolver
$

 
$
800

Super G Loan

 
1,032

Unamortized debt discounts

 
(269
)
Net carrying value


1,563

Less: current maturities, net of debt discount

 
(1,194
)
Long-term obligations, net of debt discount
$

 
$
369



Western Alliance Bank Business Financing Agreement

On July 31, 2017, the Company and its subsidiary entered into a Business Financing Agreement with Western Alliance Bank, as lender (the “Western Alliance Bank Loan Agreement”). The Western Alliance Bank Loan Agreement provided the Company with up to a total of $1,500,000 of revolving loans (the “A/R Revolver”). The maximum amount available under the A/R Revolver was limited to the lesser of (x) $1,500,000 and (y) an amount equal to the borrowing base. The borrowing base included 85% of the Company’s eligible accounts receivable plus a non-formula amount (which was $400,000 at December 31, 2017, and which stepped down to $200,000 on January 1, 2018, and to $0 on April 1, 2018) (“the Non-Formula Amount”). The Western Alliance Bank Loan Agreement provided that all borrowings would bear interest at the prime rate (4.75% as of March 31, 2018) plus 2.25% (or a total of 7.00% as of March 31, 2018) per year. The prime rate was subject to a floor of 4.00%. Interest payments on the outstanding borrowings were due monthly. On July 31, 2017, the Company received a loan in an amount equal to $1,100,000 under the Western Alliance Bank Loan Agreement, consisting of $500,000 based on 85% of eligible accounts receivable and $600,000 of Non-Formula Amount. During the three months ended March 31, 2018, the Company made total principal payments of $800,000 on the A/R Revolver (including $400,000 on the Non-Formula Amount). As of March 31, 2018, there were no outstanding borrowings on the A/R Revolver and we had availability of $764,000. All loans under the A/R Revolver were to mature on July 31, 2019 (unless such loans are not supported by the borrowing base, in which case any loans exceeding the borrowing base must be immediately repaid). As of March 31, 2018, the Company was in compliance with all required covenants under the Western Alliance Bank Loan Agreement. On May 8, 2018, the Company terminated the Western Alliance Bank Loan Agreement.

Super G Loan Agreement and Warrant

On July 31, 2017, the Company and its subsidiary entered into a Business Loan and Security Agreement with Super G Capital, LLC (“Super G”), as lender (the “Super G Loan Agreement”) and received a term loan from Super G in an amount equal to $1,100,000 (the “Super G Loan”). Borrowings under the Super G Loan Agreement were to be repaid in installments (including interest) of $33,000 per month in the first 3 months following closing and approximately $68,600 per month in months four through twenty-four following closing, for total payments of $1,540,000. The effective interest rate of the Super G Loan was approximately 33%.

On July 31, 2017, the Company also issued a warrant that entitled Super G to purchase 550,000 shares of the Company’s common stock at an exercise price of $0.30 per share (the “Super G Warrant”). The Super G Warrant had a three year term and if the profit on such warrants was not equal to at least $165,000 over the term of the warrants, at the end of the three year term, the Company was required to pay an exit fee equal to the difference between $165,000 and the amount of profit recognized. During the three months ended March 31, 2018, no warrants were exercised. The $165,000 fair value of this warrant was recorded as a derivative liability and as a discount to the carrying amount of the debt as of December 31, 2017.

On January 26, 2018, the Company and Super G entered into a payoff letter that terminated the Super G Loan Agreement and the Super G Warrant in exchange for total cash payments from the Company of $1,269,000 (the “Super G Payoff”). The total obligations to Super G at the time of the Super G Payoff was $1,434,000, including principal, accrued and remaining interest due over the term of the Super G Loan, and the Super G Warrant Liability. Therefore, the Company recorded a gain on extinguishment of the debt of $165,000, which is recorded in “Interest and Other Expense, Net” on our Condensed Consolidated Statements of Operations. In connection with the Super G Payoff, the related warrant liability and corresponding debt discount were eliminated during the three months ended March 31, 2018. As of March 31, 2018, there are no outstanding obligations related to the Super G Loan.

The total debt discount on the Western Alliance Bank A/R Revolver and Super G Loan was $339,000, comprised of $174,000 of debt issuance costs and $165,000 related to the Super G Warrant. This debt discount was being amortized to interest expense using the effective interest method over the term of the debt. During the three months ended March 31, 2018, the Company amortized $269,000 of the debt discount, which is recorded in “Interest and Other Expense, Net” on our Condensed Consolidated Statements of Operations. As of March 31, 2018, there is no remaining unamortized debt discount.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Preferred Stock
3 Months Ended
Mar. 31, 2018
Equity [Abstract]  
Preferred Stock
Preferred Stock

Our Certificate of Incorporation authorizes us to issue up to 5,000,000 shares of preferred stock. As of March 31, 2018, there were: (i) 100 shares of Perpetual Series B-1 Preferred Stock authorized and no shares issued or outstanding; (ii) 7,500 shares of Series A-2 Convertible Preferred Stock authorized and 32 shares issued and outstanding (the “Series A-2 Preferred Stock”); (iii) 2,800 shares of Series B Preferred Stock authorized and 375 shares issued and outstanding; (iv) 1,750 shares of Series C Preferred Stock authorized and 1,275 shares issued and outstanding; (v) 4,000 shares of Series D Convertible Preferred Stock authorized and no shares issued or outstanding; and (vi) 100 shares of Perpetual Series B Preferred Stock authorized and no shares issued or outstanding.

Series A-2 Preferred Stock

Each share of Series A-2 Preferred Stock has a stated value of $7,500 per share (the “A-2 Stated Value”), a liquidation preference equal to the A-2 Stated Value, and is convertible at the holder’s election into common stock at a conversion price per share of $2.16 as of March 31, 2018. Therefore, each share of Series A-2 Preferred Stock is convertible into 3,472 shares of common stock as of March 31, 2018. The conversion price is subject to adjustment upon the occurrence of certain events set forth in our Certificate of Incorporation. During the three months ended March 31, 2018, the Series C Offering resulted in an adjustment to the Series A-2 Preferred Stock conversion price from $2.40 to $2.16 per share.

The Series A-2 Preferred Stock is subordinate to the Series B-1 Preferred Stock but senior to all other classes of equity, has weighted average anti-dilution protection and, since January 1, 2013, has been entitled to cumulative dividends at a rate of 5% per annum, payable quarterly, based on the A-2 Stated Value and payable at the option of the holder in cash or through the issuance of a number of additional shares of Series A-2 Preferred Stock with an aggregate liquidation preference equal to the dividend amount payable on the applicable dividend payment date. As of March 31, 2018, the Company has recorded $62,000 in accrued dividends in “Accrued expenses and other liabilities” on the accompanying Condensed Consolidated Balance Sheet related to the remaining Series A-2 Preferred Stock outstanding. The Company, at our option, may redeem all or a portion of the Series A-2 Preferred Stock in cash at a price per share of $8,250 per share (equal to $7,500 per share multiplied by 110%) plus all accrued and unpaid dividends.

Series B Preferred Stock

In October 2017, the Company closed a registered direct offering of 2,800 shares of its Series B Preferred Stock for total gross proceeds to the Company of $2,800,000. The shares of Series B Preferred Stock were sold at a price equal to their stated value of $1,000 per share and are convertible into shares of the Company’s common stock at a conversion price of $0.28 per share. During the three months ended March 31, 2018, 75 shares of Series B Preferred Stock were converted to 268,000 shares of the Company’s common stock. As of March 31, 2018, 375 shares of Series B Preferred Stock remain issued and outstanding. The Series B Preferred Stock is pari passu with the Company’s issued and outstanding shares of Series C Preferred Stock.

Subject to certain exceptions, the Company has agreed to provide the holders of Series B Preferred Stock a right of participation for up to 100% of any future offering of its common stock or other securities or equity linked debt obligations until October 2019. In addition, the Company agreed to expand the size of the Company’s board of directors to six members and to appoint a new independent director agreeable to the lead investor in the offering (the “Lead Investor”). Subject to limited exceptions, for as long as at least 333 shares of Series B Preferred Stock remain outstanding and unconverted (subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations and subdivisions or similar events occurring after the date of the Purchase Agreement with respect to the Series B Preferred Stock), the Company may not issue any common stock or convertible securities (or modify any of the foregoing that may be outstanding) to any person, or incur any debt, without the express written consent of the Lead Investor.

In addition, the Company has agreed that it will not enter into certain “fundamental transactions,” including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company’s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series B Preferred Stock including the Lead Investor and on terms with respect to the Series B Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series B Preferred Stock.

Series C Offering

On January 25, 2018, the Company closed a registered direct offering of 1,750 shares of its Series C Preferred Stock for total gross proceeds to the Company of $1,750,000. The shares of Series C Preferred Stock were sold at a price equal to their stated value of $1,000 per share and are convertible into shares of the Company’s common stock at a conversion price of $0.30 per share. The net proceeds to us from the sale of our securities in this offering were $1,527,000 after deducting offering expenses paid by us. During the three months ended March 31, 2018, 475 shares of Series C Preferred Stock were converted to 1,583,000 shares of the Company’s common stock. As of March 31, 2018, 1,275 shares of Series C Preferred Stock remain issued and outstanding. The Series C Preferred Stock is pari passu with the Company’s issued and outstanding shares of Series B Preferred Stock.

Subject to certain exceptions, the Company has agreed to provide the purchasers, during the period that the purchasers continue to hold Series C Preferred Stock, a right of participation for up to 100% of any future offering of its common stock or other securities or equity linked debt obligations until January 2020. Subject to limited exceptions, for as long as at least $500,000 of stated value of Series C Preferred Stock remain outstanding and unconverted (subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations and subdivisions or similar events occurring after the date of the Purchase Agreement with respect to the Series C Preferred Stock), the Company shall not issue any common stock or convertible securities (or modify any of the foregoing that may be outstanding) to any person at a price per share less than $0.30, or incur any debt, without the express written consent of the Lead Investor.

In addition, the Company has agreed that it will not enter into certain “fundamental transactions,” including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company’s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series C Preferred Stock including the Lead Investor and on terms with respect to the Series C Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series C Preferred Stock.

In accordance with ASC Topic 815, we evaluated whether our convertible preferred stock contains provisions that protect holders from declines in our stock price or otherwise could result in modification of the exercise price and/or shares to be issued under the respective preferred stock agreements based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and require a derivative liability. The Company determined no derivative liability is required under ASC Topic 815 with respect to our convertible preferred stock. A contingent beneficial conversion amount is required to be calculated and recognized when and if the adjusted $2.16 conversion price of the Series A-2 Preferred Stock is adjusted to reflect a down round stock issuance that reduces the conversion price below the $1.16 fair value of the common stock on the issuance date of the Series A-2 Preferred Stock.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Based Compensation
3 Months Ended
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Stock Based Compensation
Stock Based Compensation

Glowpoint 2014 Equity Incentive Plan

On May 28, 2014, the Glowpoint, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) was approved by the Company’s stockholders at the Company’s 2014 Annual Meeting of Stockholders. The purpose of the 2014 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means to attract, motivate, retain, and reward selected employees and other eligible persons through the grant of equity awards. Awards may be granted under the 2014 Plan to officers, employees, directors and consultants of the Company or its subsidiary. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted shares, restricted stock units, cash awards and other awards, including stock bonuses, performance stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Company’s common stock, upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof, or any similar securities with a value derived from the value of or related to the Company’s common stock, or returns thereon. A total of 4,400,000 shares of the Company’s common stock were initially available for issuance under the 2014 Plan. As of March 31, 2018, 1,824,000 shares were available for issuance under the 2014 Plan. In April 2018, 1,310,000 restricted stock units were granted under the 2014 Plan, leaving 514,000 shares available for issuance under the 2014 Plan. On April 12, 2018, the Company's compensation committee recommended, and the Company's board of directors adopted, subject to stockholder approval, an amendment to the 2014 Plan to, among other things, increase the number of shares of common stock available for issuance under the 2014 Plan by 3,000,000 shares (the "Amendment"), enabling the continued use of the 2014 Plan for share-based awards. The Company is seeking stockholder approval of the Amendment in connection with its 2018 Annual Meeting of Stockholders to be held on May 31, 2018.

Glowpoint 2007 Stock Incentive Plan

In May 2014, the Board terminated the Glowpoint 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of March 31, 2018, options to purchase a total of 1,191,000 shares of common stock and 113,000 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan.

Glowpoint 2000 Stock Incentive Plan

In June 2010, the Board terminated the Glowpoint 2000 Stock Incentive Plan (as amended, the “2000 Plan”). Notwithstanding the termination of the 2000 Plan, outstanding awards under the 2000 Plan will remain in effect in accordance with their terms. As of March 31, 2018, options to purchase a total of 500 shares of common stock were outstanding under the 2000 Plan. No shares are available for issuance under the 2000 Plan.

Stock Options

For the three months ended March 31, 2018, no stock options were granted; therefore, no fair value assumptions are presented herein. A summary of stock options expired and forfeited under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
Outstanding
 
Exercisable
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
Options outstanding, December 31, 2017
1,202

 
$
1.99

 
1,202

 
$
1.99

Expired
(1
)
 
2.30

 
 
 
 
Forfeited
(9
)
 
1.61

 
 
 
 
Options outstanding, March 31, 2018
1,192

 
$
1.99

 
1,192

 
$
1.99



Stock-based compensation expense related to stock options was $0 and $18,000 for the three months ended March 31, 2018 and 2017, respectively, and was recorded to general and administrative expenses. There is no remaining unrecognized stock-based compensation expense for stock options as of March 31, 2018.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Awards
3 Months Ended
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Restricted Stock Awards
Stock Based Compensation

Glowpoint 2014 Equity Incentive Plan

On May 28, 2014, the Glowpoint, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) was approved by the Company’s stockholders at the Company’s 2014 Annual Meeting of Stockholders. The purpose of the 2014 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means to attract, motivate, retain, and reward selected employees and other eligible persons through the grant of equity awards. Awards may be granted under the 2014 Plan to officers, employees, directors and consultants of the Company or its subsidiary. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted shares, restricted stock units, cash awards and other awards, including stock bonuses, performance stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Company’s common stock, upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof, or any similar securities with a value derived from the value of or related to the Company’s common stock, or returns thereon. A total of 4,400,000 shares of the Company’s common stock were initially available for issuance under the 2014 Plan. As of March 31, 2018, 1,824,000 shares were available for issuance under the 2014 Plan. In April 2018, 1,310,000 restricted stock units were granted under the 2014 Plan, leaving 514,000 shares available for issuance under the 2014 Plan. On April 12, 2018, the Company's compensation committee recommended, and the Company's board of directors adopted, subject to stockholder approval, an amendment to the 2014 Plan to, among other things, increase the number of shares of common stock available for issuance under the 2014 Plan by 3,000,000 shares (the "Amendment"), enabling the continued use of the 2014 Plan for share-based awards. The Company is seeking stockholder approval of the Amendment in connection with its 2018 Annual Meeting of Stockholders to be held on May 31, 2018.

Glowpoint 2007 Stock Incentive Plan

In May 2014, the Board terminated the Glowpoint 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of March 31, 2018, options to purchase a total of 1,191,000 shares of common stock and 113,000 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan.

Glowpoint 2000 Stock Incentive Plan

In June 2010, the Board terminated the Glowpoint 2000 Stock Incentive Plan (as amended, the “2000 Plan”). Notwithstanding the termination of the 2000 Plan, outstanding awards under the 2000 Plan will remain in effect in accordance with their terms. As of March 31, 2018, options to purchase a total of 500 shares of common stock were outstanding under the 2000 Plan. No shares are available for issuance under the 2000 Plan.

Stock Options

For the three months ended March 31, 2018, no stock options were granted; therefore, no fair value assumptions are presented herein. A summary of stock options expired and forfeited under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
Outstanding
 
Exercisable
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
Options outstanding, December 31, 2017
1,202

 
$
1.99

 
1,202

 
$
1.99

Expired
(1
)
 
2.30

 
 
 
 
Forfeited
(9
)
 
1.61

 
 
 
 
Options outstanding, March 31, 2018
1,192

 
$
1.99

 
1,192

 
$
1.99



Stock-based compensation expense related to stock options was $0 and $18,000 for the three months ended March 31, 2018 and 2017, respectively, and was recorded to general and administrative expenses. There is no remaining unrecognized stock-based compensation expense for stock options as of March 31, 2018.
Unvested restricted stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Restricted Stock Awards
Restricted Stock Awards

A summary of unvested restricted stock awards outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
Restricted Shares
 
Weighted Average
Grant Price
Unvested restricted stock outstanding, December 31, 2017
341

 
$
1.06

Vested
(228
)
 
0.84

Unvested restricted stock outstanding, March 31, 2018
113

 
$
1.49



The number of restricted stock awards vested during the three months ended March 31, 2018 includes 78,000 shares withheld and repurchased by the Company from employees to satisfy $20,000 of tax obligations relating to the vesting of such shares. Such shares are held in the Company’s treasury stock as of March 31, 2018.

Stock-based compensation expense related to restricted stock awards is allocated as follows (in thousands):
 
Three Months Ended
 
March 31,
 
2018
 
2017
Cost of revenue
$

 
$
2

Research and development

 
1

General and administrative
10

 
12

 
$
10

 
$
15



Certain restricted stock awards have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, compensation expense is recognized over the relevant performance period. For those awards not subject to performance criteria, the cost of the restricted stock awards is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period.

The remaining unrecognized stock-based compensation expense for restricted stock awards as of March 31, 2018 was $144,000. Of this amount, $7,000 relates to time-based awards with a remaining weighted average period of 1.23 years. The remaining $137,000 of unrecognized stock-based compensation expense relates to performance-based awards for which expense will be recognized upon it becoming probable that the Company will achieve defined financial targets.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Units
3 Months Ended
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Restricted Stock Units
Stock Based Compensation

Glowpoint 2014 Equity Incentive Plan

On May 28, 2014, the Glowpoint, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) was approved by the Company’s stockholders at the Company’s 2014 Annual Meeting of Stockholders. The purpose of the 2014 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means to attract, motivate, retain, and reward selected employees and other eligible persons through the grant of equity awards. Awards may be granted under the 2014 Plan to officers, employees, directors and consultants of the Company or its subsidiary. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted shares, restricted stock units, cash awards and other awards, including stock bonuses, performance stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Company’s common stock, upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof, or any similar securities with a value derived from the value of or related to the Company’s common stock, or returns thereon. A total of 4,400,000 shares of the Company’s common stock were initially available for issuance under the 2014 Plan. As of March 31, 2018, 1,824,000 shares were available for issuance under the 2014 Plan. In April 2018, 1,310,000 restricted stock units were granted under the 2014 Plan, leaving 514,000 shares available for issuance under the 2014 Plan. On April 12, 2018, the Company's compensation committee recommended, and the Company's board of directors adopted, subject to stockholder approval, an amendment to the 2014 Plan to, among other things, increase the number of shares of common stock available for issuance under the 2014 Plan by 3,000,000 shares (the "Amendment"), enabling the continued use of the 2014 Plan for share-based awards. The Company is seeking stockholder approval of the Amendment in connection with its 2018 Annual Meeting of Stockholders to be held on May 31, 2018.

Glowpoint 2007 Stock Incentive Plan

In May 2014, the Board terminated the Glowpoint 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of March 31, 2018, options to purchase a total of 1,191,000 shares of common stock and 113,000 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan.

Glowpoint 2000 Stock Incentive Plan

In June 2010, the Board terminated the Glowpoint 2000 Stock Incentive Plan (as amended, the “2000 Plan”). Notwithstanding the termination of the 2000 Plan, outstanding awards under the 2000 Plan will remain in effect in accordance with their terms. As of March 31, 2018, options to purchase a total of 500 shares of common stock were outstanding under the 2000 Plan. No shares are available for issuance under the 2000 Plan.

Stock Options

For the three months ended March 31, 2018, no stock options were granted; therefore, no fair value assumptions are presented herein. A summary of stock options expired and forfeited under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
Outstanding
 
Exercisable
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
Options outstanding, December 31, 2017
1,202

 
$
1.99

 
1,202

 
$
1.99

Expired
(1
)
 
2.30

 
 
 
 
Forfeited
(9
)
 
1.61

 
 
 
 
Options outstanding, March 31, 2018
1,192

 
$
1.99

 
1,192

 
$
1.99



Stock-based compensation expense related to stock options was $0 and $18,000 for the three months ended March 31, 2018 and 2017, respectively, and was recorded to general and administrative expenses. There is no remaining unrecognized stock-based compensation expense for stock options as of March 31, 2018.
Restricted Stock Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Restricted Stock Units
Restricted Stock Units

A summary of unvested restricted stock units (“RSUs”) outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
RSUs
 
Weighted Average
Grant Price
Unvested restricted stock units outstanding, December 31, 2017
1,752

 
$
0.57

Vested
(306
)
 
0.51

Forfeited
(456
)
 
0.28

Unvested restricted stock units outstanding, March 31, 2018
990

 
$
0.72



As of March 31, 2018, 988,000 vested RSUs issued to non-employee directors remain outstanding as shares of common stock have not yet been delivered due to the deferred payment provisions set forth in these RSUs.

As of March 31, 2018, 546,000 unvested RSUs have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, stock-based compensation expense is recognized over the relevant performance period. As of March 31, 2018, 443,000 unvested RSUs have timed-based vesting provisions, and the cost of the RSUs is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period.

Stock-based compensation expense related to RSUs is allocated as follows (in thousands):
 
Three Months Ended
 
March 31,
 
2018
 
2017
Cost of revenue
$
5

 
$
12

Research and development
10

 
14

Sales and marketing
2

 
4

General and administrative
23

 
100

 
$
40

 
$
130



The remaining unrecognized stock-based compensation expense for RSUs as of March 31, 2018 was $419,000. Of this amount $118,000 relates to time-based RSUs with a remaining weighted average period of 0.47 years. The remaining $301,000 of unrecognized stock-based compensation expense relates to performance-based RSUs for which expense will be recognized upon it becoming probable that the Company achieves defined financial targets for fiscal year 2018.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Net Loss Per Share
3 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
Net Loss Per Share
Net Loss Per Share

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at March 31, 2018 and 2017, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant.

Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three months ended March 31, 2018 and 2017, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (decrease our net loss per share).

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):
 
Three Months Ended March 31,
 
2018
 
2017
Numerator:
 
 
 
Net loss
$
(1,285
)
 
$
(668
)
Less: preferred stock dividends
3

 
3

Net loss attributable to common stockholders
$
(1,288
)
 
$
(671
)
Denominator:
 
 
 
Weighted-average number of shares of common stock for basic and diluted net loss per share
46,232

 
36,181

Basic and diluted net loss per share
$
(0.03
)
 
$
(0.02
)


The weighted-average number of shares for the three months ended March 31, 2018 and 2017 includes 988,000 and 517,000 shares of vested RSUs, respectively, as discussed in Note 8.

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (in thousands):
 
Three Months Ended March 31,
 
2018
 
2017
Unvested restricted stock units
742

 
2,938

Unvested restricted stock awards
113

 
354

Outstanding stock options
1,192

 
1,222

Shares of common stock issuable upon conversion of Series A-2 Preferred
79

 
79

Shares of common stock issuable upon conversion of Series B Preferred
1,339

 

Shares of common stock issuable upon conversion of Series C Preferred
4,250

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies

Operating Leases

We lease two facilities in Denver, CO and Oxnard, CA that are under operating leases through December 2018 and March 2020, respectively. Both of these leases require us to pay increases in real estate taxes, operating costs and repairs over certain base year amounts. Rent expense for the three months ended March 31, 2018 and 2017 was $77,000 and $74,000, respectively.

Future minimum rental commitments under all non-cancelable operating leases as of March 31, 2018, are as follows (in thousands):
Year Ending December 31,
 
Remaining 2018
$
231

2019
88

2020
23

 
$
342

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Major Customers
3 Months Ended
Mar. 31, 2018
Risks and Uncertainties [Abstract]  
Major Customers
Major Customers

Major customers are defined as direct customers or channel partners that account for more than 10% of the Company’s revenue. For the three months ended March 31, 2018, two major customers represented 24% and 23%, respectively of our revenue and represented 13% and 59%, respectively, of our accounts receivable balance at March 31, 2018. For the three months ended March 31, 2017, the same two major customers represented 16% and 21%, respectively, of our revenue.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Geographical Data
3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Geographical Data
Geographical Data
For the three months ended March 31, 2018 and 2017, there was no material revenue attributable to any individual foreign country. Revenue by geographic area, based on customer location, is allocated as follows (in thousands):
 
Three Months Ended March 31,
 
2018
 
2017
Domestic
$
2,269

 
$
2,853

Foreign
1,205

 
1,227

Total Revenue
$
3,474

 
$
4,080


Long-lived assets were 100% located in domestic markets as of March 31, 2018 and December 31, 2017.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Subsequent Events
3 Months Ended
Mar. 31, 2018
Subsequent Events [Abstract]  
Subsequent Events
Subsequent Events

As of March 31, 2018, there were no outstanding borrowings under the Company’s A/R Revolver with Western Alliance Bank and we had availability of $764,000. On May 8, 2018, the Company entered into a payoff letter with Western Alliance Bank that terminated the Western Alliance Bank Loan Agreement. See “Part II. Item 5. Other Information” below for additional information regarding the termination of the Western Alliance Bank Loan Agreement.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Description and Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2018
Accounting Policies [Abstract]  
Principles of Consolidation
Principles of Consolidation

The condensed consolidated financial statements include the accounts of Glowpoint and our 100%-owned subsidiary, GP Communications, LLC, whose business function is to provide interstate telecommunications services for regulatory purposes. All material inter-company balances and transactions have been eliminated in consolidation.

Basis of Presentation
Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2017. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

Adopted Accounting Standards and Recently Issued Accounting Pronouncements
Adopted Accounting Standards

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (ASU) 2014-09 (Topic 606) "Revenue from Contracts with Customers." Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605 “Revenue Recognition” (Topic 605), and requires entities to recognize revenue when control of promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. On January 1, 2018, we adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Accounting Standards Codification Topic 605. We did not record an adjustment to opening accumulated deficit as of January 1, 2018 as the cumulative impact of adopting Topic 606 was not material. The costs associated with obtaining a customer contract were previously expensed in the period they were incurred. Under Topic 606, these payments are deferred on our consolidated balance sheet and amortized over the expected life of the customer contract. The impact to sales and marketing expense for the three months ended March 31, 2018 was not material as a result of applying Topic 606.

In August 2016, the FASB issued ASU No. 2016-15, which amends ASC 230, to clarify guidance on the classification of certain cash receipts and payments in the statement of cash flows. The FASB issued ASU 2016-15 with the intent of reducing diversity in practice with respect to eight types of cash flows. This guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.

In May 2017, the FASB issued ASU 2017-09, which clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as modifications. ASU 2017-09 will reduce diversity in practice and result in fewer changes to the terms of an award being accounted for as modifications. Under ASU 2017-09, an entity will not apply modification accounting to a share-based payment award if the award's fair value, vesting conditions and classification as an equity or liability instrument are the same immediately before and after the change. ASU 2017-09 will be applied prospectively to awards modified on or after the adoption date. We have adopted this guidance effective January 1, 2018, and this guidance did not have a material impact on our consolidated financial statements.

Recently Issued Accounting Pronouncements             

In February 2016 the FASB issued ASU 2016-02, “Leases”. The ASU introduces a lessee model that results in most leases impacting the balance sheet. The ASU addresses other concerns related to the current leases model.  Under ASU 2016-02, lessees will be required to recognize for all leases with terms longer than 12 months, at the commencement date of the lease, a lease liability, which is a lessee’s obligation to make lease payments arising from a lease measured on a discounted basis, and a right-to-use asset, which is an asset that represents the lessee’s right to use or control the use of a specified asset for the lease term.  Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition.  The update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. While we continue to evaluate the effect of adopting this guidance on our consolidated financial statements and related disclosures, we expect our operating leases, as disclosed in Note 10, will be subject to the new standard. We will recognize right-of-use assets and operating lease liabilities on our balance sheet upon adoption, which will increase our total assets and liabilities.

Capitalized Software Costs
Capitalized Software Costs

The Company capitalizes certain costs incurred in connection with developing or obtaining internal-use software. All software development costs have been appropriately accounted for as required by ASC Topic 350-40 “Intangible – Goodwill and Other – Internal-Use Software”. Capitalized software costs are included in “Property and equipment, net” on our condensed consolidated balance sheets and are amortized over three to four years. Software costs that do not meet capitalization criteria are expensed as incurred.
Goodwill & Intangible Assets
Goodwill & Intangibles

Goodwill is not amortized but is subject to periodic testing for impairment in accordance with ASC Topic 350 “Intangibles - Goodwill and Other - Testing Indefinite-Lived Intangible Assets for Impairment”. We test goodwill for impairment on an annual basis on September 30 of each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. As of March 31, 2018, the Company considered the declines in our revenue and stock price to be a triggering event for an interim goodwill impairment test. The Company operates as a single reporting unit and used market-based approaches to determine the fair value of the reporting unit. These approaches used quoted market prices in active markets and revenue multiples for comparable companies. As of March 31, 2018, the carrying amount of our reporting unit exceeded its fair value; therefore, the Company recorded a goodwill impairment charge of $650,000 in the three months ended March 31, 2018. This charge is recognized as “Impairment charges” on our Condensed Consolidated Statements of Operations. The remaining goodwill balance as of March 31, 2018 was $7,100,000. The continued future decline of our revenue, cash flows and/or stock price may give rise to a triggering event that may require the Company to record additional impairment charges on goodwill in the future.

The Company assesses the impairment of purchased intangible assets subject to amortization when events and circumstances indicate that the carrying value of the assets might not be recoverable.  Fair value of our intangible assets is determined using the relief from royalty methodology. This approach involves two steps: (a) estimating reasonable royalty rates for each intangible asset and (b) applying these royalty rates to a net revenue stream and discounting the resulting cash flows to determine fair value. This fair value is then compared with the carrying value of each intangible asset. If the carrying value of the intangible asset is greater than its implied fair value, an impairment in the amount of the excess is recognized and charged to operations. The determination of related estimated useful lives and whether or not these assets are impaired involves significant judgments, related primarily to the future profitability and/or future value of the assets. Changes in the Company’s strategic plan and/or other-than-temporary changes in market conditions could significantly impact these judgments and could require adjustments to recorded asset balances. Long-lived assets are evaluated for impairment at least annually, as well as whenever an event or change in circumstances has occurred that could have a significant adverse effect on the fair value of long-lived assets.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Accrued Expenses and Other Liabilities (Tables)
3 Months Ended
Mar. 31, 2018
Other Liabilities Disclosure [Abstract]  
Schedule of Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consisted of the following (in thousands):
 
March 31, 2018
 
December 31, 2017
Other accrued expenses
$
264

 
$
316

Accrued compensation costs
227

 
129

Accrued marketing expense
136

 

Deferred revenue
87

 
393

Super G Warrant liability

 
165

Accrued expenses and other liabilities
$
714

 
$
1,003

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Debt (Tables)
3 Months Ended
Mar. 31, 2018
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
Debt consisted of the following (in thousands):
 
March 31, 2018
 
December 31, 2017
Western Alliance Bank A/R Revolver
$

 
$
800

Super G Loan

 
1,032

Unamortized debt discounts

 
(269
)
Net carrying value


1,563

Less: current maturities, net of debt discount

 
(1,194
)
Long-term obligations, net of debt discount
$

 
$
369

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Summary of Stock Option Activity
A summary of stock options expired and forfeited under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
Outstanding
 
Exercisable
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
 
Number of Shares Underlying Options
 
Weighted
Average
Exercise
Price
Options outstanding, December 31, 2017
1,202

 
$
1.99

 
1,202

 
$
1.99

Expired
(1
)
 
2.30

 
 
 
 
Forfeited
(9
)
 
1.61

 
 
 
 
Options outstanding, March 31, 2018
1,192

 
$
1.99

 
1,192

 
$
1.99

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Awards (Tables) - Restricted stock
3 Months Ended
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Restricted Stock Activity
A summary of unvested restricted stock awards outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
Restricted Shares
 
Weighted Average
Grant Price
Unvested restricted stock outstanding, December 31, 2017
341

 
$
1.06

Vested
(228
)
 
0.84

Unvested restricted stock outstanding, March 31, 2018
113

 
$
1.49

Summary of Compensation Expense
Stock-based compensation expense related to restricted stock awards is allocated as follows (in thousands):
 
Three Months Ended
 
March 31,
 
2018
 
2017
Cost of revenue
$

 
$
2

Research and development

 
1

General and administrative
10

 
12

 
$
10

 
$
15

XML 38 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Units (Tables) - Restricted Stock Units (RSUs)
3 Months Ended
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Restricted Stock Units Activity
A summary of unvested restricted stock units (“RSUs”) outstanding as of, and changes made during, the three months ended March 31, 2018, is presented below (shares in thousands):
 
RSUs
 
Weighted Average
Grant Price
Unvested restricted stock units outstanding, December 31, 2017
1,752

 
$
0.57

Vested
(306
)
 
0.51

Forfeited
(456
)
 
0.28

Unvested restricted stock units outstanding, March 31, 2018
990

 
$
0.72

Summary of Compensation Expense
Stock-based compensation expense related to RSUs is allocated as follows (in thousands):
 
Three Months Ended
 
March 31,
 
2018
 
2017
Cost of revenue
$
5

 
$
12

Research and development
10

 
14

Sales and marketing
2

 
4

General and administrative
23

 
100

 
$
40

 
$
130

XML 39 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):
 
Three Months Ended March 31,
 
2018
 
2017
Numerator:
 
 
 
Net loss
$
(1,285
)
 
$
(668
)
Less: preferred stock dividends
3

 
3

Net loss attributable to common stockholders
$
(1,288
)
 
$
(671
)
Denominator:
 
 
 
Weighted-average number of shares of common stock for basic and diluted net loss per share
46,232

 
36,181

Basic and diluted net loss per share
$
(0.03
)
 
$
(0.02
)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (in thousands):
 
Three Months Ended March 31,
 
2018
 
2017
Unvested restricted stock units
742

 
2,938

Unvested restricted stock awards
113

 
354

Outstanding stock options
1,192

 
1,222

Shares of common stock issuable upon conversion of Series A-2 Preferred
79

 
79

Shares of common stock issuable upon conversion of Series B Preferred
1,339

 

Shares of common stock issuable upon conversion of Series C Preferred
4,250

 

XML 40 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies (Tables)
3 Months Ended
Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Future Minimum Rental Payments for Operating Leases
Future minimum rental commitments under all non-cancelable operating leases as of March 31, 2018, are as follows (in thousands):
Year Ending December 31,
 
Remaining 2018
$
231

2019
88

2020
23

 
$
342

XML 41 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Geographical Data (Tables)
3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Schedule of Revenue by Geographical Area
Revenue by geographic area, based on customer location, is allocated as follows (in thousands):
 
Three Months Ended March 31,
 
2018
 
2017
Domestic
$
2,269

 
$
2,853

Foreign
1,205

 
1,227

Total Revenue
$
3,474

 
$
4,080

XML 42 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Description and Significant Accounting Policies - Narrative (Details)
3 Months Ended
Mar. 31, 2018
segment
Finite-Lived Intangible Assets [Line Items]  
Number of operating segments 1
Ownership percentage in subsidiary 100.00%
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Liquidity and Going Concern - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended
Jan. 25, 2018
Oct. 31, 2017
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Dec. 31, 2016
Line of Credit Facility [Line Items]            
Cash     $ 3,068,000 $ 1,110,000 $ 3,946,000 $ 1,140,000
Working capital     3,789,000      
Debt     0   1,563,000  
Net loss     1,285,000 668,000    
Net cash used in operating activities     472,000 (18,000)    
Cash paid for interest payments on then-existing indebtedness     316,000 266,000    
Outstanding principal, debt obligations     0   $ 1,800,000  
Issuance of preferred stock, net of expenses     1,527,000      
Principal payment made     1,832,000 $ 0    
Western Alliance Bank            
Line of Credit Facility [Line Items]            
Principal payment made     $ 800,000      
Preferred Stock | Series C Preferred Stock            
Line of Credit Facility [Line Items]            
Issuance of stock (in shares) 1,750   1,750      
Dividend rate, percentage 0.00%          
Issuance of preferred stock, net of expenses $ 1,527,000          
Preferred Stock | Series B Preferred Stock            
Line of Credit Facility [Line Items]            
Issuance of stock (in shares)   2,800        
Dividend rate, percentage     0.00%      
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Capitalized Software Costs - Narrative (Details) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Acquired Finite-Lived Intangible Assets [Line Items]    
Impairment losses $ 650,000 $ 0
Software and Software Development Costs    
Acquired Finite-Lived Intangible Assets [Line Items]    
Capitalized software costs, additions 48,000  
Amortization 131,000 157,000
Impairment losses $ 0 $ 0
Minimum | Software and Software Development Costs    
Acquired Finite-Lived Intangible Assets [Line Items]    
Capitalized software costs, useful life 3 years  
Maximum | Software and Software Development Costs    
Acquired Finite-Lived Intangible Assets [Line Items]    
Capitalized software costs, useful life 4 years  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill & Intangibles - Narrative (Details) - USD ($)
3 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill impairment charge $ 650,000  
Goodwill 7,100,000 $ 7,750,000
Impairment charges of intangible assets $ 0  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Accrued Expenses, Current [Abstract]    
Other accrued expenses $ 264 $ 316
Accrued compensation costs 227 129
Accrued marketing expense 136 0
Deferred revenue 87 393
Super G Warrant liability 0 165
Accrued expenses and other liabilities $ 714 $ 1,003
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Debt - Schedule of Debt (Details) - USD ($)
Mar. 31, 2018
Jan. 26, 2018
Dec. 31, 2017
Debt Instrument [Line Items]      
Long-term debt $ 0   $ 1,800,000
Unamortized debt discounts 0   (269,000)
Net carrying value 0   1,563,000
Less: current maturities, net of debt discount 0   (1,194,000)
Long-term obligations, net of debt discount 0   369,000
Western Alliance Bank A/R Revolver      
Debt Instrument [Line Items]      
Long-term debt 0   800,000
Super G Loan      
Debt Instrument [Line Items]      
Long-term debt $ 0 $ 1,434,000 $ 1,032,000
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Debt - Narrative (Details)
3 Months Ended
Jan. 26, 2018
USD ($)
Jul. 31, 2017
USD ($)
$ / shares
shares
Mar. 31, 2018
USD ($)
shares
Mar. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
Debt Instrument [Line Items]          
Principal payment made     $ 1,832,000 $ 0  
Total borrowings     0   $ 1,800,000
Long-term debt     0   1,563,000
Unamortized debt discount     0   269,000
Amortization of debt discount     $ 104,000 $ 18,000  
Warrant          
Debt Instrument [Line Items]          
Warrants exercised (in shares) | shares     0    
Western Alliance Bank A/R Revolver          
Debt Instrument [Line Items]          
Total current borrowing capacity (up to)   $ 1,500,000      
Borrowing base of eligible accounts receivable   0.85      
Proceeds from issuance of debt   $ 500,000      
Principal payment made     $ 800,000    
Total borrowings     0   800,000
Additional availability     $ 764,000    
Bridge Bank Loan Agreement Non-Formula Borrowings          
Debt Instrument [Line Items]          
Total current borrowing capacity (up to)         400,000
Installment payment due January 1, 2018   200,000      
Installment payment due April 1, 2018   0      
Variable rate     4.75%    
Interest rate during the period     7.00%    
Proceeds from issuance of debt   $ 600,000      
Total borrowings     $ 400,000    
Bridge Bank Loan Agreement Non-Formula Borrowings | Prime Rate          
Debt Instrument [Line Items]          
Basis spread on variable rate     2.25%    
Prime rate, floor   4.00%      
Western Alliance Bank And Super G Capital          
Debt Instrument [Line Items]          
Unamortized debt discount $ 339,000   $ 0    
Debt issuance costs 174,000        
Warrants issued 165,000        
Amortization of debt discount     269,000    
Super G Capital          
Debt Instrument [Line Items]          
Proceeds from issuance of debt   $ 1,100,000      
Total borrowings 1,434,000   0   1,032,000
Monthly installment payment for first three months following closing   33,000      
Monthly installment payment for months four through twenty-four   68,600      
Total payments   $ 1,540,000      
Effective interest rate   33.00%      
Warrants issued (in shares) | shares   550,000      
Exercise price for outstanding warrants (in dollars per share) | $ / shares   $ 0.30      
Warrants, term period   3 years      
Warrant, profit over the term, or cash exit fee implemented (at least)   $ 165,000      
Repayments of debt, total cash payments 1,269,000        
Gain on debt extinguishment $ 165,000        
Super G Capital | Warrant          
Debt Instrument [Line Items]          
Fair value of warrant recorded as derivative liability         $ 165,000
Western Alliance Bank          
Debt Instrument [Line Items]          
Proceeds from issuance of debt   $ 1,100,000      
Principal payment made     $ 800,000    
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Preferred Stock - Narrative (Details)
1 Months Ended 3 Months Ended
Jan. 25, 2018
USD ($)
$ / shares
shares
Oct. 31, 2017
USD ($)
member
$ / shares
shares
Mar. 31, 2018
USD ($)
$ / shares
shares
Mar. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
$ / shares
shares
Class of Stock [Line Items]          
Preferred stock, convertible, shares authorized (in shares)     5,000,000    
Accrued dividends | $     $ 62,000    
Proceeds from issuance of preferred stock gross | $     1,527,000 $ 0  
Issuance of stock | $     $ 1,527,000    
Conversion price below this fair value of the common stock (in dollars per share) | $ / shares     $ 1.16    
Common Stock          
Class of Stock [Line Items]          
Stock issued for conversion of convertible preferred stock, shares (in shares)     1,851,000    
Perpetual Series B-1 Preferred Stock          
Class of Stock [Line Items]          
Preferred stock, convertible, shares authorized (in shares)     100    
Preferred stock, shares issued (in shares)     0    
Preferred stock, shares outstanding (in shares)     0    
Series A-2 Preferred Stock          
Class of Stock [Line Items]          
Preferred stock, convertible, shares authorized (in shares)     7,500   7,500
Preferred stock, shares issued (in shares)     32   32
Preferred stock, stated value | $     $ 7,500   $ 7,500
Preferred stock, shares outstanding (in shares)     32   32
Stated value (in dollars per share) | $ / shares     $ 0.0001   $ 0.0001
Stock issued during period, conversion of convertible securities, price (in dollars per share) | $ / shares     $ 2.16   $ 2.40
Convertible preferred stock, shares issued upon conversion (in shares)     3,472    
Preferred stock, cumulative dividend percentage rate, per annum     5.00%    
Redemption price per share (in dollars per share) | $ / shares     $ 8,250    
Redemption price per share, multiplier (in dollars per share) | $ / shares     $ 7,500    
Redemption price per share, multiplier, percentage     110.00%    
Derivative liability | $     $ 0    
Series A-2 Preferred Stock | Preferred Stock          
Class of Stock [Line Items]          
Stock issued for conversion of convertible preferred stock, shares (in shares)     0    
Series B Preferred Stock          
Class of Stock [Line Items]          
Preferred stock, convertible, shares authorized (in shares)     2,800   2,800
Preferred stock, shares issued (in shares)     375   450
Preferred stock, stated value | $     $ 1,000   $ 1,000
Preferred stock, shares outstanding (in shares)     375   450
Stated value (in dollars per share) | $ / shares   $ 1,000 $ 0.0001   $ 0.0001
Stock issued during period, conversion of convertible securities, price (in dollars per share) | $ / shares   $ 0.28      
Proceeds from issuance of preferred stock gross | $   $ 2,800,000      
Participation rights, future offerings, max percentage   100.00%      
Expansion of board of director members | member   6      
Minimum number of shares outstanding and unconverted (in shares)   333      
Series B Preferred Stock | Preferred Stock          
Class of Stock [Line Items]          
Preferred stock, cumulative dividend percentage rate, per annum     0.00%    
Issuance of stock (in shares)   2,800      
Stock issued for conversion of convertible preferred stock, shares (in shares)     (75)    
Series B Preferred Stock | Common Stock          
Class of Stock [Line Items]          
Stock issued for conversion of convertible preferred stock, shares (in shares)     268,000    
Series C Preferred Stock          
Class of Stock [Line Items]          
Preferred stock, convertible, shares authorized (in shares)     1,750   1,750
Preferred stock, shares issued (in shares)     1,275   0
Preferred stock, stated value | $     $ 1,000   $ 1,000
Preferred stock, shares outstanding (in shares)     1,275   0
Stated value (in dollars per share) | $ / shares $ 1,000   $ 0.0001   $ 0.0001
Stock issued during period, conversion of convertible securities, price (in dollars per share) | $ / shares $ 0.30        
Proceeds from issuance of preferred stock gross | $ $ 1,750,000        
Participation rights, future offerings, max percentage 100.00%        
Participation rights, future offerings, limitation on stated value outstanding | $ $ 500,000        
Series C Preferred Stock | Preferred Stock          
Class of Stock [Line Items]          
Preferred stock, cumulative dividend percentage rate, per annum 0.00%        
Issuance of stock (in shares) 1,750   1,750    
Issuance of stock | $ $ 1,527,000        
Stock issued for conversion of convertible preferred stock, shares (in shares)     (475)    
Series C Preferred Stock | Common Stock          
Class of Stock [Line Items]          
Stock issued for conversion of convertible preferred stock, shares (in shares)     1,583,000    
Series D Preferred Stock          
Class of Stock [Line Items]          
Preferred stock, convertible, shares authorized (in shares)     4,000    
Preferred stock, shares issued (in shares)     0    
Preferred stock, shares outstanding (in shares)     0    
Perpetual Series B Preferred Stock          
Class of Stock [Line Items]          
Preferred stock, convertible, shares authorized (in shares)     100    
Preferred stock, shares issued (in shares)     0    
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Based Compensation - Narrative (Details)
1 Months Ended 3 Months Ended
Apr. 30, 2018
shares
Mar. 31, 2018
USD ($)
shares
Mar. 31, 2017
USD ($)
Apr. 12, 2018
shares
Dec. 31, 2017
shares
May 28, 2014
event
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Outstanding number of shares underlying options (in shares)   1,192,000     1,202,000  
Options granted (in shares)   0        
Unrecognized stock-based compensation expense | $   $ 0        
Restricted Stock Units (RSUs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares outstanding (in shares)   990,000     1,752,000  
Stock-based compensation expense | $   $ 40,000 $ 130,000      
Stock Options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based compensation expense | $   $ 0 18,000      
Restricted stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares outstanding (in shares)   113,000     341,000  
Stock-based compensation expense | $   $ 10,000 $ 15,000      
Equity Incentive Plan, 2014            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares available for issuance (in shares)   1,824,000       4,400,000
Equity Incentive Plan, 2014 | Restricted Stock Units (RSUs) | Subsequent Event            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares available for issuance (in shares) 514,000          
Shares granted (in shares) 1,310,000          
Equity Incentive Plan, 2014 | Minimum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of events to occur to permit granting (or more) | event           1
Amended Equity Incentive Plan, 2014 | Subsequent Event            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Proposed shares available for issuance (in shares)       3,000,000    
Stock Incentive Plan, 2007 | Stock Options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares available for issuance (in shares)   0        
Outstanding number of shares underlying options (in shares)   1,191,000        
Stock Incentive Plan, 2007 | Restricted stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares outstanding (in shares)   113,000        
Stock Incentive Plan, 2000 | Stock Options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares available for issuance (in shares)   0        
Outstanding number of shares underlying options (in shares)   500        
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Based Compensation - Options Outstanding (Details)
3 Months Ended
Mar. 31, 2018
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding Number of Shares Underlying Options, Beginning ( in shares) | shares 1,202,000
Outstanding Number of Shares Underlying Options, Expired (in shares) | shares (1,000)
Outstanding Number of Shares Underlying Options, Forfeited (in shares) | shares (9,000)
Outstanding Number of Shares Underlying Options, Ending (in shares) | shares 1,192,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]  
Outstanding Weighted Average Exercise Price, Beginning (in dollars per share) | $ / shares $ 1.99
Outstanding Weighted Average Exercise Price, Expired (in dollars per share) | $ / shares 2.30
Outstanding Weighted Average Exercise Price, Forfeited (in dollars per share) | $ / shares 1.61
Outstanding Weighted Average Exercise Price, Ending (in dollars per share) | $ / shares $ 1.99
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable [Abstract]  
Exercisable Number of Shares Underlying Options, Beginning (in shares) | shares 1,202,000
Exercisable Number of Shares Underlying Options, Ending (in shares) | shares 1,192,000
Exercisable Weighted Average Exercise Price, Beginning (in dollars per share) | $ / shares $ 1.99
Exercisable Weighted Average Exercise Price, Ending (in dollars per share) | $ / shares $ 1.99
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Awards - Summary of Activity (Details) - Restricted stock
shares in Thousands
3 Months Ended
Mar. 31, 2018
$ / shares
shares
Restricted Stock, Number of Shares [Roll Forward]  
Unvested restricted shares/units outstanding, beginning (in shares) | shares 341
Vested, restricted shares/units (in shares) | shares (228)
Unvested restricted shares/units outstanding, ending (in shares) | shares 113
Restricted Stock, Weighted Average Grant Price [Roll Forward]  
Unvested restricted shares/units, weighted average grant price, beginning (in dollars per share) | $ / shares $ 1.06
Vested, weighted average grant price (in dollars per share) | $ / shares 0.84
Unvested restricted shares/units, weighted average grant price, ending (in dollars per share) | $ / shares $ 1.49
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Awards - Narrative (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2018
USD ($)
shares
Restricted stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized stock-based compensation expense $ 144
Time-based Restricted Stock Awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized stock-based compensation expense $ 7
Weighted average period for amortization of unrecognized stock-based compensation 14 months 24 days
Performance-based Restricted Stock Awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized stock-based compensation expense $ 137
Shares Withheld and Repurchased | Restricted stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares withheld and repurchased to satisfy tax obligation (in shares) | shares 78,000
Statutory tax withholding requirements $ 20
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Awards - Summary of Stock-Based Compensation Expense (Details) - Restricted stock - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 10 $ 15
Cost of revenue    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 0 2
Research and development    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 0 1
General and administrative    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 10 $ 12
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Units - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs)
shares in Thousands
3 Months Ended
Mar. 31, 2018
$ / shares
shares
Restricted Stock Units, Number of Shares [Roll Forward]  
Unvested restricted shares/units outstanding, beginning (in shares) | shares 1,752
Vested, restricted shares/units (in shares) | shares (306)
Forfeited, restricted shares/units (in shares) | shares (456)
Unvested restricted shares/units outstanding, ending (in shares) | shares 990
Restricted Stock Units, Weighted Average Grant Price [Roll Forward]  
Unvested restricted shares/units, weighted average grant price, beginning (in dollars per share) | $ / shares $ 0.57
Vested, weighted average grant price (in dollars per share) | $ / shares 0.51
Forfeited, weighted average grant price (in dollars per share) | $ / shares 0.28
Unvested restricted shares/units, weighted average grant price, ending (in dollars per share) | $ / shares $ 0.72
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Units - Narrative (Details) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Vested deferred restricted stock units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vested and remaining outstanding (in shares) 988 517  
Unvested units outstanding (in shares) 990   1,752
Unrecognized stock-based compensation expense $ 419    
Vested deferred restricted stock units | Non-Employee Directors      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vested and remaining outstanding (in shares) 988    
Performance-based Restricted Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unvested units outstanding (in shares) 546    
Unrecognized stock-based compensation expense $ 301    
Time-based Restricted Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unvested units outstanding (in shares) 443    
Unrecognized stock-based compensation expense $ 118    
Weighted average period for amortization of unrecognized stock-based compensation 5 months 20 days    
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restricted Stock Units - Summary of Stock-Based Compensation Expense (Details) - Restricted Stock Units (RSUs) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]    
Stock-based compensation expense $ 40 $ 130
Cost of revenue    
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]    
Stock-based compensation expense 5 12
Research and development    
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]    
Stock-based compensation expense 10 14
Sales and marketing    
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]    
Stock-based compensation expense 2 4
General and administrative    
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]    
Stock-based compensation expense $ 23 $ 100
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.8.0.1
Net Loss Per Share - Narrative (Details) - shares
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 0  
Restricted Stock Units (RSUs)    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vested and remaining outstanding (in shares) 988,000 517,000
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1
Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Numerator:    
Net loss $ (1,285) $ (668)
Less: preferred stock dividends 3 3
Net loss attributable to common stockholders $ (1,288) $ (671)
Denominator:    
Weighted-average number of shares of common stock for basic and diluted net loss per share (in shares) 46,232 36,181
Basic and diluted net loss per share (in dollars per share) $ (0.03) $ (0.02)
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.8.0.1
Net Loss Per Share - Effect of Antidilutive Securities (Details) - shares
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 0  
Unvested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 742,000 2,938,000
Unvested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 113,000 354,000
Outstanding stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 1,192,000 1,222,000
Shares of common stock issuable upon conversion of Series A-2 Preferred    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 79,000 79,000
Shares of common stock issuable upon conversion of Series B Preferred    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 1,339,000 0
Shares of common stock issuable upon conversion of Series C Preferred    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 4,250,000 0
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies - Narrative (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2018
USD ($)
facility
Mar. 31, 2017
USD ($)
Commitments and Contingencies Disclosure [Abstract]    
Number of leased facilities | facility 2  
Rent expense | $ $ 77 $ 74
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies - Future Minimum Rental Commitments (Details)
$ in Thousands
Mar. 31, 2018
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Remaining 2018 $ 231
2019 88
2020 23
Total $ 342
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.8.0.1
Major Customers - Narrative (Details) - Customer Concentration Risk - customer
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues    
Concentration Risk [Line Items]    
Number of customers 2 2
Revenues | Customer No. 1    
Concentration Risk [Line Items]    
Concentration risk percentage 24.00% 16.00%
Revenues | Customer No. 2    
Concentration Risk [Line Items]    
Concentration risk percentage 23.00% 21.00%
Accounts Receivable | Customer No. 1    
Concentration Risk [Line Items]    
Concentration risk percentage 13.00%  
Accounts Receivable | Customer No. 2    
Concentration Risk [Line Items]    
Concentration risk percentage 59.00%  
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.8.0.1
Geographical Data - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Segment Reporting [Abstract]      
Material revenue attributable to individual foreign country $ 0 $ 0  
Long lived assets located in domestic markets 100.00%   100.00%
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.8.0.1
Geographical Data - Revenue by Geographic Area (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Segment Reporting Information [Line Items]    
Total Revenue $ 3,474 $ 4,080
Domestic    
Segment Reporting Information [Line Items]    
Total Revenue 2,269 2,853
Foreign    
Segment Reporting Information [Line Items]    
Total Revenue $ 1,205 $ 1,227
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.8.0.1
Subsequent Events - Narrative (Details) - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Subsequent Event [Line Items]    
Long-term debt $ 0 $ 1,800,000
Western Alliance Bank A/R Revolver    
Subsequent Event [Line Items]    
Long-term debt 0 $ 800,000
Available borrowing capacity $ 764,000  
EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 68 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 71 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 139 213 1 false 52 0 false 9 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.glowpoint.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.glowpoint.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.glowpoint.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.glowpoint.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://www.glowpoint.com/role/CondensedConsolidatedStatementOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.glowpoint.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 1004001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://www.glowpoint.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Statements 7 false false R8.htm 2101100 - Disclosure - Business Description and Significant Accounting Policies Sheet http://www.glowpoint.com/role/BusinessDescriptionAndSignificantAccountingPolicies Business Description and Significant Accounting Policies Notes 8 false false R9.htm 2102100 - Disclosure - Liquidity and Going Concern Sheet http://www.glowpoint.com/role/LiquidityAndGoingConcern Liquidity and Going Concern Notes 9 false false R10.htm 2103100 - Disclosure - Capitalized Software Costs Sheet http://www.glowpoint.com/role/CapitalizedSoftwareCosts Capitalized Software Costs Notes 10 false false R11.htm 2105100 - Disclosure - Goodwill & Intangibles Sheet http://www.glowpoint.com/role/GoodwillIntangibles Goodwill & Intangibles Notes 11 false false R12.htm 2106100 - Disclosure - Accrued Expenses and Other Liabilities Sheet http://www.glowpoint.com/role/AccruedExpensesAndOtherLiabilities Accrued Expenses and Other Liabilities Notes 12 false false R13.htm 2107100 - Disclosure - Debt Sheet http://www.glowpoint.com/role/Debt Debt Notes 13 false false R14.htm 2113100 - Disclosure - Preferred Stock Sheet http://www.glowpoint.com/role/PreferredStock Preferred Stock Notes 14 false false R15.htm 2125100 - Disclosure - Stock Based Compensation Sheet http://www.glowpoint.com/role/StockBasedCompensation Stock Based Compensation Notes 15 false false R16.htm 2126100 - Disclosure - Restricted Stock Awards Sheet http://www.glowpoint.com/role/RestrictedStockAwards Restricted Stock Awards Notes 16 false false R17.htm 2127100 - Disclosure - Restricted Stock Units Sheet http://www.glowpoint.com/role/RestrictedStockUnits Restricted Stock Units Notes 17 false false R18.htm 2128100 - Disclosure - Net Loss Per Share Sheet http://www.glowpoint.com/role/NetLossPerShare Net Loss Per Share Notes 18 false false R19.htm 2129100 - Disclosure - Commitments and Contingencies Sheet http://www.glowpoint.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 19 false false R20.htm 2130100 - Disclosure - Major Customers Sheet http://www.glowpoint.com/role/MajorCustomers Major Customers Notes 20 false false R21.htm 2131100 - Disclosure - Geographical Data Sheet http://www.glowpoint.com/role/GeographicalData Geographical Data Notes 21 false false R22.htm 2133100 - Disclosure - Subsequent Events Sheet http://www.glowpoint.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 2201201 - Disclosure - Business Description and Significant Accounting Policies (Policies) Sheet http://www.glowpoint.com/role/BusinessDescriptionAndSignificantAccountingPoliciesPolicies Business Description and Significant Accounting Policies (Policies) Policies http://www.glowpoint.com/role/BusinessDescriptionAndSignificantAccountingPolicies 23 false false R24.htm 2306301 - Disclosure - Accrued Expenses and Other Liabilities (Tables) Sheet http://www.glowpoint.com/role/AccruedExpensesAndOtherLiabilitiesTables Accrued Expenses and Other Liabilities (Tables) Tables http://www.glowpoint.com/role/AccruedExpensesAndOtherLiabilities 24 false false R25.htm 2307301 - Disclosure - Debt (Tables) Sheet http://www.glowpoint.com/role/DebtTables Debt (Tables) Tables http://www.glowpoint.com/role/Debt 25 false false R26.htm 2325301 - Disclosure - Stock Based Compensation (Tables) Sheet http://www.glowpoint.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) Tables http://www.glowpoint.com/role/StockBasedCompensation 26 false false R27.htm 2326301 - Disclosure - Restricted Stock Awards (Tables) Sheet http://www.glowpoint.com/role/RestrictedStockAwardsTables Restricted Stock Awards (Tables) Tables http://www.glowpoint.com/role/RestrictedStockAwards 27 false false R28.htm 2327301 - Disclosure - Restricted Stock Units (Tables) Sheet http://www.glowpoint.com/role/RestrictedStockUnitsTables Restricted Stock Units (Tables) Tables http://www.glowpoint.com/role/RestrictedStockUnits 28 false false R29.htm 2328301 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.glowpoint.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.glowpoint.com/role/NetLossPerShare 29 false false R30.htm 2329301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.glowpoint.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.glowpoint.com/role/CommitmentsAndContingencies 30 false false R31.htm 2331301 - Disclosure - Geographical Data (Tables) Sheet http://www.glowpoint.com/role/GeographicalDataTables Geographical Data (Tables) Tables http://www.glowpoint.com/role/GeographicalData 31 false false R32.htm 2401402 - Disclosure - Business Description and Significant Accounting Policies - Narrative (Details) Sheet http://www.glowpoint.com/role/BusinessDescriptionAndSignificantAccountingPoliciesNarrativeDetails Business Description and Significant Accounting Policies - Narrative (Details) Details http://www.glowpoint.com/role/BusinessDescriptionAndSignificantAccountingPoliciesPolicies 32 false false R33.htm 2402401 - Disclosure - Liquidity and Going Concern - Narrative (Details) Sheet http://www.glowpoint.com/role/LiquidityAndGoingConcernNarrativeDetails Liquidity and Going Concern - Narrative (Details) Details 33 false false R34.htm 2403401 - Disclosure - Capitalized Software Costs - Narrative (Details) Sheet http://www.glowpoint.com/role/CapitalizedSoftwareCostsNarrativeDetails Capitalized Software Costs - Narrative (Details) Details 34 false false R35.htm 2405401 - Disclosure - Goodwill & Intangibles - Narrative (Details) Sheet http://www.glowpoint.com/role/GoodwillIntangiblesNarrativeDetails Goodwill & Intangibles - Narrative (Details) Details 35 false false R36.htm 2406402 - Disclosure - Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Details) Sheet http://www.glowpoint.com/role/AccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetails Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Details) Details 36 false false R37.htm 2407402 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.glowpoint.com/role/DebtScheduleOfDebtDetails Debt - Schedule of Debt (Details) Details 37 false false R38.htm 2407403 - Disclosure - Debt - Narrative (Details) Sheet http://www.glowpoint.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 38 false false R39.htm 2413401 - Disclosure - Preferred Stock - Narrative (Details) Sheet http://www.glowpoint.com/role/PreferredStockNarrativeDetails Preferred Stock - Narrative (Details) Details 39 false false R40.htm 2425402 - Disclosure - Stock Based Compensation - Narrative (Details) Sheet http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails Stock Based Compensation - Narrative (Details) Details 40 false false R41.htm 2425403 - Disclosure - Stock Based Compensation - Options Outstanding (Details) Sheet http://www.glowpoint.com/role/StockBasedCompensationOptionsOutstandingDetails Stock Based Compensation - Options Outstanding (Details) Details 41 false false R42.htm 2426402 - Disclosure - Restricted Stock Awards - Summary of Activity (Details) Sheet http://www.glowpoint.com/role/RestrictedStockAwardsSummaryOfActivityDetails Restricted Stock Awards - Summary of Activity (Details) Details 42 false false R43.htm 2426403 - Disclosure - Restricted Stock Awards - Narrative (Details) Sheet http://www.glowpoint.com/role/RestrictedStockAwardsNarrativeDetails Restricted Stock Awards - Narrative (Details) Details 43 false false R44.htm 2426404 - Disclosure - Restricted Stock Awards - Summary of Stock-Based Compensation Expense (Details) Sheet http://www.glowpoint.com/role/RestrictedStockAwardsSummaryOfStockBasedCompensationExpenseDetails Restricted Stock Awards - Summary of Stock-Based Compensation Expense (Details) Details 44 false false R45.htm 2427402 - Disclosure - Restricted Stock Units - Summary of Restricted Stock Unit Activity (Details) Sheet http://www.glowpoint.com/role/RestrictedStockUnitsSummaryOfRestrictedStockUnitActivityDetails Restricted Stock Units - Summary of Restricted Stock Unit Activity (Details) Details 45 false false R46.htm 2427403 - Disclosure - Restricted Stock Units - Narrative (Details) Sheet http://www.glowpoint.com/role/RestrictedStockUnitsNarrativeDetails Restricted Stock Units - Narrative (Details) Details 46 false false R47.htm 2427404 - Disclosure - Restricted Stock Units - Summary of Stock-Based Compensation Expense (Details) Sheet http://www.glowpoint.com/role/RestrictedStockUnitsSummaryOfStockBasedCompensationExpenseDetails Restricted Stock Units - Summary of Stock-Based Compensation Expense (Details) Details 47 false false R48.htm 2428402 - Disclosure - Net Loss Per Share - Narrative (Details) Sheet http://www.glowpoint.com/role/NetLossPerShareNarrativeDetails Net Loss Per Share - Narrative (Details) Details 48 false false R49.htm 2428403 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) Sheet http://www.glowpoint.com/role/NetLossPerShareComputationOfBasicAndDilutedLossPerShareDetails Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) Details 49 false false R50.htm 2428404 - Disclosure - Net Loss Per Share - Effect of Antidilutive Securities (Details) Sheet http://www.glowpoint.com/role/NetLossPerShareEffectOfAntidilutiveSecuritiesDetails Net Loss Per Share - Effect of Antidilutive Securities (Details) Details 50 false false R51.htm 2429402 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.glowpoint.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 51 false false R52.htm 2429403 - Disclosure - Commitments and Contingencies - Future Minimum Rental Commitments (Details) Sheet http://www.glowpoint.com/role/CommitmentsAndContingenciesFutureMinimumRentalCommitmentsDetails Commitments and Contingencies - Future Minimum Rental Commitments (Details) Details 52 false false R53.htm 2430401 - Disclosure - Major Customers - Narrative (Details) Sheet http://www.glowpoint.com/role/MajorCustomersNarrativeDetails Major Customers - Narrative (Details) Details 53 false false R54.htm 2431402 - Disclosure - Geographical Data - Narrative (Details) Sheet http://www.glowpoint.com/role/GeographicalDataNarrativeDetails Geographical Data - Narrative (Details) Details 54 false false R55.htm 2431403 - Disclosure - Geographical Data - Revenue by Geographic Area (Details) Sheet http://www.glowpoint.com/role/GeographicalDataRevenueByGeographicAreaDetails Geographical Data - Revenue by Geographic Area (Details) Details 55 false false R56.htm 2433401 - Disclosure - Subsequent Events - Narrative (Details) Sheet http://www.glowpoint.com/role/SubsequentEventsNarrativeDetails Subsequent Events - Narrative (Details) Details 56 false false All Reports Book All Reports glow-20180331.xml glow-20180331.xsd glow-20180331_cal.xml glow-20180331_def.xml glow-20180331_lab.xml glow-20180331_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2017-01-31 true true ZIP 73 0000746210-18-000026-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000746210-18-000026-xbrl.zip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

    HWL <%B34!EX!/HA&AW6@V20ZX9P$G87>P0 M\\F^(IV7\$ 89FP%F]1BG,0)7(QZXX#0@S>LD%2&J112$A+9S0 LV3S,9UL<%F<%1*K +(XFX'C=SHU"2))Y$YN"3; M8O:OS/N25"FFH; E,A3,1UMW4RYSV@.F8&5[8>0G)"+D.TA0J,TD-^#C!7_D MP8Z]+DCWH*W<D9J&H*GPUKS11]'0W3!P90\-? M_BTL!!T?9#YH#L"DR!6Y(LI-C[Q]L"LD(3O'"Z,@%N^2"1,AL&&@T"6W MI:I+KS(U6T0.Q<";3!-'!A#D%A7*%WR*O$!S MHLIPHD'W^83[DSK*P/86V<*?-APK13=E:=[\K-77<7]2<)7UP\432<4YOPV( MR: >N$LR]J];[<:;@PP[\"SGS?K,04KD4R 5YNOA41QT&J$X17O+Q?0KGN^"K$@=@7XRD.#P@%Q;J/,E^S'Q(DGR,MK15&RQ) M!/-!)$I60O(I+0+$A1H$*/@ADZV)BN1D0"SDN?BW@,"IVVQI_B67RMOT#GFO MR"N;K+^$_\;2R#?3W"HR\$,G%+(/C&0DENO(IY@QY7'DM^/)/!9YF]*#%,KC M;.PT$ :+CXE&4ILCIR(^3A^12@>27DAUL79B^(M=(X3SU_2LSPG@6)8!)+T3.H[Q>RAH+G_O;;*WA M:VTMI TO765HJ&)+?5/A]:*$4U))" M*#%)/B\\5;_YL#>CU4AO+Y=KB5OV^",+I=>/E#BIGZ<.:L)-?Y'AIMCCX?&9-H;#8U1?]CN3Z:3_J#?'0^Z@U-'>DO/T$I! MQPAVYXUU53K %RP,P?ZQ"Y'8#8STDP>FQ$I:$\R,@3$'E*H5DS. 5#K@+11IIJ FE4V*_ B@5P7[0:.G'OJYZ5Y3:CL?49K@ M,>#?V9Q4<%A9M=M&V0 W,IT>!N=%H'POJJH#>+4,"2Z#/CLZ?CB,?J/3KH5;R M^6R@?^:6:86,M4U7ZS-R6%_*D0YP@[6;1""[!KU* K\7G48B^96=?Z*SCZQ58?)QBG_^$_F>]+FMKR'\ MP-A<(2>8I"?[WG?M),U0>GBY*PN1' ^3;O+CGS#_,S_U293C9Z=1!NMVT^BK M 75-&C=04"3IHL+W1?>U.Z4+4Z-'-[H#M5;/^B2Q.MW+)LH7VXGETE/)#8V$ M):MPR2N?Y:')9@,R)A+=)_V8GO-*-=DL#I)XAI)#G;SWS&E[9*76T9?%0K0, M$4%,F=R\GFZ<^\HV&MS #8K0J6*#74421Q5C4,B94[&AM=NC%B8_+T^ K?F! MC2TF^!KR;W-W8FO%D'M84X!\T'632+YKBKC^0F::-4@U$Z$0M+ZP.TZ)/TR20!4B0"UBFND38!N#?#K&^(&D;<;RMM=V=:5A!3 M-D!"/,5:\;'\N\RBD%%Z(O9<"#U?JY;+V#:.EANN_9RLW#@GO$G*C]J?> MRG1RE*?UH9-[^S9TN\,,0]6%LN9N6I:1]E96YV?"(BGM\[A'Y MI7)6D/YV7H[FM40G*,F':ZC3F3)!E+2\V7#%9:#8U=]N#^^JLK.WFFU%368S MRUV[IM39"TJ641R)?Y&*)_UB)&E_0*;&DY!EF?TL=N> !83/X0:@,SJ'S0Y': M0L5$PK^&/O75RG>P(IM*:1#M5YQP/SV# 6Y3*6= -1'[9PYMN1)&ERD%[:> M*R5H[+RI(^Q&N'4Z1Q;..6YLG#, M9.K-U?9X[R(=31"N7 ?;9(O?4F<.]LTN]FRDC_S@SO3R'Q2KV. C(*A;V>E; M( -L %<-1><$>"W$\/LB M^:$;%6OH18&$F#A49 !Y:RC'!JYHM).-?5RD*4MMIWTPZ/UT9I,0(B-'"1!&1MNK/ M:2;8^.(??D!=0,1>GE5*MVCE&4S7*4KHN)ZLI3Z$S>!I"]DQ!*1B=LR,8Q_[ MM,?3-T1G -=7'RQ2_'\:>:1?@&6Z_$X&K+[!]@(GN:C%LUO1;.'D;O@L14?? MQ=&*)+TTXZ*=%K2?R@=?2G5,S@>_62%S=!\\';%L'_SF.;4/_C0^^([JH]/D M/$[SEO*X&HV&A"6TDU3PTD8S)1$/9SL1DVFQUCWRU-UGSLP'VE!_1$7O;M:<[8%% T1JR8 M3:2# O44;#HH4->@P!9]6$%08$O;FE,%!70JSFG9PMJ@H6PDZ1";K3[FARJG MG>*DZY (XTJ#0@4UW7+(@WKX%%7=-/ MA4JX55+3FLT4!\P"+B0*5M,VT872M73:NRI/H:I.1=MV+N;8RQ[;2@\$$T&6[85M,)J%V M*'*.1C+R3(TNJZXZ?EL,XJ7BQ# [#K4YI]%\B&K^(V@G *N$.M,28-GT6[1W MC[9UNKCEKO^HSI7^DZ$,0L51]4E;]LPX\HK5SGD[;3<0#QV7NZ,-W^0%%Y.=/NV5R.&JG: M%=0M\(]S2')DID;YZRHL[<,8S3;Q(%!)(X*B6E]E?7*QF%\=;F8,5Y%9TE&8 MEJ8,9C\9/75)5(V7YB%6^TV_VYKUC,'4 MF UZHYOI9#SO@B5O]/KMV=P8W9S::E=N(>[7/(PT;8?<5VG VG7]1RI:%$/3 MXA"^&;[_H,(VMBB$N _\5AB>].ZN<=8IN33671SYUWA^L#3=C\EW(G^%"__( M%H[( VYQUY7/_/U=ZQW]'JY,*_G]\)M?FL&=XXE-FG'D)Q]03H[XY-&QH_L/ MHU%SU.H:[?:@W1X9W7[_;Q^QYR,/KBV M[D*^8?DAXU)K]DI@O0G-)%P[][? MWPW?L7*9FMYN6&M ^U7\\M:T_KJC^-^U M;&]I69PO%B= WG5]0B5TA:_<7-,U3TGH.P%?%9#]I HZ+Z+8,U!Z)3 ( 95" MH]WOE@Z/JMP\?N_P$<(*$>*"!:;F,Y?-9SI;4F TGU&H\)R77I-XS["//J@T M,A3Z8H[+#B6]O4M)?P/L#M"J2Y#:[;VUYY?PIBHW7K9PUC+XC.G!:(\T/6BK M^5#ILC2#OWB4ZZE1!C$IA>EIJ:RC=3AM*U9(3IT/::79KNWR,>Q<2$R;21]G M22%'@-7Z<2GRJW:T--2VD;:-M&V4>MY&FTW%+YP>M&WT7,LE;'OR"_O3# +L MM)"6NY:BP+T0'=<*7AG JPJJ:1NK!O+N70K& M=0#C;#_&I.NW))KMGU9V%G'V?4%X9(BIYW0#0UW2STM JP4.:0/[M E FGMI M[G5 I^Q62YE+0_.O-77M9ZK5VOK\LR6'^U<+[J@Q]"+'=MP82W6_IUU=;WZ( MOA;SP%^*\D5*!?JRN#$#;)<2?N7!=VS8=D@MXG VZO=ZK=[T9M;IS=KMR7S: M;8_[-\/IH-5,^]]A7PJ:+,#E M'63#-:SL)K!L470HXO:U"31FWG'FQ9CQ3ZV2T_:9A495U \'UTBJK^GFX14X MTL.E&31I[]V%;&H@^G5C#T/:-C8FX9:);1 *#3B7[!';$HJ../]:MPJ$;=T!:L"./Y!K?(IA4FTI$_[:<>>^6P1G19+Z%VGL2EV\UH^^NH8F^J MK:_"][J-=F]SQ-F%:YS5(Z9ZR:I:4T0)(NEJ,>T9_.!YVYL-NN]=N]4>S4?OD<]V55V4AK Z8 M_[8YPO -P]'W@,_%%BGI@6ZGKW&JU>%K8AE43IE)MZN':.F!;AH7:X*+>J!; MF;;"GY@)''AL[+J.Z5F<34SO+S;^^1O[QA]\%V!S2J*O=QU()28RU:-VZ)@. MXEK@3MF^K0JQM\K)9LW&-!M[':B&+65.]GKCC$(79)5-W&,TQO[LF]YK#(NS M:RRO/?;:X%9@<)\=71B-5D=96ONY4(2V^9^K_S67/IS_?[G-; P*V4YHP:G+ M&79Z/@W;=1:3MD,K*;+.A\2NVOWRDW WT:2\Q!7E!/E>FU![P^HW'C'+#((G M3&]X,-WJ#*Q3%6^IAY"[!(]%I2FK!#1Y.[@NE,",1J^ONIW\>9.6MN5VP_8S M#\,/S(J#@,.7EV8D$RP;U-K<7Q0-O%*4SXL9V*5GZFG[L)[VX<60Z!4VT"EI MV-0KX*8MS&KIP>K%KX\[Y\&2^;?P!BIB>+OL/0 I%JCK&5MF* MQQ;X5 4CSL\NKYP>H=F-9C?Y[W44^N OA- ;CB8W-Z/.=#9M=V_.KC!RV[BZ MD$UKIVLT]EK8O%63L-,MSNXI.%T].MC@6E*>:/G MU9T<$W?679:(B2_ \IBX2=_3-;T:MTK$+5V@JR*'"6S P(S@?*5@XA&!6 <2 MK@RPSI?W:8Q3JL6U:L_@I(?DE(I(56"AS!]=)W?SE=%H#WNJ3W[>H7>MC6LF M<5E,HM]7;JJ>-XLHTZBJO=(ATF9728]H)AI+P\L=X%T'34"]P"(M==GK.KM5 M6Y2:L#1AG:(_3.UE6&(X,S.* N[U@+%-'M[A4MB8&CF=AX.C;KK@C/N M^4O'TW'B2DB1ZN!XU@-/F+G:JQRUQ^]J$XYIWG'DQC@7 =/QP^YS MA1_LE9%?AE.J=KZG;K_1UFTDM4&E&ZOFZN :QE"9BG\N)*'5\-VPG:B5-B?P M5=2ZZ_SQG!CG/\K@JM5LJ6Y3]@9X7K#?HT:\M7+*B>:@FH.>DH,J,Z@T!U7C M.7Y[?#@6#Q9AMO84X![(?49&+NP@)R*_8U;_IT' MI[?AK8X/SX5[#+O^'_GF_QD_FH']^].*CW\X8?KI-QY&@6/!GK^CN^17FK*8 MZP-AM.?3H3$=#8>C<:]O&,/)?&ZTI[T.?#*=C 9GUP>"P'!]BQ=!#1^2FV#\ M!_[,6*-JK M77N'I1G<.9[8I!E'?O*!8%ST264[0/1/W(.A4^<>#O4ZO*Z\+[D'1+DY%L_K M*"440F]V>RC5TZ8Q[4*[C=#W=!^1RL6Q+Z/7@^XCHG&K9GU$EG#=+J^2^W3= M="GLP&BO&6[7](E*6*-; ;,H O[ O8.&):E7Z+0;=2_??NV]I,<)+ZF-X=(EX0519DGY?!=(F3KP6)>,YJI@7*5:5%3&\526LG#&L]HT ME]%<1G.9P[B,LO[<%\-EU!8=J*T8J%%9PA^>$X7?OO^Q49XP:W='@T%OVAOV M!KWN?#QL]3JM^>AFW.M/#&-V?F,J#RE/ (#I6@1=BW !Z?@5^[JN1:B#>JMK M$70M0L4P3=-4Y.6N-,6_U M?.JD"UV!H)G7L9F7PMR46J/,6[F7+D'0)0C52\#U$ ^%ZOWQ MRNOJC73:[-8,LBZXJAFD0@6QHSGDT?7*FA04SN,H#OBOCN#+RN.?@WO[C.'%X?%P4F[B@=S!8 WX]Y\/ABVQ[UIIW]R:@S.KL"0 %.MA3P9 $!E$9>.Q$!E0%E\ "+_AB@U[5E>A9WJ4+. M3V#-7 (VE@/Z"[:!>J_9%N7Y9W*K8S38UB3LUZS=8("7)=-+TT'9T!NEW-52.ZM"J@JD;];&5NIW5'6@[7R-W\2+_IY"4C@+J/7 M",.SRQ\<*F.R5;G:DU!'A5RHY9)-^Q"7U 7F+"G,D=!BJ!)BJ%J6Q6E"$G4P M'2K57; > 89.MZ2FR]L"#'7 (84L[>UQA#>X^+?'#'[SO0<>8O<_#$F,KC?N>F WK$Y*9G&*UQZZ8S,GJS>6LV&8^&T[,++(Q9&"^7 M9O"$,8%8PI\%*;A@/81ZC !C5\E\G7;K([893'\U/KYG?AR%D2E\>A1B:% > MJW5O>G< EJ5I?5PA+:$Q%A4WGYO5\J;2LI?AR_GA!M<]I[XU"2)X=TOGN MJ!=2&3>%T1CT=)%U)7'DS*23SB*X["R"5K-7/B^NRM4K='96V?9Z5C-0[N_[ M+]("3LER*D-,5YU67S4@,A0H#Q+*">V]MA^/Z+BH:R8.R!X]1OR2K%+U12Q^ ML.".0O%SGN;D5;>G3"Z]"*'+%E@5(L7Z2K+S28YK-=O*TDVU>54-#;%6CM=T M;I+2\I+:Y-RII^C1Z(@EZI>0058] J^-U, /*:1S<>RTLJYS"FHEC MTH=T/NLQ\UE?@X4DX:J ACJ?M8J1PY.Z574FZ^NAVNGJ+C65Q) SDTHZC_6R M\UB-IKK4N\I?O4*?994-,)W'>JI\H;:ZK 6=%J3MQK//8QWJF;1'L49+8AD5 M-35/E+NCU,RH1UC<,$H:]*?G3F@;]S@VKI[,<\+\H N8S-/L'M(^6+/(VF<4 M?>,/W(MY. _\Y>Z4YC4%.6/ C'GOW9]^X^.P_<'H^#C@YN%#>/JS_MPP9O-1MS_K]?O3<; M' HL&6![,1=FCXO3^30;AE7*[X;5R*>I549*Q;ZNTW'JH([G,]C4)4*H=WB5 MD%_S.V:8LE]]2@Z]H>30U%E1JH=(HUW5QE15. OLU .5-.)=+N+MG19T;FE; M*N$X XL&#"SKE$1<;U]$)9)$ZN'A:C?:?74NKEICC7;R5]3)KQF89F#/,+!A MK_Q97+7 &H4N^"K;IF6"<.X''!9^C7V@M#RI#@E 1J/=ZBFCO!>@4Q4$*5M) MT+K 95-46UUES850E'8E/..Q]B/393*46@YBZ9P;I?JZSKGI-+H#98G%.NE& MNRQT7F(E<%7S2'6P[#9:PR,V9*PUWBG4+]^>F*@ZO7![$B-E/4XP26[J+U?< M"RDWCOJ8?5GAC^%AK=)RR8KMWLW<:,UZK6%OU.O-AI.;SJ _&-WTV\/YL-.9 MG?=@7UFN(F#(^(^5$V"6H6>S1=*3G0&9\(#Y<2"?=CR,M<*=LI5KPK?PZ>(Z MNEW:&;=+VRRU.NOLSQ)2.XVNDMS.SEO'_>I>:;7=O;XZG5=;<7,RW6Z_VE[O M$A+'OF3ZCRJ;1B/4)2/4S0\>6$Y(QMKA5IYF6Z_!LM,/F*]X>NQO,370 RM2 M-.=D?Z"AZ#ZAU2>MZ-#JN1Y02$T35S5VZZ""D M3M2H0VU)5;"M$N4CU6%#S5'Y%6Y5N7K-:"K*:,YST,%Q1+PF+DU<6HIK*:X9 M32D. ;C^"M2]%'>@T L@0X*4JW=*AE,94KI2-IQH$P-*=AZI!(,>^/-2K.T2\>=P];9"EO5Q M]=YY4I=221]%=53B\FU+K2MK%YO)^5JVCI7VJJ[HJ4Q[AC9 M'4::8V)J7=J*IB.>@;7_D M=^]NYH26ZX=Q<% [N$&WU^EWC6EKTIKT.JWNJ-L?#CO]_LUL.NE/IN-3MX-[ MKK?6@6A OSZ*5]_ZKBT6RO?G8S,S,I]%B.=.LD;1U9C"._<#W7+N[=O%=GY* M5MI:D?B:A:B38,#9HQFJV9GG*[I9,X(_ C$%<@"T&46!FDP/CM[8RXMK5*)UH!X<79<>;Q7[NFYP5P<;+]VN M'ARM!T=7,0Q[Z'*WS.BL@934# MTPSLM0Q,#XX^2;N!LTS:U(.C]>!HG452$8O[$BE*#X[6@Z,5>JSUX.B:Z>MZ M**H>'%T=;:1";+)R:HKFD9I'GHI'ZL'1%4OY/=K&:I=ZBJ.PKUV.0K[*76JV_*5F()0F#C@?(+\)O;&D&?^%^:99S3;)3"W,OE"RK+%6U M^3S!;>;)OYS97DB$!XQV%L#=O&AL418I?.$AN?#=V;0S;_=&,V,Z MZ'6-V6@X'\ZZK=%X.IH/NZ\0#[']E=3A-[:]#%(^ 6;+R'2]JL$^>U617@L,/V^TM!L5K M[IL>_^!$<"9K_95*>'.Z8>,C*W_SC[R.NXY#];M.RG)*WSP6F)G>D^H#O*=R M"]"4//,.M*>0!P^.Q=DJ\!\<6TSTPQ]\1FG]8"Z8J3#Q>/3H!W\Q<[6"7=+G M89-]B8-DE1"+/9C-0Z!C6#ORDV7AA18<)^#WW M!L61A[$0&G)<#<#P8,*>HR=\-? V>!/\ M"D#\DTO=E?EY<-ZY_BVLBZ<&8^[N'B\N=B/GVKHW/8^[+#1=A/H*X&Q:]_"8 M&26[#IGM!-R*DF<0O/);*S.(/#A@D_T.,)&(1@5)"S]8BB(<$P23:S[BA5I^ ML$KP [QJ_D$*G"K5?RV#[.AV>6 MAPN9YT> )#S$B[.?UW^K),_J+)"WZT=? \!C9X6H"[0R!3: K@I3JTG'/ 2 M./!D6!RK]ZST$N"7A>.9<$$F\* (/D!:RA@F\6!A;M#UI;H/$2&RN&HY$Z[] M1Q1887P;.K8# J+!?OF*K&T9>XD4:K#/GZ<-]GCOAYS=)MK[(O:LA'?DY)V# M?)\ PR+N!2#'3$LL>V^"9+WEW&/<=99P/](]8N6)I[D)^JIB7YW)9X?19X8.$<17 M(6(T.SLZ.Y/ZRK\!\3DAM@YX@M-@.7N(U$T>E"AZ"/\-#^*10>I"W MT3+H3"'R=)8',4I4JV+/C%%C%:IO1KR@?H"")JJED2-%IAD4KK0_ZJ M&P&UT$5MF=1X&]%1?'Z%7W5"$_O0E.*H\4$ MC#I$@P-A;[*%Z0392W$IO,!L/\#]'5$3#_P!%'WB%4*S)@Y/2KP9WK,%%<@G M%XJ&D \(G"FNA*4"D,"5.12=NI3%N8;[8K4^QW?$6_!FT]0YR!"%4;#UEVF?1*D M^>FAE6?'A!'9=PAHXH) KEM13)@C;A>@ZN*1 !J !H&_E B<0D];($<5#A7F M@\2NK[EPDFQ#7ZD7LO">\PCQW634/P,$A>U;,5$GQ?& -5%LC_ M$4'[48+M M"XN8'NKONZ(A+)PQ)"K[=-Y7SULI^+=O"Q .5 M4>(KQ0YGQ5>$EY%W,&N9=529=9"FF&C&B<:XQ@X.Y+QHQ: T2-1P]QEY'4H>1D8'"-R7K/^7D?=4JD3*RKSVZJ5/=JC>3S64 A3TYML;LG8 MX(<87AK@%L4[QAB$!*'"U7X^]_O*=W7K=&[.IW?^58K-_JOV?O%.K? M^6R)I/"8P+4Q<1>-@F@3TU3@DW['T/"R,06\!]B@LK-0C% !1 )HX1#6/ M##;0#27,_C>#XN,])UL^"GSR,JS@;AV417<^ZJY^+E$"HV\8"EOP(!"9)UD6 M![H;/>FW$]Y'Z>L-$V\@N6L%[.&;C_>.=9]JH=&35%E3!18_=,5+X#IY8F8* M%1N#@QO;:[(O7F8;_J<))FWPE'T@4XH;[%%FKL#B&8IAI%'X$Y>$)!SA!R ) M<5.H9B\YO-86&3-B6V(;5D8%=")R_J"ZCK$+E\MFJ_[BY9UA:U>APXN Y9I; M$Z!RYW@>.<(78%^\O&#V 2H9J=N:D03)SH[15K#QT3\$[Y460N* 38P/X7O/ M$HA@9S&7=Y5Z;3'W!N@NL,E%1EP!M9E[!Y DP":U&5&*/1Q I4V&Z3NV0ZX6 M0N/ )HQ+@P*X&[#-!(0L*UYBP!=V97-8S8GVO88O"W1.7Y_@?[ MS6_2\]=&KY$](%BLN:1 \OC[E+4[K0;)(=<,,&_Q+G:(^61?\07)P -AF+$5 M#&KQ &E0^&^ GW!G)?WO*;%(F?RD?9$YF#>Q+]P<."GT@D4U(T/9&E46%/V88DGV6I M_!7!OOS#"5<7Z^52/$D=,A@6^#$ )Y=2VZVDNJ9)@M"Q($&#I# MJ;ZE>=.YO0 RNZX@0KZ#!(7:3'(#/E[P1Y1F6_>Z(-V#MG++I<;Q[$:$8"Z M!E:0NB_MC-0L%%6%K^:5)IP.\ Q,'"&'Z1<,-6$:Q(/IQKS!'KC(K<@!F!2Y M(E=$N0E[ K,!#-,*/0 JC0$0W48-(4V2<)29B P'"KF]%RB^I#,1IB.\2 M]+;E5IF9C^HTO3A!FFC@R@""W:)IXCKQ 23X EFNF<-R?%%QE_7#Q1%)QSF\#8C*H!^Z2 MC/WK5OOM60P[\"SGS?K,04J$.2>1HEQ!U'OQ* XZC5"A%4OQ3'9 MO5ZZ-KV]F>%^4>P*N(N-AJD82M-H"NXQDN+P@%Q8J/,D^[$.*CY#:E M!RF4Q]G8:2 ,%A^#8U*;(Z>B+":3*AU(>B'5Q=J)X2]VC1#.7]_G!/KBJA)] M13C5N$.H(00PO5&&YG&@.%W8NGXC5 &)>2LS@M>1+9AX(7(>Y?PN$"ECX7-_ MFZTU?*VM10ZZ1U[PO''4[4Q9BR"-% *9O_D1%O,UTML+X]M_2-L6M^SQ1Q9*KQ\I<5(_3QW4A)O^(L-- ML;FU-Q?R4.4IBTZL>(5W+W7&!+_I97 9 :V!7XJH)]SV!->#>S3LU72AT*8A MO@V!$<$5W#S@/1S2F6'4ZHS&-ZW^H'W3;HTF-ZW>M->^,4:C46\Z-HS)V7=F MR(#'!/3*4AD4GN0\5)XQV<([VK>D0_B4-;91-87/CR-B/G]1;SC$6U2D%(/IN,F M1K2J9CD_#?K=1JNUV>?J==K<%T6EQ.@0&BK,R&SD+T+4>)-@(2\(*#_^8@$2 M &7X\5W 21 VV7=^C 8$7\T@8I\^-=DG$,"L M!]=!2LVGK&!:>:3XEKO^HU!P;>$-HO+'K$([X'<@DQ,]*0%>KBQH+P >*C)W M"4"4DL#G_OJP\/T(\ZP_PR_L!WT$ZB4 X3Z*5A]^_OGQ\;'YXS9PFWYP]W.[ MU>K\C'_^&1]\)Y]';_K?W\'*%%IZATO_O+'V?_R??_\9UW$^X'__X_\'4$L# M!!0 ( %Q J4S"V;'BMP\ +&F 1 9VQO=RTR,#$X,#,S,2YX/A;N^! 9+)S"0WF2M"R"QU2([3Y@+PNAYI?&N7G$P=9E' MZ.B\\JU?;?9;G4[EGU]^^?R7:O6/B]ZU<\G<<(*I=%H<(XD]YYG(L?/@8?'H M##F;. ^,/Y(G5*U&1(Z^>!'>F7#'>((<)"4G@U#B*\8GEWB(0E^>5T+Z/40^ M&1+L@0@^5E7,%4@]EHB/L+Q%$RP"Y.+SREC*X*Q6>WY^?C?RV7/ ")7O7#:I M'=4;G^K'QXV* WI2<::>YBCN$_HX5_QEP/UWC(^@9/VXIAX/D,!)<GI:TT^G185G*@AL&[4_;J[[&N[*EU\<1\-/)@'CTJ%+L V1&&C* M4%1'" 4*AH_5>J.J@(@:S35SD=1--*VRD;"&?2F2.]49JW<@0\6IY1.',Q^+ M+6TJD&H-VQ)(\RHBD*T5K1!GF43]JB9T576KVCC:3(J9/^:3(J';AA2G M-<1=!37 YLHJ?@E\1)%D_/4*?F>3S.=\CDM[QD2)>*I$;'S80$3-F>*1BM_9 M14I3;56.'&9)*#:NWQR/LXB1IKR-"+EP.Z[ M$7NJN2RDDK]F#FDFNN1'D5@VSS3D'-*? M*D":>_-I;'PT1Q?)]'E(1&751G MQ,4$P"_N.+Q;VF/7^M!9P%F$L"F50JA=<,QAP/SRMJ5%!-!@-_NLA_!QEO M4F2I@OF,0O=00.*&OE;B>B9DPD'%[/.* &/[.-;\IROEX6%>I8"$4++'.OEH MD%(H@F^]CF4\K67*P"H1)!%EUM*^'#7J'QKUNE-U+HEP?29"CN%' MS-1)N#J(>H[FZZ08?ZXMLENH*!38Z](O^GK1=C%Q7,1"N.#LF>GF_]T(?=X?KRUYBB8B_38R+U&YK%N_K'][7CXHU"RB8B..P85:B7V.Q M_GYH52FSW*.!O]5@$#.T87]<_W!<;Q3$_M>H@C*A>!$*0K$ OQ(N)X'B"H;O MDQ$E0^(B*L%T:@1%Z.B.^<3-$]V+\+:'^X8AW">U.*EJ-+ZIBIQ934Y2U0%D M&Q"WB'.0^@GG#??;J,L>W!N&X%ZT$0#IM/921O$"GPWE,^*XQ83,#NY*!O9(?FR(Y"E63L++T4M%/E<[M>)M69'7(HU/PR5P8P_.H7B>NV(EJ MGJ,Z^.JP^ SAL_YYS$>D[6R8BC4\-DA!V\$LY! M@ $\-2VC["L@!_?4*H(+Y*O5'_TQQGFRT?6L+(!!KPE_JN?L@RWU.C.%5_?V MLGW;;U^JJW[WNG/9O(X4C:^@SR0RC&6,-CRMXC= M/-\U0)YHS\L-) P#T[64W@^G!NP.^Y*YCV/F>YB+]O>0R-?-L+6SML-[G-E/ M^_?P[Z9]>^]TK^!'M_6OW[K7E^U>_V].^]_?.O?_.2 NW6O>=Z! B:"\Q .9&2-=V#Z9^M$PW:/(2F;2PH-U M([%].O2C8?9%L2G]Q*H4B3VA3$?#7-1D:'+-^64?*G8I%Z;2AAN=NB0\8F6*KOE M;4PL6-2GTTS3#R93EVI*,&+GI/B5")NOF(TX"L8JP;]$$F7&8XG0FC4=FQ83 MI5DXBD>)[5XXG5K+R-I'')O6]RSA4OH\:]'(/?R$:8@O7FL&_1?QENAD&R">7:T%LCLXZ2ZP8LT V?*H;06+^PO:]C8\^JZ MP4L6$"F]9]QB>?#+X!'!S%P@$>CF927K.WV"0( M(UVZPPLD8/1(O4OBAQ)[Z7)YW6?#:JSN=?3),&Q=!C5:R9=4JV:M=<6ZDXJK M7J0X^"%N#X?8E=UADTKHT\%*$)_ZV UYH6^+"S%?"_[[3.!'E>F/A%/5.;/Z M#G!S7+A_7,=G+8A+4XA&$ ]]9,K(.>>9S-36:::C3X9I)@,P)9QGNN-XB#E7 MRV^8^Y@9A 4R:[;2,'UT-V7@: ZEM7CA2+6&C350-4Q?U2T@4OHHU<-"U9O6E7F1F?&):(4]EQ*.PVV;C9N_D/AD1]!4X'+S+9NQ]. M)HB_JHUWP#!$OFX%Q95C$O5"M^)VOM& M2QMO@[-=L#-5M;8%+(V],K4 _:2J*W?2M2<;_AQ:1@)7SAS?QL.>Z9NV85J% M90G3_07#?@/&A5&)B.TIC6F)^!(B&4IVDH\[MV@Z2J_FNA70IO;5 &E?CI.HY@#LU4,Y. MS,K$WHV=&+JQE;"5L2,+!P)_#T&!]I/Z:CX[)HN$UL[KV/3V;L;"B7B4V.[% M^ZMUC*QA[=CT#F\)ES)U49]K"\>RQ#?F#F_11[?$ASEJ.!4P?\8;M?>1KS98 M>]&[P/?P2$FOCDG#*N*I$VBFV\_;2Q+?5^'HO"*A;,41@(HD,E0R?.4L#,XK M^@S$,R+QI.)$1V!$=R:, D;\M0-/E&85)[H_B/:C.J^X''M$)K<#S GS[C6# MZ. ZF3ZW)M$30?T<&)-\(7B#Y>,T2;(XXU0;/7PT_,?\)\ M7L_LQ=^,JK>,JH-+H9%>,,[9,Z0T(I/25L*=J3]5M^4C(=CP044X"O[7(Z.Q MO.-L2&07@))C?(_YA'&U:U#[A4APSXXZ:$9Q4<<,1KIOS.4'NKN'!V9O+VX? MIV=KRJ=Z%F90R'?!<8.8 MQ=8C5X)-A%67XOGXM/KQ_@7A>5GOGYE-E?3CW0=4M2]'!_((KO>$4 O+11_R M/^0Q^COB1$G70Q)?^8Q-]3 M)R7O"FUSD!>/.$%H=SA+YK="[98^#G0F?@L%R-4;:YJTM)3>MTQWA;Y11T;< M._2J-_ZD*_ TEMO;[MTJ.P263#I&Y=ZFCN**A?Q^# *.QO?/<.-5WG-N,Q,#=.C MXKBH]WYTM/4DQ[Z35:R*OZ91I&N3MS7]$$L\^$%.;I8:B^4+$O$XK2F13 MR)-G'@$Y1#S6^XF +$%0]SK#B\)QR[X?]2F M1#SF&<8_IXKEI_NA@]XL61FX#8P,U(J4Z'^'+IR^F6$&=D,>>]O#3?>;N,CH&J*@UQ0"2Z&/6X>LG8)[81#'O4'\49^C M$2N2N?AN^NNI7K=8/C/^".T'NBR.5%+AJB.,$D4LS_>M?:T,GK>,MB>!SUXQ MG@\<4R4M!?:OEX-HI_8,7TZH3 ]VE7I,I8TW. =W4"%,)#.45S"N3LXRCZ3/ M4G!GI2[IF*KS_:N;1X$\OLX)N[AMU]=L& M:)SJQ9"(5QQW>?020JI9SUF.W1$B5,VZ&02<07?_ +8K],]&^$^ZYJ\_-0M&6(!".])-E,DD]X9F/S(-ZOYC9#R7K." M\P5V,7C)HE2\4W-30H(T"*624;(.1*(GXD%W>\4X)B,(Z2&5?/H2*R_1_@8T MW3 &BZMHFVJYQD@7O7B=%8DG]W7"?,=9P.#>?&_:?$)$JPHF^,JU[2.+_81Z M=MW)KE5QL$+%9-XW><$@NG*L%@>A9%WZ[Y"^J\F,Z"5+#ZM$S= 7[U* 'VG\ M[33D5=25@Y3(WQZ('(^Q[R$U M[1F$W!TK!>>'*)E*[M\H3/=5"R]=ZO4%U>QEWHA2'S,H]7'W2BTH 6,L[%V& M*@N.PL]L<5IW:!R6Z7QJ7LOB3':==*EU]\0C*@4 *2$,X^XS!_))//\9,:R;T=)PXQDMJ+[ MI^*#\AY.F[Y/5+ZMEK$WJ6=IH'D(WH2Z?8KN=^-(7M26Q[6"!P+&[663QJR)9 M52R2?_O'U^GDX-+735G-?GE%?L*O#OS,5JZ_ M_0]"_WKSZ'5R5[?G!/YUOOAR$NIH>_+.JOY27&J$; MHH/%+Y-R]N7G^,/HQA]\;O*<;9ZV]4:TO$O]!M,10_0H2BC/STM7&O#J"'LV;1=H=&;HM_?53^*EN4 M)DJIUXMOOQ5MRE4%H5KR^E^_?3A=]!.5LZ;5,^M?_?TO!PGXWN5G$VJJXNJG+4_V6KZ.I9X?6AM/??NW=<+/VM\WUA?_E55-.+R8 R>L1>8[PN/G$ MGX3M98]\J\O) -WLT6@Z9#YK,QE"IO?K&8K_-_.FG/D&X&EL75[$,0QMGY9G MLS*45L]:8*R:SUJ82#Y6D])V4,\>5>ZQ5[_KNH8I[-)WU,X!F]ACKT>4Z5BR M?:LORE9/RO]X=UJ%]DK7_FW5M%N[L(UN;/YV5;!=ZQF,_VHZ+=MH&L19Z&VU M$"H8$QVTI -I B[?S]MY[7\K9^5T/OT$)?3D3NFNZ ]4?X+^[JQ8NU>5H!?= MELG.%0S'\NY]AWFG/X(D\D,[(L6YNY) M_PZLK&[4WIRV\#.JP4DX;2O[Y;R:./!^WOTY+]OK)W6H4XUI^M2Z.7\/ M=$_3KHTUI>]#?VWK7FVRWIU<^'KA\O87T>.JANK%D3?M-O;NEAFRW5V7I4TT M0_+UW6F,?^W W$;"T3E\JR>6/IG->]1#\MIMV7Y<EF$LL ;>@3'07A_/ M0E5/%\-I*U<=:(?B\U=?G=7ZXCS.54>ZU=MX6U=^+'YV':U=ZJVD8W-G^[0KMK/4/Q_YO^=U6_G3=M M-05+?1N7JTN/P\NN"':C'HK7WWW[H6J:C[X^/0<;>AMS:XJ/Q UX^!?S=K$& MGX0WNH&9>.:.RLD@L-Y"-:'BTR S$^]G=>[;)/T MJ7.D?NVJ_AW)1^*VV_*[D6@HSCY"X[ZNHWM8V2_;6%I=>AQ>=A5I-^JA>/WD MF[8N;;ML[O!*UVXKBQN)1N5L5S!WJF14SD_GTZFNK^.&*S0-2WZ?'FRK+$U/ M%I_!4A#C,].X^[I8'98;L8-T;Y<61NUSMYFN ^E(7/XQ*[?'TS?1C,E7ST&[ ML8XQ^?ZFABN^[#>*GUI]DMZ.,*R?WL"8/7[2H%Y!.12/JW'9QM]FJG%YVW5D M[U;+N+R?+'(QFI-Y&_/28KY?KTYLK6[%H^\#9?X>-.X_]KZF?,N6?.]TPF_ M<1SYO>5X4ME[,EERN8/.M+YX#;(2K_VD;6X_B=(3")-E&NQ? MEQ\72P[OJ>C^!>5GB=1/-C%@C M*EL_O:6/B=FCR+0:&3CH5A)5>0?S577M84:=Q%WVG;1E*VUA@_(.JX RYPAB MFAGDLF !5^P,D988UD-AZ M6F#&P2Z4S2T1^T_47WRYV+YJV^VRZDBQBJ916 M#!F2>:0MYLCP ']R*3+.<^LL"KT1RJ=].OR5WW1&9EG075./-8@.5BG476TQP92^$W8C'31@7'PG,/+(RB M%P_## D13F4J=L3M>/;YJHI=:?J/S>]U%4QFECN*D52:(J>CQ<7!CJ9>"TJ= M$IC1IVM>F@C%<]&\OL@^/XV#5OUP.O>MML)PG671)@^<<^3 24=4@75N8"P& MCTUPO-/:L,]HQ_/2NC[8IO!WGGR&-)WAEL#AVO5H9\K]H::YT_RJ\.6B0&%S MS,$Y=RC/)4>2,@4U1FGX=]]VVE#92U9X9P0 M@EN' ICWB.=8(!7[3;Q7,L HD:33#O5>M]X&4X"!H4JE&!]K?Z'+VRCI;9"T MZR3?@;J@5#&?@X$N#/2=9=XAA\$O-"Z(S,B@>4Z>NR4ZG)J,@U@Z;:G 7FZO M/T[TS1G=/^?E133U0-LT\[2+P+>4' 540#D5L.S9 M8%!NN.248J-$#U,RT<9[?UT8"IQ4PK^SEQYW:=?>T;1"#[:1%H0K9PW&R!#A M$1%@7PFL)#*>P5="*<;5_J(@*S*D-W>R<-(824E CG".E&.Q4YE$(LL-,X%9 M0SKU9Y_N\K!"JX8$:P\JO]T]6I$K$[BG++SL\^^GL9[DSI(_G'I(N3$! 7CPF::(Z,%.'A<$>2- MEEX8DVOVDD3_))$]U(!!8$H=1/NHKV-\IWOX[#Y!(:!/AH/)+S)N$=&.@6N? M 7;*V$ =>/YY#\LWC<<[L"(,AE3B#/5G=MAGGY[Q\!HQ&%C;E>+QJ;SXR2T3 MIWH2-R^_+LR>3_XL0ES5U^_]2NNO(V4A.2?$8_#BE+4QK1KL>I9A!'\)*BAA M,NNQ'J1Q@ <2^GB0[<$N[.0'KRQ?6)]KDUN/@G0<.>URI"6SB%J56^&X"J+' M&97D*\-0UF$OA/9A('93@94$A:34Y'D(H-D:K)ZXS\ ]M@BKC.=*8$VS'M9! M,%@V"6<)OUSMU;_ZLG&Q/ 5Y0N6# Y4=R![8OCX+$">:XQ$BIDE"F5!?'L MXT=]1?9X+W4 F)+EU%33:37K)/^'10L+;.1Y M%E0(- SD':*7(_Y!8$H6+'"NC!#IR4==NN/9\F#7'17>%#782EPP(A7'N42* M*XRHE##?92X>U25*<9ESR9[]>>:!]6,4U%+IRZ>8ICWS[IVN9^7LK '/>#Z= M+ZYQ./*AM.4FMV([<8%S;@V5#(E@-;)6@=4L.$4T>!T$ Y^=]$C)2K/=.K"^ MC():2M-BRQG--5;&&JH"<^DQ\0P9!7Y53C./J H<$<.M4"9@Q?4@2\Y+]3Z& M!2_-^9 >;T:E.*6QPW-/2=E9_V)3PL,CD8.H:/!?!.123R)G'WU=5K"ZV6@- M^2-_\_^F,;]#-85SU"MG-:=C(KQD$DIE=#-S[6 MU64),GAS_0<(\'AV/+OT31R,RYM.-\^!W2LI!,Z((C('_\(X),!XB*F_-.Y+ MTCP8E67\V5]--I[XJX2X)@O:+,__?:X.+:!5^[4YNIMB.9TK*8+WA((-@W+# M**P;C"/J:4 AX P;);.,]CBS2=+X>6-)_F'L9TQ84RG8&JS>ES-8E'M.82LJ M*9PW3!GP>"ST' F NE,12LYP\1JS9WI<0E"FC#2OJ>P87!-YTE>+ ?*2;B[ MA;+1?UQ-4E CP-7A 646>^2XQTAZ;I%VF$@"O\*_ESH]]9;J(W=R,! 3GNVQ MWKOF/6!VW#3SZ!>B2 \TT;VN5$T3;QLWY;5,+@FU# I9KZ^ 399B7Z7J[( M&3$P\ S2U&3@AH -(#/P>PCC/(0L2"Y[1-[3!!'&$M]C+>D%7"I%./(7M;?E M CGX?>*7EU8>3JNZ+?^C[SZ:LO)"VNWD128,MAEQB#L9S_\)@5R *1=F\%P+ M<)29?ZDVT=!J,Q*>R;:*)Y/J*MIQL.P>57/3AOGD\=42\%MU"1/SQN5KUZH* M,"6MY8PB@1W CKU"E,:X"9;6Y99ARH:Y,VP/UM'0:I8 W&0J=V=D+%^H+YM% M3\!QF);SZ28=VT9;Y$I);2UT.8O0*AW 1F P\CRE/'/"$="BMYC[37-*D) MB=1E, 33WQ5P/+W091W=R[?0B;.-R]@&JB(F7H!1Z!$C-)X/HQP9P7.422+! M+(0N^QYWD.4_DK8,"V.ZBTCN^YW'L]L7*FY\@\4YH0W*TXD>S$$7%,44.>[B MI3IYAI2"_@O#8%TV@5+7([U6_%"&SUB([D^C'IMM.RG48_+".6:"YAX1)12R MDL3W4[1"F2 $,XL="SVF)?F#Z],@@.Y/G98WO-V.BI4WO>VD8%TJ+"Q8AM8X MBG2>9>6NLZF%FJQ]/]SVO(\_9,FM"5MH:7)@\\X M8A(K9)P+2/@ U@%A3.=6*I+WV??%/Y*5-0::>]6B!V?P;X?$]VO3.UV$U+?J M N?.J4!@Q'$P3FFN+9)"B'C*PSI+I>>A3VK4#Q4XWP/83[Y@82VOM\]V/>'J MA3YU%L838IBD*->9!E>(>91G@/[RAH',$=_CCDKR0X3:]X%RPBR8R[(!B%?$ M=3?GNJPE*S)C,&6Y G,!!A4S *^5WB./I?&4&,"B1TR+I-D=3C1Y#0SDW@Y6 MK#P]\%P.6 !/2[G!MWL[TG!O@_?P4I>3:"!]KNYDF"R/@+S136DWC+X=:RHR MIPR+EKSBPB/G#$=",@*S$1?4>8%SUBG>\]_,@L'GF/'D^$+3"[XS&;/\;@Z: MS6&^_3Z W_A0U?Y.].W=U[;6(+ARINOK8T!\<0D+4((P@+^SXUGK:]]L2@(> ML=5"\RQPJAD2FL?4,9FA(#(&0LQE9D7N37CV3_'UT)['UOHS0CK95M"MV=!I MIEM1NE!2,2\5C/@<"5QP M/LQ%.V.&T8=6@0%0>G* "%3MJJKC*8;C6:AUT]9S&Y]H7!?\65>^",%X&YQ& M3MF E#?QM@]LEB$'XC2VS][JZ">(:AR8TAUE:SRT%5/4CV ZFE2+TYU+*#:, M\8UT!>7:<^LI,HQDR"C!D8IY[%9PG#G*5-Y'+1(=B1Q"+<:"*YD5X!?V#[#] MFZZ_^#C];=>-]40%R[%EGL53PR2>E&(YRI4B2 F?21NXUJ3''GZB$QU#*L:@ M6*72BE_]#-;"2>AQZQ^C1&YW.-70V)>MH8/V"T9/4-+*5AXR6/:R@*(8UPDL?X6Z$3QBZ&#ZT/ E"[_X.[E#4=EW&R?N>:F(]\V<..: M:K<\S-RYFH(&%XS! G$"HR/GF4 LUPIA6*6Y A%ZW".Y:A]*,_+>X>S>?^.7IN8VMIGT19,-8O7<_ MD/"$24D#+'U&P?2$P3;&X"I19CG!VDB)]YB:\-]'\/H)[$4_?_?(>;!D="8DXCBF7Q*P MI<")$BSK$1+?P]P]K!(\"G2DQ3I=C.QNO_Z8Z9L(CG>WEQ5TUK\5M!U$DHD\ M5SA#\3D?%*P.R&F!D6.,Y)8K)=TPJ\>8SLJ^M# 1XJG6HL_1Q1O9JZCL KD8 M_IRU97M]/ M5/;T7$AZEX5]]=5;KB_.8*GZD6YVTL:2.V\/&E\E&;ZZ_?W%8 M>[T/5A(HV*]5Y:[*R>1XUNK96;F/]I)*^T/YY[QT,)!@1/T*7YV]!:O7U^,. MIG6-)NWY;_K?5?UVWK35U->G>WW!Y@>!>"M^U).(0UQ$6.0!JG'KR]Q8FI/3"T3YU(,*O>C] F M;"HIKI\\&':E;6^O>K[2M=M#B_OO\VFTN^MK&%\WIQ"O]\_)XK-'MW,M]Z'V MQEZ"H?>@W3]F99N^P7VJY(*!;WJPXLL]*NE]WIZ;CBZX2Z"BJ_N]AR:3JNEJ M%DXN%LD:)_.V 8? @6V\/UY2B'YN&O_G/*8T7_K9R#/3P\9V$/0#(#.12/SG?_]Y._OA:[I< M31?SO_\(_P9^_"&=CQ>3Z?S+WW_\[>-/ZJ-Y\^;'__ZO?_O/__?33_^C/[S] MP2[&F]MTOO[!+-/1.IW\\&VZOOGA]TFZ^N.'Z^7B]H??%\L_IE]'/_VT:_3# M]H?9=/['?V3_^#Q:I3_\N9K^QVI\D]Z.WB[&H_7VVS?K]=U__/SSMV_?_O;G MY^7L;XOEEY\1 /CGHM71)[+_^BE_[*?L5S]!]!.&?_MS-?GQAR#A?+7]=HF/ MY(]G?YVLBP8/'Z8_[_Y8//KLU=_P]EDHI?QY^]?BT=7TT(/AI?#G__GU[<_Y#]^[UN,9VO_S9> MW/Z:3J_5-NGP['7V>SJ;K:;H*/=J^^&:97O_] MQ^P5 3CD?S M=>C88C-?ASGG_6(V'9>@9X-7]BC5N]%R&6:[KVE)=K;XB1ZECJC36+HUH[OI M>C2;_BN=?%Q+HL^BV]OP-Y*Q.K^JLZD*+< M,EGZ!>WU>#[)5N3L6ZLPHTTRLUJ/9ID-^/$F34O,.Z7?T%V?WX?)9![LBW68 MNV?-!3CXNJC2?%R'?V8TN+K^N%Z,_[A9S";!47+_W$S7WVL)5.J-WODF[J7H3G;RK^V,^FN[M+EUCMNKJ+GKVI+"IM^7I_KWL-GVOQN MU67I5)LV^W7O-&;_5:%S)QNVV<-R2^'S)UOKPSZ*%%98%Q;8]?U3$U_N;;%D*3>&3K=JK6^+Q>3;=#9[$UR%^9=IJ8X=;Q*Q5Y4)6_X5 M;?7Z[3089),PKX0)YI?PIR]A41VGR[/STKEVL?M7%=JJ[VFK_[^._F^Q-)O5 M>G$;K-]SO3S\=)R^5$6P7.NV^OHN7;]=K%;OT^7'FV"7GNO; M]78-OKK6HU68B><3.YUM@B'Z\+F2R+;S]DBRNNOK=!R<.!6LCTG6B:#SC^EX MLZRR]=#DG9'DJDK_DLTC];;<\GNR45L]>Q\^GBZ7F$K7G'S>WMZ/E]VP3,WPZ M+/E-)#CWLFXDV?XN+ 59S.,VV]'I3;6+VJ^&@/?F.F/TN:'C@C\U&<=W7=R)MA&%=_P,Q):XUJ ^T;*N/AW$Y MU[_3K>+VK>K(KO:6N'V_VN8WK*XVZRS7*TNW:R3$V=?%E:8CS:S=?/^/GI-Z]W=OOVGV_3V<[JLV]=#[VB[HS?A?Z>>-/1 M3@?23,-Z'!Y]&_YS_W36K_;2,HGM9Y_+NS1;C0Z-I.Y*N1ZO/V^&T6?WT932Z"\,*\I_3V7J5_R9; MP/A/ .X3\?]]_^O$9R*G;T-/)O>;.FJU2M>K@$+Z9IW>%IV;C3ZGL[__&#J2 M5&F>&,T )IX3:K"PU@B@$$:(82T,AH _%GZ6'4)8+/>JB2O]P['US\UTF4Z. M"Z2_[S889J/5CN(G8>WD03A01V6A%CI$- 6DOW>&GHE2V#USV9U7+\PV(Y M29=__Q'F+?=3=B6+(SM.$E/YB_X@#-*&7VP7H?\8SQ;!)O[[C^LPR]W_&I@G6B5"6 80AXPRK(0R MC.H"' L![9!?)U;ZYWSKB!*+6$AN:=8?8^PC,[4\9W;M$L,=)@9*XQ24E$LA MI"[P@UXG!\WVJ.PYZC(\YTXK6BS'C$9XO6R.],.-1S)= C7ZH41VV.3J^N,H M&.^_/G(4#]#@V;,)Q]I:H E%7%*$ 3; YNM\^,EUJ?I#WFYIO5?5T:)=9+K2 M]KM-UKDB%WG^Y>/.ICEE5!QMDVAH!7(8&F6#@2+E#*SC!]23]_WV74 M']!X]9BB*! =N7M._.?/!^(6_<0SN@BS ME#O/V\)E8KC5'E-XIS"5%K@E?+,A,F,4H>LD@P+3@$CK_&)DQF]+J7K2#6U?&][9_9YVL!T\EP>6P3G!A!4=. M.&*)AKD%>=YE>+VD(U1+$XOV,.A,GZ,_R^GSX7,)9Q0R3*RBS&@/H(.* MW_.;E#)WNW5L6]%G PRZTN?[Y2*8(NOO[V>CW0'D8&'<90:<_OXI=.2,<56B M=>*P!0*[(*NDE!!GA"RL7,-,?=.]NNXOP.QJ']'>F93U^^RF2(G6B3!*"8$4 M,Y1CK+CBAN9R$R7ML VX5C5;EC6-T?OKL&>0)N+02=,/6?(X8A92W?]HTZ_I M;+'M_C:Z>-9 *?V.;+]!:T^U03X+S! ")"DPX+S+V%-)XZ55S3X-/D7"K?>) MYK=5>KV9O9U>GXIBEFB=<"CY9?TU.QQHE5BO,' 22@9Q<)X:0#+R2_" M:E[?H"4738SV((N?)E"Z^&_+6_*M%NKMK&\E,P9B=R/^X9RJY6\[3):XS_4K MD1+Q_.'$6L\)M-@S:RDPP,K]Y$P(DA:76LTB2W8VD^'1@XD55B$O@:: : 8, M0DCN)8+&4=RAN7\R-:&),I[Z@$T0&'1&02'9-I2[+ZYP)@A^M$TBE&,62JLQ M"MZV%!I2F ,CC.B2&M5"WS7U>XPF#8'I+'O[03?/AAR?/YQ0"B5!G D!@<1* M*VU$/IR(%GC8\>D6M/4TC[LMB%X* 0898AZ$WGN*(Z?+8,^IQS7BSD>.C[=* M,";,( ^1%#)(Z2BB-)>3.SC Q(4FRGHZW[<&3+<$T+4(<+!5PL-@H<&OU(0H MQR%W#+%"3LWK3P'18GFM$Z -8+HE@*E%@(.M$B"!X9@R$ CNLV.QP.'"IF:P M_AF.:.&ZU@G0!C"=Q6JW42?U>;5>CL:'CO$_#89,C6?$V M\VHJYZ".F\'1F=T^6MVIOCL3;4VU5W2V"T]TV>WHWFN9EL?*J6(]@.;G/?K9UH@BCP:XQ"AL\E32/(8CP$QOJ_-U8KS41Z$J'3Y,X MO!M@8)+GD'M(A9KNTH_L(Z'2?\[1ZMYB/SZ[> M!Y]/)*. 2L"DU )F>Y'*^EPV!QI4Q*(#UWP;<'1KH)VUS!*, .'&$:<\L5@C MI$&.A9"*UQ_&;.#*K"5_5]I[4'HXR^M_=I=SB?!9V514.J!)^4#J\<;)8 :Z0'%%B%"/=$$ZWR?06 TQ*,2 M[2OP.$.:H=49)Q;S+Y_2Y6UVM_)Y!_W TPF !!$(,,(0:HD!3#?&1+AQ_IF M?1/IY1LF83N(^DE#7Z*$LI+ M +C*98#(UQ_BT9SV%E4 M>XQ%O2DN/6C[/M10S;9_WBY18?G2%@2/67D:[&%!L"FF,%RNRF5O*WQT\[XQ M8'U8^*7B>(<;),Q BKSC AG!E6),J (S$_XX:#N_B;9.F/JUX>EU9J@Z(R0V MF+%<4Z(<= 2 M<+@/#UY9<;15 @"14D.K$ '88*@W!UE@Y?)_)_ CFHF1(&9$>(3)CB+''%*VA MU6%:WH-D_G^,9IO3!9*>/9U(I R7QDL.J27.!,E0+I=U0XSRMZ&DY[EW#8'I M'9>1%4W1"5KO3\:9F.5IOE M]U*:?OYP(K7%W@K.(5: ,0T-![E4&#?(LHNVXD?0=6-<.HO=[XMFC6;O1]/) MF_G^6I8'7#T5Q#_;.!$$(1>0PD%&Z02&4A08V"U*G$QN4,IZ>,@#/-TZ,22%%@ YZ#PH[1VE9WPV(EO050?N- M<1E*,EB#)+#$\?!1;Z#E"B..H,?%IJ:4LL&)#'Y!3&@9I7M>Q"M3=ZX>V>X: MOIMT/1V/9H^[=T'%R<+P"VAK2%$PUJG@P F# 9 @*R?*RQ5BC2Q9Q>)D1EI/ MF14:(.$0@9H#D4N$@:EOH\+DU5#8/37*4YF 27*A.F+.X)9=@ , MV1P8AGB767=-BI.5UF_IXF35@.DL*M.P-A5@F"J)A#*:8ZL\$P[G4@DAW*46 M)RNMK?-%JNI!]%((T(_B:Q>T%"'56480@DM4Q[(;Q&&$ C,<3*\2Z]Q/I'\NKZBU$P MJIV._[@W#SIR0,NG&R3,6:R-8:&7E !''<\"2;L>8T('F'W;@E9;Q:2?<;[E MVTIMUC>+Y?1?V9T")$R@1HP([R93+I408UZ^=$'%7-BH#:N'2I_:O-NO5 M>C3/JGU4I,"#EHE'D >3-DQ_P&L'M,24YO)BX>M;_A'W7Z/RH#XX_9#A[?2? MFVS?):"_^T,Z'Z?5DO&.OR+!G'G@M*3<4,F)K:'4 M0[I>#0^A1.L$>RR54 X2:0@+2'JTEQMC%URN(6[:ML:.]@'J@1@53,H3K1(O M$#5:BN!T6Z&1E +J7$Y"9?W=>W%91&@(3&\$.&M)'FF1!..("V>X%Y@PYTFP MF5$N7YCYZI_H^%J@]*;T<@;DJ68)1T1KXB%5 GDD")<:YI*B)C=-0G") M^J\/32^IW;M.G]#]@:<3BCFT1$EID#;,VH#=WCTF")L&==K@)<0$FR/24U)6 M@<$^9'XP<>_B\K*4II((@0C54@8KW "$".*2*X.L+W>ISK#RL@!#BEJ B0<$ M0HZVAL)>(A7^.."\K-+*.)V750V!R\C+V@VSL%[<+>;;4Y\E<[,.M4N0@@QF ME7X@ L9(0ER8P_8 $<7K)TUWFY]56L_'Z-(".%TMNT^Z>C9+Y^#S"=%*.8\= MD9)Z()W"7.:R :',A61J-=/;(AY2+XL-PT[;&@ )AA"]/9NT<3 I05*J&/*2 MO"ZS^KZV;.)"_TFFDL,>)"%04A- M(9,PIKZBH^W4MZOHIHCTXE:?U?.!IQ,LK(08$$FXL$RP3)I<+H<:7 \:;4>^ M74TWQZ3G\])GM7ZR72(4]T9[8I3&B!A(H6.YK%##^OJ/MA_?KO[;1*>OL]%G M*7"X06*"WZP!UTRJ[-X&Z['BN73?+NZ;P66[HX\MWG6R@60,),8 M:2J)JN*;DK"R"L(T\M01)7AVHY@M\.!-4BTZS+2HNRL<%ZS.9H\* MF5;/O1<(H'S MD@FDO06.!4I[602_D&T0#XYF)'2E^"8X=;='\'^;U:[ ^Z?%D=#V=@K[/-KF MZ=W>!5=\>[3D0QJ 6DW7:3"4OD['V5&"Z6+R(1TOONQ4>>YH3^Q/)P"J #$W M+LMUM%X@H\Q]6%;4/S$6;:>B*V8.#/I.U[A=ZKO=+,-:O.O];HE^EW[;_NET M>+S,"Q)K "'.R"RWEA%L/$!^+SW18=P/;YNDT[6P;0![IL^6\0W8\[A]HI$@ MGCEC>%@N)&4:.IC+GAW*J$V>: <9>R9/(_P&,?68Q?QK0"JHZ^IZ]_-Z^GD6 MIMAQ>/3,Y47-7APF:NFQLYIA@B6"SC%NBY%&&IRJCG8P\*.NK@.2U^ETO3E]#JSQNQ.O"?!040(]% @YJDV>V4L4MO4O@8AV3G00 M$V($;(KQQM/)TAVI$6"@K'+%=4!4,VT1US@!Z.-#/'\:U?<:0>R'H]" MJW' 8GFR$,*)5@D)V&BA$<562@V M$6^,D&6-CB[>?'1^O9@ZX4>V^DO[[!9 MK-:_INN;16F>'&F>:,>8D&'&!)8"!H3PQ88WH<&8K$^8BX_R1\"O[Y/WJ^!0 MC%8W/K1;/>Y9<>)^W[VN>O$R+F=!Q!OG +00$$8HT$+N+E+&1G/(2H7V(DM6 ML0@ =\X3H+SD5'-/$6<.%!(Y4C]8&;\(0&EEG"X"4 V!RR@"T,J! 6@)8(9[ M#KPC!#-CO,B!R;+N.Z1&DP,#I?5;^L! -6 N)5^9\L9#ZNEYP@98'.I MD'?\4@\,E-;6^<3Q>A"]% +TH_C:!P8ZU/M+21S.["*5EMR%F7LNI%?]4L\09@8,=Y2C6#@&- M)>$ZE]0;WJ4]6#\1N*YEV"(R _ KX+-M$WYB>H"VO3S.O;[WXV6F21?4YL= MWYT=DZ>#V&[HS)OY*AC\99W((RV2P$,%. AD#/,)#50%0&)/-28Z.X-<:E^@ M"QG/N9,'GDZH$) (:;/QP2!B&D"\ETT U:!$;\L^96/=/ U*-\9BT-[E8_'. MN)7/'TZT-8 K0 4&3GCA'04BAT)RU:5]6 M=2F.-4D4Q-9;80#!BH2%V6+B<@FU- ._]K.)RDYJOS%"+Y$+@W0RAT"!JJH_ M77DXG7U(]FO_Q=C&:JR_+=+N2J \?TJ^+V==T>=2!K-(\02*8Q-P:9Z4& M6GLA,<^E"4Y9_82P:&Y$<\4LHN/4MM;?+>9^L;S=S$9ZL5PNOIVL+%3O10EF M1#"-47:E37:"5PA"](2A]J/FL._;\X412+ S4@B#* ML@M%C.&HD$H*/6RGO+Z23FB[$3(O1>^#=,#[5'=/>WO+ $[6RQ)EVQ\]F2CK MD."8"TZQAM1Y)6 NCU6DRVM=2B[>393RK%Q[$S"Z.[ 2X[(6BA##U"JJPFJ' MLEI(SN>RMA%;#7L]; MTENIRSKJ(?6RV##(57Y().A'^;]GB0XGG/B#SR4&$4\@ !PJDAU,L%P6QA!7 M:H Y.PUULF@/C=J!F,>KEMDLL_,-12S7C.Y&X\,EV"JT3H(@C!NNH='*2H@4 M0GDX4 DJ.AW&=0(Q;VOG5,1#J26-%]W0HU6ZN':SZ9?L\+X:CQ>;,&5]2,?I M].N1Y)DFKTL0%]E&D1'$!!21H%KF.X_*!RMYZ!LJK7(B%FPMD61WHGDZWB<6 M7LU+LN%YNT0(I; (:Q_%&#.'@N>K\_X'#WB I7PCJKTQ/G'T^^G;HI9^0[M$ M&*",H<@";S,O)XB3!Y.5I+S^]1P=[:G$U&]U?%K2[\/(1#G-/FR1(&N$9@9B MAA%03!- BCE'(%A?IQWMH[2JTP;(])/H%):4Z>KCW3(=3:[F#WL/#U"AZBL2 M@@UDB!LB.4.64PEYCJC"EI':W(A6)2YNNFQK4/5#EC?S=;I,5^MM#/-!-9/2 M5#GV@L1C:00V"@B,-#?&2Y%[10HVR9B+5N M+E%: JHM-^">MHM'M/6SQ>+H M/GR5=R02:(2YLP1:#1R$1-+G?E0H6DVQMO7? M$C;]V IFM%Q^#^N6NLV"%*4MA,?-D@PP(AT,MC-RP9)V4A56D?>JP>U>@P\. M1L"G'R;\-M^LTLFSB&9%8IQ\2Z*=%=E]!4H3"HC!4KLB.HJI;5!%;O !P_AP MQ8DCK:[FZ:>;Y6+SY2;\*ZT7-'SZDD1KA@ EA)/%,HFRONI41'BEYTB[+PPI+I4',0TTIP("H8C8DNDD>P>!#F#$ ZC\VY:ZO MTW%62B$(,@Y_&WTI?[K_S'L2Y[F!1B'LB#-6!MO;Y@/#(RL:6!H7&M-L%["N MR+.OJ;//JKA:?IA^N5F7NU?P7--$("8A$8P+)I'05AK+=A(;(!!L<"[T8J*9 M+6/4*RO#@@Z%= E?;G-UV;I%_?['[?!:<.;H;4J99 KAB B!F.1&&.^@MY7GO M*6Q2-6#P$<\(^+2KW??+Q?5T?97=7G*39GU:++.JO^[/Z=JGZ9O;NUVMFH.E MSEMX:V(%QV'*PD!H@ AWB&F1R^X9:9 /-?AH:/?P=7="8C'^XT,ZRS0Y>6G%A?2KXA 99 YR%R6!I('"?!I\OE-][47U'0Q811XT#5G:^SG'[= M5H=[.QU]GL[.W71U\/F$8$$Q ]0H*:! AFI;R.90@TMPT05%29L#T\=V6H5M MM.T6D5'",R94ED%&@5%8] M-Z#/MDV848'!-'.7B2:)=DEE@!3&%Q=Q:#TBMP[OQ39^O>\HXL))[:(3U=,4+LI:UO;?+>8Y7/7 M^V5Z.]WLFEXJ$VR!KM*))80F-4 ML$AR* SMM*)!XU(VI=5ZOE1\-5CZ<=F:E0<'R$ ,G67!UL < \.AR"7D!-MA M5[%IHK*R=<+K(?02N= /!ZJ7BN^< BWM]G94*IYY1J1"-MBJFG-(A6,%/%(W MN>6\&W.[CF+JE(JOAE-MK3CU,K39')-+ M/I,D$"7>488]ETIJ+01F>TF#R'J %PC&->P;P?,R0NY06V-6<>$\*HI+@P8I%)WOL;>AYGJH]*'M=XOYN)+" M[QLDW%FJ03 ^A8(,&4IH$U@>DF%KX-/<6]]W4QWKFX M\XF;KZ?K[V_FUXOE[7;/(.9W?TD77Y:CNYOI>#2SH_6HRV^5O(#-YC. M-ZG^?O\'M4Q'?6]S?-Q%E3^D=YE1,__R@ 5O2^QYE&F>4&,P1%(S#17R"CFK MR7: (2\8*>=31I*^V'(Z(8C^OO_CN0V2&F]+D"/& JTL9IXY((.CZ??8<.1Q ME]0^H4Y5QRF0-# MD.N2497V7J*2X-@U PW1Z^PXQ4[H1VO*N;C\T3:)L(8SJK1RBC'I+2.*Y3(R MP>2P-VE:T-U3-K2,U,MDQ2"W:X9$AGY(<-]1.PVNTO3S)H,_=#E=K:?CLS<1 ME&F>^&Q:Y5! S"GUV7VW%N;K>O##!EC&O@4M/DW(;A^H?BGB%\MT^F5>DR&/ M6B<809=YWMI990%U/"R_N=S8-; YH@6)NR)($YPZ6T=&LW2U]T\_ILNOTW&Z M>I>>"C$=:9$(1 @W$#*AD) >,.@*^8CWG=X.7XD'D?R:5F"*'W%Z&JN('WWZ M9;&8?)O.9F_FZ]%\>^5#UY_K,A;T=OK/S722U:B;3WY99#7K%O-QNHP:9SOV MS9)R=Q#7#L/KZMHLT]!)/QIGYU6_EPDYG6R7A/E5"N3"!&XTAMR$17A70)@2 M8"GH,=9TJ-_G(DI'VR00$2O"O 0 X(11";';'?*AV&=W9PPE;M22MIY&\EO" MY3+"0JW>,@FDPM H8A357G@+*98YY#+8.D,-#[6@\DIW35;#J2M3K9W;!5U6 M!T())!&FE@ OZ+Z84)#-&>\N) #43&^EKAFLA]3+8L.P S\#($$_RG^_W!\ MW99_*7'-]//'$\U==H\:XLABS"E#0;1",M>D+E29I,IQJ"W!FF$+/.SFV0G_ M^<.) L "0#Q6W&9W=FFXOVR]M?7UN%RC,TA>BD$&/9RWZ?>^]KE M6T[3E:FXW)]HE0#/#**8: L1T 33[ A)+B=!G>[TE5OUFRCKV?Y>6\!T2P!= MBP '6R62.4"DTQ!) )SU@#*6R\F:',^-MEW3.@': *:? Q[53V-3;AU!2#M) MJ:+82$<+;XAK5S_D4SVIOV=CKS$XEW@.UU%E..,*>B0X%!II40P4K14:ML77 M1&5E#^360^@EKM;I'3!W;+M4X8 ML4IXS3$S3(6?@S53R")E@^LENS^175HMB]@P=>;>C58WIQRZ\.=$A9XZ:+BD M 0)-)2/.Y3T'T#:XA2.6@@\MY6\;;P/6 */^R%TL_]C=-I>=##\Z0A\]E017 M@GD/$*0>2!Y<5(Q(WC=(Z0!/T[>KJ.:8#/FP+"%A$E+9X4!$B<8*,G[O+2C> MI5W=ZS!L $I7ZGV7AO5EO+A-WYZN./KHN<0H&[@9W,M 402$)LK>RZ)]_>$; M[9AL' 4W0:5##6?+P?OEXNMTDD[T]]]6Z>3-_"KXFZ,LL4]EEW>=NUN@_$L2 M3YD6S*NLA"+VCC/H"A2D!_6-K&C'::-Q(PYD71$GO^3M_6AZZ(J;0X\EUDKD ML#%68DV H5@ZOI<$8BKK!]"BE:&.H_P&H%QRF1S ! 009=7XE70:9!O&05+/ ML<3*P_IW%$0K/AU'_2V"U-TV^F+\QYO5:G/HAIQWZ;?MG\[>2W3V!0G4'B&$ MF< *$:* TGF$DD I7?WE(5IAZC@4B0)7/RDV=IJM8,>.B^A"?-G?4)<6!BP)83BG[/Z=?1_BZ79K-;!E5Y&/7'T^$N#.?.S/8,T7R^W MY^L^3%=_%,H_%?(^VBA!B +"'4?<* 4@X.$_=Z6; *16EC+$.Y+TW%&?PPT2 M&1C+!3/$&0Q)ELL:+*2=A, A4]_5:/F<3QM*>AK=;P.109_P>2:A_OXI]/I, MAL>)5HE@DLO@;@=<'*"$*^!M#H[UL,&:$#?5HZFNSU&G-D2=;?L] R!\_GQZ MY_%6"9<42$L\148)2JGS$N=R&D_(L-,^6M'@V0FE*5HOEQV#3 09&BEZ(L/> MK'O6\[,YH6=:)EP19ST10F67!FN,@YN=R\NMK%_]-UYB\J(5E'J;8K0 MWW4Z']_I8IK>#V5V#,I1@> R%*3Q'O MPX6-SA]*.=4N<5I C2AB4#N1U=M'6N2!@F#!=>F\UC4_:JNO7.6H6D!U10HU MWMZ&$;H]3J=?LY7V+!^.-4F8\U@9"(V5PM@4+]0 M431[L%.UU@6JOEJ?6CJ[?BRNGV4W/-/PV98)IPI;9J"5!"CGE%$JMY0A80TN MH>O.#WQ;>_<[#DB]18[ND_?@B97[5+/$8^($@<&[,9!#"BD'*)<4AC\.;^QW MD0Q1'Z'X>4[OTG5V4BAT<9OG&S/1Z;KZ23KT/1K^C$=;Y;;LS%])V8=[I7[ULBC:NM3R3 >VB1H0(@'J9 90G4&"&&LPE0PE*UZR*% M18LKC!H*6_ZFL38^E! .M%(HS$0"$:8T85CDB'I NBP#>3+)K'L*';VHK ?< M!YW*UA /_?WP"\Y$#R-^-1A8W!,# =/"$(J]9++@"*6=5M&H>8]:MQQ]&K8> MC&HZV_\XV.%2D:MS31./A"/80B^#!IP.LY50N<32<#SLB.<@N%"*GXTA_RN0 M;9#1T1?)L;YB\=G]5>/U_BS>;T&/JP\??SN[FWNR72*HA,(HIHS)ZO0!KX4O M0+1R@%6IVE/?L^![>T#U1(JJ9,AS)P&DVFE E W_)YS&W.:R.89H;1)$B^5T M18): '6E?'=[-UM\3]-M3Z_N,NS/$N!HFP0*H:E70!.!#20<20H+@A-3OPAA MM+I)T4C0%DB=)7YMB^>J6K6(#[9*$+2,$PD1YBX+7!HA9"ZG 7R -9:BD:$] MF+JE0YNEJ0VDE'),.'=2 0.XURQ:6:7(=&@#IF[IT&:I>N?#ZN>P M08)9);.T*5Y8WE(U2-2(5F@I,AW:@*E?'[6T2W:V1E,K[P_ZH(*$)15![9 / M.H$&[['#7LE.$]*;4*S#,'@?P'>^:SF8H@F[^,1HE4XR5-/Y:K0CVG(T_[*- M].OO]X^\WU7"4-]&RTF97;GF+T] <%AI,$TD\@9XPJE$$%, K?7*\G(5C&+O MQYT5U[U6/)TPAL. ML*_4;0_A8>Z@72YC![$ETM(^&4.642.YY )B!9V U.6R,LX&>"=OORJOM+=6 M#=S70,E#?UU#!;"CG#A!G0)0*EX8[8C ^GMW_1$SGJ?2!^2U3W-L/_GY!$Z? MO]\_\A"GW6W<]R7 5U?KFW2YOAG-=WM9JW]D5S%-IO-=B=8/:::VJ\UZM1[- MPV^_'#LDTEN'$AHF',VQS+;=0-"UTPCO$=<:XOI9"M$VJ'L@^47IJ// X=:[ MC'JTX/$>0'=?&DQ(].%UL&6BG >?3PARVUMCO;0 >>^"69OQ2", N/:PU#FS MZ('+K,OZ^U: "J'(IZT2IY@"REANG!524288S62%WG-N::E#$YW4D6VFJ>/Q MPH:(##H">/1V]%-D.7ZCNH8@3/^:"0 )@=YE]R+N@7%>=4F5NI'!^LI^5FN^ M'90Z.W_Y[)[LDK-B<=^FU@P C)@4#$E"A"QP$I"[8DB\6K,B[=+T9S?;I/[!D-DWYQDGP(SGR.LLKM4PQY"STN239%LCP M'/DFZEA$QN=R4R\]]-91A3BB1KJ '[4LEQ/@!K52XAVL;\Z#]H&YW&1+FB6B M&1;^ARP.\R+CWN5F-1"P_C9%M$3LU@G0!C"7FUYIG Z <:H4<\QB(82#N9Q( MB@$F7[=.@#: Z98 MA8!#K9*(-;,$&&A=(X!GN67@UQ.P5W])2!:NG7K!&@# MF-:LO2;&WD$Y&*304X.40XX:AB"WOIC)H&&U%1PM@3J6K=<"/)V-\]R?V87* ML_CZ8IY%RLO&= ZU2R13&!HJ*!:8,1EF-D)S69V']:^KCUS%/VI5.&VPP0=X)D"TB];+8,.QPSP!( MT(_R*UJ !Y<^Y9WBE'IN%#$L3**2J%PRRH$=7A2HH89.7CA<"Y3.@KJ+V]O% MO)RNGSV;("DIPS(8GF&-I#Z[@CVXM (K*;3GN+X)&"W,TZZBFR+2SZ#>W9"N M-NN;Q7+ZKVP_O^3P?MHPD9DUA DUSB@0[%N*9.'+,"MW4W@5N'IDPR[ M.Z\K$F'7**&(9$)I+HD'FCBF83&QD3"JAC<)Q"=!+6CJN_J/>Y#9,+L[RX_Z M]\<:)-"(+"J)F$::,VBX4KN9$ O(I*D?MNLD;EM?F:W"TN=(/IT"6;)E0J%U ME"#L F$]IPX84D2IH;;U)_9.HK=QQG1]?/KAP_O1\FKY@,1/:R:?I<6Q%R18 M,Z$8)%0BZC5&E /<@8?[^F@@!I2=4!&,B*(^ *>UI"6'_Z MZ"0TW' 5Z1*Z[MS$HL/'S9W?@D]U+^5)1[+RVQ+!M,56!1L*99?2$1%6X1P7 M#$G]U$$^;$IUAUD_JY2=?IU.TOGD0Y@_[R\>*+U&'6Z>4"V,AEIH :C%P?7: M%CS<&]Y0U"]X("Z#+1% ZHH>>6=7[T??LXT8LPERG#R#=J1%(C2W$C"C$8-* M.>\8*^3SX>.U22 O@P3MX-+/M/ AG:2WVS,[VV6QLNUZI'WBJ(%8$8.1(-**. R2!$#II8"%T/)"DYU'"L2#"2"B9DPX( M[A4O=@"-=@TV-0<>[.P$K^Z28 YZ:#M+^EWZ;?NGT]DP95Z0:&\4%MIRX+T( M_C\2K @ >,T:[(,./)H:%:?N#)+%.$TGJ^Q$?=;1T7R<7ET_'@-9<8GM+]+P MQT='9@]:*'5>F-C@LWGCO10H#!GKF3:\""-9TN#.PHL)QG: 6\]SSW9-;3#U M/&Z?6.^)D) K%^Q\$) ]_%IC42#F>="0K0Q8!K$\G0VC%AWV3K[XL1Q20QD M0&BDL==&.57L9MJPRMWNUO]_QRLU[YS7JS##-H M>"HK#//KZ,_I[>:VJKE# H[B]X%>; M0>[/N]%\QV2]&"TG5]=VNDS'01>[+*?5_L;OZ_U_'B-,U?YO!< M+0_.B[E)I^[NEHNOZ>3W\.MUFNUCK +M/Z3_W 04#N4F#:=SB:6,2B>S&]&! M"+,[HZ@8F(2#!C;ZP&/-%ZN#SI;7M]/;Z;X6V_Q!ED")4F7M?REAG%,@#<8: M(.X=Y9 6N\O>--@70P,/?P\#T,[VT$+_OV[+:;V=CCY/9^<<@X//)Y1QB0Q& M6EH)E SCRA3!.P9=@^SN@8?"VX2E]CQS[T]LPZLZ#;]Z;$JB;XI(#M MMF3BZ^4CQTI7>@N 88B X&S)+(T?$(RLD@P3K!$OE3X0";F+NGR$6^ZH !P: MHQA'!GKA]C@BCW&7AT1B7SY2FC+1+A^I!O9HR*4'ZUT^HJ%P5)K,(\9AHF<. M9956=@!(K!N$F"JSK:?+1TI3X.3E(]5P["PT_@)NQRYF$?DZ_)DBZNY59C]O0V4/H/J2S+&AF%JOUZAEP MJT_!L-2STRDS#=^<B'=@MU3N&,P%PT, M/OS!G'+"*P$L%LYIH13&@!'+F-+0ERK7_!K^2!,7X$,@V!Q(>\FSTB!"YSB& M%:#^/>,##'^4I4RT\$>EM2ZRZ;Y??I^N8FG4U&\\F']&ZS M'-]D<]3IFKKG6R9"0R61),%P9D8@IZQTN0S&Z@'=S]FB/IY=_-8F1EUYP/7V M*A!GQB/O,8!,:V6==#Z7A2+39>6L"UG$V\#Q->!;/GH%LY-[B!.,,1WWK OE*W/80'92^] ,9>\EX%H,8[;XRR2FFF.5&@,$>9 MEUUZTWWN5916<:F]BFJ@UK;(/X7!M;T(^&"X][1-7J9M8F"P7J7C-HQ$X3#E M0JI<#B7E)=[;W 4Y8@%!SL".6N>.AN[V:+[VGZ,5U^G8[3PWU_ MEYVN6 5I=Y/ZI\5Z-'OX]RSKX-UB_;_I^D,Z7GR99X7U[]^T:W2UODF7GVY& M\ZMM.:)3 ;C>^I18#0C6EHGL;&)8^1 AM A<"E/_B&A_]D"\D7 I:KKXH;2K M8!%FEOVOLN=@'^/G8$<2"P %%&)/'8&>:J[OH_W>L0'>(OH2!TT;NNDIW>OC MYO9VM/Q^=:W&Z^G7Z?K[:]K7:?(Y%DQ9(ZTSEF&IG"1V/_]QI4"Y;>;7M*\T M40YJZ*!0A&0[GAH*;7,C&IK )$*6PZAU\4D@8'2 M%[637)8E7>S+U0/VE;KM(7P).\F7Q-A+WDFF(#L#([2 "E*47?V4^VY<>2W_ M*J?>2JNXU$YR-5 ',[4=PVV7-_EF'D3=; %^&H0J?/0/B]DLN-U9HQA>7ZV. M)%@"SR6S@#(3E$LDA"[7AB'J$I,E(OHX0];-"QHINVJ#_0Z271\2J:FQ$A,7 M_DU$F+"X*70@!'])VZZ12=K]6*JEPLL?1O_8"O]FO@OT]C**'G<([)!I8GA[1N_E$'42(.7/X8*+?V>9K5$TXGZFBY'7])?PJO7 M=K1.BWJ!@['JJO0T@1H:SC725@C&$*).%RZD9[B^9S.\$7D19E]$Y?V5!N/ M1V#"'%,>!/?7,,:X==Y:GFO.$=]IR:7!+(1QN#_ ,5Q1_9<_2\VA@5IZ@47A33""7M#*^9<9PG$YT'>RS/9WSW!S?V8_OA9..F,S M @81\]IJ0XGCGF.C]Q7?,!'2O]:-+KFCCZ5T4@I,;?!OG0+.F5GK)K2M-C$0O5KDS;(ST^FWEPLEWBC'620T(AQ1H!9K"TN:P& M0#/L[)=6M%B.&8WP>MD<&62:R?"HT0\ELK3Y,,V.9NGQ(\1'GTVX"IZ]MA(0 M8)CDE(&\9#\.]@!O<.]A+ ^Q)1TMVD6FPURA-'SK1LTG-OV:SA9W&0A[_ZA, MYM"YUHG!#@?YI$(!,,NPH/TQ2Z8L9><\J^1I9)!+X%W7G@(C"N"MP;!+@O\ M]WK135D5ETKYKP9J9Y;:;*N^AV4D#FR0G3+A2KT@\0 $*UASSH&QUBLON,RE MUP"^S!3[NIL@43#M:0=V:]B^;JT>HT@P]8E4#C$+ !.22BW]_H8AX( HE4GQ MNK6:)LQ"Q33CPE.+O%MK9:F3+2MU6I@#WIKM5ZD0G(O ML!3!4]<8,DR58B('P)IR%VE?]O9I:0J2",J(\TY3 MD)L>89)@D%]2I*(T2[KP^^H!^TK=]A"^@$C%13'VDB,5'"!@A?#9:7I',',R M=]$)D%Q>XFVH455<[DK>2J!V-K45MDN1<;W%*2^#M[5+RMS 6^U%B0 H>-A2 M8^ X@5(0)4&.!@2DRZ3-[B(7S7V,"-AVS[12]2?WT9KPT]7UTPJ3VQN&JY&R MY6\FV!&+K,EKE.X8G;27 MR */D*":"RR@Y/MY"D-MR6L)T9)1 ^ZM<)9IKCE&7@$@,,MQI YWF78>.TI7 MFC+1HG35P'Z!43JJB#,62<8Y@D)ISUFA L;+'5NZ["A=:0J M;T/!R$582X"E5"@8*L86R%JJQ"5%Z4JSI(N81SU@7ZG;'L(7$*6[*,8.(DJW M]1(^?/RM:K3N<;O$6Q6)%4"BJOQTU*X1N%T1R4Y7 MF56Y60:KYB&$^XNAML[R,P!+14X:OCF!&%!+=( >"H0XAXKE.=?A%YA>(!GC M>2?=@MU/%.3=:+D[:?%:%N),D$T%ZC"*-8&0(ZHD( H#S[S5!L%R]U&_1D72 MQ!!+*,2:4L\(4Y9CBW,XJ*E*; R:A(-1Q?7RL5485^H.'DDJ(B MI5G2B8]9"]A7ZK:'\ 5$12Z*L2\J*D(88!(2R1 !%E. &,QEY=9?XA&9J"JO M%A6I!.YY(F6^9$8/ ?">'-EODO?I\GJQO!W-Q^GG3.9#G3I*DXIOR(QIIK3@ M"GBH/&4:2E+8,0!W>5[^D@@3%^;:U/D4YNN:G"G1-,&644(9\!09J;4G"M%< M"B=X_:WW_B[K[HPL[>/;U4KU:;K./*8W\\GTZW2R&#9&U=^GZYOMH'= -7J9GKW:>'FZ^S"Z7.F M=<4W)983IB6FQ%.9753O*4?%XHPM&K;#UU#'YQ@3!;M73@W2$QLVE5HR=-XM MYGERK9TNTW' _;1Y<[1!(@0R6CJ&K=76>&F$9'F/-1(#O)LRFDX6$0"KK>+M M4OKYQ'+[^?O](^>KU*^?5JF?[JO4?T@SD*XVZ]5Z%!"=?SE&H=XZE'"BA4$$ M2QD\4,>0A:9P/!'& RR$V<,VST7I:##QT!=UQV28UCAFS)'L()"!4CAEBD6. M-Z@5/.AC*G6W0P>JEJZ&1JG#.84H^T(TB_5H]O#O6;+*N\7Z?]/U_=&=^S?M M&CV%Y\10Z:U/"1#"(P(-)MXZ:RR4]_:AD[:^>]Y?:"?>T+D4-5W\4-HMMGZQ MW/\J>P[V,7X.=B1!7O#LCE'KB&6(0@9$,;%I:NO?:4Q>!TVWNNDG2["X6>K M'_/3SJ\)A*?I**U$TAD%>'!SB87 ^OW.BC$(H5*I2*\)A&D" EZ09:<9.'%: M :UY@2.$N,N#;K$3"$M3)EH"836P7V "(6'$8Z$$84Y0%R;H,%/G %!#NDQ7 M[6DWJ#0%3B805L-Q,%&'"\C"$A!ZA(U$**M+1[QW"N3(&LWLL/>3:K*DBW2L M>L"^4K<]A >Y;77!C'U)"82&6\$]"MZ21P)002GC!?"ZV\)Y/:;XE%9YI03" M:N .9LIK'@A^<&MUOQL%#Z_/5I8;I[(-&X,]HLI87NA8&W.)N;(1?9\AZ^8% MC90![:8QC13!!'OJ-:2.<.Q\K@-B.CWD%7M\1"9I;SMOU51X^<-HMTG_9K]) MW\LH>MR%!&N(D6=0"%O2+V40-=+@Y8^AH)CK=-KW M,'K6BX1;110#V"# /9 6K=/CK=&$%K_6-SP=JA?RDAJJL3+'TR%HGY/IU]N MLGW-K^ER]"7]);QZ;4?KU(^FRW^,9IMT,"Y2E9XF7$EE*12>4V@L0< 1DNM3 M>_4R"P,/V(>*J+R_TF <^ A,K#3!L!=0:$6-HT9;B0O-25]_V%VR:Q:'^P,< MPQ75?_D#][%%/LS16[&/"2:2&:0=HH!K(8P#VN8Z]$C7/ULTO)7S+S.$XW+@ M\L?QWA_8+-/5, =QE0XFU"&CI&.!?$8Z))1&,M<>YK[^"+YDA_3"1W!$ O2< M8KK]U3/,]M< ]YUDVLY%*6]+9)RV_*7$>.T"<[UCR%E+M+!T7XP4(:=)J:-Y ML=-/6[J&IG0J:HO?2X*#[;VD7D((&@$ UHX#I6D^\#$Q<-AYIZUH ML1PS&N'ULCDRR 3/X5&C'TIDS]'A%MJ//)L'CL,!!+RV FA, F<&Y M3#P@-[S(;TLZ6K2+3(=9NFGXUHV:3VSZ-9TM[C(0]FY7F5S=78$\@TT0!Q5,CNA >U21+M''L) N^P4S]B6=R91.&L^58!QI2+@V4K%<5@', M)99_C*KR2F5@0[L&U[RLPK]8+$,T4T! 8%8#%SRFB%BJ") MI/7=PVC4&LI&6Q2 ^\D1V!J_KQ6FCJ5[(Z:=UUPZYXD2@2TA:G2E(E68:H:V(/>L:\7V5"4&1"L MU3"U!Q ,$QKFZ[J3N%QBSF57F"I-@9/1C&HXOKJ$Y>U9:[%W5,)@=DIBLWH@ M.M^,<#1 ?4G1C-(LZ<(WK ?L*W7;0_@"HAD7Q=B7%,T0(#L[20GT7DJ#*%#" M%+811)U>;]IC-*.TRBM%,ZJ!V]F45]@TQ3F!+5YYC>.MO?(IV)( ^Y(YBX>U7*^IG%PSLCV"9_^U5#_!C>X:,\1^)W^Z[$^.*[T7*7']'W M\:&A1Q M\!AR@9 FB$DCC#,6&Z(U()9X2%\CB.4B&M0ZJ1"%E$KC*7;$29?C M: 3HLF)C[ AB::( M=ALA\W/YXS #!7LRZT26@'GZ2M^3C1* A9'>:,\] M<-QJXQDJ ' -JC-$\_WK0K^(A$EM;:K;K>%?2ZEEVB9 ($R5ET!3;[52#E&. M#45"!>>1L0$656U#MQ&@J:WBK4/XI ^ GU;MJ39)<*,)=(9XX9F#()B]F.6( M:-,@$2G:.94V5-HB).VJ$M10Y;Y-0J1GS (L@1?&.V"5+>Q&21IL#D4[31)- ME?4@Z6Q_)W,$SOA$Q3,)@XHIA3U 6$@,&<6T\$B1QUV>,[PPAZ@NAIWRX/RN MWOU3"890016$4,# \%9EA<_E@,3S8?M!-?1Q2*.-L+AWF]JPR'SV72"*DX9IBH!P0%/CLRNC4+6X:;X/B:'%8ELP5@2)SCW#AI#,=:%*&G, 63 M81L'-5G23998'6!?J=L>PH.T?2Z8L2\IKU$I11BT FE-+.9$AO_/916\6^[T MFM=84N65\AJK@=L5D8I$HZS'NPK"9TETM$TB&-&*HF"G"BXEI@3:8N12I[JL MQ7&)!&H+V)YFH:JS3Q[O]U@YQRR@5E.$"&.V<)"T%O7KX_97A+S'6:<6J)T9 M6)O/J_2?FZRHV=?PCQ*>XY$6B640<(:)4L 28[6!'-W[P[[+"/V%^9#M(-HC M8\[;U+3!YZ/E$&,;Y7KQ/EW>3M?;>TZF\R]'M_ZC?C7! M+-LJEQIKR0VU"!!4)#UPVVDQ_>Z.O%1-]AZ>(@839#P&]D[HO>&X4E]'TUEF M"/K%YV=ON-I* MO>KU;N_'74B8=8H@[K@W-*R64EI7^.[(LOHVY/#N4>MQ',352CPC1A]9Q=XO M%W?9,:/J$WLGWTV(,4!A )0CFB'%).0!/\J5P80;7C^A-5H6Y& -F6Y5,?@I M?C]>KS;!>!O-)\%8VP$08RX_]JT$<2BH 8;R93UP#!7:)H:6S^MB+X@>@\% M_L%3NOS]HO&H7K4/"9)"ZV W2L(D0L8#Q4S!!NEM[2' 7H= 9VH9_- X:)W] MLERLHM0L./ZU1#OOL>,B8(@- )I359R*$!#63SSDKW2/H(#.LEB[JE2-$/.$ M.\:DR"K#!!R*/5D#&]1^$"^0?E$P[3RKYE3YGF+6WR*V^K18CV8/_YZ5\'FW M6/]ONKXO[O,@,Z3Q%=%-OY\P)#!V'FKIO=,.!L46_K5VNG[40[Y /@]1)7W5 M>7KN$YPNOQ2Q -3)PO'M?/?Q!ENGWQI.>:O''7M;IFC5D28)TU@++(&@2$GJ M(,I.H@+/O#$84%IJ&>TF,>%<5:D#CR<>\*QF'.)A39- &T!4(1U1G1YV.ET@ MJK%ZSJ0@U$!CT!6<;/IY?>\#GDE[>_YPXJ&4@EO%>/A_PRR3"N=0>##@.]H; MZ771,BY=68"/.UKJ.,BQ)HGTQ @*,%:$*. !,9CF$CK$[;"SUIJH[*3V&R/T M$KDPR&RU(5"@IFJ(R6; M)]0;CQ'$'$FEJ854.)A+@Z$>8.FGYHI91,>IGP%O@A'^/;NX^7:Q.9FF22D:'6 B\;0NQ17SZ8<)O\TVP2?5BN5Q\"STWH[O1 M>+K^7I$8)]^28,\X(-Y8CP#3'A@0D-CCP(RM'Y2)EY(5ER=MPG4V8++_=?:/ M;*__O_[M_P-02P,$% @ 7$"I3&F27*B1G@ O$D( !4 !G;&]W+3(P M,3@P,S,Q7VQA8BYX;6S?OV+__MO_Z' M__)_O7GS/_#'=R NUON';%<#4F9IG6W ][S^"OYMDU5_@KNR> #_5I1_YM_2 M-V^Z_PBT?]CFNS__J?G'E[3*P(\J_Z=J_35[2-\5Z[1N;7^MZ\=_^O77[]^_ M_^W'EW+[MZ*\_]6V+.?7\;\Z^QO-O[T9?NU-\Z,WT'[CP+_]J#9_ ?3C[46>[3;9I1?/9IT&^ M^9>_L#^M]M6;^S1]7-&TW+%)JV*]X-/7M,S0EZHNTW6]@JYGN5;D)KZ#PLCV ML!/8CI7X21Q2VPV=5?N]5;9[\_NGP7K[(TW?_XL( R^Y+;.JV)?K;F)BP)IY MN/&.O6+_6'5HP=VGUI474.\V0P>#7;%M7 MPT_>-#]Y8\%^^9WT$E6M0E)NL9('-\!^E MY?I"0_2_\>NZ8+/U8_WF69LT 8YN-PK-':WCA;GQ&BM.AGEDU)CB=4U72K+4-TC7M9S#L69"4;[>I\TUC.OV6?LO6^ MS.L\J^B/]7;/HJ:$\4:*A\=]W:;8+\$?@":!'486<6%B1[9%W3!$40C$)_[!,X. 4&K[HUD"._7E*>SV_(^W>7_WEHGQ:XJMOFF_1T\2]"$'JJ3N@R-T^!'H;N[ M":;T@^C1?^R9J28>*W:M!O[(JY45(0<2Y!+DX21,8N@Y46?3M2+?14+9N9(E MPYK480('4"P48; $Q4B13,[$=S8>!3>%1"DTDW5.L3.50&IA=1FJI,F7T[1. M(T.\ZG1B*BX>TGRWHBZD"0I9*NAXL6LEH9=X@RU*$BJB2G(69E8C\$>'2U". M)-GCW)8V3IR:_%SFS,Q^]&NT3&U&*]&X#+U1].%T&UH#([SZPC+!NZQDP=:G MNEC_^5OV\"4K5SB@'HY".[!CQPD\WV:V1E.4",F+E '#ZC)B BTH,4V18XQ/ M4HR3):8H)SR!/SI$,PO*:Z1,Z(D2A\N0$S47"HU]2C*5(MNTJF[O6HMM<(1< M._$C#]$ XMAUL._$<+#7+"])I5'"5@S+2HNG697H1XM*_B3.H&#N9)0\,9D1 MX\ULTG1*"T_")$WE,M1&@Q_G$B5%9GAUY]A,'RTARXHMRTT<%,1NZ"080CP8 M"CU/:!U9XO,S*XU40RE9>D'?567I59(NRI(:M4N2)45/ M7I4E'>SPRE*L_%)Y! U&,(*\G(>9XWC3%Y1J+P(LCNMG MZ&;F_&2N:"AH9H!F3:?3?P%27ID*3%!ZW5G!B$>%N0ZH?F&E^=G;.GNH5I"B M*+0I2Z<)=F! DB 8E_YBS[)4+ZWP6S(?-G%Q@%J?.*HCPL8SQ M+0;Y]#R"N+]\^6A3N75W3]+'O$ZW*\?%?I)8-O02*PIH !W;'2Q S^.**&2^ M:WCL]FC NH,CDO$(\L.3/9JC1C!+[%DAQED1R??,L2.7UWTHJKRM"//]>2<" M#UFZJT#]-:W9/S*P+AX>T]T3R"O0EG^I"_"8/K$PZP[D=06JKT59OV%]]P&P M1.)+,P_G6?4W\+ZILWGA\^GX\?6^+)D'V];,?C<8>LBR>L)*5Z^Y^?O^OP=I M567L7W]9,UFY >EZ7>R;>X-EML[R;^U7F\H1^>X;^^6B?/KKWU03UF>M>C8Q ME6O[)22@DL@+]9XOF% 6N_O/K'LT:YXKUW4MC)P@"&S/Q0Z"?G#8HT4!XEME ME/JT\>7$!H5@2BA$#6<&:(H3P82/P>A489(6,ZG=$053F9P,4\L([.2@G^9I M\O[SCOWW6?UVQV:2[%U152N"8B8H0>PR7;&M$+LH/MC B;4Z+EA]L:.+?9NK MIT]4X;[8X1DT MB0WF58=G[$S(@QR+R] '2>R%CGXDK!!-HOFA++[EFVR#GWZOLLW;W>UC5K(@ M=7>/UBQ4;4/*5>+Y./03Q,*4R$EHX$,Z H@2RQ&6#UV&9]&6)FX&>X:1Q6K 8E&&""+T_@E]\[VO\*1K 7>;=E'IQLC@M M;;J;8C&ZI]VQEZ)HACM>Q7R[8V%U5M4?TGRSBN/(I@XA<>1@UR*>$]&@-P$= M+X)B^930IXWG4^TX?&10P%U1LN'786N6.+H"DL6N6079ORWRWSA_3[0UH] (47[;Y?;M"*Z@::JSRJ8AY2C4L[]R MOY=3J>\,QU&?,S.A-EH(78;ZZ'%E\FBJ$C_\Q52*]9]OJVJ?;>(]&YSW_2.! M35WPZGWVO?VK:@5Q8MNVXX<.LET760@/13%=&$64\X2J9J/&HZ &1WNXK[@# M57N;[1>6 %8MS+^*EES1PS.?+\R:[W&T^IG7&4*R;/>3[;.5YC@,1 MP1%*,+4C&CG>:)JB6.@>M!:#AD]1#*@ RZVS&_ X E,I9"?++9_LS4ZKF.B= M7(V^ 2/%'UN*/URF>(;2=Z_3-B%W6EE?AMCI=6FR5)X6OA2CO7]-M_OL(+*. M[Q-*8QSAB!E/; 1M--AV+9R(E='38=&PU!W'>8_C(*VZ0;GV8_';%>) M+O5K(EPIZC/(M;Z@KP6YN)CO.77B(9\D]HD;AY 0[-/(LD/O8(ZP4%-$^:2-&!:[#\,2W+":#Q[2C6!0)T\@GY+- MPIV8>!T@-;/!-8]8G2-G0IZ4^5R&(JF[46CN9V*Z@[J3MXW8%=M\G6>'%[ \ MY#%K;IC$%@J2R*;$V&[DVY!TX"A;,#9T#*#"@NMH+=.<)FA@^&EA= MQ@#2X4BAO<<)7C<[?F6NM?ET>,#2#1UB0VK%,'%Q:-O(]LE@TG$3L8*\*H;F MF<2W63L;/4,J>&M-B4T^49J-2#%9>@;KII.F)_!'_[]7>\]WBJT)C=)"\C)4 M2H\KIU?J]/'#JU3-T_$LL#A1R*=3XTF H)^@.'9BC' 20]>W!N/83H3J_FHR M:5B]6I2-(RU$T/O8FM$TS_UIFG>$5 M9)]-4,(R\<#UV3]\U!QR[>P1VQ-27'DKAJ6UOUV=_WNSY]XC8]ER)2J5"C3R M:>(\#(J)WX ),% C>\L1O;.43:B;.LW+D#$-?KQV$%X#,[S"]/>BV'S/MUNT MVS#3K-OE7[89:NM4G"JC1Z!G6X@@$MO0(L0F@>]X+&3U8%.OE8@HE4:SAJ5K M0 K^4_KP^,_@@!9T<,4$3"?=?(IV):;%)&XDN0FS7U"\'*WC)W-"_ RTR#+4 MT(1CA?'>++KK\?"0UVW\R#"0HHTKLUVSWQ+GU7I;5/LR&W=>(C?TO3!$@0M# MXL4>;:K)6 D+(]V$^(CW0)%>HR97\D><[4A^AA0B[DL M.!AEL1?7*\::3!F.<3I$S;+UMD&X 7=JK2W1/;8F@/S,Y\^G21J(G350_ R0E5-OA0FNJ!X<8I7XM[0#EGJ&CL6 MRV03FB2^2SP[1I'O!+Z;))Y 06)KYL;3>V37@O(!U\G9F+T*#*YC&&CZL0K MU1*4.9&KXO*Y*:*X"C#"81)'B,:>;UL>I#09+%DH%#JX)?-]PS/VI_77;+/? M9B_O.QR]BE>!/UJP2L\)5V._DA[,%FJ M188-KM4B7.:;^Y>O4*&/'[-OQ?9;5@[O43&9BY =!Q#A((!>2'UK,!UAEVLW M7ZM!P]KT^O-KZ->/8, IL-JAC62.9:1K\"NF6!W"5]^S.^97YD%!;40++"Y= M@W"Y)29MQ/,M-G$2O"UAXTNY28; ?"DPBG_8LL_Q[?Q:J-^/2(, ^ M=&+HNI[O!Z$5C%%R[(?\3__(?-QTX-I G]O!Y& .DG1Q"'YIAD2#$A[A8GCD^%7G#TGN2J\+$!>E> 7FOJ'2M;_;GQ($461BY$; M^I0XF$2^[[C!8 WYED+FSV_#L(B>I*@*CZ]*DRB3[YOA3V*5492Z&3+\=QQ/ MK*JRN<1,7\*+R6Q?EA4M%:-#VW,3ZOE.$D0HPC@,';\WR10/._+2(VC(L/X< M%LLVLU=8,5'>F)?.)0X@65=$RAN+\2,WE'[?I0]%63?709J-@]8NQ#$EGN=0 M1&,:VZ&-+#S8M4D4#2_;?)8=5C)&N<;6\U=M/HL/L2-D737V38]/J1:[%,DR M4[TQ8G5,^C?@F-T!WS5E[!6ZN+5,A>HE"IJ2/Y.JILZ4U-N>T,.1[UF1%] @ M1@&E$1P"D2#&'EG5!Y.NG>-5\3SD\1U?2_V$$TL:$6N/5@*+.))S-TR9N:9K=]E M5?5/XY/.#VF]+]MCBV.%VF=3N/QCN-SD\LW9Q@C5\G9*CPC\-M)Y/7WIL7#* MC"B7RU,;80\F1$>.#1GM><\<[8T%-/:P!1$.$?1MXKG>N-\?V#:UY1_4%C B M,E:D'D$Y#)FCQYITBXX(J^*Z8XA.->FA/];;??LHUI)$Z$ 5IPY)<+L\*9)Q M8D*-I#GAK^//@H@FW;B]2_)=NEOGZ?9#4>7-V!P/0B)JVW9($QSA +HN93$( M;4V[+DQBF_\M(0VV#.YG#O#:FS@#0# @O-H17Q[:)H:85M:7,>#TNO2BG+QV MOH0'8W<*, YC9">1A3W+Q;Y%F,EH,$*H)[1 +_AIT^97E"=!>=)/ MD:P07>4P[W,>>)1%C+"%:8@@^'-J(<,!MRYD95,-^_ES/_UQ!<=Q?6(GT([" M"&%$/=OS>HMV0*$G)!(*=DPK1@L-H#6"^R&;MO+5F%?YH11%3B [(]1[P><;#A#!($K8,49 %?_HXCPH'8F+0+V*/MBAN-CT) MCEI[;AB%8TX50(\*%3:1LV!8&H95^[0%]T\R&B',F8A4F*1+1C$.FZW7E8X3 M7BXJB"R/2Q(2:1]>U1,U1@0?RZN:UP_R;\TZS?MLW.>%&(36-@[0):=-)^3(43JM'A;D.JI#EK7P/!Y%O^;'M MV0%F^:1'QY O3&(DABS9^1!^96D6Q%23$0BZ.((4HB2//[S\? MLC_Y,D](7?RH8>D9<,@]!'69$CY-,<*&F'Y<),+HDTP3BB#,S3)&OSCL,X\E M"?HM\*;ELP>8F'Z,=RE&T] G :(Q]/V8)#$);!^Z@^D$"C]OJ6[0L!H<,%82 MT8<>2OD48W8VQ=3DE5?@FDO(OQRNZPP@_SK[>Y<7>9L0(ZVT+T.H]+KT\D%, MW7QQOQAR6-,YNDG4W*GV(LN/(AS"YL0RBI/!%K42L9="I"P8EK!N*5-FR462 M,#Z],L^5F$ ]7_$]0)KY&9#76)F0'S46EZ$WBCZA@1&QQ=N58UMN0*A+ M4>+&#K9M; WG?\((!;'XJNW%3\ZR7"N_3'N9$I'U6:ULR"S,7F,]]N)"+#?NE?*T.[[J; UV++"*F:U93Z:3R2DU!(+9>$,6;F M(')(-![)":D?4I%@09M1P_'#N[<(OWWW]O-;^@F@]S'X]/F6_+___?9=3#]^ M^D__,;1A\,^ _G^_O_W\/P7K%&@CG4]+KL*WF-H<01R7:^NGJQWLXV5L0JJT MD[X,,=/OUFG9 S.\20CBZ:E$RR-18GE.;-NNE[C8=7 X&'1L#TE*H*@9PZ(W MG*G='A *'D56H5!8T$RR)RUAUS^9?)XA/LF2I75Q(B7MR'E94N-&I3R=!2W+ MM5WH.[8-/11Y%G0&2^R/0KM.,M^?27H>FWJ7Q:Y]QON*19O52ZGQ\KF04:/B M 4;)&W8EYD&F"OG< _2A"$I4>6 M4F[UF8%-80%JB7PM2YA=@UYG9UJ&%!E=C!*I^O%2C+0PP_7N7F_L4[K-JL_I MCW:%Y&-VO]\VI#XE65:MF$$[2B(/QDP-41)95H &J]!.N.(>7;9FTJ:J@0CJ M!F,K3^6($MQEO.*DC=]IB;H&M7)"U:(#GT=6#P!!,C^K H_]S?[&[!^T"LY8-+QDJA07& M,(L*6G- MH2=KY<\\8F0 K^+TR,57\Y+DS)#B@^E^ 1Z=D*#T"9A@)#OAVC, MK0G[2]F-, $3L^G2IGWLAQHG2)+^* MJ6T'V',1]6G@."Z$.#[8LBW)5$' PBS9PO:UJ5W#S'Z9/X4972MU6F;R!4S? MHM,V-XD+41@U'WBF:4%&)/1E9:. Q@CZ7@#](+#"*+:&MU#"@"2.I*I<_.X\ M6J)!02XS)*P;6LF15HNK*02?+G"3M#@UX$=^7@,$O><=^:1X>,CK9N&[6?0D MQ:[.=_?9;MU8M"PWBC",D>U:#G$@HM;PR$ 8QT3H+1(5.Z:/JQV@M6OWZV-P MX)J*I]3U) UL+T.H=#CR MXM433=P(E/X]>JKI7]/M/EM%-B)!1)(H@%[L4L)LV8.EF(K=-I+YOF%A.CP_ M5HF_WB;%%Y\*F:9*3'Y.'FF[ 2V@&_"VJO;99O:JO*?,3.B+"H_+$!8E#UY6 MV55D0R0O*W9'9L+$22(G=),D1H[O>YZ%AHHR4?,8I6@R)O3Q&3*P8M;?X9N,&- \/V M;_-V0+5)A^O?N*'7_K38UU7-?M84:4J;Y]3+]5?@P!O0'+7J?MF[@3Y\\0GW MQH/6:Y^(LW7[$-_PE4 \,Q1K7?YTT%C#BN> K$VOKW>GG%Q(^Z3H6X;2R<-_ M)<%3X(%7XSZ765KMRZ=C,<6QD\1A$$ '6;Z/(0FLP9#C6/9JE]VG=;;YS"]V M$E:X1D74C8H7@/A7I'M@@^Z%CM-*3:,\O@>?J=VKHO5"A&X ^^7';%WGW[+M MDY@DR30&GRB9:@ I61I)/Q:F>07I)1\3DJ1 WC)$2<6!0EM'$KPLMMGDS;&, M=/LAS3=O=R1]S.MT>R2+J]"U;9B6CHP"@<%='"02!T:TS=G.$ [8 0 M-*],O,EW8-V!%+PRIH%8/M&9F5,Q$3JBLT$'&)T]OAMP'#?-?*'L(F43.J61 M[V7HEDZ'3N^:Z>:*5]<^9G6:[[(-3@X4.#&LP9UK7#HC IH,D)F@Z&.43M)G)%!.T 1P8 MT(%?CJGM B93H<*8UU3=5MP%06^YY.$1F$4^BB$26*- MJW$(1Y'(Z26)S\]RB*DZNQFHNA=XF3[9/4"MS!G;^[OVAI_01A\WIKUXZK(JIO(=U51C=AEZI<\=PQ#;OD>MR"&V MY0?4@XYG8::<@0^YTQ+!KYH;/%>N-,Q]8$>2L&6,"5GPA99.(Y@T),I*G9,GQKLH34W M#EMPX,L3:.&!/UJ YP>)?DHY,X>9V!1,(>2)-),YG&=I*H70P.TR=$B+)Z=) MA39VN&J ?I]M/69,'R8<0((.)3@EB9<$V/%"!T4A3@*QEX_$OVY8_+F. M;NHBBB\2-I),:I$U03"=;,:,IKQ$SIBA*1"]$6-1].]44#(W(E&CZUU^O0>)=X M%36K=([K$4J0Q6(@SX[@8#0@MM#Q=T53IC/5YX4;;IJR5]^RLL[;5]5>W+(& MO^2[_J>"5;!4&>>3IQG)%DQ>3TL_=-C =PURS^<$C6A6YH87H: Z7)FLCZ$ M(D1FUC8I3Z&:##87.9>L1'_I5 1-$Y#(N/K&).\G/4* MUE=ST*I>O.3**Y%0*2EN^#8)GENKFVM! MW>5M2$*'I8VVCVT<^) $"(6M,2>$?D0L/G52-'(%96K1=;5M1-:KY7GDV0*8 MA4!5$>J8FZ[9H)4YD>7]61B47-.78I)S%?^7[I6)6L)ZO;H3A=;.HQXS MWAY*7*T\&%//M1W*]#\)/&H1EP[S ,2Q!G019@.#OMNZ;FVXUO54&+QW,K'/$VS@-61F1PM9N_VHNQ$R.7^C:#@=W0AV1 XD!7Z&JZ"?O&SU >QO3C])[>G@$_GI"E%VF,-!-? M;G/M%A*;5H\;9WJ'L&N< ^BYCWD*LSIY$-1<&RTC'3+JX8O#I*;9E%LSBO-O M^2;;;3ZR/(U-'>LF;KG/5AX."88XQ*'EQ4X0)X3@<4,4AJ'*BI&DR?EW+/MR MCOFW#&QZS$U&TP,&)<-_TZ8XZ6ZW?[CF L?KE'(O;RBVR#)&LUZ7)I6( CS1Q?$#,':6*!RH@(])!8ZGB-5]#/,#.A1ZI<+D."E+TH]/8PE<#@ M8[;)'AZ;)8PV51Q7;ZE'H(-$N5^&6HG6:?)B,N/8Q)'-P\ M8[C=T4*/C]L\V]3%;_MMG3=_+E>6%]B.$WE1$L0^A2Z$]GA])TKX'I*8 <;5 M-/,&/(PHU;>*#+<5QU;14TEO29U6LVFJ9SK;H; M3^8(K""-?,=D3;7- C:+9G+T_'%;L]RJS[4'TT=K+($3NB&)8.33B%IAD*# M&T 03!,]\ZN4Z47,J3='*Y2ZM%FN(50G3^-MH'G"O#D2UAOP82&MH&M6--X: MAF9"X5;1,/6]QI74=*=$^M*G.#7GN*7/>Z>0\!+@OBTIP)\!4R_"NNEV]243GNN.V>'O4%J@ZXK_%\ MJQRYDTMU1EMK*6MW9IU\L9@W Z="SR>^/#+7YCWOL^_MWU2K.$G<,((!HI9/ M+(;$.ES8P78H6$-"CTWC(GP\U*OYQS(72Q-#5R_+RQBIFGUZ[4E!S8PICL/N M0-3% ZPK&D0N@;X58AL["2:(HK%F0\R".RT#5!<8XR/WV>V-NZ*KX; (O0:DZZQ45<=SLN6MVU.\LG^V8XEE@) M_I RF^O\L5T,^IC??ZVK9%_O2Q8TLM]J'MO^+?V1/^P?CG)ZRPZ3&#MAY%DV M#CTGIO$8+*+0$BBX;QR*X97B9Y!!V6*^ 7P;\)#^T+%:;*2QA%>/ MK]U.BJO)S]OL8]]FG0?@]M!FO1,ZUI>-M)OT>O.UVT_3^K.!=I19D99@DV^% MVF0S+6[%VJBSYU>PS7/,-273'X_IK@L#<)&6F]N[."^S-6N;KAQZ]7[?_,_M M7?^O*Y8:4@_:$?1H$OMA@-U#Z>(XB?GW9K5;-CSACGB;X/Q+@[CYPZ;'#!XZ ME )"K9]ZCOGTJJR+39\'PF_O0 NV^<, %_0 ;T"'N/F[WQ;0!@)SXU7;0FXJ MU-\F?!.?*%7GYCECE"]@6C/G6S%'IY7.(W_+=\T\.=A]498+[3:_[_JUL6SS M.2L?AH+\M^6KJ>^P0(X>'\OB6[;Y-_;C.FLN;59LP'S,_K%G'F]6L>=[$8V@ M[=E6R')DW[/'V=@-+*['.WXB=PQ/K[W;8-:V%;R';* M=O0$L/\[?N[@.% UN%ROHYD-[+O,W,(S;<091=(>RMPER1B]K^UA;'>Y>F7?-N= M"O'\(+*)8^,HCBP4L7B'C)T?7N(EUF:A&]QLC$\3,U!I=QJDS1A],J1!H8X4IK#@?/VIM;.&,_ MK+_F59+F9:MLQ5W]-3MZEGLL Q+:H84M9&'B!+9+&1AWS+%B:/'O/)N#8#A) M.3H@VMT._M) !PUV<,? #XG('?M1!M;=F_3=?2KE*AP&VXTC'5E&DXG)XE%K M=?4:\*&U&MQ]*-FW5H=]#%$O5D":M84$4HAEM)1*;1<2"SH6=;V TA@F#G$Q MMMS8\;Q+ KX,D :O=C2@WWQI4(-CS\"1:^#+$SC^O=X]T/IW WH/;\#!1W#D M)/ACQD<*2)CW@TL9H41?!' MZ]1YP;MV$W-.>HML7<$);MZ&-3.3Z6J'J5EK]K9>R PUO]^GL]&5F..[[AT\,.(##< ;T$ 4N=&GQB;'7M1\-(K) MR@1_X(\.':<.ZR!2Y![D;(1*7GI4(9;S?N,4!>=V=O3PMH#=&TV.%-K[E("* M(]:O-MGF@MW0=CR41!;VDA@C1&TO<(AGA\CVL>\[W$<8M%@S' 7V&($>7=?# M+X>\STZMF,ISL"JC]GKH%1#]V6F6TWXM=//- 3R,G)L*M+*Y@!E!KS^%J7XG M,#]TU=B>V[."WAZ)L LI<9,P\2FT;.PZ_C ?8>)%W/."DA73^T-="<07(\@* M!'1*C48.^9^-0<$]F+/DR:B]&HL"*C\;FW+JKL(JGZA/$7!.S+60M@ 1U^-' MH;L[J8JVU=MSH\3W8\N)K"0D";7BYEG"WE[DVOSU/Y2L7$NT+56YX:915K1- M,*A)M"UMHLW-HJIHFV!3LVASL*H@VI:$:(N2ME31%O;CHFC+,<.[T_:QV>UO M=_)\B'R$G,2RG3!RH.\Y7CQ\WTX^='#%P:\X(\+6C4BR)_;=Q+><\[\OLR M/[V-R TC$F#/L1"U0L]*8.2,B5\8<5T,E?NRX='?@Q$;]H+<\ U\<[2(#?VA M?IIHH*]G\#]C86+XR[&U# &0Q%[HZ"]B(M"=VF7_21MBV#93&)9 1%[DAU$( M1FT/S3=HI")^09;XY, <08*;H=S<&- S1,Z($< M7;\XMASH4AH$A$:$! X.QY/ +'5QA6YZ M70.@877J]\7[FSU2>M0&7H>#7I4#T MWK#Y]N!>7LJJNLS7=5^J[?==7EQ[0((=>'<6AC[,9.X$;L_P:;8< $ M9I?5G,M-2G:XQ"+JQ&* Q+_2,D+K2T^WX, O#)[H^Z&*;'*N3YFG4F[%:HK' M*R6SDUQ-K6UIX7@9TJC)E]/U+XT,\8H5?7C<%D]9]Z9Z5V.AMQ?Z+D:>S=+O M,(@BQW-A/ ;;'D50)(*5MS++,86^MH28,"DPQR=*\Y F& CVF, Q<5<2HK/\ M3(B0.J?+$" -?A2Z>YM2E#0E_TQ#I%T=,3Y_;FB MHK:XHE(@Q$N85 "DDRT]@<\B8AW1&$>0QF5(BZ(/TS&-%"/<"WG[+U7VCSU+ M_.@W]H]QV3#VH17XCHN0%;LDQ@0&XZTM'"9616]&7IU):?0RPJ$5_KK/(?HX?,0T2Y'2Q*B3J MQV4=DF)&4HF&=2-B^UY PLA)0A) $L=T3-\BX@F=9):S,+,"*6D.+VE2>F. M+T6MN4Y:]2HM_!(C2.,BY474AVEID6+$>)'P=_DN>UMG#RSR8@D?#$+;QJ[M M1R0DE(SGN-T$BD5"YN&8%BS5PM_@C\87T#JC^]"$AL;4=$1BWG84%-)YFG!9 MQ=E'XE7.3>AKU87H^HP.ZZJE+LLUW]WGQN27"51?G@Z_WRWN&MGM*HN M;M?K?5D7'[+R(:__SO[SNGFTSO&;FW\1=G 4$"^V+09\0!S$F*OZY1)P&IYC M^H?"BSN0M3!!78"B =K\X;&%"NY[K."7H@0/A=B[3M=NYNE)9@D0%SS[W(!# M_Z!C_[@=^D?G*!@\_8EZA=U](+^&\.V^T.5Z)6);4"99P?W\A M3!3+&Z(SI_B2I]X5V,I&0Z^H:/WF:KHT&7KMCDW->;%9^3)%K!S1(B!= $D4Q'>]DV+$_SU*Q;M#SS'IM/L]D MQ7)\)L/]4!:/!?O9I6C )<1"CF4AZF+?1GX$ X;9 M"Q!QW( $ A6BKXW4\!PZP.QG3FTIY#+(T[)F%\[EZPL^P=#X;%T*+Y_.VD/&% MACYFN]W759WN-OGNOG-@90/Q$)E_N9'9SCL.0($ M=N-Z:1\#[7=LV&R?FK\K.OQ76%N0;U?#BPBS-.GLJP7C>L"17\-2^D^R)'"N M84SD_LJ=X"=/\M7]UY7-:VJ)ZR^(OR]VW[*J'B;@E1V%&-N41JX?V39)+.23 M<4$_2N)EK(B+HIYG2;PXFMX6N"PNW-377A%E6UPC1)'!J$#)5#+ L''AK?8@\A%"KY M? U\IE/"/M6[WG:R2MO-D_29;K;KI7VGV\#-3YAW/\F<=[YY#"9_*IWA)Y_' M=#"@.0%4;PWNAP2V;;MEF]I; M5GXIN-\8T&-41(R.\?%K4E/NJ=>:];$F91U"P=<(-%'--SM<@6,QP1\!@K/2 M3R_0;.9A R[B)J18,_/+4%?=3IV^D6"",^'ZL5GY+5]GKT,84X56IZO/19UN MC_^>%%7]OJC_9U9_S-;%_2[_][Y<7"_I*]\.'888J%# MH#@XLVS(K\S9P"S--S$1+2LCK.,>6QAG)PK8+P,="J5NRKTI:K+ M=%VO?(=X"8P=S.R1R/,]'WF.E?@)(8YGDTO7X)6_;W#-XJ04507^&%!=MQK5 M2,[4BH$JG\L8T.IN3)>EDN5%MO1FF?S10VW%I9BJ4T^ZJ341C]K:DISD;!92FLV$/@51HS#1:J+H L7:FE* M\"&I*N_&8DD^=G#H1%;HV2CR*+11/)JS/"]44!9^([.KRSOI4G/2/$K)C!D* M5:6&A[TY].8=3^TV54(7J3L2;DQKCRPOO/H39U_JP[[[[[L]RV%P49;%]WQW M3]+'=)W73^BAV._JE9/X@>4F)$YLR\>)12QJ#PA\$GMB>PLZ+1O?8#CB;98 MAA(:\:PPWY,%X[7LOC'],7LLRJ:NTYATH@!'#K."799QVJZ'(IC8,8I\.VD> MM+IT*5+Y^P;CC X2&#%=;_'D##E3888JG\L87.ING(89>GCA'C;KK]EFO\UN M[SXV)4+W694P'^D/EC3LTBW95W7QP/('M-N\*W;W[_)OV0955=8\M/OWK+@O MT\>O^3IE7&=IU:9CG[,?-68,_;ERDQB&26PGDJU<&P'SLH:.Z%)=3QW8#&R"&M82>((F1!L31:@T'SQ_..]*K5(M9\#Z#! M*SO=R),K.FW,PJJ\_#^G\]GUHN6(^3D.N419N0&6)J[J#IT524U<<8M=G=;M M*>G;N_;DQOE%0*7(3-*'A3ZNI/@7:/-)F].(*;;#VF^>;LCZ6->I]O> M9HB"A.#$)0@[MDN@!ZD_V(08"HF)FB7#LG( !QIT;][N0(]/\#Z1&IU\8C,? MDV*R_& (@X"H0U)W;8-B]( %_PR M /YK4]SA]=60!C?H@0N>]M3>)'RB=LW6$%,[ PUA1 T%&9V025-MLPS]-.9= M,4\/EZC#=%Q<<66AR//=CQ*'%6CVT!CD]U6M:<^V;"-D1& MZRD<[H&+L_M\U\QI *=;#>_(B;'(N1)OE#K!5?<6R[,"LE>H'G1,QM1"NC1Q MRU A!?ROU=U18()_A^I4O58P((&31!YEL:*#(AP@?UPRPS#"$E(B;N0Z6G(# MOJ7;_ =).^SFLW[Q4/VKBE?%5DTB?S0 MQDEL49\-QB0:DR@[%EO>%?NRX>2$@0';V:O+/:-@HN?+4;6,3B^)O=#1641W M-O[WOJJ[PQ'%F?7*U]^R^)BQ(5CE]5#RH:OXUA=N:'[A7QMI75D0,9P!H83% MPG$2V@21PQ)$*'0A_.I@39])/E,J2'1WY=I-RKM!\Q.UIN@>S^@:J MPLN4# M#EL^-Q,E@T8OQ_)"G9_@R-&Y=XK,MMCD9M-".LLR)ICET/%BRVLIP,33HK=5 MM<\V\;YD&4)GO2R+$@\5V')):=],9=S"9DH:LU>DR: M7L >GEXL[L CDY*L+(>:=C=@E[5G^_I"=GS/$YE+J2YR>2G-TM<8RQ )W4Z] MEH[IYDS+@"5-G;&R8IIQ>]?]N(!_>#ZH6=PY %[H<+[(J.PPU]=4/\'PU^BLB"SHYEA1+MJ0 MXC(F3%S/G MI;X##CKDXVL1+?BFMNPHXBP^.W( '#Q8A*3SD2VNZ)H;<=&"KMM7/CTWPK"6 MZ.]C5M5EOJ[[VK%MK=GW67U[EQ3E79;7>_8[JP2[5@*1Y\($AK9-/4S" 1=R M8K%7B(RCF3')ZX2="4=?KKH<\?=_M6?9N,I+M.:;3DG^K]1J^J: X0# P87^ M@DO_UM#[+FD_AHPX*Y ;F" 9^X:KOFW?)/M-M6X7M%"6-F8P !Y.(X][./$#D+G:,IQX]4N MNV_N#_&INZP5+C&(.C$X!B2]2K,9@ H69I5ED4]TC=(G5W!U0'0##A1.WZ W M4UCU=68F]$Z5RV7(F+(7I\51M; B56:BBX/1^A_[G)E=N4$0XQ#;GA-'$6:C M.QYOI;MV[-EB%:Y4+(F,'JG25A_8S[\V%VU8:%$/%18Z'9)>,U"BED^-YN)4 M3)&>EZ@XY/8#M"O6JGC.T80VZ6!V&?JDQ9.I&A9*[$CI5!NI#0:;Y[=^R^JO MQ6:%J>^'$8O.K-BS?"L,D_%NNNL1-QDBI<^297)D[4K$3I\EMKG.:IB";DE3 M+2%@1NG5HF1];CI@;+:LJAIT,*^H:F>(XY4W5=X7J'/*+DT)GAZ^Y&]1NJ$= M,E,(QQ;R0DA"8M'!CN\FJ+_Z1'><*:&X!9$1]QP,]]"C+1*AZY,+O!C(2^0R MAI "_HL7 \684+@8B"R/.BA,?#N$01+A(,%#.3XW#L- >'2(FYA]>/R4-P)Y M65S(V%!PX/*-0#$NN$='?K_+[_)UNJO1>MT\I](L=A;;?)UG1U5E@RBBG@4C M/Z01"IP 6U'8594E3A!Y2&CS2(])PUM$>%_ENZRJ0)Q5ZS)OW^EM2^P?P0<' M_&!P0'"C2!/]G-M!\S,ON.DSS2WXXWHEKKFHFU(WO=PO1/$T.W6J@B8XXZXW MEU=_-L\-_,Z8*)LB5,VQK[&BKT>2("$.LGT;,S-)Y!.OLVE9GA\2WN)I2D;, M#<065RMWSY!=K;#U)$\3HTX/O\L8;)I\.2VPII$AWJ%%&H=WS$)[/8X!Z-[= MC6SD!*%/7$H+ 8)U"H5P\L B,)32>%<5NXMD$A9[GT21R!HLD<5VU0(C?SK64 MJ8.G'!,)$"H;&)GA4I,V7:)QIAAIY$@H4!)G=J'J)./)Q9!)EAUN=>K?6WQA MN:^_'2"7QHD;AL@)/0<[#DKP8#6((R*D4(JV3*M4#P^\'&>" J7**:=(S4BG MH%"=9_)*)?HO<#4E6)I87HAHZ?+F5+BTLJ20].%LM_[ZD)9_MA%=E#A1Z&(? MVC#Q/&86'S0S"BRU^$K4V/Q!UHA/5PXHR*YT(FB.6.6(BYO3N5+"9UR)Y85R M-"]$R;2Y21"]5SV3=N:AG2CQQGS=*M\TU^F_9;C_4 MPZS>9W4?#U(<0FQ[M@\Q#8,8!3;N=_(MF$!+:$E>S9)A)>MQB9X64B./3ZGF MXTU,IEIIFCH+I(7B90B4)E].3_YH9(B[8GQWQ(B9 M76?YMV93LC?GT\1!!$(21RQ3=5F %R2#.<]RA%1)VHAA01IP@0,PP>+LTNSQ MR=(LQ(DITBN<7>NEVS/D3&B0,I_+D!]U-T[K?.OAA3^_8\:R\C$MZZ?WZ4._ MX^@AV[%Q[$3,'L:ADQ!_,.7'B=CJNHP!XWG< 1-H0$DN1,E0QYNN&69--$43 M),Q05O:2E,E,3('#9:B+F@LO,BYE/OC?RG[L;_JB^S++FE<+3JWW61[V8>3@ M@(9Q"%UD03$<)8%*?42/XXQ=C%*+"^$ M@ZEFI8M'[)0,S'54X7WQ-P#YM$R-L&G9FHTKR7,('23 ,%W.VS22MBG6^V9 MM$NOUR?O&1RS))X(?>-B(]^AY?3B/>7T*SJMA:/K2K(>%PJ-?49::#]_+WI3 MF.7*- I"RTH\VP^Q!VUOS)4=BZO6K)*!.876EM8, <*$A=8,5VI"RS"I"ZT M:=)":X8\/4++1:*,T(Y.\PFM.$>+$UH)%\X+K2P?TB=!WN6[[&V=/50KV_8L M-Z"!'1#$(F@K8/\Z&HPCM8N3_&;F/_WQ1P,.M.A4SWT(L,F[A#@+D:+)N1R' M\YSR&!D2.=\A3NLRSI! U_>X-C)TV3*L3OWL7-R!]0!)),31P"5/B#@OC:K:= ,.K)(KL2H2 M0\[+KF0XJ<@R9V1YD8JS0:8^$I<0;VKTIC#3U12CT ]9V?P@O<_@*G%<&KH0 M!@F! ?2@%UCV8!*ROU2*0T4,S1J)EDT4]3BB4XQ#A?B4C$1-4:FN]Q\NTSA/ M*'I$D4@P*L/L0L-1*5 !:%\"7)] Z 5HOY H;&6X]/KU<3L.) M":KY-C-SBEJ%[@EQGJ<9EZ'>,_EZ>DI[1H9Y]?_M;LWBWT\L*VH/';QK&H9- M/MUAJS#V+3N ON<[*$3$]_!H,8:6)Z+N*G8,:W<'#8S8P !.ZIBE$J%\@CL7 MEV)R*DVC$96EZ"B5U$%.15B65,L"H-IVZRL'+29[$M4J0WT6KE:@O?'HEQ1#_ M@E]5W]ZU]_&&HBT.CF,+NYX=1)[M6 ZQXMY.\R>AAZ3%OVY\::]J'P\NN[N' MHHMYPESQKN"9I$ETV:YCJ+N/>Z6Z3:=\3*[1R7*W#"E1P/]B-4Z-"5[).)\$ M5H<-:8)]RW&3P/6($\8Q":WF(DQGVH&6T)D5+08-"\OD.DRE<))%#]M\.C0[ MT6+2I(-C(WK%P]N$A&FE?1FJIM>EPF W%=.^_M#UW>UCUNQZ[.X_9?=-K%:M M,(Q#FSJ0H)B9BAP'T62PYU$D5$5 WLILIV"* 1JH>FQBLJ9 ))^6S<.AF( = MZ!M1@4^7Z#.B6&?9F9 I=4:7H4T:_"AT]S6!LJK/L M]ON.#>6O^>-A^_7+TX>T9']<1;X;> 1#@K$7NPG3PC%K)(E'N=:<#)@UK%,C MM*.#&Z!Y/W1T0N"8F6;"I^7KREP+[DB..,$ ] 8S'?@. HQ=.XLH!F:%W LT)!CA?$N*EA1:U9;^]H6N[8W%@Q?.WCP.BAN3'.IDAD.=0+7!HV M,R*,4 =SX)QG"#;A4*[MO,@,CQY'3O!HNO!"Y#U;H"FMX'UP9$FH,QZ5YH) MKWLF^P:DK3M<#V=?LWWYXOGE-:W87/FL50\. /JL5/WZ3U,*0Z<"+NA8T4VI-AV>F8.O6D] L=>@R.WFUSD^/=ZUT'K^PWHO =' M[H/6?] 0 'H&;D#?Y5B_ZEBX 1T/X(B(_S.ZFDC^NE@O9LB%?XZNQYEF7ZLA MSZ;LB^]92TC_ET]2\5.IA=BRQ&FL^CG[46/6.'^NHH!$V',]ZKH8$XHMG]FS M$C^)H]B/Q9X$EK=B>H\N:XX(5D "+;"9 MCQ.<)6@B@U8G=1E9L08_"MW=3?$*=9Q7ZVU1[8]-8^J2V N1:[M^S,P[ ;;Z MRY%.C/@JJ&DU:%B4^EMH8D4>]#+*)TZSDRFF4Z\4^#D O*)D\= V>8A3(^O+ M$#*]+EVZ>*W.%]?B'"[SS7V&T]V?[XIT-Y;^?5_LDJ)\V&]37)1E\;V1V_X( MJN.[H8\=V\*1$U@T"D/7:R?VL6)\H=VF[SE#'3H$&[S:?]8U;^G:2/>9UNA_?( M+&033%QH199K8\L*+#(8QQ9"W'.8/I.&YZX>*!B0=@.6804M6/!WT,,5$$N- M?'/,5=>A6FR.XF999F[22+? G'0=VN7F(HWT\\U!W.2 4X71 M'BET5ONE&1\Y/L;0]6CL$(M ZB(ZF+%=ZJ^^9>67@O-,MOCG1<;5,1*!PZA\ M,P3O05/NT:'"Q@+&@1+\0E.O$%OJ_->TS)M:/Q_3NG_N+'$0)+;'+'@$AXZ? MQ,Y@QD=4Z-:G\,=-'V[I\8 &D%2I'7&Z^-8LC3(E%M((D61D)?*4C(E51VG> MEK'"* ^_T-1_Y-5B>(3>C:GH^BB! 2V*.A*!2JB"/Q^7D50ZKTC0QI MXJIA@"\EW;A*89N7A'!JAR![RU,/40;6ZMT%L-V%YO!5 Y(9A0N,@&@.8 "&A9X_% MOFQZ8;8#(Z8)@MSP*8(Y6@0743L<5Q*#9RQ,2($<6\L0 DGLA8[^(K#6%F=? MZL-95+(OFYNOXT8221_3=5X_K9A9/R!!B6=^C EP$>6/?XP"_[1U 7(M=Q=!'-L8MS!8[%U*'11X ;T& \[ MV&! >06&!39NKL"TW*Z-#L;YEI[Y*#FW&JV9T 4L4.OVJ##7_:2GC=$D3JNL MN*/;O"LNMEXW]UVKC]DZR[^UY>WM(,0X"4GH$AA;=NCA*!R@)"S9E9Q'] $P M?;QM'&[-O9"V!$&/%:0]6%".:*7%3V.#",\WUVD+Q0GHT"ZX;YHZ[:-IVM+43C)3&3=O?'.;_F98W&1GP,7SLY\I/B6FP^[B7K[N;_W= M[K)5&"+DA C:GN,X/K4M O%@D^"0ZPZ='DN&)[@&6[K=MF=3'_L+PIM]!OZ? M=+=O*FW!&] ,-&D%E>%6> HS3*OB7#6@&R]@,WRS\BD]]1CF5=,<(\2OS$SR MD@:^*4.!OL7-#2J^G)\$E!E25_O/WXM52"Q$B&?'5A(S.PT$--B,O(#_A6]E M2U=2>_18YEO=6L_%K*K6ZR95M]8S?+/RJ4OK=?-J2NNG^-6@]>SS4EHO0M_2 MM5[(%VZM%V=(0NN/SVRL[)B$V"?0\1W;0CYV+7?,(T(;RJJ\D(VYSF*5W$E6'7'H*7[TTBWE$#I.4[#2]_$21OM+;", M0SCZW2H,]UP507R[8[*1575[HGA?YKO[+D9>)4Y$0H<@*W1L'!"21.%PKA@U M3V/*RZ&T2>,+$QVN5OS ID4&ZJ]94^B=P5.10WF69<1P%H(5I7 DNSU?W*'L M,^MK"N$YZKAE4)G[)8J@NE.3$JB),YE#* ?Q+9Z);[(MBG(56=AV AJ[,,86 MA="-O.'L) I"OBJ6^JT:EL'NV'^C@3?@K@$D?W)!D5WQ8R3S$6LR$KP!R55Y MES\F,A__NLZ&J+2#U(F028HXCX'HH7EQJPNZ_)HX\*&3.?Z[=,4ZRS95\]3' MVZK:-\4Q;N\:8"OD4M^.8NHER"748^M M.8BU8>A$;]W)D\D72\_$H]@$\IS"MT<4QE,4&KJ6=XZ@B2A9 ZO+B(QU./+B MWIXF;N26 $A:ED\LZ.Y?&G*1X[D1A=BU;$J@0R,TKCHD"?+XJN9H,24RGJ0J MZ'1W=L:[.C,_#3S%#7?"*4GI,@:3'E;%8X7<]7I-6'7$N_I3GS(M\*W!PR,>(F M^>(>@'I87^)XU.39Y/#4R9[Z0;SJ=I=]_EH6^_NO['^R;(6QSWBT8L]-7&1C MASK!>#H$N8ZOYU2>L%G#8_6W8E=_W3Z!_)6C>G=%">[RLJI!W4 %#\WOLKBT MV&[[^Z[;HA)["DQSDP@O&\W9&HKK1J=GSZKFH#'HT8(6[O6(UW7NSV@#&#H$ M*-(0&LX$GE(D=4!0FN?%K1QI%#-KBV2!;2%MJG,?)L8F]"$VT;'O/8J7W*SFQKUBY_C%-WCG^ET M\"BWD'*"I*EUF""/V'X"L>=9CN6B,1UT,>:J**3'DN&9K%N7[.89*E=XEK2M*^3*XBJ3&D?G*2WMUEZSK_EC$@S7-Q MZ7VVHDE ($&V0UU*XLB*XG@0R,2.0X5U7E7+AL5KA,0"\:,3E;K.3TIQ+:-J M<]*LJ'+/3E/>@$,+'. NY53E*TQ*':Y4:9$E"J,VW[B/6JHSR/U0[S:MJMN[ MOC#E;?DQO_]:'S]/'MI^!-W0#T(_LD,<1R3V.[/$"FT8BNTY*YLSON_<0ZO: MPS#9!OR2[T#5/)E<<9:'U,-J87H;(Z7/G]&%>O3PI21G]P10TK[(/9=Z-$&Z*[38MJ^;: M32>*.C11O8D4A'+6UM&FGF.;M;"/?J<:?VGF U-2Y(IJK;;&6K Z_.11Y4U M,\JU=]8"*09;16?J+K #YH67[<>"&)* PB;U@,.E!ONN-6@P9%MZ! M[!O _N,'H:N,>GCDV-6:DT)MZMC@N[ET8]$ GP([4W/R*K<+I$=R!]S(8CC_WU=X+"Q/=#U!1E]BR"@HB. M>WA.0#R1,23\<,?EX5^SNFT2H-<%F^,CW D1=]O^8/$'H6.-4'^) M1#J$/FQ8-AHL;]J]G,GB.4:Z_C$/$]U>BJYE='DYZ(6&[B+6U?^>YKOJ75%5 M676[HS]J%NCN\^IK,\;Z(>83Q(:5UYQU<1/79T8M-,[0,+3$CM2IVS-^IJZ! MV)1P:X8%2[R/(8K-H1JXY9M4YR55;)9MV?RE ??7AM3GZ*XS\5ZD:T*2]%&] M#)W2Z$]AJE.JE=!)'XJRSO^=I?%YU3['N$((>ZX%/9M$21!%R L/2AI"AZ@4 MII*Q9US1CD!UJK;IH5VW:,X+IB;S:5TL+V/<:?3G0ED<5:;XQ]U=5I;9)LEW M3=TY4E1U]?>2C?]51 *6X,>^EX0.P9[O$PL.]GR2""7?\E8,A]/M59JQ).6Z MP25Z44F:/[XH81[JQ**#[@+2P%H+Z0:TH.:6IC/<3$J2*I]+D2)E/UY(D!YF M>*5GV"9#NTUW$O3X^#X,;=MR/$BL!/DP2I![V+3T[#@241\E0W/M%797@<3$ M1XU!/OV9C3PQ"1IY8TCZP^C7N^\SQ=&$%&FA=AEJI,>5PD#7$],DU(5=[?F> M+M\9XJ\/9?:0[Q]6T, MTUI_S3;[;79[UQZ"P&F5;4CQ\)CMJA9+>W;B]K'Y8X6:^^!Y_?2Y>1?A<_:C MQHR;/U>8!"BQ,8:)'R&;TB2!KF-9D64C3#U72/)F@&-8$S_M'Q[2\JD9OMU9 MI XM&- *GN^:H7GX='-A+2,FK"WD-U\:S. 8],VS-F)9ZH <_-%B!PUXT*+_ M7S.?%5.F>^H8V7QMN0S=GM/AT\-G- MD><3G%B00A38,8I\)PP(<87.X8I]V; >]V#$9%>0&SX%-4>+F!CV., ?'9*9 MA>T9"Q,:)X8%8X!X UJ0[0K2"/,&-##!'PW0 M\P/''-5\2C,WRV+ZHX%@4R]776)M0J]T$CS MW2HD"(6AC7SB!8Z# A00;[#LHDBH.*,.>TM0O ZJ+LT3(5M1\PSQ;$#S+E$\ MK^H=>)-1/0G6%ZYZ,A[QJIXT6]S+?,5=_9VEG\SH\,G3MN!S_Y0AK=XI!<.U.'^><2W17 MH5MP)8Z/Z2LEI]P,3BVN:6^%90BC ;].E\H,,<>]N[MF>MR=<,GK[%W^+=N\ MW=6L]^9?MAFJJJRNWN6[[&V=/;#HE"+'BV(K02CQ"76@YXW1J6?Y0@MF6@V; MWO/ML8(.[)L6+3C !1U>\$>#&+20!8-&OM AKAP&>64!P@&A),@G"P# -/ MZ,D6'?8,:R=)'_,ZW;9']JLA]EEWYV/W+4JP93 UY=@B/"OFV(8HUIIC=QC! MNRF"Y\VP#ZS)9-@2G"]# +5ZQ)MA2[.E+'?#T];5RHE#8D/LVU[D40H].[3Q M8)B&GJ5%[?C-75'LT@&D)JD3X%A1Z+.CS?_>U_5C:6D*(\/+*X(C,+8]W&,7.K8V$N"9-R-,7V?A3#!7Y:'+3 YZCHVIA%.9P67HC@8_3E-)3\52R)C!NI MZ]T'2&#;WK<7DQPE%OE$9R[ZQ&2G1=6M@X$C#GM@\PK1!$,34J2#UV6(D19/ M"OV]3O .?%ZMV1#:%;#6^)X;W3 VY# 68R]G3N^IS[9BFE*UC;.M#>$E@%KILDD9=$T&$]V44>CLB -7 =H27T MZR T?;:C=ZI1G\$MT/L%SE\,.CC7_(<']_H*TL,QA=9%P0W.*W4$SD,DB^\# M@@=.KMG\AJ^&:6RAJ0,M5^T1RYC'KLS!V3MEUVL1[B=1F8';NT_I-AL.[]@$ MQ1:%211;;*)U+>@3I[=C![Y%!9]S%OZ^\=2]@=2H1IE]RW;[F7<;7_ Q,;+E MN5O&J%3 ?_HRI2(3_#7,JXS][E>TVQP=;:,_FK&:]9:I1WV, C> KN.&!'H) MI(/EQ$6^V/C08='XB!E MEM9FP-,T?+F&LCEBY+F9E4LYGE&Y_'9VA[@E4[7 MYV9;][3TS_%M:_IDU)6*?FT64!J$#X]"* M7=^U;$)C:S!K!S@2TS=E<\;%K9U5VJ'X," 4S!>5&>5,_>:D4C"+ZZ"U+([@ MKBQGE^B:2JET,;T,(=/GSFFBHYVXZ0 MY;G-H[5N4YH)6W9@C[9IF%BK75;S:9@>>URC+^I&WP"->P#V$-L!F#X#*5@^ M7P^U?((V(Z]R9?2/2'V.\,K2QD7\OSZ?:2&UTP;KU:>QN9%S0WS,0, M%\L8B/H758E#'1H$$;)=8L4^I9'?;VXX+K0MH6UR'?8,SS/""ZH_Z8(?+\W+ M&-9:/9)8\!-C2V^V#!&S&\78L1$,8CN(48P&VU80"K[/I,>F\:4_B:SY)\[G M>.E>QF#4[)-4/B?&F- )^J/WF ^GX<83;J'O!R$- XHA@DY H.W$G>$@IC:$ M(D? U2R9/@E^A X<'46]UK'2RXQ=.AFNA^YEC$&=#KUV3EPG5_Q59-;E/ML< MF2;[LFRNYPUV+823)+1\ZF(OIA&U,"&CW3BVQ4K'J%HS'(GV (<%S8HEM!U MGB%HBF ^=9N76S%Q&V@] B?$K*'B+Q<(F] V?60O0]HT^O.BMHM>IL0NYITS MOO(BA]J>'R;$MR.;VC9!]F 4V3X6435%4X8EK0LLTGX$9KVPR=S/DR=3(#Z; MAT>9V&Q*Q*YQ4^\<49=",G6&EZ%9NIQY])HY$-[7Z*S^OV'5)1",_0$D$ MH8NL&,;)J))A& F](:EN;:8P;'V\FR#QH*T&6L7V@.9A5$R]!FQOROX"X_4% M[")=''LMZE0O0\8T^G-F/T074X(YY7@(JMU6.9B,/=^G410B&,6NX]L>'DPZ M%A&J5J]D:"8)&T]1#J&75/HHR:50YFB>1KFD\7""LK]Y?17)FB+IK!J7O&HR$XVBTC+ &M.MIRM%+E,,38J.!F*7HD Z7'DA1]KX4=ZL6UEA M0*P(1W;$_@!)Z)#$&1,Y2I@P%76Z5=RDNVA%2)5&0,()P;"&W1Y4*=JUV>T! M[$(VD60VC[@)7L:PTN '[V:1(#/:BZ7AX\I+A[>.:6S'<>P'D1_1,,0,2=3? MNM?*+SQGN;/9[/+%+ LYQ)R(F6$(XP1D*<19 M;3 4_P-$O1[< "-*@Z-O$;@K0Z/"Z145T"IJU=^9-%0=DJ<P5.:BYGG5EO;K-(Z M1--J8-X>V60Z=DR1FG[U)M8YW>KOR7F]&LA.;YUJEJUP!E"24<03$,&,1S%N M=TR 3 :#01JE:&,*?=)8FC7+9T]=LD#E<$VZ\6I8$PO2U27MH6PZ*D2Z7EP3 MH5ZL]!:@PU4[%$:$1#R(<1+R,(E02H+69(CTZG8,,C2%%.FN6UN@MZ;^EYRP*MML2B6.WG-_V-^NUM7EY*S'[?+W2)?<.&O/+VZ MVS9'5K/Y>B7$;M.N:-5/U4?()QB'?A0F800QB2!(0!A"@%G(_2CK=ZML%&B6 MM>SP(/RA/][>(:_UR).]RSOPJ3H]WWBU7T%NSK]K5ND>N\75]-/AQM:3WBG: MV?+E!A,M$0#'Y*$ M1C'@*4Q)BSB.(="JU3DA3LM1[)RB?9;@=)^+F+(YU:+2:VE)O1#5LQ'M%!6R MQ_"%D.-"N[H1?YQ@XK@TD@N8#$2FW^"J"848" A+< MFDTI,A!>-(Q-$R-N/ G1^UR#-!(K= @>(OB6N#6BVJJTCJC>>[JT);@'TR[K M:!]WE,2P-T\:3_J2A+ M@5X!BV&V=$9?E. MKS&&>HZRQA;R@YADQ(^P?'8TR8BL =_8RF 8#QI=BC8F'%7S[_/U8MIAI3N< M-$EU+#/W R7LL(V\G@YR\Z%,3.<43?&C0$_SKQ>-)09Y4V_?"WG MP\_OZ#06PX!!%*5!"% 6Q,BG29*V%JF/?,W:9 ,L60]!S5'F\DX^OM:=A*H. M8U9UI7:/U5-L\OK@IMF48O[;$8: 'Q1Z<=?R?Y MO#K^AK6"2^-OH"KB5G_7"/;V]?7; MV8V8,+[;9G?L^_*N&FU^*\O%]V*YQ*O%F]56C"I9# AO-OEVLW_+ W_9;-?S MV^TLX0 C&$+LDS"(*((I3NMJNTE$.5&]$6#6J#UA:7%63XSMD7HU5._@E9W/ M+=J1A4.+R0OJ8*=%W) 2[Z58_1I"X-Y7SL[ D'$&2,Q\%D609IUSQ,FD1]# MK7?+#)NVG 9V _M_SQ\>_\_!T#Z_5S *X0;ETP[7UO1SLH<*],@<*J'ZK?** M-+2'O\U6]<;7I7NSY4"Z7O%S+/YIAAFB&09I&%/ PQI0A'_@<@UOW7IA;I*K>&W,+M;TP M<^ZM'._ 5^_+TZFW+KW*X1NO=MD[\-FKG/:VPFNOC,%T+XK4"S" )<00BP&-.@CB+$,AXBS^B<3![K-XM M^KB=KQ7/5[F#74>SC]T<=MRQTM3_J$X1'];=N?&^Y/?%:C5IZ?C1VF=:H=7L M(W\:C=7E97QY[=5RTROKWRKP;U;U0V\S0 (0)Y\*V6AWQR=!MZ#NU MTS]+\'W>E)/$WIZ]Z6.(Q9#Z:W-RV1+C'HMYY"D_CTO[K^*?_&W M?#V_SW\3'[UE(L_G\V)=/4=UN$6%<(I9'"0AG4=1Z23C.G#NB8=2[ MRY8?W7OQN[OIY#K/]:^H)UO0=R]5)V,&)D#/=5=+C27Z:5PZG M.BKN6.^8-O&PTH__-.F)'?;&3V(L]H+7E.K,6$I#'"5!0G!,LY@2EH+.M91G M3AYA&>Z6$Z=;;KSO;=R8-W'COHH;CS+-.3[O,O0UXE?1+J\HW3':QWZ:'.?/ ME]@XGLTH=]/_G\+H4^9@WJ+9WM,G*\\WT*_[!Z(4TI!D8>PCDB0T\PEK_>,A M";4>4WHU7EF^%=D>%[N4D#B>A1CO1U.G(E-V(5?SD>,#:'^VM$2S3SAPDLU< MO_W9$Q1KO$UT%LYTRT^?JC3G"G9""J\[%VJ2Y23EX%#=*\Y3S':BJ9.4R?J/JQG* 2%_MN1$IR],>:K/;&?]V=,2.Z2- M?1;01IM/GY#H+ N%&)+43Q).@H0"632E.P$99S1Q\ 3A<*<<.%QX;9/GX+BA M1L[RRB+#3[2:KMCC?O:H8(,R)U?3M=K[6D2X7Y;?9S6\?4'0C]OY=E>_PRE- M("*?A@XX#N* H3@ /HP8A%A83E3FC$-M6)[$-6GTX5.--3BMUY('$WEYWC0F MAWH3&4?H6Y2WU="JAJ03-#Y#9)_.HP L/95A-?%!$U2O^'XBSIEB:]K08\R+ MTFP?&BS0S<.B&6"Q+SXYB5B613'#5)#3V!-MSP9*M**5Z41:ZZ%B W3V%FH+ M3!J3ZK%)'"S7%LCL)]@M==Y=N?8F4>^S;SB;H\]9!=?UX[J&]V)&2<6KN<'F M[\7VZ]=\N9BO%A_R1]&IOLK90OM\+0EP&J910C)(DS##+,U:JY213%G+#=BR MK.@U0J^%6)5E/@"IH40F>%40]9$I[;&=<)Y-[W.-4$?@3="J(?,CT]M/[ ?3 MK*;SU[DXI_8&671 \TUZ4]KI:QKZ_ZEXR*N-O*,WF*LEHLW^'3V&TPRQD/,D M S%*4MS:Q6D*E". $6N68X#$V.QMOKAWB2\_+VZ+7H5 ,#JS>J'@.JE]HH$9 M=C7BP>@L]XL()MA6"PHJA)P+"T;)=" PF/6GM-7M-(+#^WPM)I /<^'[5?,8 M @JSF,4X"A+J8Q\1T)J' 5*/$2:-6@X5!U"-10RCG"L$CJGHUHL?RDSW"2-& M*=>()E-1WR^H&&P"M=BB0<^Y$&.#80;'@Y?K3_$\9AY !F*2<::)>RV$2;[4N+Q![!Y"K M[U6_XY$7)W G..*D2>RU(TFVVLFA(T367#QUY,2SH:77V\+@LG_+\8[[^5MSFIVUWAS[K'/]3N9TO#W].R\WV]W+[/_GV0WY; MWJ^*?XDY0?=)]1\='R2=,>)'@#"8)"$! 8!A%,7=OD5"J8[8N^N%Y6CQQVK= M8?4V4[[U]F[?//NP9EGGY3V^<2/?9(U\(72ZW_'S+\O]_WMP.G M?Y)X?[(]IPCRPSK63Q[9!Y(S5C@WT8;*FV*[+YO\G[M\M=CCGS/DM87H5K[ +[Y_BYM'[0(:8416?#_DF%[_[ ME>7?\F7Y6-TC7U7RN1-C^6-YMQ6BF;-B<[LL-[MUOL>39#SFB"<)!22$:1PF M:5;A 6D, U]K^<\>"LOB1>>/A0@G59;>PJSR+TT5L]@,:BKG1@OHJ6"+^<8[ M0'U3G8]H@>\;90]]0JWLS?(%+;7?1%_ND;MS0]@RPW@H@,N)\$2N7=;0]WXB/8]5*_!ZM&I:=5?.NQNH]U& U MQ- 8WPK19PJJ]>).Q7(%T:LQ>F_W++,NE18[H>:"^.W7?+%;YN_N^$X6K_UKL2H>=@\?9 ]=ML?O1$Q[ M]YBO19<54//Y)M]\DF%O/P>#84 91$F[8C7G9F5.X2=+U[MC.:R_#AMJ+B$[USS:2[W#VLY[W/E MB3?=%H$)_B]M)XS:OFXLAXWL\_$VQ02,JX8/?%NMZ6P$#&D.KQ;B.^M=OGA; MS+\4RZH UZE%.QY"@C&*2(1("G&8QFF#)O&3B&G=,[2%P7*(:$!Z67W>>%.M MI=VK>(O09RU0AMRQR@=F-+HR>_%]3<=HNYH=_6 MO2S''0=Z&OU;62Z^%\OEFX?'>;&6T>)MN=G,HA#AF-,0,29+7Z4\#9I]DR3, M@E"IW,A $Y85MD7E%1TL[_;K?'VO>;FC+X%JHCD"=WJ:V *Z\?:0/(EI7+$[ MSV6L1S8*, M < 9!!'@F"(_I5':80"A5@IHUK)E67ISK$8;.=1AGF7DVZIJ-= M3]$.&!=,[Y&V:ZF_=&"]%NW(3^)H,7E! ^VTB!O2:,FW>#2M M#U+.L@Q@/X$DH@'F@.(: .(HP'&_E=?!9D=<7K4QCS;9 +K+IJ-RWW]M]-0D MV9VUSVLD*BUP&FL)-_33AF-GERH-47E,9:L.R)G:PZE*"FD5O^O*FIFYC4*8G94=L3;BH=X:;"PHU ME$TWY&BP%\>U8HRPXM!;JQ_*I3Q-)O]H!E*?HQ0R/X84 Q:E0=#,2JS?>[SM9=5/F,$T]P<\2KM?@'3ME&;4Q+J4];O8*-[3*57+& M?\FT?QLZI*Q7GV,]]#(@ 46(A(0E"81A&&H;Z-KVHX'O M5?B]]_(-ZY]=IW5:;EHAM]+'_C1*;X<]!Q^U[M\+-&Y4'U95;^JIHYC$( 4T M(BCDJ9\ #J(ZXX_"*(JT%+N?!/3+;:'1&8*\"8[KOU%@9@0-9O#!6QVH?-T;U:-Z6TXR"OMN/7:RO M0.#;;?%-) ='*_DTS#!(LPPSR(1R8>S3L 819A @I"<,AHU;UX&/NX>'^?I) M+B>]D(0_5L5VX[7(I]H+4^%1:3_,:(.X,?!M.7=V7\P"A_K#6JF4&UY6C2.^ M>G=W7*RM$J8]7D #SED,,4]"'J L E'6XB4T);-5OM4=_6-C5!**M!:*UIT^ M(O&L>F1VI=:X964PS+&2B$S5KJ[IS60\G)6F:5M&>1J3?]F>.CM/:9*FC$-* M$8U3/R8T3IKS!#@$$&A.3WI:L9YN2&!Z6_N]"5/;VA^#*;VM?8G(C?LZ9[BY M-.T:R*8;*C?8B^-IDA%6U(JK%/_<%0N9DNUOY00H2@'%"11I6(K3$/#FC">F M)(HR-67I^^G6%:7#5!V<_*V4IZ"I;.>U8LWSWKQ=%I@Q"-,3ECU32I)BAB2= MI9N42/-,42)2\\/:&I0SEQH?#( /2EF9[1=X[Y,;^7G>5#_B@?6UC= MOUE5[^'*OD.>FA]6T]Y9F$64^00S #G,_!01R)O")BCDFAOL%NR/>):]P>5U MJ+T#V#?>EZ?N-^JCUHKB8[5UU-+$J1M&3^GMM(GEV;PRL4KS=//-Y$9N:M7# MLW-K6VPJZ[*(VM6V_V]Y>;^>/WXM;N=+_*/8S&":H)ACS'D09SA&*$5I:R\2 M$W4M]>UMQ;+&'N+Q/DM$NLK9GS]%?1R%.CT5U&'-CK:=(^62@@TFTA&=&N[' ML1H98D99YO953-J3'I MJDY_!A559Q3RAJC.-=[LZ,XY6B[ISF J'=&=X7X(RK4)!$@ 4QQPA1EGSP@M/<)1H/?=DQ*!E-6K1:%:^,4*EFA:- MSF)?6?(.\=WLJ^]^KC&.K%4JM%V0+:.LNZ%@9ETZ+JACGJ]ANM;4FV\L@S 0 M6NJG)&.8^7&&Q*2QM0PRO=F<"7N65:T!8T+4-'DV+%2XIVC/2 MM 6M'^4NZUE/CY3D; A;FK/#4RMB;XM5_D9,53>SF%(0A"F!), AQV'&2-2: MAE'B]Y@H#C-H>R_@TEJS]UGB]"J@_2:2 \G6FE..Q[/FTOYPBFW..2_2=GWZ M:89U-W3/K$NG)Z4F^5)6OODRWS2O"#5G[3:_Y]M9$D81HD$ $QPF*?=AD'4Z M&W&N>,YDJ!7KYTVJ-Z&]!IFFC/5E3E&Y1J!,4ZPDHI:KF_:U^LV-)V"-+$^G MN;FD2 /9=$2$AGIQK#M&6-'>]GMW1^>;KWQ9?M_@+R+1F]]N9X$?8)1E*0(B MN?,#'@: U2= LB F>IKMH-L6!PZ+:SJT+T YE7(O,\MMJGVLD[0I+*=-81= M1X:2$5?.;6H-YT=U4(GA*DV]7Y??BD6^($]_;/+%FU7W_$9SJ:?(]T 08#@A M!,4^Q!FGS ]QW +QN=Z&EP7SEFB[JT:?[!5>V;V9,^^P_J=>)F"C#=3D M;F+Z]410@*VUKX4KCRO](A%[Q>HO!X\7[5%/)I#ZQ%Z038NMY(:8VG2P'*W' M:POOF]5M^9!7->P92"'" ?.I3\,8Q"R&G;B'*/#UIDMZGVU]DB0'[G+T)Q>> MD7!Y=/4@RYF!TP?[RS'1FP'EM[46_W>WV=8W_DMYUVYU6RSS9Y8_E;HC,^&$ ML5@,2I2%C$=1R(.@A9JF<:#U\-84 "WG*@<^R6>\UZU7WJH9D?*[\NM;&58? M#\/JK@VK!O*;:=I>+0-ROMGUZA>Z'X7*%M72N_AZF5?7S%<+_"!7YO]5WWOC/DTH M@\(RB4.:I#$F26LZ AG4O=UMP*3U'/ 0974W7%0Q;&^%%>:E@N MR^]SX?()DR)[S(MO\FZBS"-%)B-2PAGU*4 P B3"& 6!R3.6ABRO.]LE=_+ M"H:?-%833&-0&H5=1:\CN/I2]LNZAO9T_NG D;A7G,9/PG>_*7H+];3J>7NX M-]X>\,@3;DTZ+TVF;;6,&Z)IS[WC2;!='I7%]2"I?'?7UC*2*-ZO\X=B]S"+ M48@@89S@ &!ACB<8M'9Q2C1+*P^W9WUJ>PA1GL^H!'31H+RIUE?%=^_GA?CI M2B2)'(P#7GS_%(-QJQ/@BK&L6_?I' O-L#9)IG,GM2J):DC,"=7BI2 6I( MHRJDC?@:S:5C9,-X=$-_ACJA]$2*)B>J2E.]HE*](KU_8)K6K[_/$I%TI"QD M81@%E 40\ RU%D-(M?9DA]BQO.CS\MW[<0?-!6HNC!P3A+HQ?(QX4IKO;GH# MZ M[H] -5 G._^DSJ*6-@YN"E<%LDU=UV *GPQ/0]_.G M*B* &"-&DC@(DHREH1_&I#O,!7%"]/89A]NSO^_?YD6/-2)3>:OMCW*6V8^I04*VWHED:[^LUBIJ-\D_^-F, M9( P$B8L 'X&"48DQ-T$'V4#ER(-@[&\0-F@/95R'JQ2&A!&HPTT0#>G:AM3 MLEJUU@'(@SQTO]SY5J'IQE->#SPK/8-Y%E.30&^J M.F;53I> ]B&_WRUEXSWQ7&Y]13#Q_="'69SZ,,5I@%H\*/5#I"+W]E&,I/.; MJH3?5F*LE&/=H?3N<,#;>^!Q MEYI*XTE09YJLW^.AUIM.[;G1(2R>"+#CM8P#3YB.XV50[U2#0FU.&^\"NE-17MVE78[-5F42;P@HQ9:P@WYM.'8-TFT]#W4U^322="HWA1MJ:<.QWDFF)G<#U9(7J_GJ]G26"S 5@LVC)$YX M$+$,@J#-%9_@5A]@371 M2DX+K1$'U037')>JPOLA?VPRY7=W;\O5_:=\_2 +_\AK$C%.PH B/^(9!5D< MMF4#$L!AJ#>'[VUFA+L'A6#\<;[T6H3>;B4ZFO>E7*_+[Y6BKM?R-FOUPW'' M[SG:+HS2P4R[,1:'NU$:[H':]85O\WRQX<*S-YO-3M:_>W?W?MT<@*^*/HE9 M:/V-7/RP^L[,!QFG/L91*)(K2DD6!V$+)F)!IEEYV 8$RXE-B[I.:SY6%0$] MZG6PO0JE5S0.=57JNH.T"^ER.&_E^9'=^LG;2(#]UL^'T*RW;FZ;VF'KY;)R[QY>]2AK!;"6U6D6 MR<\SIK X;H!N1\30H$-G%L.-<65^66=&TP1'&> Q#3A'<18ES.]6X4$6&5@$ M[V-V[$7P4^LXMI9QKG-N>OG&*-W6EVU<7:LQLD:CW!1NJ*,-QWJOR6ARIZJ6 MTKK(/^4_^AZRFF6=[5-',RRO54D[8,5U\<(+WQ:JS>B;L! MX^JF#I,7E--*@[BAG79<*T?HT/KZ.0.,,)K&G$.8^;&?)J K[Y,@H=FSQPK2 MQ^U\O557QZL?JS,$CQ%HCL:M]R6_+U8KF:S(4V;5IXT_YJZ,)67&W!DCZI!/ M]'U-?[7Z= H2POP LS3"B+*(1J!;HH81P$V?SE:*NS%*'ZK?HUO[VOTYEW?O MW>W)JDPYU).5(9_JR7K^*C_RL7M\7%:;:/.E-,.7Y?QR',ZOV=9;G9K>N]C-OVH(=(>#O@ MFB<[C%&OEMM.P;I>6ON,\$J%)$;O .1D1S84R;N@6:;I=T/6C'MU_ R)%=;4 M:_L(V<@WV_?S8C&C).(P0G$C0\>X\Q:54MPL5O+ M['7[-6^"?K4O4318QR[=LF?HPJCJ1:0;0Z#^MY=F"P[&O44N(,W3:56 M%78N:*51R&;Q>VV.5_XQZK8;CY\_..O^<.7?#WC$?1A M&D0I#".?@=@/80!\#CDC%#&>Z C:,$N6E>QO IR0KT6K8^L.;"-I.PEW[-/U M%PB[,/K,$.W&L#/DRXO#]N884BJ4^3Y?5TLUPN?J4>!3 !KK ,OD)4'8YP'F M,21!&K764Q\H#3G3-BT/O@.DS9O)>ZS->?H_+@X_NX1?3BBFY%HOIU"EV?M< M0ST_=[/+MT;ARHEX[U>FTAS_:O4HUM K4D;7I5V.Z5&J/E4/%PW MRV A@U)W24H_3F^-_*K;+_-W=FU6U M+K>;+_&/8C.+DR#(F'QLD- H@Y$/ 6AM@91#G;E]/PO6E5^ DF=4]K"\SQ*8 MHBX-I$]M'=(^<[KBKDV:E<6/D[Q<6/08QJ,;BQT#?2A-]JR!"O/W8OOU0[ZL MHMWF:_'XJ;&:,11!DH(XXG%*&$QXC,)NB04PK9UPT[8MJ](A M,ED>LL;F?:[1#96FH;SW%*T1*=>3L[YLCZ-IEVG343M##>"H#IKR[II"&F51 M:;;^>[G*'AZ7Y5.>LV*=WPK:FU0P24)*T@P")@_N\Y0F*6R-D3 ARG/T_B9& M. +4(O-::#K3\0'D*4S"Q^%-3\Y.4M9GNCV .HU)]C@4]IM:]Z12;3I]UO%S MD^CA3#DP=3;@1&FT]VC> /DZ7^=$SM!I^2"K-=4GJ_?5U:FA7X^WQ= MU6K>/KU9B6G]KB[A)1_A^_1UOGKW6(42X='8'M\ZH[?4R]!\-GGH[WBMWV\UV+L+WZM[[I5AY&^GF9N0+ MOJ/1?R$?=*\+N)%).LC+\;T.]Q"J9Z^LB;RR7GV5*!_<2)GY4*3+$<SFM@U4\XU%/* V0:>=@P!C52L=&8[)>-_?JK M/&F>_[OX?^_9)WCYCV+3% ;;?BTV7E[?@OIW[]=?!R9IER@YEZ<9H=&!5,V, M'Z7I#J:F/8N\F-4V/N3WA3SVO=K^/G_(9R'BU/&^HRN1E A2NOY\LUJD?_X[_QIYC.&>,!3 MPG#$08 )R$AC!^$D5EI8Z__IXZA$@\JK8'D"EZY.:).F*A0V^>JE%.I4&=.* M(PXNBD5?OEQ1B][X7\C%,"94]**Y=L&+S>U\^3_Y?)VM%FR^S6> )YA!'B>) MR%40S(+ !ZTI0'SEO**W #R:F">1":F-0M/8E-7CO[T71>/49C3TX]> MI!G0D'-4G)&1PI\]3NY18?):4+J)AR9;JFF'/:)Z)1V*'!G+.)ZY?S'?Z$?4 M]!HQ"/V+7&,("RK*T"Z6?!)_,?/C" +$0Y@"S./$[VPEG/=3$1T+(^M($U<'*8D6 M@;I:8HN[86JB1)MQ/3G@0DE1^G#GFJ;T\N&LJO1G1$57L#"TJ(PMY_>S+$( M^2 -:0)!"C."6)?[ (2 JI;H?:IE_>C >!*-NF)H4G-=)>RQHJ<,BH08T()G M'I\9__U8F7[,]\1=#NT/VFCHM,H]>)-+J M4].G2#JA3T:Y=>.FCAE7SCPL;8 ?Y4N$^;TT^2%_+->R;/F^0/FG_,>6+.5C MUAGE+*,!#C,>^TD4^S&N3[J&G-%,KTRX"7N6=>JWO+Q?SQ^_%G+%@'=\6-,Z6 M\N,W(LDKMI6:RF=4RY4TGZ]NG[W!L 7;TXCZ,*G%U><)YK'6 M4S=F35M6NP.T]7F3:#6W4X_*"3%IJ%#<4TY9S MQR_+V.10_26]V_(A_[B=;ZMKK-VK-4F ,IK!(/"Y#U)*8\S2>IX<1#2.53.8 MOA]O;Y36B+P.TF1O0YVAYL*@&TJF&Z-KL!R'+"&2;[I!R665#TH(3:. ,)2$) :M M.8*!UEIH;R.6Q\F[QWP]K^;#>8-,]\7(WNRI9M0C$*>;.V^:K+D%-=V;C6?8 MN9@-#R34#IN/9=EB&ZW(H&>A3&/LR2& M,0\"0A-$2%OK(XB%<:7MXV$6K,_P-UNY;;"NU=W[)?]QN]QMBF]5W>Q%_KC. M;XNZ>(T<8/,'N5;SK^H;BMO' PF^K$KC<:LG20VDBK/B&:A12-,I:SD&>;WJ M*!V-6L5BE6?<.2' 9MQWH/[158H0AE@+"(<^CZ#G=9SJ/6NPS!+UN='-;A*,19[>'K)WT RU3+ \7C4T]QG M%!X@:[/"T1^\/,_2A730#+MNY(2&?'GYX*4QAM1WPI?+^MWNO\[7_\CE!*TU MR"+?3X.0!R%!E#&:AC!H#491IE1/Q8 9V^=SY!) -;(>6F2Z.]_]&53=\!Z% M/-U][@I4Q5P':QI%.L_/Q2WMP:2ZH44F''FQ@6V(&U45^BU?Y>OY4AC$BX=B M516H+>OG<"IX]:3T&4 ]61I, MJ9HVCE37^+4 M9&D$SO34J +D'9!&KY!F18-.TW)!>@;RZ(;B#'6B--JW]/2%'2Q42VD[6*:> M,1Z'/D 8!92B., (L:B;$6:!4HU<$W8L*PV[M%:O)SJ#V%13GK&(U).?0U0W MGOBO9=[1>0CQ1A;X?UR7B]WM17:MJ-,%ZBY(E G"W= I(YZ4YKOCL%,.LPPG M/O9A @.>! @#/TV[Y?7,S\3DK=S.EVHRI?WA6MK4X5 >5Y_DGWCEB[,-PXXV M7*=,38NLLJ4G0"^/,DQ[?D'CW((R:VZH2'_X5\XI:/*@JA?=P:#ZR.+;E.:ZDYZ0B,RU?&ZL7?I)8(K\ M*/&3 "=I%$0\!-W661!!K8E2?RNV%V16XH_R3?W<62F?F6NSD1MOE6ONMP_@ M4DUEQJ%13VL.,75RT\ :67'.TG-!=X93ZH;Z&/"C--W9^EP?DE+'A7?U'::= ML/VNB_8DORO7>?U[G^8_\DWV8[N>"VJ+U7S]]&:;/\B7(05A6\'*FVQ6&N9"$'"A.[@11IQ@ MXN2M/!=:1R^4"21-Q"3Y*K\KY TI2L, !B"- ^ASCGD0M]:X[Z/9*K^?;_/% M)_7,NJ\I)15*:Q5Z@4I7D400:=/J/J&D!Y$Z8< 2>4,D7$!JE_R\7QI4(R?3 M9[BYJJ+]V71) 0=X<5*]AK*B/)W/MP=+!A'A/D0$H"0+_2C-A-#MU0WYB4[: MJ_?)EA-5 <9;"APCSR\/*;@TI^Q%E1O=OR?VX[GC :4"R6*ELW7ZWQ1%4!C MQ;=BD:\6FZ,[_/+(P:V(\P"A,,C\*(Y!%*7$1ZB[FQQ20D3DW:J- Z-F]:+P M5F^0=$B]354%<-%BU:RD:)1GM< \/LG]*BUV#-=U%CN@-^W<:E\;I 8[B!\N\T_E08';K^52D+TA\TUQ.Z,9 M2TD,8IIB#%$H$I*PK7@2LX!DO3,' [9'RBV\^7:[+K[LMA*MMRV]V[K6\^8 ML.;^@.E&4-PUF)!_S;T$>=KSV2)6!U,8Y(#*$@,8$TCKN97D"3 M2&;K^LV!\\5LK(S;<^1=&*"#^79C) YWHS3<#X>-K6H< MRQN_Q7*WS178\1#%',,@2C%"*P_:0%0015'H4S)0MRR.M@E/7!:@!R7,* M]=CKQE7UJL>B7"[GAZ--L4*+,<[5LI,QZ=;+1EID\BFQ^FF/)MNH2PK4^*95 ML".R-(2L+\UNZEEO;Z[(VC"65-7M[WEQ_U5\//Z6K^?W^>^[AR_Y^MW=BQ=' M.I&-0@C2(.4<^RFA/J ^:A,8"!E4>E;=FG'+^M?B_75> _96%6)9GZI^QTA^ M=9AU:%;,,]\8:CHX:3OH"6,+U6NP>K]W3?#R!:2;5BDGJ\*GR^P%%;762&[( MJCWWRI$ZNSGA/4!Q' 50%&>9+RQ3@& 81X2"/1A(4E/R.P#"Z$FH]CMRMMM@ MN.J.1+]5[9TX7^U';T\!-M!>[LNP"2F*@O8:[7 M8A!4VR3D:?\KS2-8^/M\O7CW6!T%.P#\04R >;F6/YR%40PI1$GD,T)BR+*0 M1,"'$8,",(1Z-=6G@6A9TBO(OWZ1F+U#O[P#Q[PO3][A[S7.>95W-U[CW\VS M!T8_2Q^]QLGSF9]3G4$M=KR"?J 76R;N G;*G%EII L1:N)>X48$FYJ$X])L M+K3)!!&P#N4S/X0\$:$:X21,:!HS!,(6)XT1GSWFZZ)K-Y7PWSF9Y&8>Z#8CP&$LMI" M%'>X_8#S'I+7I+ 9(<]WFYPB8!ODP'$!-M]0$ ;5#&C$>9)$/ ?0#/XMAP@EMD<8( MD&E#J#),1X-FXXHC85.]T4P&N9VM, MM^*%.<\PB#G#&24T#9(P3CJ<(8/-BE>V6DRUWG4-H?YZ5^N,Q=E?_;LJ4-OIV^10= MS(FM=(6^-=$AV_%;=YS@;;JK_731W3A!]L*_G;9T+#^8Q1PGT,<93V,?9"A$ M$44M^D1,VR;=[1^$?/0S %?$]MG^OX$;=Z[P[%9 -]HM7D<4_RE#]_3Q6KDG M_:F"M#HKTT1FS59SYF#*19\H2'#"6!I2'HE<(^849JU/$=)[R=YM3RQ/XK7" M]>'QE:F#M>7^X\@IE]&ZCAO;?&=/P/QD(7]0NT]Y?,9(?_PYTH.1N!K[V(W! M%C:62FSTMUHONA' &+ X]BD/?>IG&851MX%!L ^,9@]C@W6R9@N&V'!/^INMDKB?>3T:,;XJ=M1]?6Z\.(9)R' M,8C]D$(>@(S&+7K XV#"LTJ#<(]\@NGZY']_>DDCD#LY_7H]*ZZJG>252.S8 MK$RTXJK7:M8%%2\6A?S5^?*W?"7@+EFQN5V6FVH2V%:(HHQA$/(8Q5% &*$4 MT[2[OI@ K9IXTR)]1<>>FFY3%?M5.'GB8K>PO% Z>H\8?2%T[Z'7N.@=^/CZ M#B2IM)B-R&JTI[SR>&J6"U-1U$(+C349.1#J]A TSE(:8X*B-,!^EH2$]#&.9\/0;AM/MPEXX-=-TTM>2;@[US 6 M)X_].\$K#VO#_3<\(1S:$M.%+\A\R"F.PX A!/T HXBT.%/6U;0:;=5,'^$( MZV/:H>NUW_";5L546_QG53%E_ZVKF%Y+3*!B%Y??" T3G- IS[+0H111F!7 M5S#$8-+4?!#RT1/V5W:"WU@/&3V;'ZU;.)+COZY-?#/M.$XP-=*3?KH0:X85 M>X'78*NY%HY1FJ!,S(=\ZOMI&G 4D&XW+ N39,*IQB#<(T] _DP;]*]'4%4[ MR9]+4)59F4A0]5KMFJ#>+\OO,S%S$H9$XW8[&7%*4 @SEN$D]E$4QR3Q@<\A M9R@#A/@J.^H]/]KR%G@'2/%MN+X$7<["1^!&+UGNL&COY?[N08J(;) ME$0] V*'L*- )9V2X4=@;H+/:3=/Q(B!?$PKY4/!ET;ZA%ZF^>R!\1D.$DPC M$J64IE$J2T3$K+7!DPC/5KGBLHS>YRKUYZZ\J>:B2?N ][AYUC,"+F1#_8AR M(V?IB?W2&_>:#*AV\_>B9?/U.E]\E.^FLN);L?/P*$=: M0&G (40)0U"D'+[XE[00Q)0NT#EO9]2PY=SA;;[9_*?WV"*NWYCU%BWF<<>/ M#G$7AI<5_MT8?79<*T?HOQJY.\M7Y4.Q>A8)69@&+( Q\X.,4)(%P3X2!B(V M*F?O?3[<\A@\@*23P?>B22&'M\V07A9_@*9?'M^+)HU,WC9=_7)Y3=K4LOD3 MKI[+YX>PXD!&/PA^::AWC/+Z,Z-#,NVDV9>*];C5%5"WCW*]0=A[FT^W^0;OI.75O]:K(J' MW4.SO+OYD#_,"WG6ZMT=+S:W\^7_Y//UC"81I"P@$,/,1YQD,$YK/)%/1(JH M,WVRA\)R'E>#DIL^,G3J';6P2+W:X0DW6-?+#3O,7@WZQJMA>PWN]NR#^$$' M70IY#=Z3Z,>5Y-XD7U!E^PWGAC"/X&2AB;&4I]GF:4 MQ("D<8)$F(AHBR.-J=:JEGGKEN58C,'4O AK$FQ.?.UQ:TUT!619*4: KK1V MY-5$;5('BFR_!GH]XMK3OQZB.H1)\V(J^F1>(Y&[$@A@@"#F69)DD&/6(H$X M(W;D5-V^=4$-?5N"JD&R:4FUPZ]U496PW9;5CE@CPJK?3*]-6GMXV%M<^[)I M6%YG# '(((C#+(1)"&/N ]Y:#U :SK;E=KXT*JE7;6K): =/>:Q_DG]B14>O MLVE4.XT2:4DOI5PZJ8_#-5&9_E>E@^I>]=,^3=94]6Y?.^/=W>%AV0_Y4C[, M3,O-=O/BK.SF4_YC2P1)_Y@%P(]91)@?!DD8(A1@&(4,IQ \0T0JY_"LHW$ MZKFM#_EFNRYNY59*=?C ^V-5;$=.< 82>&%@C]4T;@SXT;PMIQD QP)QV$O? MBJ_^Z]_:[XC_DW?Q_NO?_A]02P,$% @ 7$"I3)S8K,!R; ^J\% !4 M !G;&]W+3(P,3@P,S,Q7W!R92YX;6SLO6F3&SF2)OQ]?T6]M9^K"_3;';S]U___/R;^FS>O?OU M__SO__&__K_??OM_^M/[7VP^7MVEL^4O9IZ.ENGDE^_9\O:7?T[2Q5^_7,_S MNU_^F<__RKZ-?OMMT^B7]3^FV>RO?RO^W]?1(OWEQR+[M\7X-KT;O<_'H^7Z M;]\NE_?_]OOOW[]__]N/K_/IW_+YS>\( /Q[U6KO%\7_^JW\[+?B1[]!]!N& M?_NQF/SZ2Y!PMEC_[1I_I/S\QZOOO^/UUU!*^?OZM]6GBVS7AZ%;^/O_^^/] MY[6__N__\/>OD9II_O\^SV?)O MX_SN]^*+W]5X/%^E$_?C/ITMTH6:3:Z6M^G\?3;ZFDVS998NPHC6'=_.T^N_ M_UIT$<" N -%/^S?@_+A_OT[[\NLKO[:8#D]Q;'7, S64W3J^OCW]IT.[0^;+Z.NT"9T^[Z>I\>O5(INEBP#/8CS/[HLY'/[VY^QFEEUGX]%L M&0:6KV;+8$@^YM-L7(.>$5WV*-6'T7P>3-BWM"8[&_P3/4K=HD[;TJT9W6?+ MT33[KW3R.;]>?A_-4Y,OED=%.-:N[?&=2K!3^VEL_/G=7;8L7(/""IE\K=3@ M3-1@28VF'8S2KY:K>?I'-LON5G>?PA>CZ9.OZZ+?4/\=R'LRL4[OJ@,IZBV3 MM3MH;L2S2;$B%W]K$2S:I/"5]6A:^("?;].TAMVIW4-W8_X8C,DL^!?+8+NG M\0+L[*Y5:3XOP_\O:'!U_7F9C_^ZS:>3L/MQ_UIERX>S!*K58S\\2IZW5534MCTZ_+8\)Y^T^3?/759 M.M2FR7$];AJ+_W7"X XV;'*$]9;"UU\V-H;MT5!885U88)'#KS:=O@M;A=E-5FM@^YNT.*J3"5N_BZ9& M_3X+#MDDV)5@8/X1?G43%M5Q.C]JEXZU:WM\IT)[:C]-C?^/T7_F<[-:+/.[ MX/T>&^7NK]L9RZD(UFO=U%@_I,OW^6+Q,9U_O@U^Z;'![?F\I=&$7?/]:KE> M@Z^N]6@1+/%L8K/I*CBB3[^KB6PSO;"]S$I!A%T_CD=K^:G M7#W$]-F27*?2OV;SED9;;_D]V*BID7T,?SR=SXLM5]C6'QO2[J_;&';:7FXV(=\I?:%7F>I:N1M.61OGG+#M^ M1GVH39OCBIRT!_MH<]P5#7?\,FX6G]M])]*V,*W/_P-M2GS6I-[1LJDQ[L;E MV/@.MVIW;*?.[--Z:7?L5^OXAL75:EG$>A4Q=%%"'.VN76GJ<;E.V\;&N?JZ M2/^U2F=+]ZVX 3DZMCW?MS6>D[E;L_U9XWT:WR@WXYVE-\45TOO1U_3%==JN M=M/Y_%FS(K!2%H&5D*U'OZNWAD=:[/,:'>S+#AL>;]B09OG$S1J&>'>WK8S] M\W(T;QCS?1TW//XOZ7R1-CORUUTV/>9\.9HV/.97738WYC.(L7P]S)HLN)^G MBR)&JEA.WHCQ9?UY*N M%K_=C$;W 27(?T^GRT7YD\+0\]\ W$:A_\_MCY-7T<798CS-%ZMYJKX&IW T MKJ[4IP5*?_\U#".IWSA1C&A,D:4>(DP4K$S.:CU]Q_'G# M[1>_WZ_C6'X;WV;32=FZR,!HCS1Y'PH(XI:&X?>=EJ$CFQ&=-'!!9D8PQH43 MW&FH(.8F\,9N-,BM0Q#V:F9>,-"LYL4\J2'XT;8)4-I[ 9@CFEHG'=#&5'); MBWXZTU&;"*]-1Z-0/QJ)#B;6WL$?FU1[&R948H!U0$M7,X)";"(81'\N!C4&K MV$ERZM[R@ M8QO$"<(^K!4\S&X!0%@RU%8I'G'*^CNV>76X]E(I=0Z$ZW>20.FMK<$A_&M9@EH=)%Q*1P&43#BI..8:2%$BP"55EV4%FJ#"R]G? M!LZ#G?F'XW/>L"4@0=M<8>,X0,1QK[T#&"&&M="(BUKSH'V_X%^K+$PFG\VR M9=BW?$LGC^F#:K%(E_IAD[HU'2TV2T]-5^'D?A--%!+8:46,D0X!:2TM\8)> MQ1Q_O2V[49LX![R&MN'O:H?Z;A9L2UK59R@K&ZH?V>( $0^T2H2P+)ADR"C# M2BC#J*[DM!!D\["MRLN%?<-5]>?1]-T\4=Z]S6='^#/JV\3CK6U0!.*@A.' M,, &V*U,Q;_<3\&94_6;-XMJ5TS9;XL7P?%.WP50#BUS=9HG1C. B>>$&BRL M-0(H5$J.(>"7=5/=SWK7@B*ZHN"'53$_JK)7LYO/Z]X.R,>)]#J'IOA)4B329)-L-']X-_N6 M+I9I>O5]%C"]S>X_IO-QH:*;].O#IO#;#K:'4:&BTII;X %AE[XVG M+L9?&J"M:H4^K:,^V(.DBSM*IHH*:(CP%BCN)7(&$$R!]8A(@F"/:0>/M1.# M7M;C?JAS@'RH64($-@@Z8*$G6B"D$#.EM&$"U(I^?CM+1Q-J?^7T-H9N5\Y' M49]HL;[D>@K&0WU&U>L@\5Q!%OPWBZU6VEM(@E'=2J^1O[QHS::YU0K.G;FX MZ?3&=33.O9<2[ M.U\,Z,]&TS\7:?E^P&;@!\\6][1)8!#%*Q^0XX2%_\<4@:6,!M$85@TSZ+-I M5C4%;5?T*6M[!A_XY5:AOO&JWTE"#:0(**.,#2@:@PQGF ;#3F'X%[^\F-"F M"=8:UMULO^H]S_*&]U8<<\ AP@9+IBG6S&NZ"9Z0U%M6ZU2T'4D_!:4%)=_: M]%LZS>^WY;LW93W3>:F-TY*ZS^XS$Z4,4>#)YY\%>:;MTYP805'3CABB8:E'-#("XLZ M/D-_NQAP%G9=<6#[IM]1%CS[+@F>&?>4>1&V:YX0B)RO["[S_,+"^\[28MX< M?IUQ8?2C'A>>?I=P1B'#Q"K*C/8 .OBX!AM#R&4=^S?"A0C\NN+"QWE^G\Z7 M#Q^GH\W+5F'97.^K],.7,) C?D:-UHG#%@CL@JR24D*06YF_CMDJ@$/ MI'D]],Z_8MQ' X9KM$Z$44H(I)BA'&/%%3>TVCLH>6&9$(TRH2[+SD:[*Y:5 MQRM%U$MY2/1XA+0^=#FZ&M;NHP@IT]I3;9 /4@>$@22/NU5^8=OV1EGQ M$N;=E80XM@;4"DT^I9O$.86IM, KY9EQ81M#J]E- 8OQTP9X2=[/>MNB0GI? M>/]KZ?OL^M"Y9HW6"7=2PK6J<8"L,@IHA*JESD"*!="FU$S0F5GZ NXQ^R78NZIVMNI/_ M7"V6Q4A]/E=W^7R9_=>S]V%V+;'[VB0&2F$9TU81AY$N;A&K?;NU+N;2=H#K M:2?,:@KLK@BU*=E:"/_N[GZ4S=?.Y^UH?I,>LEH'6B7&&PRT?U_?G>7K:?!8AW%L+[[3&>]IET<&--)I;Y. MZB]=(U3.DJT-\P0S8D,!A$@'O@J M2D2$\A=V\](26U[E=+2H@MY-AE\MP_"W]T^?BOZG3[[N.Y2H'[L2EA$LG87! MEW ,."\IA4%[S%L"*-8]5@VJ$E'?IZ/%"^5]'#VL!?R4%H=GDR)OU0?91M/_ M2$>'3BC/[C,Q@C!C@R.OF /<:\<"<%N<-(PJ-OKFK4UM#KWT1CK21F=.< UY M["I]-_OR/2_$..@:G]I7PB7PTIDB6%12P84'Q)282&IB$AH'N+\?#D-CM# \ M9H:_FC;'S:JWA%H,.%:8,^6=$*Y(VRMQ82HJU7Z 9P1#8^>Y>A@8/^,YF5B. MF668(H>"K\JH!]B7\D,NNWV_H/6BX8/BX8G8][Y=&$R203\[ TD$H\71#X'" M4$L#*\A66V';I\Y*1=A3^N4%@3:E:/)K/QJ_>.KS9;F7HPT3CSSD6 M!'4*8 M,AFH5DJA"+RPDG@M:3AO$?*>EIAB^[]]0^!#>K B_Z%V"9,0X >X2H *1RF MOI)56GYA%83:I5<;B/>^B/3\&$5/ATJ :.=!T+@FAED %"^/'ZV@OE: 3=M9 M;#L. TM?Q>?S%QP\X_6*B/X3AJ"QC LJ(>+?;-.TQC;XJM%J!E(.*^EYI 0!\ V5I<0Z"W"/1J;$Q6\CR>1<'9%F:?#/)H#\OKCA%(H">)," @D5EII M([92(:(OEB3G:_?E17DLI)W9EG1>E GX6&ID/>+CF1S[6R48$V;"%A])(8.4 MCB)*2SFY@Y<6=Q&AZ)(=XA-DZ<) M4#MWB=_72/YZ_7%BK><$6NR9M1088.4V2KJ0RD8],CU .].T$WPNCIVE+ZS# MH>M4VGKV8<)$D5P)@"*&=J,>I\F8X0@V.WK'CQ*O91VAS7+X=<(H<2), M%":Y\%XH1%TUTN2S>]'V63[86TFDT> M4ZH6QYE4HW6B"*/!RS>JJ/UJM0=$Z4IN(V/B> >XRVF64,WCVXOS4M=I"696 M!W,*F$4T[/3#JOW$S IO8PH(##":L6'C$X%D[S4!#L4UYWQ= MSZ-X*;Z45&L0$P$[V 4KVL%M$-&NN%,^"7" )^4GB;2 >Q-0T;*HNN>MI.4) MH@C_8I>XYD1SXDSTNM+_R^SQP%3W8SQ=3;+930UNU&F>0&:XWAQ#\,TPYL6D.V^S,/B0SX;'_56=GZ?2$8!E8!)J04L#BN5]:5L#D0] M4S[$UUZ:84T34';KS![U8A., .'&$:<\L5@CI$&)A9"*QY@/-E3WM:&SMA.Q MZTKS[[/1UVT>0%&1L+AGNLVG02.+PF-:/M0XEJW;1>(==( 88760&(;MG*P< M?^&8B'FY?H".;(.G^2TAW /'ZA_V[V^4 &JD!Q1;A CU1!.LRUM5@=&E5>%K M7OG[V16'=&=\RF5YZ@*?+H_X_EXRR0,'TDO:=@/ M*J&\!("K4@:(HEZV'^"A3(/T: ?@_MSBD]SA!"N,(+":AWVDT\PBR"JT($'= MOL';^F:\#2F/)XE'3:'NIUNT2%)5=;("A7GH:]@R#85*831U75'[9' MT_HV*AKL/G92M4CG7&3=0"YHG2M,*!(/#;!M%KN6+F%E,;! MF".<8>_1VR%48TAW&$;\)!7OWT?3@\4M=WR=2*0,E\9+#JDES@3)4"F7=9=V M:]6$@E_'"D>"VN5ZEL]J,>7EIXGPV$LLB/=68<8H!:J,(Y)%-N!E[E5!A'1077]W#DAB>S]*8H M8?7E+=(E&MK.KJ2V3Y05Q<^RR;N9&=UGVP629^G$C>:SX-.#'*!0U"Y=TK+F%W7 .--6V!.-*9#B4.-B#]-' ]_U!MHN<*((^AQ M%2,@I8Q*NN,_!8L:1OB14_U66?VXQO,V76;CT?3Y$"^LY*H%P#!LF.<6,BAA M<#T<#NX[6+]!BFLE<+0L_8DE5XVTGC(K-$#"(0(U!Z*4" ,3L_T9Y&E*DTH^ M7'+U-&2[\R2:++EJ 27*!$O('<&L2!=&MI21(7YA\;_G*KAVR=73X.SL%"ZR MY"I@F"J)A#*:8ZL\$PZ74@D1E:XR9)*R[ = M YX'M\@@4\H9-F@75HXH1M$GE%P]#=1NR=-HR56EN6 (\ATV)DYPH NY>28 MUGK'Z>W< #1.GB9 [98\399<%50 J0PF0CI@$?<857)J3<1E!3XT3IXF0.W< M)7Y_7LE5#XJMNH8484&HX,")RIXZ3KN-OGMS3O"Y./83L/!Q-+^:K\<^6=]Q M?4SGGV\#;K5C&/9UD&#M'9!.,*B1"G!JR4DI/7(XYMIH@*Y.C/H/AC,TA._9 M"4[/1_-D(#L89O/L_]*)[7MRLN&"7?24L&(4\QBYK7BAE6&&<*8K=, '9C6[$DDKGVRZ-UB ML3J909M&B9-4&4XYM=(XQPUU2%;6$H)NZBM643'+M\R=LQ#MDS=7J^5B.9H5 M5;E.),^3E@GQ@E//O-, 4*B=@*R25S$3DW%0/UCA,AAT/JS]T.A]]J]5<4T8 MM+;Y13H;IZ>%^N[O(J$N[$B=QA8CR0/"7%A0':-B%W.L$O,XMU#,7>CI\0UOB5G-@]L#J4YPO0^T2K0S M@#J-+ F["ZVTD@I5DT>:F-,@\;.0*!+4WLASU./>TR)Q3'$7O$ ).6-&:H1- M=8IFH(VQ//+G(LU9@/9&F'JN]J%FB0;<>L,$EUJ&M1D)2Q]OE2V(.C<$/Q=W MSH>UEV27S: /\&;'UXF%DC-MN/* $FV\Y; Z!(-2Q52>A9=]SAR/9H_QFD\" MW_;'!/<9LGEFGG&-]@D0F +..?/%0SH,*F<505QR99 1IM99UK""-@%#BH8] M&?& 0,B1Q!B7$JGPRPN]*VI&RX>C-D^#MO,KZHW08>6ZSV?K*@(U(S=WM4N0 M@@P6U?T@ L9(0ERPB%M9B>(Q62%#IM&)BM['EP8@[8H^+X9Z-(ASY_<)T4HY MCQV1DGH@G<)?-(]O/H>[1:*J=$3^24L60EYP[Q8)@C"%0 MS3(K+HPSD=H]>%Y[%J ];&R/\N35MXD+XR::2PQXD(5!2$TEDS#FPMZL;I8D ML6CVLG,]RI$=7R=86 DQ())P89E@A32E7 [Q;DN8O3&6Q./9%GD:I&\W+1)!J D2F@7Q MI%H_>5:Y;E; F*JL Z1.C*)/2(L\#=2WFQ:)G;5.$ >0@MCYL H;79H ]>VF12*MJ7?0!*--#3'6N4=WWU(>XQ /.'F: /6MI$4J M'3Q](1"A6DK,F0$(55+Y2SNO:=H)/A?'KMCQ;C8NSI12FV[^^]WL]=WLIWPZ M]?G\^VA^*";NQ)Z2X"L*PC3RU!%5!.-8:BL\>-3;R0-T?F((\>KY]3:![LPL MG1 X]SJL"RC)&(1%]GFPLM@)3"OLJ(O*2CF9//=A2G]I>V* M1+N[A2VNF";DAF,OJ9-$8R5UD7=3^7I0UBH"UY0#?7$,H&TM\"Q,"F\K X_D8VZAQB@3]05:6(P[NY>ZS]7B\W+ M+U_R/5+M8X_I0&H1;9,PQ;B6S8N,FK"E/^4CO.;V;J7 M8YEU;?_I!$ 5(.;&F: RZP4RRCP>Z8N8C+P!WJYUQ>J!J:W3U7F3Q6%7\^!% M;$:_<2X^I-_7OSJ\%:W306(-(,09B0$TC&#C ?);Z8D.-N.RKO8Z7;^;!K]G MZJUG2P3SGK=/-!+$,V<,#\N4I$Q#!TO9L8YZXW. ^+F]M5$%>F'/>74=D+Q.L^7JNF*R3;[EDW2V63Q_-K\ $'WM$A0<.ZYHCH JIGVB O\9*:2CM+> MGS_S>!',:P;P'NLGJ'' 8GZP:LN!5@D)V&BA$<562AU4;*LL"H(LC4K%/ODV M*+A;7_,+,6G-@=X+N=:FMQRPR1?+/]+E;5Z;97N:)]HQ)F2PUL!2P( 0O@H5 M(C0XT#%T&^YSM;UPKAD5O(VP""*0"&(I;8&B AIA@"ME8L1'O:E^\A7.YD[; MS2YC@8P%^ZU$12A '5;",R0@]U)SK\OZ&\0*$56'ZN0+E0NC4"S:0R@\M+BZ M-J/%K0_M%L]'UT_!H6HPI]49>M4L@0 J[ISDF $)H$<0V_6;G=C!HLY\'>*W M%J-2#/?C/"]\](E^^#,HY]WL*LR.H-_9C1HO@_>^?HWT. :G=Y84[\8(K7E8 M)I7SQ@*D:(D,\.Q2Z\M$D>1U:$N[J \[7LIBR;B"%AA@@K=/+645;(C#F'2# MDQG4Q>:J374?#)HZ#>A>@J:*^)79.)NFST;^)6_.Q+7QYQ+ABS.0H!KND/6$ M( ]AB:R4-.:Z?X#I5AT2> #:ZNP<- UZ'F=K_8=_3],U$683=9?/E]E_K7]^ MZ%"T1O/$@[ 1L2P(KBDR0E*E12DYP:[3=.0N3&V_]'EYBMJ\AKJK$A;@*2Y\ MPR['YJNOR^O55(W'^2H >X"3AYHECD'C2%AX #'8(<,5*4T"HE+$W-L/T&8. MBHD-ZJ4S+V$:7.W1;)SN&'* ,\V^%2EY!;#?UDF8ASR $[M*@KN$.2-8$Z4P MMA1JZDI$6-R3$<,]CAT485M6666(,VV]5A"K(*H7"IYJ>9O.U6(1H+J['V7S=;V@(,#- MP47[0*M$!%,O+;(($6@L9-@[7LJ)V*4%VP^*>Q]'7SQ"KNB092>.") M )XRYDO)1<"DDV/+7N,ZXTEQE'?1N/?'N+#%"L['I#3P[D?A Z=J-GET3TY; MTNMTF' (C?="*R"TQ0A!:LOK-"0%C0F&J7^ >>FL;$$3_5O&CZ.'L\WBMFV" MJ2KB8RF$PEF) **Z.J9E2L38Q).KC/03DMRA33P/]%Z)-E\%Y66CK]ETXZAL M9TP%VI/?G%C_9/\ZM"5]\'DW3Q7H7%H;[*;U930O5/_AT)R&C^TP880( !)BC M$C"I).2EW%P"%+-!>F9CB] ,,WN@RZKCV3)8_R*=X;[X MY%"H4.U.$JT,0XR (HA5$X")$:43+ISQW02Q=;CO;I,H+P.#VM+"\.QB(_8P M80!I[$%16D]+K[URH/1DA.G:#K:^AG?(Q-9TT#,3?38;!<^GF17Z0&<)5B;, M3$\$%1X2ZQB&)? "$'%ACSATN4(WAWI77/R4WF\-^]7U^WQV\R6=WQ4A2@<8 MMZ])<2= E4#0<$"\,]A15-[J"^P[>I:^_]6W$1*\>DRO$;###1+ODHQ-JV!XCF C#F!BI%#$84\-])Y31X0%U<8,NT[#P'O; MDK3!P-9TT!43B]$'>UW\5[&/_S::%A-J4T7NY7G^ 2Z>TDVBD-* *XR @E92 MRPDM?6^AA8UQ%P?(QE:V(2WBW27SCC JP59;(ZGWC#E @12X"C82/$RF+N_G MNGIQIS6^G(CFD'@@L= VB&XE4=Q88@BN-CN,X)@R52='\W=38J@]%IR&96$F(\,$Y**S!&R&.&>;74,XYBN#3 MXO:M\*@=J+L+C0JPIXME\:#.P3"GQ\\2HXEGA%.*E+,2$(:8KIRWH)9.3KBZ M(TW3^GT5KW0VM%VN2H78'_+9./SS\8YA-MGAW!=YG=-\L9JG-0Q5;->)-MAQ MIC3%1!,MD-"Z0@QC'^,_#S UH[65L$,==%8OIBK*O E.-:MY 7&0JA!T\S\. M,+-.\\1""L/V6!?1_Y@9"3DNT^@%\K)6V;NW8PJ[(\K>^MJ-Z6)HU2 _KC5P MFRZS\6CZ?*AOO#2DER+8(BF$QPB&)9(XNLWK-]J#EP^[[YXC+4O[Y4BVP8MW MS8.1]00H+SG5W%/$PQ:RE(@[$I-//W#RD&:Z6@1)NOF M0N='=OAQD#UM$F@)8(9[#KPC)%@HXT4IH\2XTU>W.V3-B0K>QY-(.#MSE9\, MT^9WH^Q0J9#7'R=A702ZJ%_,D0VR(62 +:5"WD45D!XP2<[7[DM?-A;2SFS+ MN@Z3>7Y9_$=Z]S6='[(N^ULE!EK!$.*62T84#FX60J6*,P$&XX-UIAX#&DG!=^7F&7ZK+>X:J]X1E-(#J0+:L MVR2@\-O>MJF;E*AJ4/6*O>QJD0C(G7$,0N !EL9093WRU8YP=^ M2K^ELU7YA/WB0WIP%[Z[12*Y5I1@Z#$.M/6" :JW,E(I5#<1J5TF=L9I^J79 M;P35SO8?A5TI\E"V6:9UCN#W-$F\<,H8K8TD4%LND-[N[8.$6N$+\Q*:YDU# ML)Z=7QXX^CV?%_&G[V;7\U'XXZMQ\0FT$UUJXQ"(-?ZN(IK+!XDWS=2K;%HJ#R1 'VB64"%:X-@Y; M2[1G %A6(>=93#[B .U(8P1J ]SN3C>FT\W%T!^C^5]I<4ETG$7[&R66 " A M\A!I;JPU$C%82DF(BTEA&&"R5N,4:@S9KOCSCW06-AG3XO&'R5TVRPKYE]FW M]#B)CK1,+/#2A*T6";,$8B&LVI8K* QO6-X[C;=]>TQJ%MZNZ'1R->5]%7LA M<8P2R22S'&/%B%6E=$B"F)W4 $OD-$Z>1E#M+'SDR6LTY[TR]/+I&NLI I@K M#HWA%"K.+:E@.5XI7QA$+& MW/J=[AFWSI.F#VGB$>TL2S*?Y<\'>]P7WMLF$4SR(I5/0"7"S"(>X6K7" F+ M68H&Z 4WS9JF<.TNR+\D=Y&I;O)9&/@JC/WQ)D>GU_D\?5+XW_T($ 6-9K/1 M_&%] U9$6H:6 ?;I6NQ-U/K1*Y=6_FK"/:+ $J6%I!Q3;Q0#)^ZC$$[!(P%M\,"!6>\VDVT!XQKS(O$'2)=F!./$X&#F.<[!^C -[[$1F#9 M77V?IP%C58[""RB*\XZ#]Z^G=)-PS#F"#A!*,2%2 \ZK6V<4]DD1K*J?[E29 MGW:3OYOF5(M ]V**U+=1-BU"VK[D3ZJ\W.;3H,Z%'BVR<5UC=;RGQ#@KP]Z; M&JD4XRA88U2"3BW4,3

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end